{"meta":{"query_hash":"61c17db8e2f9","filters":{"venue":"Cancer Treatment Reviews"},"cohort_total":188,"direct_labels_cover":0,"predictions_cover":188,"exported":188,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/61c17db8e2f9","api":"https://metacan.xera.ac/api/v1/cohort?venue=Cancer+Treatment+Reviews"},"results":[{"id":"W1591039646","doi":"10.1016/j.ctrv.2015.05.006","title":"New molecular targets in non clear renal cell carcinoma: An overview of ongoing clinical trials","year":2015,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Associazione Italiana per la Ricerca sul Cancro","keywords":"Medicine; PI3K/AKT/mTOR pathway; Renal cell carcinoma; Cancer research; Discovery and development of mTOR inhibitors; Targeted therapy; Immunotherapy; Clinical trial; Immunohistochemistry; Pathology; Oncology; Internal medicine; Bioinformatics; Cancer; Signal transduction; Biology","score_opus":0.4860007036524934,"score_gpt":0.528739808086189,"score_spread":0.04273910443369561,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1591039646","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012216554,0.9993481,0.0000640489,0.000119771445,0.00006111479,0.000010049133,0.000029820581,0.000004361173,0.00024063955],"genre_scores_gemma":[0.0007791922,0.99854726,0.00019115699,0.00022465509,0.00005707173,0.000011059376,0.000041442083,0.0000013565274,0.00014668526],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9997135,0.00006030713,0.0000577061,0.000048998358,0.00008750828,0.000032021024],"domain_scores_gemma":[0.9992561,0.00043133,0.00013086846,0.000013226726,0.00012777057,0.000040576004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001213607,0.0009837319,0.0031989478,0.0021262455,0.00023795542,0.001358643,0.0010785537,0.0010614672,0.0041363165],"category_scores_gemma":[0.0013780372,0.0003729698,0.0017520682,0.0021659732,0.00035623327,0.0013228606,0.0006195354,0.0019124992,0.0008419982],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054280367,0.00018249326,0.00033576885,0.07114685,0.0006883737,0.00014891113,0.000059812668,0.00071523205,0.0018575325,0.0016302455,0.020062188,0.9026297],"study_design_scores_gemma":[0.00056348054,0.0013282559,0.002985606,0.038654633,0.0050340174,0.0013420858,0.00019073547,0.00057831156,0.0014158755,0.002794807,0.94502544,0.00008671476],"about_ca_topic_score_codex":0.0011457327,"about_ca_topic_score_gemma":0.0037208972,"teacher_disagreement_score":0.0041363165,"about_ca_system_score_codex":0.0006294505,"about_ca_system_score_gemma":0.0014066744,"threshold_uncertainty_score":0.013837397},"labels":[],"label_agreement":null},{"id":"W1649073062","doi":"10.1016/j.ctrv.2005.01.010","title":"No clear evidence for adjuvant therapy in people with stage II colon cancer☆, ☆☆, ☆☆☆Abstracted from: Figueredo A, Charette ML, Maroun J et al. Adjuvant therapy for stage II colon cancer: A systematic review from the Cancer Care Ontario Program in evidence-based care’s gastrointestinal cancer disease site group. J Clin Oncol 2004; 22: 3395–407.","year":2005,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Adjuvant therapy; Colorectal cancer; Stage (stratigraphy); Oncology; Adjuvant; Internal medicine; Cancer","score_opus":0.14000114603089833,"score_gpt":0.42623223677067673,"score_spread":0.28623109073977837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1649073062","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00030943294,0.99890625,0.000021278547,0.00033453276,0.000106397914,0.000012285319,0.00009483799,0.0000019165693,0.00021308308],"genre_scores_gemma":[0.0044480385,0.994672,0.000106944484,0.0004858378,0.00008046253,0.000027130645,0.00008185194,0.0000016197381,0.00009606373],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9981584,0.0008038119,0.00043013215,0.00018272911,0.0003435198,0.00008139329],"domain_scores_gemma":[0.99039876,0.007393533,0.001444526,0.00010035401,0.0005257081,0.00013716257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003003479,0.00069860346,0.0052610342,0.0023322827,0.00025120284,0.0011446145,0.0008209227,0.0016799618,0.008767726],"category_scores_gemma":[0.019458449,0.00045741117,0.0054067695,0.0034700444,0.00040621747,0.00091843767,0.0006589059,0.0011486597,0.0005404132],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012781486,0.000035268844,0.001502703,0.6953441,0.010411139,0.00014614082,0.00012558745,0.00019011412,0.00039028164,0.00059702125,0.016581248,0.2733982],"study_design_scores_gemma":[0.003328935,0.00085024186,0.019035926,0.7264337,0.120904885,0.0010134763,0.00025693662,0.00014474106,0.0005304238,0.001201177,0.1262359,0.000063740415],"about_ca_topic_score_codex":0.0068288553,"about_ca_topic_score_gemma":0.02191564,"teacher_disagreement_score":0.008767726,"about_ca_system_score_codex":0.0013900547,"about_ca_system_score_gemma":0.0032429702,"threshold_uncertainty_score":0.029330969},"labels":[],"label_agreement":null},{"id":"W1699998114","doi":"10.1016/j.ctrv.2004.08.003","title":"Adjuvant chemotherapy with uracil–tegafur prolongs overall survival in people with primary adenocarcinoma of the lung☆☆☆☆☆☆Abstracted from: Kato H, Ichinose Y, Ohta M, et al. A randomized trial of adjuvant chemotherapy with uracil–tegafur for adenocarcinoma of the lung. N Engl J Med 2004;350:1713–21.","year":2004,"lang":"en","type":"letter","venue":"Cancer Treatment Reviews","topic":"Medical Imaging and Pathology Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario","funders":"","keywords":"Medicine; Chemotherapy; Tegafur; Adenocarcinoma; Adjuvant; Internal medicine; Oncology; Randomized controlled trial; Lung; Adjuvant chemotherapy; Adenocarcinoma of the lung; Gastroenterology; Lung cancer; Surgery; Cancer; Breast cancer","score_opus":0.02217442976376168,"score_gpt":0.29626116339422165,"score_spread":0.27408673363046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1699998114","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12922826,0.12373252,0.0002703616,0.7010136,0.018329525,0.0001130735,0.0015772608,0.00007562723,0.02565975],"genre_scores_gemma":[0.40876323,0.069319576,0.00048057362,0.45684093,0.04837794,0.00023237958,0.0009969177,0.00002724809,0.0149611505],"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992417,0.00038170535,0.00007549493,0.00007570719,0.00013532094,0.000090034584],"domain_scores_gemma":[0.9972838,0.0015835217,0.00035573746,0.00006111389,0.00032349667,0.00039240016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011504414,0.0001870467,0.00094873604,0.00032029246,0.00055045635,0.0005475881,0.00031052495,0.0035696882,0.0039807367],"category_scores_gemma":[0.007936477,0.00014974756,0.0005986231,0.0005148697,0.00033389733,0.00041640713,0.00024055659,0.0024878723,0.0010705395],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022354996,0.00054947095,0.08170874,0.0014948526,0.0006138684,0.006452872,0.00023042009,0.00043288025,0.0035326227,0.0015474897,0.61324096,0.26784092],"study_design_scores_gemma":[0.020267507,0.009376489,0.27249184,0.002589551,0.0029804884,0.012317862,0.0006459678,0.0023033821,0.00327297,0.006670087,0.66694903,0.0001348369],"about_ca_topic_score_codex":0.0024471367,"about_ca_topic_score_gemma":0.0056902734,"teacher_disagreement_score":0.0039807367,"about_ca_system_score_codex":0.0011301931,"about_ca_system_score_gemma":0.0008210028,"threshold_uncertainty_score":0.01331687},"labels":[],"label_agreement":null},{"id":"W1782889137","doi":"10.1016/s0305-7372(02)00128-7","title":"Annual screening may not decrease breast cancer deaths among women aged 40 to 49 years☆☆☆★Abstracted from: Miller A, To T, Baines C, Wall C. The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up. Annals of Internal Medicine 2002; 137: 306–12.","year":2003,"lang":"en","type":"letter","venue":"Cancer Treatment Reviews","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Mammography; Gynecology; Demography; Cancer; Gerontology; Internal medicine","score_opus":0.11389119629263876,"score_gpt":0.37695858823160594,"score_spread":0.26306739193896717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1782889137","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.030995816,0.026921459,0.00014282063,0.88817316,0.011055242,0.00005571386,0.0021556376,0.00014070673,0.04035947],"genre_scores_gemma":[0.2107384,0.04547212,0.0006199432,0.6621263,0.036267936,0.00018204088,0.0015350913,0.00007407248,0.042984076],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9985812,0.00033870866,0.00015735584,0.00012902994,0.00049166736,0.00030206313],"domain_scores_gemma":[0.99366575,0.003214568,0.00060193415,0.00011375929,0.0015121038,0.00089184364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023297733,0.00027465308,0.0009320972,0.00066543464,0.0009778161,0.0008268692,0.00082608324,0.008024377,0.011554108],"category_scores_gemma":[0.02164451,0.00024514383,0.00071210286,0.00092929066,0.00045664553,0.000591063,0.00029923607,0.003532449,0.0028674137],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013046806,0.00014803035,0.035237197,0.00042260747,0.00012398596,0.0010246661,0.00015352156,0.0001885434,0.0004632551,0.0008650157,0.8515624,0.10850615],"study_design_scores_gemma":[0.001945895,0.0012141627,0.25841755,0.002146311,0.001036241,0.0022310326,0.0007329303,0.00083901675,0.0007147216,0.0027252333,0.727888,0.0001087571],"about_ca_topic_score_codex":0.08407273,"about_ca_topic_score_gemma":0.22769718,"teacher_disagreement_score":0.9159273,"about_ca_system_score_codex":0.0028416044,"about_ca_system_score_gemma":0.0045664,"threshold_uncertainty_score":0.16716677},"labels":[],"label_agreement":null},{"id":"W1814699096","doi":"10.1016/j.ctrv.2004.08.002","title":"Gefitinib does not improve survival when combined with paclitaxel and carboplatin chemotherapy in people with advanced non-small-cell lung cancer☆☆☆☆Abstracted from: Herbst RS, Giaccone G, Schiller JH et al. Gefitinib in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: a phase III trial – INTACT 2. J Clin Oncol 2004;22:785–94.","year":2004,"lang":"en","type":"letter","venue":"Cancer Treatment Reviews","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":406,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario","funders":"","keywords":"Gefitinib; Medicine; Carboplatin; Paclitaxel; Lung cancer; Chemotherapy; Oncology; Internal medicine; Tyrosine-kinase inhibitor; Epidermal growth factor receptor; Cancer; Cisplatin","score_opus":0.01463295194877606,"score_gpt":0.32321337576972325,"score_spread":0.3085804238209472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1814699096","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.060860354,0.07834439,0.00030282108,0.8030335,0.020619709,0.00008109231,0.001143321,0.00021544377,0.035399355],"genre_scores_gemma":[0.3479258,0.05097986,0.0007114542,0.4955959,0.078213744,0.00017645364,0.00082468014,0.00009931347,0.025472827],"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","domain_scores_codex":[0.999143,0.00027228397,0.00010118212,0.000096590185,0.00022266278,0.00016429918],"domain_scores_gemma":[0.997976,0.0012083071,0.00021161448,0.000043871107,0.0002409625,0.00031921826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012468137,0.00031322025,0.0017214788,0.00037882346,0.0007962468,0.00076935533,0.00042151744,0.006538305,0.0056417696],"category_scores_gemma":[0.006467468,0.00017188347,0.0010215075,0.0005402566,0.00049164053,0.0008104823,0.0002685315,0.0030451082,0.002444633],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007932032,0.0002888511,0.022985004,0.0009970178,0.00048238205,0.0119943945,0.00018611668,0.0003627307,0.0034571348,0.0014775537,0.6500162,0.29982057],"study_design_scores_gemma":[0.0088405255,0.006486249,0.09236597,0.0014367067,0.0016995105,0.02583051,0.0004676285,0.0016316765,0.0029009476,0.005463522,0.8527438,0.00013293835],"about_ca_topic_score_codex":0.0018594293,"about_ca_topic_score_gemma":0.0069218786,"teacher_disagreement_score":0.006538305,"about_ca_system_score_codex":0.0014133777,"about_ca_system_score_gemma":0.0007990158,"threshold_uncertainty_score":0.018873572},"labels":[],"label_agreement":null},{"id":"W1867786678","doi":"10.1016/j.ctrv.2015.09.007","title":"Identifying an optimal antiemetic regimen for patients receiving anthracycline and cyclophosphamide-based chemotherapy for breast cancer – An inspection of the evidence base informing clinical decision-making","year":2015,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Nausea and vomiting management","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Antiemetic; Nausea; Breast cancer; Randomized controlled trial; Regimen; Chemotherapy-induced nausea and vomiting; Intensive care medicine; Anthracycline; Cyclophosphamide; Vomiting; Oncology; Internal medicine; Chemotherapy; Cancer","score_opus":0.17517578384422972,"score_gpt":0.49847993703188065,"score_spread":0.32330415318765093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1867786678","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003500804,0.9988794,0.00008206665,0.0003243271,0.00006086689,0.00003905103,0.000036322028,0.0000019625186,0.00022593708],"genre_scores_gemma":[0.0049114847,0.9935905,0.0008740381,0.00043887197,0.00004914877,0.000029792389,0.000041452753,0.0000013631374,0.00006333123],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9968104,0.0014212187,0.0010214259,0.00015489955,0.00053043314,0.00006159646],"domain_scores_gemma":[0.9919957,0.005961648,0.0013501017,0.00008277129,0.0005326478,0.00007712264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005091587,0.00076012424,0.0036162848,0.0022605807,0.0002835896,0.0015013396,0.0011697548,0.0012767093,0.002641673],"category_scores_gemma":[0.014548672,0.0004195763,0.0035521209,0.002198828,0.00044182767,0.0013302598,0.00058741675,0.0019442138,0.00023557812],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060699513,0.000071525625,0.00052598823,0.47013757,0.0060865562,0.000077626115,0.00013089574,0.0004506204,0.0004201502,0.0013251634,0.0045958087,0.5155711],"study_design_scores_gemma":[0.0012102536,0.0009034804,0.0050828313,0.7753824,0.0516467,0.0006713251,0.00039544606,0.00065180875,0.0008583891,0.0029495168,0.1601761,0.00007173097],"about_ca_topic_score_codex":0.0043637455,"about_ca_topic_score_gemma":0.016862502,"teacher_disagreement_score":0.005091587,"about_ca_system_score_codex":0.0017512102,"about_ca_system_score_gemma":0.0040349206,"threshold_uncertainty_score":0.026927233},"labels":[],"label_agreement":null},{"id":"W1964917977","doi":"10.1016/s0305-7372(06)80002-2","title":"Optimizing patient therapy: the role of bone markers?","year":2006,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Bone health and treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Notre-Dame","funders":"","keywords":"Medicine; Bone remodeling; Bone disease; Oncology; Disease; Internal medicine; Cancer; Osteoporosis","score_opus":0.07744950362391258,"score_gpt":0.3827776965620042,"score_spread":0.30532819293809166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964917977","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000025551557,0.99810755,0.00009542581,0.0012354266,0.0002305389,0.0000021219773,0.000005843789,0.0000035187497,0.00029396414],"genre_scores_gemma":[0.0003918144,0.99793506,0.00034958206,0.0007729335,0.00033349943,0.0000054669254,0.000008844834,0.0000015937269,0.00020117624],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987286,0.00048970163,0.00017686505,0.00011852775,0.00042445815,0.00006184284],"domain_scores_gemma":[0.9968522,0.0021389723,0.0003462715,0.00005651589,0.0005145573,0.00009149617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002955388,0.0015715724,0.0053095375,0.0021421828,0.00039424587,0.0024465374,0.0020250913,0.0033601283,0.0035216592],"category_scores_gemma":[0.004656135,0.000540043,0.0009346873,0.0033929632,0.0013297544,0.0025566819,0.00079947844,0.0050032693,0.001957588],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012522178,0.00010525161,0.00024389254,0.012031023,0.00024460297,0.0001167162,0.000053082043,0.00033922828,0.00035809015,0.0050597535,0.060262635,0.9210605],"study_design_scores_gemma":[0.00012598145,0.00012739634,0.0014705117,0.017849762,0.00041338897,0.001134943,0.00016554625,0.00024538615,0.0002451476,0.0062642638,0.97191566,0.000042024283],"about_ca_topic_score_codex":0.00348842,"about_ca_topic_score_gemma":0.008100792,"teacher_disagreement_score":0.0053095375,"about_ca_system_score_codex":0.0014163617,"about_ca_system_score_gemma":0.0025545051,"threshold_uncertainty_score":0.015629768},"labels":[],"label_agreement":null},{"id":"W1968104780","doi":"10.1016/j.ctrv.2010.01.004","title":"New developments in arc radiation therapy: A review","year":2010,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Advanced Radiotherapy Techniques","field":"Physics and Astronomy","cited_by":144,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Ontario Institute for Cancer Research; Vanderbilt University Medical Center; Varian Medical Systems","keywords":"Medicine; Radiation therapy; Arc (geometry); Medical physics; Radiation oncology; Internal medicine","score_opus":0.062250255176207664,"score_gpt":0.41000702395242117,"score_spread":0.34775676877621353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968104780","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000085368345,0.9989429,0.00010649806,0.00009479598,0.00021737891,0.00000472903,0.000018526755,0.00000721556,0.0005225467],"genre_scores_gemma":[0.0003114083,0.99873835,0.00019755543,0.00011930428,0.00022261144,0.0000043286373,0.00002607651,0.0000014397019,0.0003790593],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998004,0.000026865306,0.000038176964,0.000037768332,0.00007824027,0.000018664488],"domain_scores_gemma":[0.99957746,0.000178225,0.000080913036,0.000009719898,0.00011768546,0.00003600349],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005509234,0.001231075,0.0018296987,0.0031317289,0.00024704248,0.0010492081,0.0010000584,0.0009140409,0.005343948],"category_scores_gemma":[0.0007327893,0.00037491356,0.0005971481,0.0040443363,0.00039736705,0.0017004949,0.00062305626,0.0013671233,0.00248778],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011428466,0.00008828371,0.0002039831,0.029388184,0.0001228352,0.00020830051,0.000055087126,0.00038986065,0.002634367,0.000901445,0.037670575,0.92822284],"study_design_scores_gemma":[0.000041666208,0.00013624366,0.0010779883,0.0045385435,0.00037804607,0.0015820004,0.00007861466,0.000113239876,0.0006063777,0.0008230873,0.9905929,0.000031320924],"about_ca_topic_score_codex":0.0012270999,"about_ca_topic_score_gemma":0.0027470642,"teacher_disagreement_score":0.005343948,"about_ca_system_score_codex":0.00052763504,"about_ca_system_score_gemma":0.0013238171,"threshold_uncertainty_score":0.01787728},"labels":[],"label_agreement":null},{"id":"W1971209307","doi":"10.1016/j.ctrv.2013.09.001","title":"HER2 testing: Current status and future directions","year":2013,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":161,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"Genentech","keywords":"Medicine; Clinical Oncology; Human Epidermal Growth Factor Receptor 2; Medical physics; Breast cancer; Oncology; Intensive care medicine; Gynecology; Cancer; Internal medicine","score_opus":0.33526958615058944,"score_gpt":0.5178544713757319,"score_spread":0.1825848852251425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971209307","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003967669,0.9992003,0.000040120587,0.00032624602,0.00010190611,0.0000020723876,0.0000122747615,0.0000031958639,0.00027425264],"genre_scores_gemma":[0.00037620898,0.99890554,0.00009897197,0.0003015363,0.00013675322,0.0000028541665,0.00001838792,8.981094e-7,0.00015883255],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995828,0.0001029057,0.000067019515,0.00007062664,0.00013668866,0.00004000457],"domain_scores_gemma":[0.9984107,0.0010444933,0.00018222307,0.00002215082,0.00025679174,0.000083534156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015280078,0.0009428172,0.0022709277,0.0025143619,0.00022747564,0.0013372661,0.0010518187,0.0012539261,0.005734592],"category_scores_gemma":[0.0023915423,0.00033501908,0.00088431645,0.002666291,0.0005573797,0.0017947528,0.00078724313,0.001893826,0.0012599342],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011484117,0.00005093908,0.00027752115,0.016806755,0.00012766989,0.00010176033,0.000029223469,0.0002602112,0.0003961739,0.0013598474,0.03534853,0.9451265],"study_design_scores_gemma":[0.00009241051,0.00015810126,0.0015791907,0.019080438,0.00082165946,0.0011200875,0.00013578233,0.00022255509,0.00031132207,0.0026112956,0.9738313,0.000035826746],"about_ca_topic_score_codex":0.0017018846,"about_ca_topic_score_gemma":0.005505594,"teacher_disagreement_score":0.005734592,"about_ca_system_score_codex":0.00088588387,"about_ca_system_score_gemma":0.0018197802,"threshold_uncertainty_score":0.019184113},"labels":[],"label_agreement":null},{"id":"W1974605771","doi":"10.1016/j.ctrv.2010.02.009","title":"Possibilities of new therapeutic strategies in brain tumors","year":2010,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medicine; Intensive care medicine; Medical physics","score_opus":0.1312581474431459,"score_gpt":0.42972007438482407,"score_spread":0.29846192694167817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974605771","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000092697446,0.9984586,0.00014361602,0.00022498785,0.00020597919,0.0000052392415,0.00001376191,0.0000068193276,0.0008482531],"genre_scores_gemma":[0.00053105573,0.9982974,0.00025861035,0.00022735671,0.0002079884,0.000007023104,0.000026307735,0.0000014388701,0.00044282337],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99983144,0.00003632667,0.000027353892,0.000026061296,0.000057327663,0.000021525979],"domain_scores_gemma":[0.9997454,0.00013212945,0.000034649096,0.0000075387366,0.000062192856,0.000017993636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068837346,0.0010821512,0.001819607,0.002338068,0.00031121727,0.0011611145,0.00085684925,0.0010836744,0.0037816202],"category_scores_gemma":[0.00065125397,0.00029181485,0.0006500321,0.0019865402,0.0004913143,0.0014672931,0.0005695234,0.0018633114,0.0018586427],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011079249,0.00010540946,0.00013106315,0.015373721,0.00010909936,0.0002969559,0.000046944315,0.00048527698,0.0022392294,0.0033272048,0.035121985,0.9426524],"study_design_scores_gemma":[0.000055456814,0.00013988816,0.00077953737,0.003613579,0.00025430293,0.0014434968,0.00005901428,0.00015561706,0.0005833033,0.0020526266,0.99084014,0.00002300392],"about_ca_topic_score_codex":0.0014854805,"about_ca_topic_score_gemma":0.0038597796,"teacher_disagreement_score":0.0037816202,"about_ca_system_score_codex":0.0007451267,"about_ca_system_score_gemma":0.0011564371,"threshold_uncertainty_score":0.012650788},"labels":[],"label_agreement":null},{"id":"W1980359360","doi":"10.1016/j.ctrv.2009.12.008","title":"Ingestion of selenium and other antioxidants during prostate cancer radiotherapy: A good thing?","year":2010,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Selenium in Biological Systems","field":"Nursing","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University Health Network; Princess Margaret Cancer Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Prostate cancer; Radiation therapy; Cancer; Oncology; Chemotherapy; Clinical trial; Prostate; Internal medicine; Pharmacology; Bioinformatics; Biology","score_opus":0.06416306169515845,"score_gpt":0.3762800237607115,"score_spread":0.31211696206555306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980359360","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009557205,0.9992054,0.00003461965,0.00030449068,0.00018832333,0.0000015315177,0.0000054760308,0.000002287838,0.00016232257],"genre_scores_gemma":[0.000685354,0.9984352,0.0001236987,0.00033150468,0.00018274615,0.0000035229643,0.000011168997,9.252834e-7,0.00022576643],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99954104,0.000124945,0.00010196011,0.000059304253,0.00014464544,0.000028092643],"domain_scores_gemma":[0.9990858,0.00046773287,0.00019723894,0.000019516341,0.00019551913,0.000034221062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001145023,0.0009123738,0.0031110544,0.0023822247,0.00032026193,0.0011384891,0.0008807317,0.0022559715,0.002274116],"category_scores_gemma":[0.0018212898,0.00035052947,0.0009042067,0.0024749306,0.0004850113,0.0013836464,0.0007322105,0.0016375608,0.0008983638],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000253719,0.000097073,0.0007620499,0.040030085,0.00049907155,0.00021974997,0.000117299845,0.000087204586,0.0012855438,0.00064862147,0.025859302,0.9301403],"study_design_scores_gemma":[0.00017486664,0.0006011921,0.0068181516,0.047786534,0.001957509,0.0033799682,0.0005737674,0.00012863251,0.0015026127,0.0016669749,0.9353443,0.00006556474],"about_ca_topic_score_codex":0.0031425299,"about_ca_topic_score_gemma":0.007346045,"teacher_disagreement_score":0.0031425299,"about_ca_system_score_codex":0.0005089779,"about_ca_system_score_gemma":0.0014466398,"threshold_uncertainty_score":0.0076076984},"labels":[],"label_agreement":null},{"id":"W1986348063","doi":"10.1016/j.ctrv.2012.07.005","title":"MicroRNAs: Novel mediators of resistance to microtubule-targeting agents","year":2012,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Wellington Medical Research Foundation; University of Victoria","keywords":"microRNA; Paclitaxel; Drug resistance; Cancer research; Medicine; Function (biology); Suppressor; Vincristine; Gene; Bioinformatics; Cell biology; Cancer; Biology; Genetics; Chemotherapy","score_opus":0.06283064558799728,"score_gpt":0.3593625567153348,"score_spread":0.2965319111273375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986348063","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00028778228,0.99712,0.0007069435,0.00039642662,0.00036948436,0.0000066218367,0.000017957478,0.000021375366,0.0010733618],"genre_scores_gemma":[0.0028376798,0.9941081,0.0008014164,0.00044852673,0.0004428434,0.00002393103,0.000047829777,0.0000065421987,0.0012831158],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997532,0.00004747144,0.000029683984,0.000041044612,0.00009682825,0.000031825984],"domain_scores_gemma":[0.99972695,0.00014776186,0.00004313567,0.000007788936,0.000049338367,0.000025040454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000700069,0.0011532024,0.0017711519,0.0011262359,0.00027589264,0.0011730164,0.00070179807,0.0012928039,0.0019031777],"category_scores_gemma":[0.0007315089,0.0004071836,0.00039000984,0.0011801667,0.0007164218,0.000947304,0.00062966644,0.0024198072,0.0016311093],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014732023,0.00008386908,0.00018308527,0.0047296775,0.00008071851,0.0002658401,0.000049285005,0.00045954407,0.012984702,0.0046894327,0.030075531,0.94625103],"study_design_scores_gemma":[0.00007407816,0.00016003645,0.00077022234,0.0009820414,0.00016306096,0.0016082317,0.00005617652,0.00033566504,0.005544078,0.0029981993,0.98727345,0.000034779354],"about_ca_topic_score_codex":0.0004173818,"about_ca_topic_score_gemma":0.0012585903,"teacher_disagreement_score":0.0019031777,"about_ca_system_score_codex":0.0006454613,"about_ca_system_score_gemma":0.0006257864,"threshold_uncertainty_score":0.0063667297},"labels":[],"label_agreement":null},{"id":"W1988277782","doi":"10.1016/j.ctrv.2011.05.002","title":"Locoregional radiological treatment for hepatocellular carcinoma; Which, when and how?","year":2011,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Alberta; University of Alberta Hospital; Alberta Hospital Edmonton","funders":"","keywords":"Medicine; Hepatocellular carcinoma; Percutaneous ethanol injection; Radiofrequency ablation; Response Evaluation Criteria in Solid Tumors; Liver transplantation; Stage (stratigraphy); Radiological weapon; Milan criteria; Target lesion; Radiology; Sorafenib; Curative treatment; Percutaneous; Oncology; Transplantation; Surgery; Internal medicine; Ablation; Progressive disease; Disease","score_opus":0.3692608274712213,"score_gpt":0.35966202905389855,"score_spread":0.009598798417322751,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988277782","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000049351424,0.9993118,0.00003921269,0.00021190762,0.00009408493,0.000002992446,0.000012658307,0.0000025367171,0.00027548257],"genre_scores_gemma":[0.0003944241,0.9991573,0.00008105461,0.00012596474,0.00008315668,0.0000030922984,0.000013820206,6.2416683e-7,0.00014050401],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9997484,0.000062141524,0.000056725352,0.000033883724,0.00008396674,0.000014862397],"domain_scores_gemma":[0.9994597,0.00024721646,0.00013900836,0.000011851021,0.00011710613,0.00002513071],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006828099,0.00056904706,0.0019591434,0.0020014085,0.00021921452,0.000767864,0.00060952624,0.00069798785,0.0023585092],"category_scores_gemma":[0.00129762,0.00026597225,0.00055680913,0.0029530565,0.00038388034,0.0009311647,0.00032190545,0.0010704437,0.00091070356],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056255005,0.000034545177,0.00029055343,0.03204353,0.00020535059,0.000103639046,0.000040439783,0.0002069507,0.00043101455,0.00088485813,0.044026922,0.921676],"study_design_scores_gemma":[0.000058473837,0.00016177712,0.003426798,0.022932144,0.0012587775,0.0021483882,0.0001629342,0.00016956957,0.0004705038,0.0011254216,0.9680453,0.00003986345],"about_ca_topic_score_codex":0.003295444,"about_ca_topic_score_gemma":0.0086346865,"teacher_disagreement_score":0.003295444,"about_ca_system_score_codex":0.00070981175,"about_ca_system_score_gemma":0.001326489,"threshold_uncertainty_score":0.007889926},"labels":[],"label_agreement":null},{"id":"W1988557714","doi":"10.1016/j.ctrv.2003.10.002","title":"Epidermal growth factor receptor: a promising target in solid tumours","year":2003,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":254,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Epidermal growth factor receptor; Monoclonal antibody; Tyrosine kinase; Cancer research; Cancer; Receptor tyrosine kinase; Signal transduction; Targeted therapy; EGFR inhibitors; Cetuximab; Blockade; Pharmacology; Receptor; Immunology; Antibody; Internal medicine; Biology; Cell biology","score_opus":0.2218575342477881,"score_gpt":0.48518779668646167,"score_spread":0.2633302624386736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988557714","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012104163,0.9971686,0.00017860343,0.00040426245,0.0005117049,0.0000074236063,0.000026766445,0.000012050897,0.0015696236],"genre_scores_gemma":[0.0004926945,0.9971521,0.00023401415,0.00037068178,0.00030456737,0.000008307701,0.000041574098,0.0000018843577,0.0013941863],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99977,0.000037183505,0.000029430961,0.00003576421,0.00010455488,0.000023127164],"domain_scores_gemma":[0.99970967,0.00012858553,0.00004406911,0.0000083354535,0.000075219825,0.000034151868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008243148,0.0013023783,0.0021006872,0.0022341656,0.00032492832,0.001255317,0.00079270225,0.0014558356,0.0050712386],"category_scores_gemma":[0.00064334495,0.00030136819,0.0005050566,0.0027920126,0.00044522184,0.0016465135,0.00053046376,0.0018169043,0.0036554725],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015520329,0.0000891942,0.00011907761,0.010524842,0.00008729262,0.00036706938,0.000035741312,0.0003236285,0.00305092,0.001829484,0.08130823,0.9021094],"study_design_scores_gemma":[0.000051477433,0.0001439147,0.00044153622,0.0015540838,0.00016509974,0.0013915971,0.000042020027,0.00007168593,0.0005234434,0.00074654975,0.99485564,0.000012910601],"about_ca_topic_score_codex":0.00116896,"about_ca_topic_score_gemma":0.0031895298,"teacher_disagreement_score":0.0050712386,"about_ca_system_score_codex":0.0008262415,"about_ca_system_score_gemma":0.0012746948,"threshold_uncertainty_score":0.016965032},"labels":[],"label_agreement":null},{"id":"W1992904267","doi":"10.1016/j.ctrv.2012.07.004","title":"Photodynamic therapy of malignant brain tumours: A complementary approach to conventional therapies","year":2012,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre d'expertise et de recherche en infrastructures urbaines","funders":"Ligue Contre le Cancer; Agence Nationale de la Recherche","keywords":"Medicine; Photodynamic therapy; Oncology","score_opus":0.17740687088413024,"score_gpt":0.4395065235343096,"score_spread":0.2620996526501793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992904267","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006524682,0.999423,0.000051583975,0.00007020394,0.000060942195,0.0000030727338,0.0000063006873,0.00000200539,0.00031763405],"genre_scores_gemma":[0.000373773,0.9992073,0.000109761524,0.000072628376,0.000068069596,0.000003179986,0.000008302251,5.1054656e-7,0.00015646627],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99980825,0.00003198719,0.000033203545,0.000031269996,0.00008060328,0.000014640083],"domain_scores_gemma":[0.9996716,0.00019490397,0.000051062212,0.000008693943,0.0000598687,0.000014018506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004914468,0.0008716164,0.0018239624,0.0032809991,0.00026267598,0.0010070604,0.00068615476,0.00086990726,0.0031040243],"category_scores_gemma":[0.0005997762,0.000272056,0.00072683487,0.0030349193,0.00049876305,0.0012633806,0.0005475983,0.001305079,0.0009252769],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009935027,0.00012499295,0.00015011389,0.054306235,0.00021046316,0.00019853128,0.000065914974,0.00024848786,0.0038588173,0.0024889496,0.015994864,0.92225325],"study_design_scores_gemma":[0.000065433655,0.00022803116,0.0014778675,0.012263952,0.0006754942,0.0023165185,0.00011900677,0.00010812907,0.0014099563,0.0020407273,0.97925466,0.00004020493],"about_ca_topic_score_codex":0.0013713385,"about_ca_topic_score_gemma":0.0030269672,"teacher_disagreement_score":0.0032809991,"about_ca_system_score_codex":0.00054645404,"about_ca_system_score_gemma":0.0010619381,"threshold_uncertainty_score":0.010384023},"labels":[],"label_agreement":null},{"id":"W1995994098","doi":"10.1016/j.ctrv.2008.03.039","title":"OC13. Development of the European organization for research and treatment of cancer bone metastases module (BMM) (EORTC QLQ-BM22)","year":2008,"lang":"en","type":"article","venue":"Cancer Treatment Reviews","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Cancer; Oncology; Medical physics; Internal medicine","score_opus":0.2803384651569181,"score_gpt":0.45414330770804356,"score_spread":0.17380484255112544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995994098","genre_codex":"other","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016912699,0.020954324,0.02138007,0.030700633,0.008106726,0.00759527,0.07812968,0.004429481,0.811791],"genre_scores_gemma":[0.06356509,0.016842967,0.048502203,0.021585198,0.002944146,0.004395253,0.12695687,0.002593286,0.712615],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99834764,0.00025566103,0.00008746759,0.00013955386,0.00083925773,0.00033045202],"domain_scores_gemma":[0.9975145,0.0001946712,0.00024286675,0.00012318128,0.0012435898,0.00068120484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043617734,0.0008129602,0.00069987454,0.0023927244,0.00059856725,0.0014756204,0.0018027459,0.0014413252,0.12886874],"category_scores_gemma":[0.0034139145,0.00027210635,0.0007203233,0.0014394514,0.000354861,0.00039953063,0.0014531526,0.0009526822,0.047787722],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007488912,0.00042917815,0.001944869,0.000516313,0.000033243272,0.00008247563,0.00003752324,0.00026494585,0.005290321,0.002948171,0.45010078,0.5376034],"study_design_scores_gemma":[0.00027660505,0.00024939945,0.0042539123,0.00015462752,0.00004036624,0.0000995014,0.000014713931,0.00023656846,0.0044371923,0.00043758866,0.9897899,0.000009658895],"about_ca_topic_score_codex":0.022829724,"about_ca_topic_score_gemma":0.032693796,"teacher_disagreement_score":0.12886874,"about_ca_system_score_codex":0.0030854705,"about_ca_system_score_gemma":0.011367532,"threshold_uncertainty_score":0.4311089},"labels":[],"label_agreement":null},{"id":"W1996168994","doi":"10.1016/j.ctrv.2008.03.098","title":"P72. Dexamethasone for the prophylaxis of radiation-induced pain flare following palliative radiotherapy for bone metastases: A phase II study","year":2008,"lang":"en","type":"article","venue":"Cancer Treatment Reviews","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Dexamethasone; Radiation therapy; Flare; Oncology; Surgery; Internal medicine","score_opus":0.1254565380039686,"score_gpt":0.41854004315942855,"score_spread":0.29308350515545994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996168994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9748512,0.016825525,0.000893181,0.0006113878,0.0003389189,0.0028873126,0.0007375528,0.00015811264,0.0026969367],"genre_scores_gemma":[0.97550577,0.015943976,0.0015863273,0.0006483471,0.0004578986,0.0017258893,0.000801337,0.00004634493,0.0032841451],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99963415,0.00015122985,0.000018048588,0.000054146873,0.00004305592,0.000099495075],"domain_scores_gemma":[0.9994473,0.0001501132,0.00010309192,0.000037733902,0.000027970837,0.00023382783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090425246,0.0014385668,0.0031667028,0.0006474075,0.00048191857,0.0010086559,0.0013217397,0.0015660945,0.0043230415],"category_scores_gemma":[0.000823363,0.00051119435,0.0015062232,0.00073734496,0.001182299,0.00067825447,0.00027797028,0.003198151,0.00091109244],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6637435,0.06361886,0.0017484948,0.0026017614,0.0018018687,0.00042329807,0.00031853773,0.0024562313,0.028572734,0.00053899596,0.0028960488,0.23127964],"study_design_scores_gemma":[0.5276592,0.46120372,0.0041206097,0.00012281083,0.00061276223,0.0003484467,0.000068856345,0.00056846166,0.002728406,0.0001614552,0.002366047,0.00003918627],"about_ca_topic_score_codex":0.002001359,"about_ca_topic_score_gemma":0.0038020175,"teacher_disagreement_score":0.0043230415,"about_ca_system_score_codex":0.0006468524,"about_ca_system_score_gemma":0.0016130214,"threshold_uncertainty_score":0.014461994},"labels":[],"label_agreement":null},{"id":"W1998765212","doi":"10.1016/j.ctrv.2008.05.001","title":"Bone markers and their prognostic value in metastatic bone disease: Clinical evidence and future directions","year":2008,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Bone health and treatments","field":"Medicine","cited_by":122,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; McMaster University; University of Waterloo","funders":"National Cancer Institute; Cancer Research UK; Novartis Pharmaceuticals Corporation; Novartis","keywords":"Medicine; Oncology; Disease; Value (mathematics); Bone disease; Internal medicine; Intensive care medicine; Osteoporosis","score_opus":0.17814975031118124,"score_gpt":0.4584829651475898,"score_spread":0.28033321483640855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998765212","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000048053036,0.99963355,0.000026357622,0.00013561668,0.000056047134,0.0000018018694,0.000009617905,0.0000012319398,0.000087808316],"genre_scores_gemma":[0.000479614,0.99909174,0.000117062795,0.00014649912,0.00008678809,0.0000036650163,0.000011776234,4.4813615e-7,0.00006233056],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99953663,0.00010029357,0.00009400823,0.00007966446,0.0001618589,0.000027596256],"domain_scores_gemma":[0.9980057,0.0014040718,0.0002338373,0.000025733032,0.00028737145,0.000043460397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019004921,0.0011043982,0.004994077,0.0023884154,0.00024263017,0.0017007792,0.0010642537,0.00159928,0.003297457],"category_scores_gemma":[0.0030009742,0.00048313977,0.0013707014,0.0037067404,0.00068660843,0.0011709377,0.00056363986,0.0020627917,0.00089414354],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049389165,0.00008761229,0.0008697133,0.043996975,0.0009453928,0.00019372569,0.00005732394,0.00036174728,0.0007439371,0.001686472,0.021123542,0.9294397],"study_design_scores_gemma":[0.00070566946,0.00075479905,0.010526885,0.056463335,0.008557143,0.003054353,0.00043044164,0.0005721546,0.0008027858,0.005879452,0.9121289,0.00012403235],"about_ca_topic_score_codex":0.0032187153,"about_ca_topic_score_gemma":0.008298483,"teacher_disagreement_score":0.004994077,"about_ca_system_score_codex":0.00066970685,"about_ca_system_score_gemma":0.002024383,"threshold_uncertainty_score":0.011031091},"labels":[],"label_agreement":null},{"id":"W2000127756","doi":"10.1016/j.ctrv.2012.02.001","title":"Biologic rationale and clinical activity of mTOR inhibitors in gynecological cancer","year":2012,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; PI3K/AKT/mTOR pathway; Endometrial cancer; Ovarian cancer; Cancer; Cancer research; Sirolimus; Kinase; Protein kinase B; Targeted therapy; Oncology; Bioinformatics; Internal medicine; Signal transduction; Biology","score_opus":0.20128096533366224,"score_gpt":0.45457944599036504,"score_spread":0.2532984806567028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000127756","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012395332,0.99894303,0.00008267,0.00018775335,0.000115941075,0.0000051885177,0.00002086216,0.0000054665325,0.000515093],"genre_scores_gemma":[0.00095314794,0.99776196,0.00022334048,0.00034568732,0.00015153839,0.000010306929,0.000049554954,0.0000020575164,0.00050226407],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99978536,0.000038048744,0.000034613357,0.0000400849,0.00007545911,0.000026460662],"domain_scores_gemma":[0.9996928,0.00015643187,0.00005312133,0.000008027544,0.000066262364,0.000023336646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008606927,0.0010781809,0.0019216276,0.0019227463,0.0002962962,0.0011166289,0.0010738126,0.0010978705,0.0030395512],"category_scores_gemma":[0.00094748044,0.00041840863,0.000812655,0.0018766893,0.00048580024,0.0010892422,0.00053012965,0.0027941177,0.0017076316],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002900954,0.00014909935,0.00016421227,0.012896547,0.00015824434,0.00023189289,0.0000337751,0.0005315951,0.0026189408,0.0024990968,0.031621624,0.9488049],"study_design_scores_gemma":[0.00019551645,0.00040095948,0.0010306544,0.003522491,0.00042099296,0.0015666783,0.000041744253,0.0002221551,0.0012845268,0.0015667315,0.9897149,0.000032520627],"about_ca_topic_score_codex":0.00096146204,"about_ca_topic_score_gemma":0.002744526,"teacher_disagreement_score":0.0030395512,"about_ca_system_score_codex":0.00068975484,"about_ca_system_score_gemma":0.0010194309,"threshold_uncertainty_score":0.010168254},"labels":[],"label_agreement":null},{"id":"W2001948214","doi":"10.1016/j.ctrv.2012.05.004","title":"The evolving landscape of protein kinases in breast cancer: Clinical implications","year":2012,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Druggability; Medicine; Kinase; Breast cancer; Carcinogenesis; Cancer; Drug discovery; Bioinformatics; Cancer research; Internal medicine; Biology; Gene","score_opus":0.3287504679105725,"score_gpt":0.5473864501181303,"score_spread":0.21863598220755776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001948214","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000058648257,0.998966,0.00005209329,0.0004766542,0.00014003114,0.0000012361512,0.00001041688,0.0000033784036,0.0002915562],"genre_scores_gemma":[0.00034375873,0.99883455,0.00009711244,0.0003131135,0.00020336558,0.0000022181523,0.0000136352255,7.9866516e-7,0.00019140755],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997236,0.000054090757,0.000039610197,0.0000521925,0.000098563025,0.000031934313],"domain_scores_gemma":[0.99911815,0.00052410684,0.000094300056,0.000016328797,0.00018891595,0.000058195783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011130569,0.00090115087,0.0018407983,0.001806718,0.00027446513,0.0014799146,0.0009052391,0.0014802966,0.0033466916],"category_scores_gemma":[0.0014047045,0.00028223527,0.0006051744,0.002496324,0.0006471811,0.002086582,0.0007646322,0.0024118102,0.0015600489],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012349921,0.000059806946,0.00028932517,0.018015316,0.00012267868,0.00018593733,0.000052162257,0.00037066976,0.001238014,0.004093121,0.04885656,0.9265928],"study_design_scores_gemma":[0.000041830343,0.00010363046,0.0011195106,0.0051536397,0.0002264497,0.0010425481,0.00011488899,0.00012543591,0.0003215376,0.003261714,0.9884643,0.000024606788],"about_ca_topic_score_codex":0.0010366658,"about_ca_topic_score_gemma":0.0032958102,"teacher_disagreement_score":0.0033466916,"about_ca_system_score_codex":0.00091325614,"about_ca_system_score_gemma":0.0013443737,"threshold_uncertainty_score":0.011195779},"labels":[],"label_agreement":null},{"id":"W2002036713","doi":"10.1016/j.ctrv.2004.06.006","title":"Autologous tumour cell vaccine may reduce risk of tumour progression in people with primary renal cell carcinoma","year":2004,"lang":"en","type":"article","venue":"Cancer Treatment Reviews","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Renal cell carcinoma; Nephrectomy; Oncology; Cell; Carcinoma; Kidney; Internal medicine","score_opus":0.021932125755524574,"score_gpt":0.2912317810521755,"score_spread":0.26929965529665095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002036713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89299846,0.083758645,0.0018127246,0.004818628,0.00058783573,0.000109632405,0.00016000007,0.000099534744,0.015654549],"genre_scores_gemma":[0.98138225,0.014680417,0.0005655235,0.00049699575,0.00025320594,0.000038265363,0.00008356337,0.000006091317,0.0024937666],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9999057,0.000045272685,0.000004919093,0.000008373456,0.000021571866,0.000014191255],"domain_scores_gemma":[0.99975425,0.00013777842,0.00004699066,0.000007593533,0.000024877185,0.00002853971],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000253694,0.00011387996,0.00048616892,0.00013387586,0.0001365605,0.00017438114,0.00012474504,0.00032942268,0.0034799236],"category_scores_gemma":[0.0010935679,0.000050061208,0.00031917772,0.0001534766,0.00009303923,0.00015545524,0.000083078514,0.00042574882,0.00020858037],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015284883,0.004725376,0.07366833,0.0025215924,0.0009307426,0.0008662933,0.000363721,0.001941473,0.0140999155,0.0017048536,0.011011925,0.872881],"study_design_scores_gemma":[0.010435925,0.10662774,0.7092972,0.001376225,0.005449264,0.007736344,0.0010555073,0.0046553006,0.027771465,0.007096679,0.11843063,0.00006774526],"about_ca_topic_score_codex":0.00070049945,"about_ca_topic_score_gemma":0.00093017076,"teacher_disagreement_score":0.0034799236,"about_ca_system_score_codex":0.00015076135,"about_ca_system_score_gemma":0.00024297718,"threshold_uncertainty_score":0.011641502},"labels":[],"label_agreement":null},{"id":"W2004606206","doi":"10.1016/s0305-7372(02)00089-0","title":"Management of the menopause in cancer survivors","year":2002,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Menopause: Health Impacts and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Menopause; Hormone replacement therapy (female-to-male); Cancer; Intensive care medicine; Hormone replacement; Surgical Menopause; Premature Menopause; Hormone therapy; Gynecology; Hormone; Breast cancer; Internal medicine; Testosterone (patch)","score_opus":0.19015083362911708,"score_gpt":0.44554605796313135,"score_spread":0.2553952243340143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004606206","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009155487,0.9994199,0.00003043602,0.000113543676,0.00010484462,0.0000062708086,0.000009974083,0.0000017805031,0.00022165463],"genre_scores_gemma":[0.0007512144,0.9986206,0.00015610842,0.00019486308,0.000080842525,0.000008340695,0.000012885334,6.090552e-7,0.00017452845],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99959356,0.000119444936,0.000093564486,0.000050988834,0.00011836044,0.000024117],"domain_scores_gemma":[0.9990897,0.00059295713,0.00016143851,0.0000117339905,0.000112204,0.00003198237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092924986,0.0008307477,0.0024053336,0.0028447772,0.00035908647,0.0008169525,0.00071535923,0.001165691,0.0031366136],"category_scores_gemma":[0.0022335886,0.0003767269,0.0010147392,0.002811939,0.00033952945,0.00092607026,0.0004909081,0.0012447769,0.00051011035],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022450513,0.00009407912,0.00037271465,0.071756065,0.00041062688,0.00024676707,0.00009348712,0.00026838935,0.0005231819,0.00061892276,0.016951766,0.90843946],"study_design_scores_gemma":[0.00034881243,0.00067457516,0.008655577,0.09453544,0.003922045,0.00438132,0.00045503877,0.00022049379,0.00067772646,0.0010892076,0.8849777,0.00006214386],"about_ca_topic_score_codex":0.0036838711,"about_ca_topic_score_gemma":0.011535303,"teacher_disagreement_score":0.0036838711,"about_ca_system_score_codex":0.00068309146,"about_ca_system_score_gemma":0.0014284913,"threshold_uncertainty_score":0.0104929805},"labels":[],"label_agreement":null},{"id":"W2005542697","doi":"10.1016/j.ctrv.2008.01.002","title":"Cancer in pregnancy: Gaps, challenges and solutions","year":2008,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":159,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Cancer; Pregnancy; Intensive care medicine; Oncology; Obstetrics; Internal medicine","score_opus":0.2552469059883008,"score_gpt":0.4302623060746265,"score_spread":0.1750154000863257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005542697","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00002982147,0.998852,0.000033538487,0.00071012427,0.00014185584,0.0000015664393,0.0000058728,0.0000018580155,0.00022341928],"genre_scores_gemma":[0.00022847626,0.99926776,0.00008975471,0.00020505633,0.0001110625,0.0000024789795,0.0000054049933,3.939819e-7,0.0000895671],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99937963,0.00019360564,0.00011728305,0.000072119474,0.00018910239,0.000048304668],"domain_scores_gemma":[0.9978586,0.0013839992,0.00028976606,0.000024653684,0.00036345256,0.000079546495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020006115,0.0010307133,0.002830595,0.0026927562,0.0005078948,0.0019001936,0.0008527966,0.0018658716,0.0027721294],"category_scores_gemma":[0.0031669994,0.00050693325,0.00077522843,0.004558357,0.00069253315,0.002225925,0.0010801115,0.0023218563,0.00081407104],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007882252,0.000057063167,0.00050060544,0.035733685,0.00017799421,0.00021564717,0.00015933826,0.00029195796,0.00026521718,0.003290307,0.05172434,0.9075049],"study_design_scores_gemma":[0.00003553197,0.000083869614,0.0018643193,0.04910762,0.00054215215,0.0014378988,0.0005806601,0.00015441717,0.00016152221,0.0026447524,0.943353,0.000034342407],"about_ca_topic_score_codex":0.0056469934,"about_ca_topic_score_gemma":0.014701424,"teacher_disagreement_score":0.0056469934,"about_ca_system_score_codex":0.0016814867,"about_ca_system_score_gemma":0.0044784755,"threshold_uncertainty_score":0.012200117},"labels":[],"label_agreement":null},{"id":"W2007790489","doi":"10.1016/s0305-7372(03)80005-1","title":"Can we optimise treatment of thrombosis?","year":2003,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Hospital","funders":"","keywords":"Medicine; Thrombosis; Anticoagulant; Concomitant; Low molecular weight heparin; Heparin; Venous thrombosis; Cancer; Surgery; Venous thromboembolism; Anticoagulant therapy; Internal medicine; Intensive care medicine","score_opus":0.19376038456030753,"score_gpt":0.43061406846393824,"score_spread":0.2368536839036307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007790489","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008334683,0.99193597,0.00021895979,0.0053977133,0.0011135002,0.000007416043,0.0000153503,0.000015036984,0.0012126296],"genre_scores_gemma":[0.0010264518,0.9927579,0.00060691877,0.0035266876,0.0013987583,0.000016704336,0.000020191805,0.0000047390417,0.00064167136],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990195,0.00037256486,0.0001655588,0.00008582093,0.0002773609,0.000079153615],"domain_scores_gemma":[0.9976876,0.0013957116,0.00040159552,0.000046793764,0.00036889905,0.00009931364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023340553,0.0011530877,0.0028588725,0.0024142219,0.00047428656,0.0019634163,0.0013091067,0.0026610596,0.008469103],"category_scores_gemma":[0.0057282965,0.0003893874,0.001310597,0.0021904379,0.0008390065,0.0028513314,0.00068846927,0.004597703,0.0029405134],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019221914,0.00011756263,0.00039415783,0.014807855,0.00037221986,0.0003207003,0.00009003487,0.00060630665,0.0003560191,0.005574307,0.09818194,0.8789867],"study_design_scores_gemma":[0.00036648434,0.00022910441,0.0019902554,0.027066646,0.00089488574,0.0018528941,0.00021355123,0.00022811741,0.00016174065,0.0063017383,0.96065634,0.00003824318],"about_ca_topic_score_codex":0.003667233,"about_ca_topic_score_gemma":0.008754334,"teacher_disagreement_score":0.008469103,"about_ca_system_score_codex":0.0012968552,"about_ca_system_score_gemma":0.0024672095,"threshold_uncertainty_score":0.028331995},"labels":[],"label_agreement":null},{"id":"W2010059199","doi":"10.1016/j.ctrv.2013.01.002","title":"HER2-targeted therapy in breast cancer: A systematic review of neoadjuvant trials","year":2013,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Lapatinib; Pertuzumab; Trastuzumab; Oncology; Breast cancer; Internal medicine; Neoadjuvant therapy; Clinical trial; Targeted therapy; Chemotherapy; Cancer","score_opus":0.30647694075076715,"score_gpt":0.523487102194639,"score_spread":0.21701016144387186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010059199","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00049918564,0.99888855,0.00007789246,0.00009132999,0.000052912066,0.00010626765,0.00015206874,0.000004567759,0.00012736257],"genre_scores_gemma":[0.007420563,0.9914341,0.00038611447,0.00038806992,0.00004200979,0.00012843109,0.00009988382,0.0000036042272,0.00009716201],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9972646,0.0009342006,0.0010504266,0.00025140587,0.0003998099,0.00009951818],"domain_scores_gemma":[0.9930774,0.0045489725,0.0017279806,0.00010036551,0.0004291311,0.00011617292],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004784888,0.0015501664,0.008863924,0.0040152273,0.00031869247,0.0017523776,0.0014880954,0.0012688368,0.0044877687],"category_scores_gemma":[0.013561507,0.000837514,0.0076646814,0.00536148,0.0005639505,0.0015226565,0.0011482359,0.0013420505,0.00025846585],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079597125,0.000025445876,0.00045064834,0.92572224,0.02346248,0.00007006682,0.00008608656,0.00018132295,0.00033324497,0.00014133842,0.0018353112,0.04689589],"study_design_scores_gemma":[0.002141318,0.0007586224,0.005897217,0.54374343,0.40364614,0.00051040837,0.00024386588,0.00018345135,0.00038654942,0.0005394967,0.041874293,0.000075273245],"about_ca_topic_score_codex":0.004178512,"about_ca_topic_score_gemma":0.020681186,"teacher_disagreement_score":0.008863924,"about_ca_system_score_codex":0.0020075333,"about_ca_system_score_gemma":0.0038178603,"threshold_uncertainty_score":0.025305152},"labels":[],"label_agreement":null},{"id":"W2011223682","doi":"10.1016/j.ctrv.2008.01.008","title":"Metastatic breast cancer: The role of pegylated liposomal doxorubicin after conventional anthracyclines","year":2008,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; University of Ottawa; Ottawa Regional Cancer Foundation; Ottawa Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Cardiotoxicity; Anthracycline; Trastuzumab; Doxorubicin; Breast cancer; Metastatic breast cancer; Oncology; Adjuvant; Internal medicine; Regimen; Adjuvant therapy; Chemotherapy; Cancer; Pharmacology","score_opus":0.07097432120529847,"score_gpt":0.42110653563821765,"score_spread":0.3501322144329192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011223682","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002888693,0.9986773,0.000118884374,0.00013866594,0.00010181616,0.00000399467,0.000008197672,0.0000042452134,0.0006579879],"genre_scores_gemma":[0.0014744133,0.9971807,0.0001728088,0.00019439646,0.00011741817,0.0000055131095,0.000022038836,0.0000014890443,0.0008312711],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99987674,0.000026367781,0.000015367421,0.000026649326,0.00004257474,0.000012292588],"domain_scores_gemma":[0.9998536,0.00007485871,0.000035143912,0.0000048381507,0.000021989854,0.000009622491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047290177,0.0005830956,0.001418414,0.0008690005,0.00015786273,0.00069189654,0.00060597464,0.0007616433,0.0022888843],"category_scores_gemma":[0.00040333578,0.00019370273,0.00036541006,0.0010368371,0.00034007302,0.00084545085,0.00040110978,0.0012064058,0.0010480309],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021366603,0.000082894854,0.00011386135,0.0075696846,0.00007238282,0.00018185521,0.00003832834,0.00035261453,0.0037369644,0.0020423087,0.015542779,0.9700528],"study_design_scores_gemma":[0.00009540313,0.00034560982,0.0014839713,0.0023919381,0.00019557014,0.0023448495,0.000036348923,0.00018654637,0.0017919213,0.00096256577,0.99014354,0.000021707376],"about_ca_topic_score_codex":0.0008410043,"about_ca_topic_score_gemma":0.0018167945,"teacher_disagreement_score":0.0022888843,"about_ca_system_score_codex":0.000505619,"about_ca_system_score_gemma":0.0005257299,"threshold_uncertainty_score":0.007657051},"labels":[],"label_agreement":null},{"id":"W2013017791","doi":"10.1016/j.ctrv.2014.08.002","title":"Temporal changes in the efficacy of chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck: A systematic review and meta-analysis","year":2014,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Chemotherapy; Oncology; Internal medicine; Cisplatin; Methotrexate; Head and neck cancer; Head and neck squamous-cell carcinoma; Cancer; Surgery","score_opus":0.2098117257612688,"score_gpt":0.4336556581788757,"score_spread":0.2238439324176069,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013017791","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0076576853,0.99129206,0.00026984242,0.00008125531,0.00014215644,0.000071955066,0.00033178495,0.000009387765,0.00014380825],"genre_scores_gemma":[0.24380052,0.75261486,0.0011626943,0.00083538686,0.00027606453,0.00030263545,0.00062554964,0.000026094312,0.00035622745],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99447507,0.0021940547,0.0017423816,0.0008026739,0.0005541263,0.0002317747],"domain_scores_gemma":[0.9886592,0.007875176,0.0022321916,0.0004166242,0.0006780945,0.0001386086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007808715,0.0017904481,0.010309478,0.0026410576,0.00041465354,0.0019999926,0.001382725,0.0015879528,0.002472924],"category_scores_gemma":[0.022168832,0.0012442784,0.029715229,0.0046718605,0.00058806705,0.0013779425,0.0013355605,0.0021980654,0.00020312578],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004269394,0.000037431902,0.008258641,0.21702522,0.75535685,0.00015451686,0.000117373245,0.0005586805,0.0003827569,0.00010893372,0.0005274965,0.013202728],"study_design_scores_gemma":[0.0005226787,0.00022131916,0.0070344717,0.007961388,0.9826649,0.00009519654,0.000052241216,0.00009303212,0.000113207716,0.00009164125,0.0011286223,0.000021338516],"about_ca_topic_score_codex":0.009346425,"about_ca_topic_score_gemma":0.021750469,"teacher_disagreement_score":0.010309478,"about_ca_system_score_codex":0.0020058642,"about_ca_system_score_gemma":0.0023438581,"threshold_uncertainty_score":0.0412969},"labels":[],"label_agreement":null},{"id":"W2013822060","doi":"10.1016/j.ctrv.2011.11.006","title":"Tissue confirmation of disease recurrence in breast cancer patients: Pooled analysis of multi-centre, multi-disciplinary prospective studies","year":2011,"lang":"en","type":"article","venue":"Cancer Treatment Reviews","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":175,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Ottawa Hospital; University of Ottawa; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Biopsy; Breast cancer; Prospective cohort study; Cancer; Internal medicine; Estrogen receptor; Immunohistochemistry; Oncology; Progesterone receptor; Recurrent breast cancer; Pathology","score_opus":0.060037529948947295,"score_gpt":0.36437695089809247,"score_spread":0.3043394209491452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013822060","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8144297,0.17702025,0.003970091,0.00014708198,0.00016720478,0.00016891392,0.0029912982,0.000047142395,0.0010583133],"genre_scores_gemma":[0.98981094,0.0073051965,0.00081746426,0.00009331876,0.00008927692,0.00007172158,0.0016607643,0.000020572637,0.0001307637],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9723545,0.01750196,0.0039973827,0.0037677344,0.0018126694,0.0005658227],"domain_scores_gemma":[0.93690574,0.031044096,0.017167633,0.01020248,0.0039755804,0.0007044912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019549605,0.0013257767,0.0046775206,0.003735988,0.0006392971,0.0024694614,0.0012616959,0.0014726347,0.0011604318],"category_scores_gemma":[0.038293496,0.0012055391,0.008586391,0.005403178,0.00062484294,0.0010407914,0.001804365,0.0008072789,0.0001935231],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0086103715,0.00004176362,0.8434055,0.001928743,0.13433181,0.0001912841,0.00018902944,0.0005294964,0.00096557516,0.00006538005,0.00031334936,0.009427715],"study_design_scores_gemma":[0.00048497866,0.0012369958,0.8600964,0.00044096832,0.1342356,0.0009075871,0.00036355644,0.0004645855,0.0006433268,0.00014680458,0.0009158056,0.000063384876],"about_ca_topic_score_codex":0.0028928637,"about_ca_topic_score_gemma":0.004042577,"teacher_disagreement_score":0.019549605,"about_ca_system_score_codex":0.00053141214,"about_ca_system_score_gemma":0.0005557429,"threshold_uncertainty_score":0.10338944},"labels":[],"label_agreement":null},{"id":"W2015277770","doi":"10.1016/j.ctrv.2008.01.005","title":"Meta-analysis of ifosfamide-based combination chemotherapy in advanced soft tissue sarcoma","year":2008,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Mount Sinai Hospital; Cancer Care Ontario; Ottawa Hospital","funders":"Canadian Medical Association; Cancer Care Ontario; National Center for Theoretical Sciences","keywords":"Ifosfamide; Medicine; Dacarbazine; Regimen; Soft tissue sarcoma; Doxorubicin; Chemotherapy; Oncology; Sarcoma; Internal medicine; Randomized controlled trial; Adverse effect; Surgery; Urology; Pathology; Etoposide","score_opus":0.203705741555171,"score_gpt":0.43182510487720044,"score_spread":0.22811936332202945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015277770","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008049872,0.99044985,0.0005214994,0.00014322817,0.00018518617,0.00006973437,0.0002657161,0.0000186242,0.00029620904],"genre_scores_gemma":[0.2526701,0.7428005,0.0020446558,0.0007214995,0.0003039646,0.00018345848,0.00066051446,0.0000328948,0.00058234856],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99687153,0.0017717746,0.0005707856,0.0003269669,0.00037609582,0.000082829676],"domain_scores_gemma":[0.9956474,0.0030278107,0.00076449837,0.00016411376,0.00030655402,0.00008959512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005442449,0.0015430474,0.00989811,0.0017982664,0.00025062964,0.0010838375,0.0009937075,0.00080035656,0.0026465317],"category_scores_gemma":[0.010185846,0.00078572653,0.015118106,0.0031704681,0.00024363252,0.0007086749,0.0006308029,0.0011406434,0.00019438061],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010317605,0.000050035767,0.0044104015,0.12147123,0.81552696,0.00013923022,0.000059475868,0.001471705,0.0006688853,0.00015331211,0.0015604665,0.044170745],"study_design_scores_gemma":[0.0015218309,0.0005254026,0.0049769557,0.003788063,0.98507845,0.0001403039,0.000021609725,0.00026763443,0.00019824083,0.00018636504,0.0032762156,0.000018905961],"about_ca_topic_score_codex":0.00397394,"about_ca_topic_score_gemma":0.0116819395,"teacher_disagreement_score":0.00989811,"about_ca_system_score_codex":0.0015644304,"about_ca_system_score_gemma":0.0012740587,"threshold_uncertainty_score":0.028782785},"labels":[],"label_agreement":null},{"id":"W2018470847","doi":"10.1016/j.ctrv.2005.03.002","title":"Brachytherapy improved dysphagia more than stenting in people with inoperable oesophageal cancer","year":2005,"lang":"en","type":"article","venue":"Cancer Treatment Reviews","topic":"Esophageal and GI Pathology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Dysphagia; Brachytherapy; Radiation therapy; Palliative care; Cancer; Surgery; Esophageal disease; Esophagus; Radiology; Internal medicine","score_opus":0.025183704885882494,"score_gpt":0.3318005125469733,"score_spread":0.3066168076610908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018470847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81939906,0.16124992,0.00034670014,0.0060553523,0.0009944845,0.000060068167,0.0007717059,0.00009041592,0.011032229],"genre_scores_gemma":[0.9676032,0.028105156,0.00052997697,0.0013625436,0.00045358622,0.000019028574,0.00026303154,0.00002214104,0.00164135],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9994168,0.00025346407,0.000088385976,0.00007620205,0.00010656261,0.000058599235],"domain_scores_gemma":[0.9986357,0.000763406,0.00030915067,0.00006141405,0.00013726538,0.00009304756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010414316,0.00025058925,0.0015265042,0.00034250823,0.0002749869,0.0004835913,0.00016564867,0.00066609675,0.0042016474],"category_scores_gemma":[0.005223128,0.00014659643,0.0019450551,0.0007227372,0.00017479899,0.00053508877,0.00021116978,0.0006774653,0.00023905878],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.041265722,0.0014459818,0.22032805,0.009109567,0.009805782,0.0011167262,0.001514301,0.0004426352,0.006080146,0.0004101708,0.013074815,0.6954061],"study_design_scores_gemma":[0.0033456385,0.020297728,0.93246967,0.0017315506,0.01609273,0.0017440266,0.0006195397,0.0002688755,0.002585471,0.0005311017,0.020251697,0.00006198319],"about_ca_topic_score_codex":0.0022989344,"about_ca_topic_score_gemma":0.0051996685,"teacher_disagreement_score":0.0042016474,"about_ca_system_score_codex":0.00038927514,"about_ca_system_score_gemma":0.0005233455,"threshold_uncertainty_score":0.014055908},"labels":[],"label_agreement":null},{"id":"W2020317271","doi":"10.1016/j.ctrv.2006.11.003","title":"Common cancers in adolescents","year":2007,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster University Medical Centre; Health Sciences Centre","funders":"","keywords":"Medicine; Neuroblastoma; Leukemia; Soft tissue; Pathology; Young adult; Oncology; Internal medicine; Biology","score_opus":0.15265555086111882,"score_gpt":0.46625882292106585,"score_spread":0.31360327205994704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020317271","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019277606,0.9982863,0.00004689988,0.00024393568,0.00020692861,0.000008886297,0.000056471305,0.000005160362,0.0009526212],"genre_scores_gemma":[0.000942243,0.9981047,0.00009967053,0.0002679363,0.00012440876,0.00000740383,0.000051376446,9.94823e-7,0.0004012666],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9996972,0.00007628408,0.00006280932,0.000045550172,0.00009354519,0.000024598125],"domain_scores_gemma":[0.9995378,0.00017171462,0.00016764538,0.000009944654,0.00007830444,0.000034607758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004385524,0.00072499196,0.0015044872,0.003443282,0.00025536312,0.00084864825,0.00044415996,0.0005901125,0.0053858985],"category_scores_gemma":[0.0011198572,0.0003319536,0.00061941345,0.0039397664,0.0002907554,0.0008018712,0.0006498766,0.0009891145,0.0010733099],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008253101,0.000046616373,0.0019895267,0.038312845,0.00022942932,0.0003128913,0.00010110175,0.00023348277,0.000508002,0.001114327,0.051446714,0.9056225],"study_design_scores_gemma":[0.0000669412,0.00012804767,0.0076338765,0.04049207,0.0011297377,0.0040347287,0.00021366664,0.00007572782,0.00036001843,0.00060953235,0.9452349,0.000020797881],"about_ca_topic_score_codex":0.003912582,"about_ca_topic_score_gemma":0.010778256,"teacher_disagreement_score":0.0053858985,"about_ca_system_score_codex":0.0006664473,"about_ca_system_score_gemma":0.0017907795,"threshold_uncertainty_score":0.01801765},"labels":[],"label_agreement":null},{"id":"W2021777913","doi":"10.1016/j.ctrv.2011.12.002","title":"Controlling angiogenesis in breast cancer: A systematic review of anti-angiogenic trials","year":2012,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":105,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Queen Elizabeth II Health Sciences Centre; BC Cancer Agency; Sunnybrook Health Science Centre; Health Sciences Centre; MacEwan University","funders":"Alberta Health Services","keywords":"Medicine; Sunitinib; Pazopanib; Bevacizumab; Oncology; Clinical trial; Sorafenib; Breast cancer; Internal medicine; Adverse effect; Randomized controlled trial; Chemotherapy; Cancer; Angiogenesis","score_opus":0.10315423392928001,"score_gpt":0.39669616206870056,"score_spread":0.29354192813942054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021777913","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014378535,0.99955195,0.0000426344,0.00006966014,0.00003520471,0.000020078924,0.000055464756,0.0000024985013,0.00007854847],"genre_scores_gemma":[0.0015264796,0.9979234,0.0001901023,0.00019870292,0.000035116325,0.00002375888,0.000046921203,0.0000013950743,0.00005411027],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99913883,0.00023201908,0.00028665044,0.00011130391,0.00018719847,0.00004390514],"domain_scores_gemma":[0.99701643,0.0019895127,0.0006604078,0.00004073272,0.00022521825,0.000067789566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023553353,0.0011753864,0.00558785,0.0031165148,0.00021949163,0.0012702981,0.001271757,0.0010675167,0.003346439],"category_scores_gemma":[0.005212821,0.00051726773,0.0037813042,0.0037666606,0.00034395666,0.00096118863,0.0007108258,0.001122167,0.00030886589],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010901712,0.00007660001,0.0005046927,0.592554,0.009287201,0.00013419204,0.000081403385,0.0004559058,0.00091994775,0.0004621588,0.008999846,0.38543385],"study_design_scores_gemma":[0.0030159352,0.0018291601,0.009207023,0.4681309,0.17270045,0.0014380469,0.00032575885,0.000503229,0.0011867894,0.0017519899,0.33974245,0.00016826298],"about_ca_topic_score_codex":0.00241853,"about_ca_topic_score_gemma":0.008613519,"teacher_disagreement_score":0.00558785,"about_ca_system_score_codex":0.0009678948,"about_ca_system_score_gemma":0.0022581802,"threshold_uncertainty_score":0.0124563575},"labels":[],"label_agreement":null},{"id":"W2022753648","doi":"10.1016/j.ctrv.2006.01.008","title":"Adding raltitrexed to cisplatin improves overall survival in people with malignant pleural mesothelioma","year":2006,"lang":"en","type":"article","venue":"Cancer Treatment Reviews","topic":"Occupational and environmental lung diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Raltitrexed; Medicine; Cisplatin; Mesothelioma; Oncology; Pemetrexed; Internal medicine; Cancer research; Chemotherapy; Pathology; Fluorouracil; Thymidylate synthase","score_opus":0.020823836779793926,"score_gpt":0.2937547142645107,"score_spread":0.2729308774847168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022753648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87556374,0.11730781,0.00042122952,0.0016896682,0.00030567896,0.00007164525,0.00026128907,0.00008559641,0.0042933156],"genre_scores_gemma":[0.9691084,0.027924722,0.00076566765,0.00054017163,0.00024074117,0.000035258934,0.00020090444,0.00000895639,0.0011751953],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9998292,0.00006320527,0.000026737716,0.000020888632,0.000042377997,0.00001756696],"domain_scores_gemma":[0.99967074,0.00014564233,0.00008285071,0.000015015929,0.000041581356,0.000044179582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029874095,0.00019541645,0.00092607236,0.0002249854,0.00015973789,0.00021341839,0.00022226626,0.00023522887,0.0015315447],"category_scores_gemma":[0.0010786025,0.00011382351,0.00076562015,0.00028746514,0.0000858088,0.00021532357,0.00012581133,0.00044383976,0.00017499644],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017873598,0.0016565111,0.069615565,0.0026598917,0.0031808878,0.0005089855,0.00032285924,0.0009822182,0.017345041,0.00009378243,0.0063929027,0.8793677],"study_design_scores_gemma":[0.010951005,0.06577082,0.84984493,0.0007226395,0.013086085,0.004077907,0.0004720525,0.0013957171,0.014293671,0.0003800616,0.03894212,0.00006295809],"about_ca_topic_score_codex":0.001137483,"about_ca_topic_score_gemma":0.0036872379,"teacher_disagreement_score":0.0015315447,"about_ca_system_score_codex":0.00024613613,"about_ca_system_score_gemma":0.00023503987,"threshold_uncertainty_score":0.005123496},"labels":[],"label_agreement":null},{"id":"W2023295373","doi":"10.1016/j.ctrv.2004.09.008","title":"Using aromatase inhibitors in the neoadjuvant setting: evolution or revolution?","year":2004,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Aromatase; Neoadjuvant therapy; Oncology; Internal medicine; Breast cancer; Cancer","score_opus":0.06883962482000135,"score_gpt":0.3904823749099029,"score_spread":0.32164275008990156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023295373","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007128917,0.99783474,0.00010935307,0.0009892907,0.00043413287,0.000001989769,0.000006484008,0.000005352126,0.000547357],"genre_scores_gemma":[0.0005040372,0.99750096,0.00019071189,0.0007792076,0.00043643438,0.000004133658,0.00001204626,0.0000015669453,0.000570829],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997054,0.00007552348,0.000041004307,0.000044508353,0.00010711471,0.000026392216],"domain_scores_gemma":[0.9991529,0.000524353,0.0000801211,0.00002010892,0.00016405842,0.00005840993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013251486,0.00090806565,0.0020647529,0.0013198875,0.0003345955,0.001317666,0.0011379122,0.001888929,0.0038627693],"category_scores_gemma":[0.0017144375,0.00026154515,0.0005386814,0.0019773177,0.0007693776,0.0017061635,0.00045432177,0.002801124,0.0020186421],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001905684,0.00007167638,0.00020976164,0.004866648,0.000089935,0.00029498735,0.000038923456,0.0002508484,0.00092220725,0.002920376,0.065599404,0.92454463],"study_design_scores_gemma":[0.00008346462,0.00014585571,0.00065357494,0.0019859576,0.00013944646,0.0020048164,0.00008593112,0.0000836609,0.00032741638,0.0014655322,0.99300635,0.00001799832],"about_ca_topic_score_codex":0.0016440739,"about_ca_topic_score_gemma":0.0051524495,"teacher_disagreement_score":0.0038627693,"about_ca_system_score_codex":0.0009331644,"about_ca_system_score_gemma":0.0012671811,"threshold_uncertainty_score":0.012922227},"labels":[],"label_agreement":null},{"id":"W2024588260","doi":"10.1016/j.ctrv.2008.03.090","title":"P64. Skeletal related events (SREs) in patients with bone metastases from breast cancer treated with intravenous (i.v.) bisphosphonates (BPs) in the non-trial setting","year":2008,"lang":"en","type":"article","venue":"Cancer Treatment Reviews","topic":"Bone health and treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Credit Valley Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Breast cancer; Clinical trial; Natural history; Oncology; Internal medicine; Disease; Metastatic breast cancer; Cancer; Bone disease; Surgery; Osteoporosis","score_opus":0.01809548469759504,"score_gpt":0.28630878071063326,"score_spread":0.2682132960130382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024588260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89810455,0.07792175,0.00049971574,0.003843818,0.00039920796,0.0004092435,0.0023300466,0.000055008924,0.016436702],"genre_scores_gemma":[0.98581463,0.0109693,0.00031432664,0.00063773553,0.0002952882,0.00016913562,0.0005861239,0.000006397829,0.0012070085],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99864894,0.0010053967,0.00011234729,0.0000654991,0.0001079493,0.000059830047],"domain_scores_gemma":[0.99698216,0.0014729304,0.0011035263,0.000051587074,0.00012558687,0.0002641632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014980828,0.00018212732,0.00059680326,0.00031654644,0.00021382312,0.0004110995,0.00016173924,0.00046022318,0.005076149],"category_scores_gemma":[0.005596683,0.000111507754,0.00074919616,0.0007951409,0.00018614711,0.00021779141,0.00018225989,0.00085283193,0.0003272344],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.23604238,0.0021075867,0.25997815,0.008364315,0.0034064897,0.0011415384,0.00019080623,0.0006937998,0.003219453,0.00095098803,0.019043246,0.4648613],"study_design_scores_gemma":[0.07115594,0.052080683,0.84403795,0.0013876761,0.0046953545,0.0034148651,0.00027500183,0.001530475,0.0013673243,0.0017590268,0.01824521,0.00005042821],"about_ca_topic_score_codex":0.0010466131,"about_ca_topic_score_gemma":0.0032614945,"teacher_disagreement_score":0.005076149,"about_ca_system_score_codex":0.00030851213,"about_ca_system_score_gemma":0.00064646447,"threshold_uncertainty_score":0.016981363},"labels":[],"label_agreement":null},{"id":"W2025769302","doi":"10.1016/j.ctrv.2008.05.007","title":"The kisspeptin (KiSS-1)/GPR54 system in cancer biology","year":2008,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Plant Reproductive Biology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":94,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Kisspeptin; Paracrine signalling; Autocrine signalling; KISS (TNC); Metastasis; Metastasis Suppressor Gene; Cancer; Cancer research; Mechanism (biology); Medicine; Biology; Cell biology; Receptor; Bioinformatics; Internal medicine","score_opus":0.08958089845718112,"score_gpt":0.4000963147817178,"score_spread":0.3105154163245367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025769302","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018759696,0.9968381,0.00038578574,0.00053189485,0.0005225675,0.0000069156195,0.000017298276,0.000016249282,0.0014936093],"genre_scores_gemma":[0.0010674846,0.99592376,0.0004961207,0.00035649494,0.0003479617,0.000012987959,0.000036385325,0.0000027348551,0.0017560631],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99987423,0.000021745764,0.000012911171,0.000021084235,0.000055933207,0.000014203481],"domain_scores_gemma":[0.9998331,0.000072614355,0.000019085459,0.0000057669954,0.000048465186,0.000020954318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006218256,0.00081786735,0.0014614584,0.00097335456,0.00030005828,0.000862651,0.00079027895,0.0010660122,0.004060296],"category_scores_gemma":[0.0004580419,0.0002517898,0.00034514462,0.0012792618,0.00044171608,0.0010771783,0.00058624917,0.0016318642,0.0026801557],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000119707176,0.00007362747,0.0001279858,0.005207523,0.00006885228,0.00024032402,0.000034766876,0.00054098206,0.0058403476,0.0052249567,0.062281977,0.92023903],"study_design_scores_gemma":[0.000039247643,0.000087891814,0.00049488276,0.00080640835,0.000074564865,0.0008599712,0.0000395712,0.00012086382,0.00087407505,0.002126337,0.9944606,0.00001553737],"about_ca_topic_score_codex":0.0009159104,"about_ca_topic_score_gemma":0.0020412917,"teacher_disagreement_score":0.004060296,"about_ca_system_score_codex":0.00069917424,"about_ca_system_score_gemma":0.0008134887,"threshold_uncertainty_score":0.013583064},"labels":[],"label_agreement":null},{"id":"W2027713593","doi":"10.1016/j.ctrv.2005.12.009","title":"Effectiveness of stereotactic radiosurgery alone or in combination with whole brain radiotherapy compared to conventional surgery and/or whole brain radiotherapy for the treatment of one or more brain metastases: A systematic review and meta-analysis","year":2006,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Occupational Cancer Research Centre; Institute of Health Economics","funders":"","keywords":"Medicine; Radiosurgery; Radiation therapy; Whole brain radiotherapy; Brain metastasis; Randomized controlled trial; Quality of life (healthcare); Cohort; Meta-analysis; Overall survival; Surgery; Oncology; Metastasis; Internal medicine; Cancer","score_opus":0.13471160289476167,"score_gpt":0.407240938416746,"score_spread":0.27252933552198433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027713593","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022026747,0.97571373,0.0006754633,0.00014660947,0.00034106287,0.00029689338,0.00038888174,0.00003766733,0.0003729724],"genre_scores_gemma":[0.32379535,0.6712076,0.0022102685,0.000644448,0.00032557358,0.00067649793,0.00045650333,0.00003160929,0.0006521863],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99633336,0.0018150668,0.00082077953,0.0004760643,0.00041653597,0.00013810059],"domain_scores_gemma":[0.99265105,0.005523617,0.0011487919,0.00016835841,0.00036920127,0.00013904313],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.005608672,0.0025778778,0.017508663,0.0028323897,0.0004775169,0.0017009224,0.0016402261,0.0018966725,0.0031216536],"category_scores_gemma":[0.013528305,0.0014827994,0.02532246,0.0030850058,0.0006609701,0.001059743,0.00086619187,0.0021598346,0.00028147263],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016064085,0.0001082742,0.0020892136,0.21697852,0.7448956,0.00016170548,0.000102026635,0.00075972156,0.0005367632,0.000116259675,0.00063050387,0.017557317],"study_design_scores_gemma":[0.0045846147,0.0009827011,0.0022883757,0.00569543,0.98480135,0.00011781357,0.00004069067,0.00018484879,0.00022519138,0.00010469486,0.00094789,0.000026501419],"about_ca_topic_score_codex":0.0076094624,"about_ca_topic_score_gemma":0.01903658,"teacher_disagreement_score":0.9824913,"about_ca_system_score_codex":0.0025773835,"about_ca_system_score_gemma":0.0018250141,"threshold_uncertainty_score":0.029661894},"labels":[],"label_agreement":null},{"id":"W2030627370","doi":"10.1016/j.ctrv.2007.02.004","title":"The effect of anticoagulants on cancer risk and survival: Systematic review","year":2007,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Warfarin; Low molecular weight heparin; Cancer; Oncology; Malignancy; Clinical trial; Lung cancer; Anticoagulant; Heparin; Internal medicine; Intensive care medicine; Randomized controlled trial","score_opus":0.07865189832177222,"score_gpt":0.4311788321912527,"score_spread":0.3525269338694805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030627370","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009482509,0.9984113,0.000070977294,0.000104142986,0.00009768905,0.00007698381,0.00014821677,0.0000054753796,0.0001369298],"genre_scores_gemma":[0.016504107,0.9824818,0.0003268424,0.00032139212,0.00007892391,0.00009690814,0.00008194346,0.0000036170288,0.00010455719],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99665916,0.00122549,0.0010698093,0.00032512879,0.00060041976,0.00012001221],"domain_scores_gemma":[0.9871243,0.008978718,0.0027777273,0.0001575793,0.0007816968,0.00018003296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047607794,0.0013132172,0.008771382,0.0037698452,0.00041161143,0.0017638619,0.0013716357,0.0017884977,0.0045147985],"category_scores_gemma":[0.020865247,0.0011113405,0.007500902,0.0063171173,0.00061244104,0.0013631416,0.0010266311,0.0015277431,0.00027101842],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008395905,0.000034705172,0.001675331,0.8916109,0.06473556,0.00014812418,0.00011215121,0.00022275872,0.000180422,0.00016836904,0.0025449793,0.03772718],"study_design_scores_gemma":[0.0019560284,0.00057574926,0.011534631,0.32367527,0.63802254,0.00061516475,0.00021718605,0.00020551647,0.00029867043,0.0004574443,0.022374962,0.00006689804],"about_ca_topic_score_codex":0.011421402,"about_ca_topic_score_gemma":0.03613433,"teacher_disagreement_score":0.011421402,"about_ca_system_score_codex":0.0020761162,"about_ca_system_score_gemma":0.0050761895,"threshold_uncertainty_score":0.025177777},"labels":[],"label_agreement":null},{"id":"W2035360235","doi":"10.1016/j.ctrv.2006.01.005","title":"Trastuzumab after primary treatment for early stage HER2-positive breast cancer reduces recurrence","year":2006,"lang":"en","type":"article","venue":"Cancer Treatment Reviews","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Trastuzumab; Medicine; Breast cancer; Oncology; Adjuvant; Internal medicine; Chemotherapy; Stage (stratigraphy); Metastatic breast cancer; Monoclonal antibody; Cancer; Antibody; Immunology","score_opus":0.06632819832425466,"score_gpt":0.4043932864000384,"score_spread":0.3380650880757837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035360235","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7213358,0.26299486,0.0007073399,0.0035213914,0.0009273031,0.00007791484,0.00020372563,0.0001513142,0.0100803245],"genre_scores_gemma":[0.9313498,0.058439646,0.0004810924,0.00089755864,0.00069257716,0.00003923535,0.00022782071,0.000028156299,0.007844206],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998522,0.00005670382,0.000010114175,0.000013446057,0.000035542595,0.000031995427],"domain_scores_gemma":[0.99966776,0.00014567468,0.00008536693,0.00001813408,0.000032132255,0.000050882936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035331785,0.0002147458,0.0009942903,0.00023950115,0.00012430451,0.00027199456,0.00023467556,0.00029814374,0.0033894388],"category_scores_gemma":[0.0014683924,0.000086129745,0.00033324797,0.0002244155,0.00008035713,0.00019970837,0.00010450173,0.0005584863,0.00033784108],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017259689,0.001718164,0.009024145,0.00098039,0.00063872023,0.00036079195,0.00014923303,0.00054029323,0.010681368,0.0002970195,0.015432059,0.942918],"study_design_scores_gemma":[0.01792747,0.096310325,0.67733204,0.0011255379,0.0064813085,0.0070105228,0.0004897955,0.002425812,0.030477133,0.0015692975,0.15877202,0.00007875214],"about_ca_topic_score_codex":0.0007756127,"about_ca_topic_score_gemma":0.0025759279,"teacher_disagreement_score":0.0033894388,"about_ca_system_score_codex":0.00030412173,"about_ca_system_score_gemma":0.00026891194,"threshold_uncertainty_score":0.01133883},"labels":[],"label_agreement":null},{"id":"W2041419946","doi":"10.1053/ctrv.2000.0204","title":"Locoregionally recurrent breast cancer: incidence, risk factors and survival","year":2001,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":121,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Incidence (geometry); Breast cancer; Disease; Oncology; Retrospective cohort study; Internal medicine; Cancer; Risk factor","score_opus":0.06059515640962599,"score_gpt":0.3620871464756759,"score_spread":0.30149199006604993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041419946","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000084967716,0.9994541,0.000034895962,0.00015056787,0.00011235212,0.000001698268,0.00001653326,0.0000027614153,0.00014215402],"genre_scores_gemma":[0.00036390877,0.9992416,0.000061866456,0.0000753428,0.000112182315,0.0000031987463,0.000019017933,4.515593e-7,0.00012250658],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9997086,0.000066716224,0.000044798246,0.000043777858,0.00011709598,0.00001889698],"domain_scores_gemma":[0.9993432,0.0003588053,0.00010600096,0.00001589542,0.00014604296,0.00003001084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010141854,0.0010247808,0.0028104323,0.00196185,0.00022819512,0.0010198506,0.0010633168,0.0010569964,0.002278847],"category_scores_gemma":[0.0016029052,0.00033077272,0.0005988942,0.0044913664,0.0003540095,0.0008131841,0.00034629324,0.0012885955,0.0010532998],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022359134,0.00008177137,0.0010990589,0.017452793,0.00030948286,0.00011533877,0.000041560226,0.00036587566,0.0006460048,0.0009028993,0.04959361,0.92916805],"study_design_scores_gemma":[0.00013893226,0.00041527936,0.011625885,0.012303306,0.0017094306,0.0026597923,0.00020915938,0.0002567121,0.000573518,0.0023035319,0.9677518,0.000052712923],"about_ca_topic_score_codex":0.003654674,"about_ca_topic_score_gemma":0.006073678,"teacher_disagreement_score":0.003654674,"about_ca_system_score_codex":0.0006987159,"about_ca_system_score_gemma":0.0012417614,"threshold_uncertainty_score":0.007623434},"labels":[],"label_agreement":null},{"id":"W2041834416","doi":"10.1016/j.ctrv.2012.12.006","title":"A contemporary update on rates and management of toxicities of targeted therapies for metastatic renal cell carcinoma","year":2013,"lang":"en","type":"article","venue":"Cancer Treatment Reviews","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal","funders":"National Cancer Institute; National Comprehensive Cancer Network","keywords":"Medicine; Renal cell carcinoma; Oncology; Carcinoma; Targeted therapy; Internal medicine; Intensive care medicine; Cancer research; Cancer","score_opus":0.07822416874921215,"score_gpt":0.3204338860142576,"score_spread":0.24220971726504545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041834416","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021758443,0.97298247,0.0015829484,0.011879544,0.0036030952,0.00002616769,0.00084945385,0.00012688992,0.006773593],"genre_scores_gemma":[0.012689393,0.9609153,0.0033808844,0.010538396,0.007988672,0.00006677771,0.0014979782,0.000093094066,0.0028295086],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997829,0.00046689424,0.00071545976,0.00018033331,0.0007219912,0.00008619222],"domain_scores_gemma":[0.9819567,0.010046134,0.0030681167,0.00036565636,0.0041604973,0.00040291421],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035662178,0.0006857847,0.0020344693,0.0032104834,0.00029985237,0.0021795947,0.0010642072,0.0012663672,0.003435721],"category_scores_gemma":[0.013810176,0.0003541351,0.0014660445,0.004913895,0.0004028977,0.002602633,0.0006162484,0.0024205672,0.0013402955],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002312179,0.0000528211,0.00246469,0.0047257603,0.00022637025,0.00010405322,0.000070658774,0.00047509617,0.00048796096,0.0009061288,0.12604594,0.86420935],"study_design_scores_gemma":[0.00006790725,0.00027216028,0.010946868,0.008206664,0.0010597856,0.0017786439,0.00010457769,0.00035399894,0.0005677395,0.0007303049,0.97587085,0.0000404681],"about_ca_topic_score_codex":0.003113713,"about_ca_topic_score_gemma":0.008632727,"teacher_disagreement_score":0.0035662178,"about_ca_system_score_codex":0.0018790495,"about_ca_system_score_gemma":0.0020714959,"threshold_uncertainty_score":0.01886022},"labels":[],"label_agreement":null},{"id":"W2042215902","doi":"10.1016/j.ctrv.2007.11.001","title":"Aromatase inhibitors in adjuvant therapy for hormone receptor positive breast cancer: A systematic review","year":2008,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":87,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston General Hospital; Health Sciences Centre; Cancer Care Ontario; Sunnybrook Health Science Centre","funders":"","keywords":"Anastrozole; Exemestane; Letrozole; Medicine; Tamoxifen; Breast cancer; Aromatase; Oncology; Internal medicine; Adjuvant therapy; Hormonal therapy; Aromatase inhibitor; Randomized controlled trial; Gynecology; Cancer","score_opus":0.023350227821109612,"score_gpt":0.334381716166746,"score_spread":0.3110314883456364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042215902","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019741277,0.9994362,0.000036322006,0.00007393468,0.000044600543,0.000020740408,0.00005825457,0.0000024869234,0.00013009332],"genre_scores_gemma":[0.0021667867,0.99734336,0.00013950681,0.00017256178,0.00002866708,0.000023620081,0.00003794748,8.441148e-7,0.000086585416],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9995154,0.00013558139,0.00014637533,0.000059715432,0.00011369777,0.000029322595],"domain_scores_gemma":[0.99860865,0.00086100295,0.00035739178,0.000016478918,0.00012007336,0.00003641473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013480971,0.00084834505,0.0037243085,0.0023702865,0.00016617974,0.00077499985,0.00090757344,0.00079321954,0.003725554],"category_scores_gemma":[0.0034106032,0.0003883927,0.0020247262,0.0035769884,0.00025625993,0.0007103362,0.0005168183,0.00059545133,0.00027236278],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006835749,0.00004574038,0.0005786172,0.6390546,0.007058981,0.00018586243,0.000079387784,0.00038871611,0.00064504065,0.00037346155,0.013727691,0.33717826],"study_design_scores_gemma":[0.0021822883,0.0011239679,0.011387088,0.5273615,0.13888517,0.0018243234,0.0004063989,0.00041053208,0.000908434,0.0011175176,0.3142914,0.000101389676],"about_ca_topic_score_codex":0.0042140246,"about_ca_topic_score_gemma":0.016069818,"teacher_disagreement_score":0.0042140246,"about_ca_system_score_codex":0.0009168954,"about_ca_system_score_gemma":0.0019479915,"threshold_uncertainty_score":0.012463212},"labels":[],"label_agreement":null},{"id":"W2043588430","doi":"10.1016/j.ctrv.2014.10.005","title":"Orphan nuclear receptors as drug targets for the treatment of prostate and breast cancers","year":2014,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Nuclear Receptors and Signaling","field":"Neuroscience","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Office of Naval Research; Canadian Institutes of Health Research; Prostate Cancer Canada","keywords":"Nuclear receptor; Medicine; Tamoxifen; Androgen receptor; Prostate cancer; Receptor; Estrogen receptor; Cancer research; Prostate; Breast cancer; Drug development; Cancer; Internal medicine; Transcription factor; Pharmacology; Biology; Drug; Genetics; Gene","score_opus":0.06341336605189725,"score_gpt":0.3519563982047676,"score_spread":0.28854303215287036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043588430","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008460707,0.99865365,0.000105266285,0.00018093974,0.00016184304,0.0000040349996,0.000016257172,0.0000060791963,0.000787325],"genre_scores_gemma":[0.0004743933,0.9984993,0.00012801409,0.00014235452,0.00012340592,0.000004156118,0.000024519213,0.0000011158422,0.00060277415],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998173,0.000031417105,0.000021711992,0.000027366656,0.00007911279,0.000023063678],"domain_scores_gemma":[0.9997681,0.000098686774,0.000039682818,0.000006153065,0.00006313484,0.000024199391],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005256773,0.00087085186,0.0014558932,0.0018936916,0.0002532131,0.00079886994,0.00084163126,0.0008696085,0.004335514],"category_scores_gemma":[0.0006032182,0.0002487748,0.0005348562,0.0015837777,0.0004351987,0.0008778391,0.00057866366,0.0018672664,0.0018815598],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014121109,0.00007450135,0.00010643478,0.013212445,0.00010495809,0.00018929607,0.000044416163,0.0005222477,0.0032030398,0.0037730488,0.04247177,0.9361566],"study_design_scores_gemma":[0.00003992429,0.00012032659,0.0004907373,0.0026221834,0.00014758293,0.0008785899,0.000041118616,0.00012804924,0.00052804174,0.0015800282,0.99340254,0.000020894417],"about_ca_topic_score_codex":0.0015316914,"about_ca_topic_score_gemma":0.005305492,"teacher_disagreement_score":0.004335514,"about_ca_system_score_codex":0.0006328645,"about_ca_system_score_gemma":0.0009878037,"threshold_uncertainty_score":0.014503777},"labels":[],"label_agreement":null},{"id":"W2046320256","doi":"10.1016/j.ctrv.2005.03.007","title":"Neoadjuvant taxanes in the treatment of non-metastatic breast cancer: A systematic review","year":2005,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Taxane; Breast cancer; Oncology; Neoadjuvant therapy; Anthracycline; Chemotherapy; Internal medicine; Mastectomy; Metastatic breast cancer; Randomized controlled trial; Clinical trial; Cancer","score_opus":0.05156857427744584,"score_gpt":0.38660226890609795,"score_spread":0.3350336946286521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046320256","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003154884,0.99937314,0.000032243774,0.00006678714,0.000035790505,0.000020969741,0.000057741607,0.0000015996837,0.00009622532],"genre_scores_gemma":[0.0024526461,0.9971796,0.00011635172,0.00011726193,0.000022405757,0.000024112074,0.00003565383,6.805356e-7,0.00005126083],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99916005,0.00026966204,0.00027880052,0.00009698266,0.0001625905,0.0000319203],"domain_scores_gemma":[0.99700373,0.002102858,0.00059711916,0.00003373571,0.00020264098,0.000059946276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019034069,0.000772909,0.004484147,0.0023290296,0.0002262449,0.00083752675,0.0009163678,0.00075278874,0.0030794367],"category_scores_gemma":[0.00542814,0.00042915775,0.0025990473,0.0033636186,0.0003366261,0.0007676383,0.0005273575,0.00068663683,0.00023331887],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009948156,0.0000542893,0.0007586665,0.73151296,0.009215043,0.00016701482,0.000087411376,0.00031309488,0.000699262,0.00030879688,0.0066654216,0.2492233],"study_design_scores_gemma":[0.0021805582,0.0014825115,0.013675214,0.6577543,0.16465399,0.0016204626,0.00036948832,0.00030118704,0.001157962,0.0008165872,0.15589345,0.00009425901],"about_ca_topic_score_codex":0.00436764,"about_ca_topic_score_gemma":0.017944736,"teacher_disagreement_score":0.004484147,"about_ca_system_score_codex":0.0011766393,"about_ca_system_score_gemma":0.00283161,"threshold_uncertainty_score":0.010301769},"labels":[],"label_agreement":null},{"id":"W2046702168","doi":"10.1016/j.ctrv.2009.06.006","title":"Management of prostate cancer recurrence after definitive radiation therapy","year":2010,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Prostate cancer; Androgen deprivation therapy; Prostatectomy; Brachytherapy; Cryotherapy; Biochemical recurrence; Radiation therapy; Salvage therapy; External beam radiotherapy; Prostate; Urology; Radiology; Surgery; Cancer; Internal medicine; Chemotherapy","score_opus":0.08981952920318581,"score_gpt":0.4027478522663139,"score_spread":0.31292832306312807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046702168","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008972717,0.99949384,0.000049750637,0.00006994306,0.000060048333,0.0000036246638,0.000007889822,0.0000025143686,0.00022272991],"genre_scores_gemma":[0.0012210959,0.99813724,0.00015894319,0.00017551328,0.00010433327,0.0000048799784,0.00002197439,0.0000011369561,0.00017478218],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99952304,0.00010619246,0.00010788307,0.000079916616,0.00015793458,0.000025130672],"domain_scores_gemma":[0.9992568,0.00043055086,0.00017610504,0.000011986637,0.000101803846,0.000022713388],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008086505,0.0008346333,0.0024589088,0.0023284093,0.00021331546,0.0010592272,0.0012822285,0.0009191192,0.0025368545],"category_scores_gemma":[0.0019152354,0.0004013337,0.0012555736,0.0015188097,0.00042336923,0.0009048259,0.0004342696,0.0012962315,0.0006565759],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011999367,0.000047901958,0.00049167237,0.04489808,0.00046329494,0.00025004032,0.000059714297,0.00039494855,0.00045903347,0.0005611223,0.016205613,0.93604857],"study_design_scores_gemma":[0.00028094044,0.00068260037,0.010246522,0.067484245,0.004945031,0.009470512,0.0003408482,0.00057206344,0.00094749255,0.0014821565,0.9034449,0.000102727536],"about_ca_topic_score_codex":0.002877174,"about_ca_topic_score_gemma":0.0072763804,"teacher_disagreement_score":0.002877174,"about_ca_system_score_codex":0.0007444765,"about_ca_system_score_gemma":0.001118435,"threshold_uncertainty_score":0.0084866285},"labels":[],"label_agreement":null},{"id":"W2047332601","doi":"10.1016/j.ctrv.2005.05.001","title":"Major cytogenetic aberrations and typical multidrug resistance phenotype of uveal melanoma: Current views and new therapeutic prospects","year":2005,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Ocular Oncology and Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Fondation Mérieux; Ligue Contre le Cancer; Fondation pour la Recherche Médicale","keywords":"Monosomy; Melanoma; Medicine; Cancer research; Disease; Metastasis; Cancer; Natural history; Pathology; Oncology; Chromosome; Internal medicine; Gene; Karyotype; Biology; Genetics","score_opus":0.14828088918315627,"score_gpt":0.428477861503706,"score_spread":0.28019697232054974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047332601","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013076751,0.9991942,0.000078635836,0.00018516832,0.0000792321,0.0000016893661,0.000007181083,0.0000040623454,0.00031898645],"genre_scores_gemma":[0.00066976633,0.9985746,0.00014436136,0.00012793842,0.00016664452,0.0000030016527,0.0000208588,5.74267e-7,0.00029219032],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998029,0.000030417788,0.00003466831,0.00004451134,0.00006763693,0.000019984576],"domain_scores_gemma":[0.9995962,0.00018550942,0.00007816762,0.000009749241,0.00009531846,0.000035121124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063466904,0.0007504759,0.0021316186,0.0018266123,0.0002423206,0.0012686024,0.0009022252,0.001122924,0.0030548295],"category_scores_gemma":[0.0006664895,0.0002901581,0.0004953827,0.0023168363,0.0004696827,0.001444308,0.00047728687,0.0011966081,0.001419791],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024780256,0.0000793498,0.0005822417,0.010807134,0.000117234384,0.000914322,0.00007136203,0.00022958875,0.003229357,0.0016911457,0.024213297,0.9578172],"study_design_scores_gemma":[0.000089270914,0.0002729479,0.004185742,0.0034059677,0.0004970459,0.009761324,0.00024104642,0.00017995184,0.0012865124,0.0026238419,0.9774115,0.000044785436],"about_ca_topic_score_codex":0.0011552129,"about_ca_topic_score_gemma":0.002480019,"teacher_disagreement_score":0.0030548295,"about_ca_system_score_codex":0.0004981022,"about_ca_system_score_gemma":0.0011485935,"threshold_uncertainty_score":0.010219395},"labels":[],"label_agreement":null},{"id":"W2048922859","doi":"10.1016/j.ctrv.2014.12.010","title":"A systematic review of factors influencing older adults’ decision to accept or decline cancer treatment","year":2014,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Frailty in Older Adults","field":"Medicine","cited_by":263,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Ontario Council of University Libraries; Université de Montréal; Princess Margaret Cancer Centre; Jewish General Hospital; University Health Network; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Cancer; Gerontology; MEDLINE; Intensive care medicine; Internal medicine","score_opus":0.08762258422028803,"score_gpt":0.432860757652245,"score_spread":0.345238173431957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048922859","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001673967,0.99725586,0.0000742232,0.00021436515,0.00011097343,0.0001846134,0.00028737745,0.0000049292767,0.00019368863],"genre_scores_gemma":[0.033610724,0.96398664,0.00071745523,0.00088491297,0.00008013991,0.00038832484,0.00017083898,0.0000040050695,0.00015697548],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9941499,0.0020479276,0.0023340718,0.0004394798,0.00081171945,0.00021687942],"domain_scores_gemma":[0.9854359,0.009436772,0.003700519,0.00016774757,0.0009834018,0.00027561947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005846665,0.0014053548,0.007032134,0.005168192,0.0005654745,0.0020137748,0.001007741,0.0016263478,0.004235648],"category_scores_gemma":[0.03353558,0.001014207,0.010226304,0.006343527,0.000550354,0.0014309018,0.001347055,0.0017207584,0.0002053428],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056648825,0.000038466736,0.0034894506,0.89746815,0.04938869,0.00010051164,0.00027990364,0.00012523988,0.00011389831,0.00015285455,0.002299812,0.04597654],"study_design_scores_gemma":[0.0010031039,0.00037590347,0.013072821,0.6279271,0.33864096,0.0002860414,0.0003724677,0.000102268656,0.00012006853,0.00027713974,0.017756665,0.00006541244],"about_ca_topic_score_codex":0.019561043,"about_ca_topic_score_gemma":0.083034955,"teacher_disagreement_score":0.019561043,"about_ca_system_score_codex":0.003977503,"about_ca_system_score_gemma":0.009066118,"threshold_uncertainty_score":0.038894415},"labels":[],"label_agreement":null},{"id":"W2052249651","doi":"10.1016/j.ctrv.2014.08.003","title":"Prognostic relevance of receptor tyrosine kinase expression in breast cancer: A meta-analysis","year":2014,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Receptor tyrosine kinase; Odds ratio; Oncology; Breast cancer; Internal medicine; Meta-analysis; Confidence interval; Cancer; Fibroblast growth factor receptor; Epidermal growth factor receptor; Receptor; Tyrosine kinase; Cancer research; Fibroblast growth factor","score_opus":0.23622312007243446,"score_gpt":0.4790153302447197,"score_spread":0.24279221017228525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052249651","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005772183,0.99283147,0.00040959058,0.00016072542,0.00013278889,0.000031026684,0.0004432081,0.000016562737,0.00020242963],"genre_scores_gemma":[0.21486993,0.78077614,0.0014688743,0.0009007891,0.00033232287,0.00013508984,0.0009629485,0.00003321337,0.00052074],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99702185,0.0013091157,0.00065153756,0.0005076462,0.00035859403,0.0001512482],"domain_scores_gemma":[0.99563533,0.0030966713,0.00067158893,0.0001945522,0.00030665967,0.00009523367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047710566,0.001860496,0.008444816,0.0023371475,0.00026730463,0.0014912892,0.0011909611,0.0011309254,0.0030683414],"category_scores_gemma":[0.00819343,0.000971093,0.022008162,0.004363834,0.0003236913,0.0010129575,0.0010223965,0.0015299997,0.0002991491],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031238159,0.00003339678,0.013955356,0.12006411,0.8325856,0.00015744612,0.000061284416,0.00093147065,0.00050438906,0.00016447957,0.0019255424,0.026493056],"study_design_scores_gemma":[0.00045708395,0.00013181366,0.008700934,0.004538458,0.98301214,0.00009601508,0.00003454216,0.00018697121,0.00010510585,0.00023433761,0.0024774978,0.00002505109],"about_ca_topic_score_codex":0.004331718,"about_ca_topic_score_gemma":0.011577805,"teacher_disagreement_score":0.008444816,"about_ca_system_score_codex":0.0010243806,"about_ca_system_score_gemma":0.0012804039,"threshold_uncertainty_score":0.025232017},"labels":[],"label_agreement":null},{"id":"W2054510044","doi":"10.1016/j.ctrv.2014.03.001","title":"Psychosocial predictors of health outcomes in colorectal cancer: A comprehensive review","year":2014,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Cancer survivorship and care","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brain and Cognition Discovery Foundation","funders":"Conselho Nacional de Desenvolvimento Científico e Tecnológico; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior","keywords":"Medicine; Psychosocial; Distress; Personality; Clinical psychology; Psychological intervention; Population; Quality of life (healthcare); Coping (psychology); Mental health; Psychiatry; Psychology","score_opus":0.10006587990176898,"score_gpt":0.4456100506702709,"score_spread":0.3455441707685019,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054510044","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018498587,0.999613,0.000017188197,0.00006196937,0.000035769135,0.000005838699,0.000031962372,0.0000011340748,0.000048149846],"genre_scores_gemma":[0.0013715033,0.9983588,0.00008410221,0.00008903965,0.000039192488,0.000008601823,0.000024763127,4.025705e-7,0.000023579729],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99926287,0.0001702402,0.00021678203,0.00011960087,0.0001883868,0.000042189637],"domain_scores_gemma":[0.996947,0.0021384726,0.0005640966,0.00003402457,0.00024212952,0.00007437392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015789277,0.000993272,0.0031547546,0.0033202434,0.00033086358,0.0012692484,0.0010104174,0.0010150872,0.002730985],"category_scores_gemma":[0.0049519455,0.00052309566,0.0030349037,0.0043338966,0.00042725517,0.001154963,0.0010289904,0.001285982,0.00023641178],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027938085,0.00016076927,0.00639183,0.3677676,0.00733857,0.00014168558,0.00019326416,0.0003029654,0.00033657686,0.00046451882,0.012490098,0.6041327],"study_design_scores_gemma":[0.00038796433,0.000716324,0.081998155,0.5879053,0.077598415,0.002110553,0.0011157932,0.00043410202,0.0005052311,0.0017543843,0.24521814,0.00025565422],"about_ca_topic_score_codex":0.00588533,"about_ca_topic_score_gemma":0.016243236,"teacher_disagreement_score":0.00588533,"about_ca_system_score_codex":0.00071328634,"about_ca_system_score_gemma":0.0026041253,"threshold_uncertainty_score":0.01170218},"labels":[],"label_agreement":null},{"id":"W2063000484","doi":"10.1016/j.ctrv.2005.04.007","title":"Radiotherapeutic management of brain metastases: A systematic review and meta-analysis","year":2005,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":172,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Radiosurgery; Radiation therapy; Brain metastasis; Randomized controlled trial; Oncology; Quality of life (healthcare); Dose fractionation; Cancer; Surgery; Metastasis; Internal medicine","score_opus":0.20633974142822736,"score_gpt":0.45643957404128843,"score_spread":0.25009983261306107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063000484","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003760461,0.9951407,0.0003471984,0.00010340464,0.000110496796,0.0001596122,0.00019664623,0.000012217479,0.00016926361],"genre_scores_gemma":[0.120856464,0.8757313,0.0017770311,0.000566174,0.00014236293,0.000407627,0.00025130957,0.000017771748,0.00024988689],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9948178,0.0025446755,0.0013299028,0.0005286443,0.00061418564,0.00016482177],"domain_scores_gemma":[0.9900849,0.006867973,0.0020539295,0.0002532331,0.00061000057,0.00013009194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006927538,0.0019234271,0.014266133,0.003653325,0.00044834954,0.0015299524,0.0015437595,0.001501702,0.0030067419],"category_scores_gemma":[0.020157134,0.0012978906,0.017039798,0.0050377767,0.0005647848,0.0010947608,0.0010832822,0.0014451438,0.00022392692],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025351406,0.000044312732,0.0029710068,0.45760554,0.5103839,0.00018115828,0.00014034477,0.00066370436,0.00034146305,0.00013228807,0.0010407813,0.023960302],"study_design_scores_gemma":[0.0010821405,0.00033352798,0.0035300453,0.025709568,0.9660162,0.00017943297,0.0000650227,0.00014541084,0.00013741788,0.0001566537,0.0026165496,0.00002805653],"about_ca_topic_score_codex":0.008031163,"about_ca_topic_score_gemma":0.02697788,"teacher_disagreement_score":0.014266133,"about_ca_system_score_codex":0.0023153552,"about_ca_system_score_gemma":0.0025467216,"threshold_uncertainty_score":0.03663677},"labels":[],"label_agreement":null},{"id":"W2064815063","doi":"10.1016/j.ctrv.2013.11.001","title":"Exercise training for people following lung resection for non-small cell lung cancer – A Cochrane systematic review","year":2013,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Physical therapy; Lung cancer; Confidence interval; Randomized controlled trial; Meta-analysis; Quality of life (healthcare); MEDLINE; Vital capacity; Strictly standardized mean difference; Lung; Internal medicine; Lung function; Diffusing capacity","score_opus":0.080934093989471,"score_gpt":0.4138930445958479,"score_spread":0.3329589506063769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064815063","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0023827513,0.9961773,0.00009374135,0.00019114811,0.00016948712,0.00031253466,0.00027465017,0.000012725591,0.00038564383],"genre_scores_gemma":[0.032786705,0.9649797,0.0005127297,0.0006638627,0.00010799335,0.0004473712,0.00013286906,0.0000063364823,0.0003624474],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9987066,0.00045826702,0.00040319323,0.00013625999,0.00019889398,0.000096724296],"domain_scores_gemma":[0.99642986,0.0021637937,0.0010421119,0.00004445332,0.00019713791,0.00012269462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017422355,0.001110442,0.0063312314,0.0038945707,0.0004537859,0.0014659063,0.00085767964,0.001728292,0.00650729],"category_scores_gemma":[0.008854542,0.0008648534,0.0069047306,0.0040194686,0.00053165987,0.0010695058,0.001032772,0.0018535216,0.00027129063],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009965394,0.0000714273,0.00058444974,0.9204675,0.017980631,0.00010365093,0.00015015207,0.00020454165,0.00027528236,0.00014283013,0.0024560816,0.056566916],"study_design_scores_gemma":[0.0044736476,0.0012341175,0.011076783,0.7475208,0.20406187,0.0005910694,0.00044370093,0.00025089516,0.00039338766,0.00038104816,0.02948978,0.00008285504],"about_ca_topic_score_codex":0.0165841,"about_ca_topic_score_gemma":0.05657976,"teacher_disagreement_score":0.0165841,"about_ca_system_score_codex":0.0027698039,"about_ca_system_score_gemma":0.004301975,"threshold_uncertainty_score":0.032975137},"labels":[],"label_agreement":null},{"id":"W2065151790","doi":"10.1016/j.ctrv.2011.06.009","title":"Endometrial cancer and venous thromboembolism in women under age 50 who take tamoxifen for prevention of breast cancer: A systematic review","year":2011,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":87,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; University of Toronto; Women's College Hospital","funders":"","keywords":"Medicine; Tamoxifen; Breast cancer; Endometrial cancer; Internal medicine; Pulmonary embolism; Gynecology; Relative risk; Cancer; Oncology; Deep vein; Placebo; Obstetrics; Thrombosis; Confidence interval; Pathology","score_opus":0.04801220906922657,"score_gpt":0.35870183004189293,"score_spread":0.3106896209726664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065151790","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00036788924,0.9992823,0.000028905743,0.00006644457,0.000040348816,0.00002881497,0.000092668604,0.0000020893228,0.000090572285],"genre_scores_gemma":[0.0039048044,0.9956132,0.00013466713,0.00016617899,0.000032927466,0.000031958592,0.00005245026,9.825799e-7,0.00006285484],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99909294,0.00022250602,0.00033891056,0.00010877366,0.00019006662,0.000046776942],"domain_scores_gemma":[0.9966924,0.0021111388,0.00082380406,0.000035748428,0.0002706692,0.00006610603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015372077,0.00089834246,0.004926803,0.0040497235,0.00026409983,0.0010272998,0.00094327773,0.0011274762,0.0036243137],"category_scores_gemma":[0.006780227,0.0006636012,0.0042726505,0.0046996702,0.00034860458,0.0009053883,0.00078761793,0.00078382593,0.00020208953],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044150546,0.00003237991,0.0013797994,0.85305244,0.013705857,0.00016254578,0.000113862014,0.00015276346,0.0003226772,0.00018392976,0.00460088,0.12585132],"study_design_scores_gemma":[0.0010917069,0.0006102414,0.016582768,0.64685607,0.25112966,0.0013232474,0.00037737412,0.00017284251,0.00040668467,0.0005538942,0.080802865,0.000092663046],"about_ca_topic_score_codex":0.008949624,"about_ca_topic_score_gemma":0.028916162,"teacher_disagreement_score":0.008949624,"about_ca_system_score_codex":0.0011494823,"about_ca_system_score_gemma":0.0030579069,"threshold_uncertainty_score":0.017795086},"labels":[],"label_agreement":null},{"id":"W2068928636","doi":"10.1016/j.ctrv.2010.04.006","title":"The safety and effectiveness of endoscopic and non-endoscopic approaches to the management of early esophageal cancer: A systematic review","year":2010,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; MEDLINE; CINAHL; Cochrane Library; Systematic review; Adverse effect; Meta-analysis; Esophageal cancer; Esophagectomy; English language; Intensive care medicine; Cancer; Internal medicine; Psychological intervention","score_opus":0.09218007709715578,"score_gpt":0.3808785577789474,"score_spread":0.2886984806817916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068928636","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017497193,0.9977059,0.00008196907,0.00008447028,0.00007248308,0.00008003773,0.000113181624,0.0000032253206,0.00010914059],"genre_scores_gemma":[0.029308349,0.9696332,0.00038982226,0.0002907841,0.00008462082,0.00011011287,0.000102398524,0.0000032403595,0.00007735449],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9946584,0.0020450514,0.0018660224,0.000447934,0.0008472489,0.0001353761],"domain_scores_gemma":[0.9770445,0.016897831,0.004367496,0.00025775933,0.0012000574,0.00023244636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006596468,0.001169459,0.008918031,0.0034095743,0.0004012637,0.0016531282,0.0013069647,0.0016541218,0.0024186543],"category_scores_gemma":[0.03030502,0.000920069,0.009538667,0.0039660754,0.0008317778,0.0014024536,0.0010638711,0.001584501,0.00017866048],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002207728,0.000046596502,0.0017450126,0.8631436,0.078834996,0.00011891845,0.00014944663,0.00021083755,0.0003023111,0.00015024545,0.0011555683,0.051934674],"study_design_scores_gemma":[0.002683112,0.0012453776,0.011594503,0.31378707,0.655704,0.00053284026,0.00033316037,0.00019772106,0.0004934617,0.00039632275,0.012956311,0.00007602512],"about_ca_topic_score_codex":0.00599319,"about_ca_topic_score_gemma":0.017967321,"teacher_disagreement_score":0.008918031,"about_ca_system_score_codex":0.0022512581,"about_ca_system_score_gemma":0.004014693,"threshold_uncertainty_score":0.034885824},"labels":[],"label_agreement":null},{"id":"W2069700598","doi":"10.1016/j.ctrv.2008.03.011","title":"Long-term outcome of laparoscopic surgery for colorectal cancer: A cochrane systematic review of randomised controlled trials","year":2008,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":373,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Colorectal cancer; Laparoscopic surgery; Hazard ratio; Cochrane Library; Surgery; Randomized controlled trial; Cancer; Laparoscopy; Colectomy; Meta-analysis; Rectum; Internal medicine; Confidence interval","score_opus":0.1825859753002003,"score_gpt":0.467226585925209,"score_spread":0.28464061062500867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069700598","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0029989919,0.99551326,0.00021613446,0.00013465669,0.00016603558,0.0004957975,0.00027063585,0.0000189398,0.00018558041],"genre_scores_gemma":[0.061310604,0.934622,0.001415407,0.00071177684,0.00013970412,0.0011990177,0.00028949408,0.000016204902,0.0002958117],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9913334,0.0036714962,0.002760964,0.00077867095,0.0011535281,0.00030190864],"domain_scores_gemma":[0.97952384,0.013725149,0.0051371264,0.00031597647,0.00091274874,0.0003850857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009608658,0.002355494,0.016866423,0.004543525,0.000738872,0.0028984793,0.0024250837,0.0029215103,0.0050785094],"category_scores_gemma":[0.035993785,0.0018668034,0.013698494,0.0054448186,0.0014443176,0.0023720383,0.0019235655,0.0032896851,0.00027442668],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039279833,0.000030461611,0.0007364227,0.90891135,0.06972364,0.00009201716,0.00012797645,0.00019351274,0.00018111819,0.00012462134,0.00091560045,0.015035287],"study_design_scores_gemma":[0.013543951,0.0011608613,0.0072375503,0.33168948,0.63567907,0.00048769114,0.00030947386,0.0002773414,0.00030139627,0.0006027778,0.008602763,0.000107699765],"about_ca_topic_score_codex":0.011809965,"about_ca_topic_score_gemma":0.032328032,"teacher_disagreement_score":0.016866423,"about_ca_system_score_codex":0.0054465053,"about_ca_system_score_gemma":0.0072149364,"threshold_uncertainty_score":0.05081606},"labels":[],"label_agreement":null},{"id":"W2069702330","doi":"10.1016/s0305-7372(02)00044-0","title":"Cancer and thromboembolic disease: pathogenic mechanisms","year":2002,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":153,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences","funders":"","keywords":"Medicine; Angiogenesis; Coagulation; Cancer; Tissue factor; Metastasis; Thrombosis; Cancer research; Immunology; Pathology; Internal medicine","score_opus":0.10017798728227666,"score_gpt":0.38186910538659924,"score_spread":0.28169111810432257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069702330","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005866143,0.9989864,0.000045584904,0.00020737373,0.000245036,0.0000042244974,0.000008727629,0.0000034753311,0.00044043892],"genre_scores_gemma":[0.00032021973,0.9988581,0.00009381629,0.00021438014,0.00020929902,0.0000044841972,0.000011294114,5.079059e-7,0.0002878076],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99960214,0.000090020694,0.00007108616,0.00005507422,0.00015127605,0.000030317859],"domain_scores_gemma":[0.99937636,0.00028928166,0.00012768923,0.000013863661,0.00015329313,0.00003951371],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077145715,0.0015110228,0.0025451656,0.0032797235,0.00038175128,0.0015847387,0.00077114365,0.0016464689,0.0035803367],"category_scores_gemma":[0.0011489848,0.00044413962,0.0006467917,0.0047964486,0.0005455696,0.0017119593,0.0006940637,0.0016128102,0.0016328915],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013659202,0.000099593955,0.00045422075,0.029889662,0.00018887811,0.00049375586,0.000085487125,0.0003825732,0.0011425704,0.0015688649,0.0563802,0.9091775],"study_design_scores_gemma":[0.00005998189,0.00014394025,0.0018705742,0.0090407245,0.00058483693,0.0026747228,0.00012696687,0.00009992068,0.00023663892,0.0010292487,0.984108,0.000024486406],"about_ca_topic_score_codex":0.0021675671,"about_ca_topic_score_gemma":0.0054248977,"teacher_disagreement_score":0.0035803367,"about_ca_system_score_codex":0.0008234959,"about_ca_system_score_gemma":0.0020217232,"threshold_uncertainty_score":0.011977375},"labels":[],"label_agreement":null},{"id":"W2069941849","doi":"10.1016/s0305-7372(03)00165-8","title":"Delaying post-operative radiotherapy may increase risk of local recurrence in people with breast cancer","year":2003,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec","funders":"","keywords":"Medicine; Radiation therapy; Breast cancer; Cancer; Oncology; Internal medicine","score_opus":0.024251541734225966,"score_gpt":0.35027359381570095,"score_spread":0.326022052081475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069941849","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005923718,0.99808025,0.00006473099,0.0003900169,0.00017119593,0.0000031052568,0.000020883657,0.000004030903,0.00067340536],"genre_scores_gemma":[0.0033717065,0.99573743,0.00011703596,0.00022564459,0.00015424677,0.0000063813627,0.000023126195,8.667102e-7,0.00036350585],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99979776,0.000059771453,0.00002438003,0.000028848865,0.00007260341,0.000016641137],"domain_scores_gemma":[0.999332,0.00043008567,0.00012379234,0.000012915201,0.00007780243,0.000023370087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050865806,0.0005190698,0.0015249483,0.0008101688,0.00019247492,0.00057266036,0.0005654317,0.0009706375,0.0038232065],"category_scores_gemma":[0.0014471579,0.00019596783,0.00066448847,0.0013970275,0.00023823735,0.00038044373,0.0001928096,0.00086969556,0.00066575815],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033243868,0.00014458798,0.005750016,0.01305898,0.00046926524,0.00041282718,0.000055197856,0.00028338665,0.000776732,0.00065191236,0.02065666,0.957408],"study_design_scores_gemma":[0.0003782962,0.0015686911,0.09841384,0.01778814,0.0051353015,0.010612489,0.00045428504,0.0002856619,0.0019759547,0.0028496739,0.86044914,0.00008849882],"about_ca_topic_score_codex":0.0029635164,"about_ca_topic_score_gemma":0.006104504,"teacher_disagreement_score":0.0038232065,"about_ca_system_score_codex":0.0004339991,"about_ca_system_score_gemma":0.00079410966,"threshold_uncertainty_score":0.012789965},"labels":[],"label_agreement":null},{"id":"W2070095096","doi":"10.1016/j.ctrv.2015.02.001","title":"Primary and secondary bone lymphomas","year":2015,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":130,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Lymphoma; Malignancy; Pathological; Disease; Radiation therapy; Pathology; Radiology","score_opus":0.11476396420634723,"score_gpt":0.3917319352950804,"score_spread":0.27696797108873317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070095096","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008944779,0.9988488,0.00003201042,0.00013925807,0.00012560346,0.000007804629,0.00003308442,0.0000046999953,0.00071922754],"genre_scores_gemma":[0.0009302459,0.9979803,0.00010251278,0.00039759552,0.00013422145,0.0000075634875,0.00004820792,0.0000013463862,0.0003980007],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99957234,0.00009047199,0.000117053896,0.000060504546,0.00012332054,0.000036295092],"domain_scores_gemma":[0.9993649,0.0002834393,0.00019985702,0.0000144067735,0.00009887952,0.000038428283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006040484,0.0008096506,0.0018913993,0.0038169518,0.00023438799,0.0011596743,0.0006343778,0.0007924149,0.008803342],"category_scores_gemma":[0.0017513469,0.00036092827,0.0008370956,0.0031083876,0.00041162065,0.0011655033,0.0008438995,0.0011808095,0.0013344486],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013320417,0.00005845418,0.00044298067,0.090931304,0.00037875117,0.00020680571,0.000086661574,0.00021674746,0.00053817226,0.0011154496,0.044741787,0.86114967],"study_design_scores_gemma":[0.00013016758,0.00015723177,0.002727545,0.06265373,0.0024396952,0.0026920305,0.00015289093,0.00008852936,0.00031105801,0.0010058053,0.9276083,0.000032892913],"about_ca_topic_score_codex":0.002055938,"about_ca_topic_score_gemma":0.0076177274,"teacher_disagreement_score":0.008803342,"about_ca_system_score_codex":0.00079622894,"about_ca_system_score_gemma":0.0017779372,"threshold_uncertainty_score":0.029450119},"labels":[],"label_agreement":null},{"id":"W2070849505","doi":"10.1053/ctrv.2000.0174","title":"Breast cancer risk following irradiation for Hodgkin’s disease","year":2000,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":114,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Breast cancer; Disease; Radiation therapy; Cancer; Oncology; Internal medicine; Stage (stratigraphy)","score_opus":0.04497273947181886,"score_gpt":0.37368563754867035,"score_spread":0.3287128980768515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070849505","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00028748732,0.9986518,0.000048956124,0.00020767984,0.000114778355,0.00000179444,0.000017123442,0.0000026477194,0.0006676918],"genre_scores_gemma":[0.001367939,0.9978295,0.00006597362,0.0001321251,0.00013157162,0.0000033522417,0.00001820516,6.2711405e-7,0.00045077244],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999793,0.000058261252,0.000021927186,0.000037010082,0.000075318196,0.000014555439],"domain_scores_gemma":[0.999554,0.00028972878,0.00007223849,0.000008758743,0.000062192754,0.000013120611],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006544646,0.0005397008,0.0013403633,0.0011462168,0.00016437296,0.0005964223,0.00046907307,0.0008425938,0.0022748648],"category_scores_gemma":[0.0011358291,0.00020347042,0.0003782832,0.0016999559,0.00026229108,0.0003635206,0.00023032723,0.00076406513,0.0008181],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026426144,0.00005006026,0.0017426702,0.010373974,0.00024592842,0.00034718929,0.000045332938,0.00027170804,0.0011722238,0.00095508527,0.026252424,0.95827913],"study_design_scores_gemma":[0.000109257235,0.00059758365,0.023740105,0.010955271,0.0013419128,0.006531836,0.00016069716,0.00012311037,0.0019186968,0.0021735516,0.9523101,0.000037941805],"about_ca_topic_score_codex":0.0021245738,"about_ca_topic_score_gemma":0.0046499097,"teacher_disagreement_score":0.0022748648,"about_ca_system_score_codex":0.0006233446,"about_ca_system_score_gemma":0.00073213346,"threshold_uncertainty_score":0.007610202},"labels":[],"label_agreement":null},{"id":"W2071668211","doi":"10.1016/j.ctrv.2004.03.005","title":"No difference between pamidronate disodium and placebo in relieving bone pain in men with advanced prostate cancer","year":2004,"lang":"en","type":"letter","venue":"Cancer Treatment Reviews","topic":"Bone health and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Prostate cancer; Bone pain; Bone resorption; Concomitant; Placebo; Osteoclast; Prostate; Bone metastasis; Pain control; Palliative care; Internal medicine; Oncology; Cancer; Surgery; Pathology","score_opus":0.02770496021028831,"score_gpt":0.3182080621686497,"score_spread":0.29050310195836143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071668211","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09311246,0.10689975,0.00043163067,0.72263,0.039129976,0.00033920005,0.001464599,0.0001784907,0.03581391],"genre_scores_gemma":[0.37717608,0.032746837,0.001351816,0.50789046,0.056077037,0.0003519777,0.0005817966,0.000056852547,0.02376717],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985391,0.00078325067,0.00020798638,0.000108474545,0.00025461114,0.00010658504],"domain_scores_gemma":[0.99426854,0.0040978,0.0004251715,0.000092441114,0.0004411974,0.0006749165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028385792,0.00029130033,0.0020881114,0.0003969061,0.00083883427,0.00067213346,0.0007287341,0.00974303,0.011279339],"category_scores_gemma":[0.012721618,0.00034716786,0.0011749968,0.00045606826,0.0005945618,0.00073298416,0.0002739974,0.0041226936,0.0013968206],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15118301,0.0017254605,0.009340454,0.00613804,0.0020074495,0.0050208233,0.00042649615,0.0003660173,0.006131031,0.002542746,0.46102154,0.35409692],"study_design_scores_gemma":[0.18290246,0.052326236,0.07880453,0.003809879,0.007853243,0.008221208,0.001188072,0.0012151948,0.0044892756,0.005723813,0.65320486,0.0002612956],"about_ca_topic_score_codex":0.0024648916,"about_ca_topic_score_gemma":0.008939843,"teacher_disagreement_score":0.011279339,"about_ca_system_score_codex":0.0015000205,"about_ca_system_score_gemma":0.0010873901,"threshold_uncertainty_score":0.037733138},"labels":[],"label_agreement":null},{"id":"W2072076152","doi":"10.1053/ctrv.2001.0227","title":"Integration of Chinese medicine into supportive cancer care:A modern role for an ancient tradition","year":2001,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Complementary and Alternative Medicine Studies","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Regional Laboratory Medicine Program","funders":"","keywords":"Medicine; MEDLINE; Integrative medicine; Alternative medicine; Traditional Chinese medicine; Evidence-based medicine; Western medicine; Health care; Cancer treatment; Traditional medicine; Cancer; Internal medicine; Pathology","score_opus":0.20861068330316107,"score_gpt":0.4909616684070676,"score_spread":0.28235098510390655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072076152","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00030627847,0.99672097,0.00008565516,0.001072721,0.00029054165,0.0000031982142,0.0000037682773,0.0000022234447,0.0015146094],"genre_scores_gemma":[0.002557215,0.9951722,0.00035010316,0.00095673004,0.0004804778,0.0000050813796,0.00000576966,0.0000011069794,0.00047125708],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996755,0.00011380603,0.0000422855,0.000043831467,0.00010502717,0.000019556224],"domain_scores_gemma":[0.9990526,0.0006371744,0.00007889615,0.000028104874,0.00016883168,0.000034391556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015408744,0.0005491224,0.0014464408,0.0023701524,0.00074054307,0.0017221868,0.0007310027,0.0011572979,0.0036038223],"category_scores_gemma":[0.0011720351,0.00016836161,0.00039979065,0.004182961,0.0017292266,0.002666763,0.00086174556,0.0016559726,0.0003639856],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012074827,0.00011880509,0.00056453375,0.028586011,0.0001461535,0.00021259958,0.0007321019,0.0001509712,0.001483169,0.015081436,0.0114672035,0.9413363],"study_design_scores_gemma":[0.000081303995,0.0002456681,0.008404133,0.021941008,0.00043579758,0.001526609,0.0011502703,0.00015477465,0.0008004911,0.009731014,0.9554726,0.000056311565],"about_ca_topic_score_codex":0.0024863477,"about_ca_topic_score_gemma":0.0076086842,"teacher_disagreement_score":0.0036038223,"about_ca_system_score_codex":0.0013880216,"about_ca_system_score_gemma":0.0029828814,"threshold_uncertainty_score":0.012055993},"labels":[],"label_agreement":null},{"id":"W2076971514","doi":"10.1016/s0305-7372(02)00042-7","title":"Managing thromboembolic disease in the cancer patient: efficacy and safety of antithrombotic treatment options in patients with cancer","year":2002,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Cancer; Antithrombotic; Thrombosis; Disease; Intensive care medicine; Quality of life (healthcare); Vomiting; Internal medicine; Surgery","score_opus":0.05495761042026679,"score_gpt":0.3476526322073705,"score_spread":0.2926950217871037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076971514","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015097392,0.99937314,0.00003683429,0.00011190108,0.000067870664,0.0000031016561,0.0000074736836,0.0000017341216,0.000246934],"genre_scores_gemma":[0.00076670916,0.99877566,0.00013174875,0.000116331415,0.00007443364,0.0000034055574,0.000012247416,4.4065953e-7,0.00011892489],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99956423,0.00010322904,0.00008786295,0.00005026833,0.00017714073,0.000017297545],"domain_scores_gemma":[0.99887973,0.0007050831,0.00019443393,0.000012828771,0.00017029846,0.00003768066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00097652106,0.0006469684,0.0022178951,0.0019318031,0.0002269661,0.00089795515,0.00071276247,0.0010359989,0.0016177847],"category_scores_gemma":[0.001794452,0.00023081372,0.0007339543,0.0027794272,0.00025616758,0.0007511646,0.00024284564,0.0010155332,0.00042963316],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019592766,0.0001029489,0.0006074672,0.03438853,0.00046158038,0.00023479994,0.0000712156,0.00026583442,0.00070453616,0.00059876154,0.01773342,0.944635],"study_design_scores_gemma":[0.0003573743,0.0008139465,0.01362104,0.04010157,0.003831842,0.0059896093,0.0003024459,0.00037886915,0.0009897649,0.0012817344,0.93226177,0.00007010166],"about_ca_topic_score_codex":0.0025706603,"about_ca_topic_score_gemma":0.0076268413,"teacher_disagreement_score":0.0025706603,"about_ca_system_score_codex":0.000562251,"about_ca_system_score_gemma":0.001219241,"threshold_uncertainty_score":0.005412042},"labels":[],"label_agreement":null},{"id":"W2078764279","doi":"10.1016/j.ctrv.2009.10.003","title":"Switching from tamoxifen to aromatase inhibitors for adjuvant endocrine therapy in postmenopausal patients with early breast cancer","year":2009,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Cancer Institute; Sanofi; AstraZeneca","keywords":"Anastrozole; Exemestane; Medicine; Tamoxifen; Letrozole; Oncology; Breast cancer; Internal medicine; Aromatase inhibitor; Aromatase; Adjuvant therapy; Hormonal therapy; Randomization; Gynecology; Cancer; Randomized controlled trial","score_opus":0.019433821561315134,"score_gpt":0.32440740210594454,"score_spread":0.3049735805446294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078764279","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018983924,0.99892503,0.00007806628,0.00015171432,0.00015006369,0.0000037737911,0.0000134135935,0.0000037213547,0.0004843244],"genre_scores_gemma":[0.001564439,0.99708754,0.0002322285,0.00032579195,0.00016930887,0.00000722963,0.0000313851,0.0000015594651,0.00058048376],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99985373,0.000033798635,0.000023435665,0.000023294771,0.000052244362,0.000013467831],"domain_scores_gemma":[0.9997577,0.00014844198,0.000043456464,0.000004206026,0.000034511406,0.000011566368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005165942,0.0005352882,0.0014028992,0.0008556997,0.00013989741,0.0004688947,0.0007376686,0.0006512934,0.0026103437],"category_scores_gemma":[0.00074980577,0.00017582855,0.00043058582,0.00087141717,0.0002110464,0.0004224298,0.00020585328,0.0010927395,0.0008627578],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020353292,0.000059297585,0.0001795201,0.011022348,0.00014615941,0.00015401776,0.000019919435,0.00021654379,0.0013692753,0.0007775793,0.024204448,0.9616473],"study_design_scores_gemma":[0.00027818364,0.00039140086,0.0029401616,0.007621887,0.00093432306,0.0024661836,0.00008466995,0.00022623723,0.0011529755,0.001387149,0.9824876,0.000029281837],"about_ca_topic_score_codex":0.0011640543,"about_ca_topic_score_gemma":0.004430317,"teacher_disagreement_score":0.0026103437,"about_ca_system_score_codex":0.0004168633,"about_ca_system_score_gemma":0.00053529587,"threshold_uncertainty_score":0.008732498},"labels":[],"label_agreement":null},{"id":"W2079118647","doi":"10.1016/j.ctrv.2007.10.003","title":"Biochemotherapy for the treatment of metastatic malignant melanoma: A systematic review","year":2008,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Ottawa Hospital; Cancer Care Ontario; Sunnybrook Health Science Centre; Windsor Regional Hospital","funders":"Cancer Care Ontario","keywords":"Medicine; Hazard ratio; Internal medicine; Oncology; Chemotherapy; Confidence interval; Randomized controlled trial; Melanoma; Meta-analysis; Incidence (geometry); Surgery","score_opus":0.11308282804319754,"score_gpt":0.39236118988544927,"score_spread":0.27927836184225174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079118647","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004122186,0.99925023,0.000037779788,0.000052633426,0.000045836034,0.000040616418,0.000043928463,0.0000026827063,0.00011414515],"genre_scores_gemma":[0.0052377144,0.99423003,0.00020022148,0.00016845681,0.000034341647,0.000036652913,0.000030598203,0.0000012777234,0.00006072489],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99875426,0.0004341076,0.0003752684,0.00013100085,0.0002535965,0.000051741696],"domain_scores_gemma":[0.9964461,0.0023663354,0.0008226498,0.000041572046,0.00025361602,0.00006978946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018706572,0.0010097111,0.0057273377,0.0027965512,0.00036852955,0.0010252622,0.0010960182,0.0011228652,0.0036888393],"category_scores_gemma":[0.007076372,0.00056938233,0.004343106,0.0034676606,0.00045388265,0.0008377235,0.0006248993,0.0009454893,0.00023569516],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007505255,0.00006654372,0.00055875734,0.85325116,0.015194237,0.00013256093,0.00009772938,0.0002030277,0.00038071288,0.00016413562,0.0033737016,0.1258269],"study_design_scores_gemma":[0.0024953736,0.0014568244,0.010328379,0.68049586,0.23763917,0.0011913643,0.00034385096,0.00030428282,0.0007552048,0.00051132764,0.06438583,0.000092503906],"about_ca_topic_score_codex":0.007094533,"about_ca_topic_score_gemma":0.024147654,"teacher_disagreement_score":0.007094533,"about_ca_system_score_codex":0.0013008094,"about_ca_system_score_gemma":0.0025279773,"threshold_uncertainty_score":0.014106452},"labels":[],"label_agreement":null},{"id":"W2080073879","doi":"10.1016/s0305-7372(02)00036-1","title":"Tamoxifen (‘Nolvadex’): a review","year":2002,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":224,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Tamoxifen; Medicine; Tolerability; Breast cancer; Oncology; Aromatase; Internal medicine; Male breast cancer; Antiestrogen; Gynecology; Cancer; Adverse effect","score_opus":0.06805263237191005,"score_gpt":0.3792060415056269,"score_spread":0.31115340913371686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080073879","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012946517,0.998287,0.00016226742,0.00024157956,0.00036151882,0.00000894428,0.000028911618,0.000013515265,0.00076667947],"genre_scores_gemma":[0.0005341758,0.9972256,0.00040214043,0.00038999933,0.00026655084,0.000016734011,0.00004942182,0.0000026278724,0.0011126503],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998709,0.000017777249,0.000023052953,0.000026219232,0.000049836992,0.000012304033],"domain_scores_gemma":[0.99977607,0.00010658495,0.0000355926,0.0000065750833,0.000046737023,0.000028476521],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048133076,0.0011705585,0.0018199846,0.0022021038,0.0003320837,0.00089409755,0.0011201564,0.0013038389,0.004725966],"category_scores_gemma":[0.0006038912,0.00033096675,0.0003677273,0.0026145917,0.00040146802,0.0013123875,0.00055173377,0.0014183309,0.0032213433],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019956837,0.00008984868,0.0001107369,0.009566305,0.00007017692,0.00027942777,0.000029553545,0.00019709574,0.0017405668,0.000985839,0.05364709,0.9330838],"study_design_scores_gemma":[0.00008031242,0.00014186108,0.0005787743,0.0018059992,0.00020742445,0.0016167334,0.000042123396,0.00006391935,0.00053121883,0.00063531165,0.99427927,0.000017136426],"about_ca_topic_score_codex":0.0013197139,"about_ca_topic_score_gemma":0.0035953051,"teacher_disagreement_score":0.004725966,"about_ca_system_score_codex":0.00052619836,"about_ca_system_score_gemma":0.00091893534,"threshold_uncertainty_score":0.015809894},"labels":[],"label_agreement":null},{"id":"W2081176426","doi":"10.1016/j.ctrv.2013.09.009","title":"Major depressive disorder in breast cancer: A critical systematic review of pharmacological and psychotherapeutic clinical trials","year":2013,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Cancer survivorship and care","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Clinical trial; Cancer; Breast cancer; Oncology; Internal medicine","score_opus":0.25156299452656433,"score_gpt":0.5505509218171463,"score_spread":0.29898792729058193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081176426","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00059856416,0.99881846,0.00006707175,0.00012669899,0.00006535596,0.00012666249,0.000106028485,0.0000040550863,0.000087044726],"genre_scores_gemma":[0.015723636,0.9826717,0.0005874819,0.00057296397,0.00008081115,0.00019460775,0.00009480779,0.0000035429873,0.00007052528],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.995349,0.0016818858,0.0017586803,0.00038283007,0.000685907,0.00014168241],"domain_scores_gemma":[0.9833189,0.011403625,0.0038353002,0.0002409787,0.0009786929,0.00022243106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008149481,0.0013718233,0.009688541,0.0044311625,0.00044592263,0.0020123092,0.0019627495,0.0015609375,0.0038762926],"category_scores_gemma":[0.025223868,0.0010145671,0.0076644053,0.0047247373,0.000770606,0.0015429108,0.001446374,0.001417103,0.00019455103],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083328184,0.000032085965,0.0008331181,0.9076692,0.038607754,0.000062527615,0.00010706077,0.00013250257,0.0001930775,0.0001745325,0.0017053767,0.049649473],"study_design_scores_gemma":[0.0023193937,0.00065208913,0.00733039,0.5363057,0.42615637,0.00039304016,0.00031377177,0.00019873526,0.0002613831,0.0005779966,0.025410054,0.00008096328],"about_ca_topic_score_codex":0.0054964195,"about_ca_topic_score_gemma":0.025820237,"teacher_disagreement_score":0.009688541,"about_ca_system_score_codex":0.0024550299,"about_ca_system_score_gemma":0.004988249,"threshold_uncertainty_score":0.043099046},"labels":[],"label_agreement":null},{"id":"W2083788852","doi":"10.1016/j.ctrv.2012.05.008","title":"Optimal management of elderly patients with glioblastoma","year":2012,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":153,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; University of Toronto; Health Sciences Centre; University Health Network","funders":"","keywords":"Medicine; Temozolomide; Cohort; Radiation therapy; Randomized controlled trial; Population; Oncology; Internal medicine; Adjuvant therapy; Glioblastoma; Cancer; Adjuvant; Clinical trial","score_opus":0.05812854951909599,"score_gpt":0.3517011236841146,"score_spread":0.2935725741650186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083788852","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002073414,0.9992052,0.000051236973,0.00020702329,0.00007113536,0.0000030689832,0.000011485065,0.0000022259424,0.00024126987],"genre_scores_gemma":[0.0018222282,0.99744284,0.00020356213,0.0002647214,0.00012697329,0.0000056532094,0.000030318508,7.221699e-7,0.000103031365],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9998141,0.000046179433,0.00005288311,0.000022820093,0.00004984709,0.000014224368],"domain_scores_gemma":[0.9997757,0.00010230707,0.00007020547,0.0000029771566,0.00003688886,0.000011841887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000365874,0.00059742556,0.0013553462,0.0012371913,0.00016810992,0.0005551634,0.0006007439,0.00057027844,0.0012557271],"category_scores_gemma":[0.0010814834,0.00016023536,0.00059771806,0.0010386583,0.00017752343,0.0006461226,0.00040140277,0.00071293366,0.0002915318],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000119513345,0.000043090135,0.00083906145,0.02555168,0.00027226325,0.0003253047,0.0000506569,0.00030391617,0.0003922212,0.0006276209,0.020159999,0.9513147],"study_design_scores_gemma":[0.00029899186,0.0004661601,0.015500619,0.06960022,0.003446665,0.007884041,0.00038598772,0.0004968163,0.0009005378,0.0032671834,0.8976706,0.00008221539],"about_ca_topic_score_codex":0.0018630711,"about_ca_topic_score_gemma":0.006125573,"teacher_disagreement_score":0.0018630711,"about_ca_system_score_codex":0.00053006754,"about_ca_system_score_gemma":0.0008996658,"threshold_uncertainty_score":0.004200816},"labels":[],"label_agreement":null},{"id":"W2088955344","doi":"10.1016/j.ctrv.2011.05.009","title":"Recent clinical developments and rationale for combining targeted agents in non-small cell lung cancer (NSCLC)","year":2011,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Merck KGaA; Pfizer","keywords":"Medicine; Epidermal growth factor receptor; Targeted therapy; Growth factor receptor; Lung cancer; Growth factor; Platelet-derived growth factor receptor; Oncology; Growth factor receptor inhibitor; Insulin-like growth factor 1 receptor; Cancer research; Receptor; Cancer; Internal medicine","score_opus":0.2202845222937452,"score_gpt":0.47681434557765334,"score_spread":0.25652982328390816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088955344","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024054413,0.9982357,0.00018117318,0.0002741345,0.0001472168,0.000012506589,0.000027901782,0.000008413399,0.0008725006],"genre_scores_gemma":[0.0012559338,0.99704045,0.00050283055,0.0003728443,0.00013158307,0.000019593343,0.00005826487,0.0000022728277,0.00061624957],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998368,0.000029477675,0.000028210294,0.000032853408,0.00005219557,0.00002037459],"domain_scores_gemma":[0.9997118,0.00015874443,0.00004475048,0.000006825244,0.00005879849,0.000019014946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007492522,0.000784872,0.0014801705,0.0012499808,0.00024272132,0.000983715,0.00086587627,0.00083445787,0.0033115759],"category_scores_gemma":[0.0007496304,0.00027064863,0.000847697,0.0012504274,0.00032746626,0.0008523822,0.0004766404,0.0018472861,0.0013738857],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001952991,0.00012439398,0.0001704664,0.013259186,0.00013886724,0.00015378138,0.000026622514,0.000382033,0.0023025512,0.0016911839,0.017638067,0.96391743],"study_design_scores_gemma":[0.0001881922,0.00053906994,0.0014797291,0.0050946884,0.0006706256,0.0015469444,0.000050032362,0.00021888946,0.0017699368,0.0015107146,0.9869021,0.000029013341],"about_ca_topic_score_codex":0.0009889897,"about_ca_topic_score_gemma":0.0030843855,"teacher_disagreement_score":0.0033115759,"about_ca_system_score_codex":0.00053747464,"about_ca_system_score_gemma":0.0008729376,"threshold_uncertainty_score":0.011078298},"labels":[],"label_agreement":null},{"id":"W2089605820","doi":"10.1016/j.ctrv.2013.03.009","title":"Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the treatment of breast cancer","year":2013,"lang":"en","type":"article","venue":"Cancer Treatment Reviews","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":378,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"PI3K/AKT/mTOR pathway; Protein kinase B; MAPK/ERK pathway; Medicine; Cancer research; Signal transduction; Kinase; Phosphorylation; RPTOR; Cell biology; Biology","score_opus":0.030303178491005927,"score_gpt":0.2958380245302369,"score_spread":0.26553484603923094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089605820","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012595213,0.994181,0.0004863303,0.0014074439,0.00034410745,0.000009568089,0.000013902688,0.000019531526,0.0022786178],"genre_scores_gemma":[0.007900144,0.9881904,0.0006394029,0.0005243981,0.0004058316,0.0000147198825,0.00002669792,0.000005270777,0.0022931509],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99982435,0.00003331223,0.000014014365,0.000018767156,0.00008062433,0.000028975974],"domain_scores_gemma":[0.99988437,0.000043237735,0.000020134046,0.0000036637673,0.000032864875,0.00001570006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005308859,0.00062516524,0.0007191422,0.0011584979,0.00029850606,0.00068151753,0.0004735265,0.0007554085,0.002142716],"category_scores_gemma":[0.00031843368,0.00021053328,0.00051752373,0.001048022,0.00044291327,0.0007040815,0.00042526817,0.002198992,0.0008417387],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039982636,0.000344199,0.00025284535,0.003512471,0.00010522996,0.0002605272,0.000058829384,0.0010551849,0.019620247,0.006447688,0.033679187,0.9342637],"study_design_scores_gemma":[0.00027403468,0.0010907663,0.0034834272,0.0012530182,0.0002494448,0.0026548337,0.00010859611,0.00090504653,0.01563444,0.004929234,0.96936214,0.000054954635],"about_ca_topic_score_codex":0.0011453704,"about_ca_topic_score_gemma":0.0044272975,"teacher_disagreement_score":0.002142716,"about_ca_system_score_codex":0.0007224349,"about_ca_system_score_gemma":0.0006400473,"threshold_uncertainty_score":0.007168114},"labels":[],"label_agreement":null},{"id":"W2095245646","doi":"10.1016/s0305-7372(03)00101-4","title":"Radical prostatectomy may improve disease-specific mortality, but not overall survival compared with watchful waiting in early prostate cancer","year":2003,"lang":"en","type":"letter","venue":"Cancer Treatment Reviews","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Watchful waiting; Prostate cancer; Prostatectomy; Oncology; Disease; Urology; Overall survival; Prostate; Cancer; Internal medicine; Surgery","score_opus":0.07937016260928091,"score_gpt":0.32790578111345015,"score_spread":0.24853561850416922,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095245646","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.044783026,0.016780086,0.0002498222,0.9099067,0.010706305,0.00003354901,0.00033834964,0.0001099432,0.017092248],"genre_scores_gemma":[0.24491718,0.014304314,0.000661533,0.67691123,0.049594704,0.00009690221,0.00030847793,0.00004594769,0.013159745],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9993605,0.00029172923,0.00007215036,0.000057929174,0.000109742134,0.000107978725],"domain_scores_gemma":[0.9960807,0.0028094456,0.00031304063,0.000062448795,0.00020338595,0.0005309661],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013413924,0.00023265177,0.0009868423,0.00025966033,0.00090091693,0.0007139851,0.00048341963,0.006809773,0.004487639],"category_scores_gemma":[0.009178802,0.0001987303,0.0007359813,0.0004612597,0.0005126284,0.0006598985,0.0002459398,0.004225129,0.000917109],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00780879,0.00063444005,0.043928646,0.0007800569,0.000415901,0.009081268,0.0003267933,0.00074542593,0.0019278369,0.0028598185,0.7172847,0.21420634],"study_design_scores_gemma":[0.011889734,0.007213397,0.26959932,0.001595566,0.0019376148,0.02568756,0.0014244941,0.0035240937,0.0030652273,0.018709743,0.6550874,0.0002658132],"about_ca_topic_score_codex":0.0044031953,"about_ca_topic_score_gemma":0.019855164,"teacher_disagreement_score":0.006809773,"about_ca_system_score_codex":0.0014224051,"about_ca_system_score_gemma":0.001612394,"threshold_uncertainty_score":0.015012622},"labels":[],"label_agreement":null},{"id":"W2099688828","doi":"10.1016/j.ctrv.2007.06.004","title":"Treatments for metastatic melanoma: Synthesis of evidence from randomized trials","year":2007,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":171,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Bristol-Myers Squibb","keywords":"Dacarbazine; Medicine; Jadad scale; Internal medicine; Randomized controlled trial; Meta-analysis; Melanoma; Oncology; Cochrane Library; Chemotherapy; Cancer research","score_opus":0.5073897111193665,"score_gpt":0.5047787779505932,"score_spread":0.002610933168773255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099688828","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029803996,0.99901664,0.00009497826,0.00012535875,0.000098154254,0.00009159878,0.000101440906,0.000004618797,0.00016917728],"genre_scores_gemma":[0.0047683516,0.9941222,0.00047121418,0.00031868383,0.000062467814,0.000100910234,0.00008221441,0.0000034160678,0.00007049421],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99631137,0.0014897843,0.0011242738,0.00034270436,0.0006130981,0.00011881613],"domain_scores_gemma":[0.98794866,0.009376058,0.001858456,0.00016349556,0.00052236713,0.0001310099],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007714405,0.0016810594,0.009936593,0.0031221877,0.00034643817,0.0018874948,0.001871677,0.0015414688,0.0050769798],"category_scores_gemma":[0.019989112,0.0007756352,0.007418142,0.0037362862,0.00062607304,0.0013069847,0.0007952592,0.001956243,0.0003685229],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024793474,0.00006181744,0.0004145593,0.7987622,0.031205624,0.000086207045,0.00007984071,0.00044146992,0.00034120757,0.00039910403,0.004314099,0.16141453],"study_design_scores_gemma":[0.00661917,0.0015125682,0.005275939,0.5601229,0.34648746,0.0005827525,0.0002538395,0.0002894536,0.00077109307,0.0016732092,0.07633524,0.00007634374],"about_ca_topic_score_codex":0.004992307,"about_ca_topic_score_gemma":0.01317753,"teacher_disagreement_score":0.009936593,"about_ca_system_score_codex":0.0021323287,"about_ca_system_score_gemma":0.0033890603,"threshold_uncertainty_score":0.040798187},"labels":[],"label_agreement":null},{"id":"W2100502384","doi":"10.1016/j.ctrv.2004.12.003","title":"Androgen suppression therapy, in combination with radiotherapy prolongs overall survival in men with clinically localised prostate cancer","year":2005,"lang":"en","type":"article","venue":"Cancer Treatment Reviews","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Prostate cancer; Radiation therapy; Androgen suppression; Oncology; Internal medicine; Androgen; Prostate; Androgen deprivation therapy; Combination therapy; Overall survival; Urology; Cancer; Hormone","score_opus":0.03470590341126252,"score_gpt":0.3476175070251087,"score_spread":0.3129116036138462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100502384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8006394,0.19461213,0.00022318869,0.0007506351,0.0002687378,0.000042360374,0.00018856041,0.0000397588,0.003235165],"genre_scores_gemma":[0.970667,0.026934918,0.00019478958,0.00019628645,0.00025900002,0.000015090325,0.0001468558,0.000007065958,0.0015790646],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99986506,0.000059734273,0.000010681103,0.000016669308,0.000026495449,0.000021359934],"domain_scores_gemma":[0.9996747,0.00012407605,0.00010240136,0.000012308542,0.000019692887,0.00006696767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003379456,0.00025524115,0.00092604145,0.00025685946,0.000256266,0.00027093134,0.00021081472,0.0002643331,0.001725773],"category_scores_gemma":[0.00087840774,0.00014328623,0.00053259847,0.00035924825,0.0001680918,0.00022309026,0.00017247499,0.00051586964,0.00017380413],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09814003,0.0034679272,0.098131835,0.003706603,0.003212411,0.001044728,0.00059431116,0.0027310494,0.019909818,0.00025008942,0.008071797,0.7607394],"study_design_scores_gemma":[0.0072041177,0.11008378,0.85531694,0.0003222088,0.0043253778,0.0038304464,0.00034002008,0.0008199862,0.0022657912,0.0003209096,0.015129575,0.000040843093],"about_ca_topic_score_codex":0.0017562138,"about_ca_topic_score_gemma":0.009924295,"teacher_disagreement_score":0.0017562138,"about_ca_system_score_codex":0.00028552502,"about_ca_system_score_gemma":0.00035497503,"threshold_uncertainty_score":0.0057732463},"labels":[],"label_agreement":null},{"id":"W2100891604","doi":"10.1016/j.ctrv.2008.03.013","title":"Adjuvant/neoadjuvant trastuzumab therapy in women with HER-2/neu-overexpressing breast cancer: A systematic review","year":2008,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McMaster University; Cancer Care Ontario; Sunnybrook Health Science Centre; Kingston General Hospital","funders":"","keywords":"Medicine; Trastuzumab; Oncology; Breast cancer; Internal medicine; Adjuvant; Cochrane Library; Adjuvant therapy; Randomized controlled trial; Clinical trial; Neoadjuvant therapy; Cancer","score_opus":0.11580775246216311,"score_gpt":0.432500353013039,"score_spread":0.3166926005508759,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100891604","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010158683,0.99827826,0.000077860765,0.00011914371,0.000076028686,0.00011356711,0.00013775857,0.000004876523,0.00017673457],"genre_scores_gemma":[0.01424122,0.9845828,0.0003745458,0.0003826688,0.000044730987,0.00014956671,0.00008167826,0.0000029142825,0.00013995169],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99846447,0.0005562036,0.0005320267,0.00015964606,0.00021770208,0.00006994516],"domain_scores_gemma":[0.99612504,0.0024340665,0.0010680488,0.000050422932,0.00024187338,0.00008060351],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025774327,0.0011129094,0.006744814,0.0028425679,0.00025999796,0.001089827,0.0009378555,0.0010264653,0.0036282954],"category_scores_gemma":[0.0083978,0.0008194092,0.0054612583,0.003709474,0.00041251213,0.0009871202,0.0007679182,0.0010142825,0.00020043844],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011674598,0.00004700635,0.0009056223,0.897938,0.025085427,0.00015229927,0.00012450878,0.00024369544,0.00050222664,0.00014654735,0.002786138,0.07090104],"study_design_scores_gemma":[0.003404118,0.0013464228,0.009007438,0.52096325,0.41978484,0.00079261797,0.0002882999,0.0002213653,0.00056465215,0.0003734539,0.04318225,0.00007132657],"about_ca_topic_score_codex":0.0059521357,"about_ca_topic_score_gemma":0.02504888,"teacher_disagreement_score":0.006744814,"about_ca_system_score_codex":0.0019585553,"about_ca_system_score_gemma":0.0033338147,"threshold_uncertainty_score":0.014210343},"labels":[],"label_agreement":null},{"id":"W2105158042","doi":"10.1053/ctrv.2002.9258","title":"Interventional radiology in the treatment of hepatic metastases","year":2002,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Radiology; Interventional radiology","score_opus":0.3329101993664592,"score_gpt":0.40761822476070914,"score_spread":0.07470802539424992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105158042","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008005902,0.9991007,0.00011174134,0.000094066316,0.00014847904,0.0000044335975,0.0000061705223,0.0000049045416,0.00044951847],"genre_scores_gemma":[0.0004758447,0.99864894,0.0002361081,0.00012209718,0.00017929656,0.000004278314,0.000014357472,0.0000012575053,0.00031783938],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996557,0.00007726832,0.00006580681,0.000054760098,0.00012704534,0.000019474212],"domain_scores_gemma":[0.99918264,0.00044143718,0.00013969,0.000020774436,0.0001732089,0.000042174222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000833465,0.0010260752,0.0022904342,0.0037760593,0.00032651454,0.0009896264,0.00096202095,0.0010473197,0.0027522566],"category_scores_gemma":[0.0013234384,0.00038602625,0.0006640178,0.004171092,0.00062353746,0.0013593956,0.00052533316,0.0015999136,0.0017514544],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000076466706,0.000061230385,0.000222012,0.019694334,0.000121401165,0.00040226648,0.000048095084,0.0003933917,0.0009229079,0.00087679166,0.020683097,0.9564979],"study_design_scores_gemma":[0.00006879881,0.00023634385,0.0027430856,0.011138258,0.0006379298,0.0069850623,0.00011664875,0.0002150448,0.0007147531,0.0010993882,0.97599685,0.000047691457],"about_ca_topic_score_codex":0.0022895976,"about_ca_topic_score_gemma":0.004974352,"teacher_disagreement_score":0.0037760593,"about_ca_system_score_codex":0.00065631873,"about_ca_system_score_gemma":0.0011972676,"threshold_uncertainty_score":0.009207189},"labels":[],"label_agreement":null},{"id":"W2107249642","doi":"10.1016/j.ctrv.2004.03.004","title":"Aromatase inhibitors in the adjuvant setting: bringing the gold to a standard?","year":2004,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":131,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Aromatase; Adjuvant; Gold standard (test); Oncology; Internal medicine; Gynecology; Breast cancer; Cancer","score_opus":0.027705599571916328,"score_gpt":0.3521868601886385,"score_spread":0.32448126061672217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107249642","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000051197057,0.9969501,0.00012167229,0.0015211452,0.00079577713,0.0000024142748,0.0000070901033,0.0000068844142,0.0005438427],"genre_scores_gemma":[0.00044346455,0.99647176,0.00022915185,0.0012928782,0.0007942451,0.0000045522675,0.000014642887,0.0000019810116,0.0007473872],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99960905,0.00009469587,0.000052044223,0.000049089587,0.00016169828,0.000033404434],"domain_scores_gemma":[0.99898976,0.0005490543,0.000088664565,0.00002757787,0.0002567283,0.00008810261],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015354961,0.0010058834,0.0028109057,0.0015113372,0.00039347092,0.0016645922,0.0013858231,0.0024639727,0.0037907262],"category_scores_gemma":[0.0019231325,0.0003016499,0.0005387512,0.0018192597,0.0008804343,0.002184628,0.0005443448,0.003984531,0.0026198295],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024183818,0.00008371656,0.00021028164,0.0055382233,0.00010429958,0.0002558704,0.000036123773,0.0002823298,0.0009631642,0.0036782073,0.12475605,0.8638498],"study_design_scores_gemma":[0.00008364403,0.00013188363,0.0005449625,0.0027491932,0.00013995268,0.0013242741,0.00007821862,0.000100454905,0.00023635862,0.002235577,0.99235743,0.000018040482],"about_ca_topic_score_codex":0.002153909,"about_ca_topic_score_gemma":0.0062003783,"teacher_disagreement_score":0.0037907262,"about_ca_system_score_codex":0.0010991325,"about_ca_system_score_gemma":0.001513909,"threshold_uncertainty_score":0.012681305},"labels":[],"label_agreement":null},{"id":"W2111003603","doi":"10.1016/j.ctrv.2006.12.002","title":"Chemotherapy dose–response relationships in non-small cell lung cancer and implied resistance mechanisms","year":2007,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; Canadian Agency for Drugs and Technologies in Health; Élisabeth Bruyère Hospital","funders":"","keywords":"Medicine; Lung cancer; Chemotherapy; Drug resistance; Oncology; Cell; Internal medicine; Cancer research; Biology","score_opus":0.08004728811877747,"score_gpt":0.4160621748165402,"score_spread":0.3360148866977627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111003603","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000408691,0.99769115,0.0004360888,0.00033842665,0.00012701824,0.000009586281,0.000020124746,0.000013573907,0.00095527014],"genre_scores_gemma":[0.0030006373,0.99512094,0.0005244901,0.00037998575,0.00018196504,0.000021815207,0.00003525196,0.0000034571358,0.0007314198],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9997452,0.00008123591,0.000037990285,0.00004337841,0.000076341596,0.000015764785],"domain_scores_gemma":[0.9994142,0.0004209978,0.00009048166,0.000014222096,0.000050888753,0.000009312857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006722279,0.00066950935,0.0017910149,0.00092904235,0.00013768993,0.00064896024,0.00090660586,0.00068352517,0.0030484102],"category_scores_gemma":[0.0010964705,0.00032905542,0.0007348897,0.0012203029,0.00032150766,0.00080139714,0.00028027216,0.001384233,0.0009945157],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002401835,0.00008781749,0.0002708539,0.012904705,0.00022915957,0.00019811031,0.000039054677,0.0012789292,0.00482165,0.003614109,0.016463676,0.95985186],"study_design_scores_gemma":[0.00020791998,0.0008929552,0.005004582,0.0055113994,0.0011653588,0.004344786,0.00006388986,0.0009906223,0.0051248944,0.005323671,0.9713154,0.000054560147],"about_ca_topic_score_codex":0.00055896025,"about_ca_topic_score_gemma":0.0014302405,"teacher_disagreement_score":0.0030484102,"about_ca_system_score_codex":0.00069597986,"about_ca_system_score_gemma":0.0005810396,"threshold_uncertainty_score":0.010197997},"labels":[],"label_agreement":null},{"id":"W2115028635","doi":"10.1016/j.ctrv.2010.03.006","title":"Targeting DNA repair in breast cancer: A clinical and translational update","year":2010,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"DNA repair; Synthetic lethality; Medicine; Breast cancer; Homologous recombination; Poly ADP ribose polymerase; Cancer research; DNA damage; Genome instability; BRCA2 Protein; DNA mismatch repair; Cancer; DNA; Mutation; Germline mutation; Genetics; Polymerase; Biology; Gene; Internal medicine","score_opus":0.12089813744190153,"score_gpt":0.46419491885373404,"score_spread":0.3432967814118325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115028635","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007577286,0.9988055,0.00011531029,0.00033371933,0.0002138804,0.000007166074,0.000022590477,0.00000892113,0.00041707378],"genre_scores_gemma":[0.00036301126,0.9985411,0.00021851737,0.00029900158,0.00018465822,0.000007073483,0.00003396153,0.0000014326482,0.00035131685],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99975985,0.000043101023,0.000037373895,0.000036356574,0.00009938837,0.000023814],"domain_scores_gemma":[0.99927443,0.000340798,0.00010502038,0.000014480674,0.00020859043,0.00005669732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011738441,0.0012793568,0.0025253524,0.0022088427,0.0002825667,0.0012931813,0.0012053864,0.001552212,0.0036631273],"category_scores_gemma":[0.0011986707,0.00042779962,0.000767053,0.0026400415,0.00048003564,0.0015947842,0.0006822967,0.002888507,0.0023222044],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021030923,0.00012990367,0.00017156034,0.01821519,0.00016710881,0.0001868313,0.000040881267,0.0004139045,0.0022972939,0.0012337287,0.06441596,0.91251737],"study_design_scores_gemma":[0.00012869101,0.00027637606,0.0008798349,0.00380566,0.00050989405,0.0011393225,0.000053608608,0.00022108585,0.0006858578,0.00090339687,0.9913652,0.00003103119],"about_ca_topic_score_codex":0.0014967332,"about_ca_topic_score_gemma":0.004154819,"teacher_disagreement_score":0.0036631273,"about_ca_system_score_codex":0.00073248905,"about_ca_system_score_gemma":0.0015223825,"threshold_uncertainty_score":0.012254357},"labels":[],"label_agreement":null},{"id":"W2121576318","doi":"10.1016/j.ctrv.2009.12.012","title":"Lapatinib and HER2 status: Results of a meta-analysis of randomized phase III trials in metastatic breast cancer","year":2010,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Lapatinib; Medicine; Internal medicine; Metastatic breast cancer; Oncology; Breast cancer; Hazard ratio; Randomized controlled trial; Adverse effect; Cancer; Clinical trial; Discontinuation; Trastuzumab; Confidence interval","score_opus":0.46909519296310337,"score_gpt":0.5766936765117843,"score_spread":0.1075984835486809,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121576318","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01047013,0.9879313,0.0005279866,0.00019330582,0.0001529268,0.00010863616,0.0003412885,0.000027927064,0.00024644716],"genre_scores_gemma":[0.24792491,0.74670565,0.002533108,0.0010128592,0.0002622239,0.0002682859,0.0007469676,0.000052906846,0.000493028],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99574775,0.0025567673,0.0007156881,0.00046474923,0.00037663613,0.00013850107],"domain_scores_gemma":[0.9919275,0.006274042,0.00111879,0.00023382308,0.0003166491,0.00012921498],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0086111305,0.002219849,0.011907787,0.0013864203,0.00028422053,0.0016663587,0.0013675765,0.0011397743,0.0027141501],"category_scores_gemma":[0.015805872,0.0010773573,0.017371692,0.0027117378,0.00045291707,0.0009346945,0.00083763374,0.0018113046,0.00020871186],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019225286,0.00006142598,0.0039931443,0.17781118,0.7588266,0.00013845805,0.0000744488,0.0011353792,0.0006219428,0.00016222421,0.0019338435,0.036016148],"study_design_scores_gemma":[0.0048495554,0.0004622635,0.0043421206,0.005051247,0.98188204,0.00012150307,0.000035778194,0.00020926504,0.00018130653,0.00028671284,0.0025526143,0.000025537136],"about_ca_topic_score_codex":0.0039833104,"about_ca_topic_score_gemma":0.011617456,"teacher_disagreement_score":0.9880922,"about_ca_system_score_codex":0.0016457668,"about_ca_system_score_gemma":0.0016688695,"threshold_uncertainty_score":0.04554051},"labels":[],"label_agreement":null},{"id":"W2123420272","doi":"10.1016/j.ctrv.2010.02.012","title":"Langerhans cell histiocytosis: Current concepts and treatments","year":2010,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":274,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; SickKids Foundation","funders":"","keywords":"Langerhans cell histiocytosis; Medicine; Malignancy; Histiocytosis; Immunotherapy; Salvage therapy; Disease; Immune system; Pathology; Immunology; Chemotherapy; Internal medicine","score_opus":0.11609083667682,"score_gpt":0.4510513757680648,"score_spread":0.3349605390912448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123420272","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006773155,0.9992755,0.00005076764,0.00011582271,0.00010643826,0.0000038108608,0.000009617688,0.0000044078697,0.00036589394],"genre_scores_gemma":[0.00044603535,0.9988543,0.00012802468,0.00013194961,0.00013917028,0.000005458868,0.000015825251,6.8536997e-7,0.000278534],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99980384,0.000029223393,0.00003558592,0.00002990542,0.00008122999,0.000020147407],"domain_scores_gemma":[0.9996526,0.00014507827,0.00008852274,0.000008802854,0.000074959455,0.000029997838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046365205,0.0010792192,0.002022904,0.0027111564,0.00026487725,0.00121508,0.00080701435,0.0010089378,0.0034316566],"category_scores_gemma":[0.00059735356,0.00036939184,0.000524187,0.0027901214,0.00052062643,0.0012933428,0.0006073062,0.001738266,0.0017704136],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012837602,0.000105024366,0.00019042248,0.017223049,0.00010138793,0.00023379672,0.000041642077,0.00033971312,0.0018184228,0.0015074658,0.03053538,0.94777536],"study_design_scores_gemma":[0.00007127217,0.00017358748,0.0012324732,0.005387366,0.00042829584,0.002759019,0.00009116327,0.00018082806,0.00061890366,0.001691602,0.98733217,0.000033318025],"about_ca_topic_score_codex":0.0012520541,"about_ca_topic_score_gemma":0.002607537,"teacher_disagreement_score":0.0034316566,"about_ca_system_score_codex":0.0006398658,"about_ca_system_score_gemma":0.0012633607,"threshold_uncertainty_score":0.011480033},"labels":[],"label_agreement":null},{"id":"W2125752165","doi":"10.1016/j.ctrv.2009.11.005","title":"SRC kinase inhibition: Targeting bone metastases and tumor growth in prostate and breast cancer","year":2009,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Bone health and treatments","field":"Medicine","cited_by":124,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Sanofi","keywords":"Medicine; Dasatinib; Prostate cancer; Proto-oncogene tyrosine-protein kinase Src; Bone metastasis; Osteoclast; Prostate; Bone resorption; Breast cancer; Cancer research; Metastasis; Oncology; Internal medicine; Tyrosine kinase; Cancer; Pathology; Receptor","score_opus":0.0557956574279283,"score_gpt":0.37794086484034706,"score_spread":0.32214520741241875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125752165","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020357085,0.99878865,0.00011647069,0.00013445475,0.00012979336,0.000007920119,0.000027176371,0.000008444925,0.0005834981],"genre_scores_gemma":[0.0010122396,0.9979183,0.00018633858,0.00018262227,0.00007241601,0.000008911616,0.00003987192,0.0000015925498,0.00057769613],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998454,0.00002254969,0.000023465594,0.00002430203,0.00006520559,0.000019046962],"domain_scores_gemma":[0.99981874,0.00008325959,0.000038563496,0.0000043045047,0.000041058694,0.000014074464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047391505,0.00096256967,0.00230849,0.0019437679,0.00022933107,0.0006990933,0.00082448253,0.00091084157,0.0030775035],"category_scores_gemma":[0.0004914756,0.00035428433,0.0007597919,0.0020508743,0.0003232651,0.0006273594,0.00040563953,0.0016350945,0.0013342001],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020379228,0.00014027987,0.00012905871,0.022156307,0.00025236895,0.00017047924,0.000039219944,0.000550319,0.003806938,0.0013847596,0.036824677,0.9343417],"study_design_scores_gemma":[0.00024312537,0.00048474953,0.0017594972,0.005502403,0.001040514,0.0018553465,0.00006085286,0.00029587245,0.0017214675,0.0010722092,0.9859233,0.0000406869],"about_ca_topic_score_codex":0.002129372,"about_ca_topic_score_gemma":0.0067658215,"teacher_disagreement_score":0.0030775035,"about_ca_system_score_codex":0.000499661,"about_ca_system_score_gemma":0.0008401941,"threshold_uncertainty_score":0.010295272},"labels":[],"label_agreement":null},{"id":"W2127154017","doi":"10.1016/j.ctrv.2009.08.001","title":"Irreversible pan-ErbB tyrosine kinase inhibitors and breast cancer: Current status and future directions","year":2009,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Genentech; Pfizer","keywords":"Lapatinib; Medicine; Trastuzumab; Tyrosine kinase; Receptor tyrosine kinase; Breast cancer; Tyrosine-kinase inhibitor; ErbB; Monoclonal antibody; Cancer research; Cancer; Pharmacology; Internal medicine; Receptor; Immunology; Antibody","score_opus":0.08835437902740187,"score_gpt":0.4363174976594466,"score_spread":0.34796311863204477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127154017","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001505793,0.9987791,0.000117996664,0.00016597135,0.00010978315,0.000004205726,0.000014766775,0.000008091524,0.0006495715],"genre_scores_gemma":[0.00070425466,0.9983205,0.00018265407,0.0001481123,0.00009195615,0.0000048627962,0.000023666957,0.0000011986574,0.0005226942],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998338,0.000026304562,0.0000232183,0.000030446592,0.00006452783,0.000021671805],"domain_scores_gemma":[0.999731,0.00013852965,0.000052489537,0.000007327832,0.000049603048,0.00002107233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066524406,0.00095347356,0.0021441844,0.0013433804,0.0002128577,0.00094166264,0.0009034623,0.00091912446,0.0056383037],"category_scores_gemma":[0.0005895989,0.000288382,0.00054487603,0.001808344,0.0004057281,0.0013967361,0.00047071738,0.0015813044,0.0021708678],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017418683,0.00011455012,0.00013306255,0.010118981,0.000089866924,0.0001458299,0.000026450678,0.0004312173,0.0016993354,0.0017551281,0.026385522,0.9589259],"study_design_scores_gemma":[0.000115892304,0.00032956232,0.0010300251,0.0029614056,0.00037432084,0.0013921208,0.000060753602,0.00026048528,0.0008972411,0.0016477038,0.9909044,0.000026063944],"about_ca_topic_score_codex":0.00091110286,"about_ca_topic_score_gemma":0.0033717537,"teacher_disagreement_score":0.0056383037,"about_ca_system_score_codex":0.00053665426,"about_ca_system_score_gemma":0.00093160715,"threshold_uncertainty_score":0.018862009},"labels":[],"label_agreement":null},{"id":"W2131562428","doi":"10.1016/s0305-7372(03)00102-6","title":"Overall, watchful waiting and radical prostatectomy have similar quality of life in localised prostate cancer","year":2003,"lang":"en","type":"letter","venue":"Cancer Treatment Reviews","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Watchful waiting; Prostatectomy; Prostate cancer; Quality of life (healthcare); Prostate; Urology; Prostate disease; Cancer; Oncology; Internal medicine; Nursing","score_opus":0.07722641572436362,"score_gpt":0.3626080971760545,"score_spread":0.2853816814516909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131562428","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1886422,0.02738881,0.00030970701,0.74534875,0.0061043003,0.000058953152,0.00076475274,0.00007045508,0.031312026],"genre_scores_gemma":[0.51810646,0.011857654,0.00045995956,0.44142377,0.012906687,0.0000734147,0.0006554561,0.000035234403,0.0144813135],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9992749,0.00032426527,0.00007084175,0.000047102476,0.00013621483,0.0001466448],"domain_scores_gemma":[0.9966813,0.0017266099,0.00046197925,0.000072512164,0.00038154586,0.0006760737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012026047,0.00013493859,0.0008772953,0.00022160583,0.00076117855,0.00089364697,0.0003130414,0.003926203,0.005998686],"category_scores_gemma":[0.0069844713,0.000114304814,0.00078251056,0.00058153016,0.0003548167,0.00064388075,0.0002729339,0.002714251,0.0007401807],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008988232,0.0010582012,0.2098817,0.0011936706,0.0008411787,0.012318394,0.0011590263,0.0007950206,0.0022450252,0.0035028078,0.53776175,0.22025497],"study_design_scores_gemma":[0.0041599562,0.0061862958,0.6613995,0.0012812999,0.0015265186,0.029136313,0.0042589298,0.0016752229,0.00091734785,0.007708704,0.28155842,0.00019141767],"about_ca_topic_score_codex":0.0052489205,"about_ca_topic_score_gemma":0.019068373,"teacher_disagreement_score":0.005998686,"about_ca_system_score_codex":0.0014147459,"about_ca_system_score_gemma":0.00092488376,"threshold_uncertainty_score":0.020067632},"labels":[],"label_agreement":null},{"id":"W2133493764","doi":"10.1016/j.ctrv.2010.05.006","title":"5-Azacytidine in myelodysplastic syndromes: A clinical practice guideline","year":2010,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Myelodysplastic syndromes; Context (archaeology); Guideline; Intensive care medicine; Clinical trial; Disease; Internal medicine; Palliative care; Oncology; Pathology; Bone marrow","score_opus":0.21304195759432804,"score_gpt":0.5385010240775383,"score_spread":0.32545906648321027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133493764","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00035211927,0.9803104,0.00081602467,0.011541827,0.0021434776,0.00022882276,0.00033140118,0.00005696512,0.004219045],"genre_scores_gemma":[0.002660878,0.9803254,0.004728215,0.0076472596,0.0010135582,0.00028173882,0.00047726755,0.000010398506,0.002855371],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99856323,0.00033095328,0.00054932386,0.00011164024,0.0003834736,0.00006145518],"domain_scores_gemma":[0.9966139,0.0011634113,0.0010526966,0.000056900262,0.00090147683,0.00021155656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024049869,0.0010743493,0.003041429,0.003822769,0.00040222288,0.001280851,0.0018218732,0.0029886828,0.0034288412],"category_scores_gemma":[0.0047133113,0.0006163721,0.00173526,0.003307648,0.0005066618,0.0014079369,0.0009550347,0.0030353665,0.0018754766],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019861686,0.0001369105,0.00046212567,0.035200454,0.00046915,0.00033858314,0.00007077744,0.00038673604,0.0011303981,0.0011958003,0.27476102,0.68564934],"study_design_scores_gemma":[0.00054636557,0.00024172147,0.002864444,0.05824403,0.0024273987,0.0013243197,0.00009478324,0.0003790491,0.0005723888,0.0014290261,0.93183416,0.000042452397],"about_ca_topic_score_codex":0.0057354327,"about_ca_topic_score_gemma":0.020094559,"teacher_disagreement_score":0.0057354327,"about_ca_system_score_codex":0.0019477144,"about_ca_system_score_gemma":0.00577207,"threshold_uncertainty_score":0.014131725},"labels":[],"label_agreement":null},{"id":"W2135258573","doi":"10.1016/j.ctrv.2009.12.003","title":"Bevacizumab as a treatment option in advanced renal cell carcinoma: An analysis and interpretation of clinical trial data","year":2010,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Centre for Applied Research in Cancer Control","keywords":"Medicine; Bevacizumab; Renal cell carcinoma; Oncology; Targeted therapy; Combination therapy; Internal medicine; Kidney cancer; Context (archaeology); Alpha interferon; Cancer; Chemotherapy; Immunology; Interferon","score_opus":0.23586084353472192,"score_gpt":0.4972069989666378,"score_spread":0.26134615543191586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135258573","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018148703,0.99709284,0.00019458705,0.00028204534,0.00007150257,0.00006401727,0.00013664181,0.0000055337987,0.0003380012],"genre_scores_gemma":[0.020191224,0.97771925,0.0009911654,0.00053548714,0.00010658409,0.00008289489,0.00017775735,0.000008731493,0.00018699527],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9969073,0.0016274031,0.00055337895,0.00024764353,0.00060339784,0.00006095133],"domain_scores_gemma":[0.9859688,0.011159391,0.001969292,0.00017371833,0.0006218245,0.00010691927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0072619286,0.0007855274,0.0044966056,0.0018764382,0.00014427555,0.0013673994,0.0009428634,0.00069724326,0.0014418069],"category_scores_gemma":[0.014799305,0.00036658152,0.003127186,0.0026802223,0.0003805141,0.0007571987,0.00034665756,0.00092764746,0.00016816492],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004723623,0.0000937166,0.0023315297,0.1916686,0.025240943,0.00018507129,0.00015256992,0.0015666262,0.0011416236,0.0010374883,0.010572077,0.76128614],"study_design_scores_gemma":[0.009543737,0.0053649656,0.04079817,0.23089515,0.30911693,0.002871833,0.00047202175,0.0032080153,0.002754283,0.004898656,0.38982862,0.0002476924],"about_ca_topic_score_codex":0.001282659,"about_ca_topic_score_gemma":0.0048019756,"teacher_disagreement_score":0.0072619286,"about_ca_system_score_codex":0.0013142513,"about_ca_system_score_gemma":0.002076467,"threshold_uncertainty_score":0.03840524},"labels":[],"label_agreement":null},{"id":"W2139918385","doi":"10.1053/ctrv.2001.0205","title":"Does treatment at the time of locoregional failure of breast cancer alter prognosis?","year":2001,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Systemic therapy; Breast cancer; Radiation therapy; Cancer; Oncology; Internal medicine; Intensive care medicine; Surgery","score_opus":0.03658015217378618,"score_gpt":0.3387142203316966,"score_spread":0.30213406815791044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139918385","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000083186475,0.9986712,0.00005434762,0.0005877023,0.00023437983,0.0000020965397,0.000010492029,0.0000021863793,0.00035439758],"genre_scores_gemma":[0.000608484,0.99859744,0.00009182591,0.00029007494,0.00018896213,0.0000040608215,0.000013855815,8.050904e-7,0.00020441305],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99967086,0.000117993266,0.00004485307,0.000049758644,0.00008775559,0.000028819495],"domain_scores_gemma":[0.9988098,0.0008234795,0.00013514228,0.000033135922,0.00015805369,0.00004043572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001467001,0.0007757517,0.0027781308,0.0011289825,0.00028938564,0.0011308376,0.0013343475,0.0015659677,0.0028981173],"category_scores_gemma":[0.0025866393,0.00026807384,0.000672572,0.0022148886,0.00065415713,0.001121935,0.00034969155,0.0019589812,0.0014388217],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003584734,0.00010036109,0.0006280742,0.008331835,0.00021881629,0.00019180086,0.000036095826,0.0002515658,0.00072115584,0.0022385793,0.031610634,0.95531267],"study_design_scores_gemma":[0.0002688145,0.0006332121,0.0068508903,0.01235395,0.0011058048,0.0030848181,0.00020882412,0.00017059599,0.0009852907,0.00488468,0.9693987,0.000054400472],"about_ca_topic_score_codex":0.0026149214,"about_ca_topic_score_gemma":0.0060036727,"teacher_disagreement_score":0.0028981173,"about_ca_system_score_codex":0.0009194381,"about_ca_system_score_gemma":0.0013534745,"threshold_uncertainty_score":0.009695172},"labels":[],"label_agreement":null},{"id":"W2139955444","doi":"10.1016/s0305-7372(02)00045-2","title":"What is the role for antithrombotics in cancer care?","year":2002,"lang":"en","type":"article","venue":"Cancer Treatment Reviews","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Cancer; Intensive care medicine; Oncology; Internal medicine","score_opus":0.0713271157303598,"score_gpt":0.3630805981750084,"score_spread":0.2917534824446486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139955444","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011818255,0.6835243,0.00025505907,0.30368817,0.006689444,0.0000125443585,0.000051200623,0.000019496363,0.0045779035],"genre_scores_gemma":[0.024674468,0.85338956,0.0015079582,0.08446208,0.03381123,0.000051717703,0.00005840209,0.000022575376,0.002022034],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9921482,0.0040455437,0.000984205,0.00043181406,0.0020791208,0.00031117472],"domain_scores_gemma":[0.92875564,0.047358274,0.007353145,0.0007951354,0.01252921,0.003208625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015699089,0.0006035273,0.0025142482,0.0021057762,0.0012850227,0.005856073,0.0015551723,0.007271416,0.007418138],"category_scores_gemma":[0.053600825,0.0005381546,0.001803847,0.0022463505,0.002744462,0.008244114,0.0007104801,0.007402397,0.0014595482],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010174802,0.0003721275,0.010029058,0.01244418,0.0010948643,0.00071325834,0.00051999534,0.00050276826,0.0006209562,0.015867911,0.20442596,0.75239146],"study_design_scores_gemma":[0.0007335897,0.0007182114,0.02242925,0.03813667,0.0020813097,0.00278658,0.002228267,0.00084300165,0.00034633986,0.015452392,0.91406804,0.0001764488],"about_ca_topic_score_codex":0.009520053,"about_ca_topic_score_gemma":0.027601162,"teacher_disagreement_score":0.015699089,"about_ca_system_score_codex":0.004425354,"about_ca_system_score_gemma":0.0072451583,"threshold_uncertainty_score":0.083025694},"labels":[],"label_agreement":null},{"id":"W2140583113","doi":"10.1016/j.ctrv.2014.10.002","title":"Navigating later lines of treatment for advanced colorectal cancer – Optimizing targeted biological therapies to improve outcomes","year":2014,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Alzheimer Society of Canada; Foothills Medical Centre; Queen Elizabeth II Health Sciences Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Regorafenib; Cetuximab; Panitumumab; Bevacizumab; Aflibercept; Colorectal cancer; Oncology; Targeted therapy; Internal medicine; Randomized controlled trial; Clinical trial; Cancer; Chemotherapy","score_opus":0.10275960320422338,"score_gpt":0.44091157697765077,"score_spread":0.3381519737734274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140583113","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016827953,0.99925464,0.000038713184,0.00017731822,0.000058173762,0.000008194233,0.000015734931,0.0000021213955,0.00027676925],"genre_scores_gemma":[0.0015761851,0.9977729,0.00016984553,0.00026319115,0.000050311788,0.000011350913,0.000021840162,7.7634166e-7,0.00013370201],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999617,0.00012836214,0.00009103073,0.00004554504,0.000090769274,0.000027229014],"domain_scores_gemma":[0.99920124,0.0004896067,0.00019372882,0.00001164049,0.00008175978,0.000022178381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009943282,0.0006870103,0.0019122735,0.0017491332,0.00015071435,0.0006967159,0.0005213085,0.0006545937,0.0038376332],"category_scores_gemma":[0.0020718202,0.00024238347,0.0015778674,0.001802498,0.00024249071,0.0006785464,0.00041737763,0.0010757975,0.0004148188],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028736625,0.000078604804,0.00037636905,0.14156583,0.0015604541,0.0000756196,0.000059936177,0.00038110893,0.0008200805,0.0010681774,0.012545168,0.8411813],"study_design_scores_gemma":[0.00072406535,0.0012404432,0.007924975,0.19982716,0.018146068,0.0015439598,0.00030222113,0.00038297154,0.0014759738,0.0023524251,0.7660009,0.00007874454],"about_ca_topic_score_codex":0.0019662404,"about_ca_topic_score_gemma":0.0074977074,"teacher_disagreement_score":0.0038376332,"about_ca_system_score_codex":0.0006893349,"about_ca_system_score_gemma":0.0014485051,"threshold_uncertainty_score":0.012838185},"labels":[],"label_agreement":null},{"id":"W2143715586","doi":"10.1016/j.ctrv.2015.07.003","title":"Obinutuzumab in hematologic malignancies: Lessons learned to date","year":2015,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Pfizer; F. Hoffmann-La Roche; Amgen","keywords":"Medicine; Obinutuzumab; Hematologic Neoplasms; Oncology; Intensive care medicine; Internal medicine; Cancer; Leukemia; Chronic lymphocytic leukemia","score_opus":0.4738322693286079,"score_gpt":0.5435361784067422,"score_spread":0.06970390907813429,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143715586","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004328468,0.9994191,0.000025362435,0.00022658495,0.00009798071,0.0000016477253,0.00001121103,0.000002493823,0.00017233138],"genre_scores_gemma":[0.00042465393,0.9988701,0.00008246153,0.00032531816,0.00012950384,0.0000029300097,0.000016315562,9.447418e-7,0.0001477217],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997247,0.00006294309,0.000053877113,0.000048754006,0.00007845326,0.00003137246],"domain_scores_gemma":[0.99914837,0.0005101167,0.00012392856,0.000016026117,0.00014547283,0.00005618638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010697856,0.00067346933,0.0019061383,0.001862657,0.00025075057,0.0014334011,0.00081708294,0.001046179,0.0038020082],"category_scores_gemma":[0.001921846,0.00026390274,0.0008381375,0.0020171653,0.00043921277,0.0015221229,0.0008198559,0.0019658566,0.0008195087],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019734782,0.000060111164,0.00025885476,0.033621944,0.00030165853,0.00008966896,0.000055073902,0.00026446872,0.0005788666,0.0021862774,0.041494153,0.9208915],"study_design_scores_gemma":[0.00010692183,0.00014133427,0.00092302833,0.020408424,0.00091745064,0.0005741298,0.00009991333,0.00011363082,0.00027515672,0.0019699412,0.97444665,0.000023402243],"about_ca_topic_score_codex":0.0015626528,"about_ca_topic_score_gemma":0.004737709,"teacher_disagreement_score":0.0038020082,"about_ca_system_score_codex":0.0007371085,"about_ca_system_score_gemma":0.0017770089,"threshold_uncertainty_score":0.012718976},"labels":[],"label_agreement":null},{"id":"W2147226575","doi":"10.1016/j.ctrv.2015.03.007","title":"Role of CD154 in cancer pathogenesis and immunotherapy","year":2015,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Canadian Institutes of Health Research; Pfizer","keywords":"CD154; Medicine; Immunology; Cancer; Immunotherapy; Immune system; Cancer immunotherapy; Cancer research; Immunogenicity; Immunosurveillance; CD40; Inflammation; Cancer cell; Cytotoxic T cell; Biology; In vitro; Internal medicine","score_opus":0.06984839867788352,"score_gpt":0.3702846875741137,"score_spread":0.3004362888962302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147226575","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005513384,0.99840134,0.00010531419,0.00025333697,0.00045767496,0.0000039665865,0.000009858414,0.000005708824,0.0007076056],"genre_scores_gemma":[0.00052247563,0.99746203,0.00017140116,0.0003502728,0.0006194486,0.000006544968,0.00002200657,0.0000012841749,0.00084446906],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99977106,0.000042817268,0.00002916839,0.000029840343,0.00009576177,0.00003135465],"domain_scores_gemma":[0.9996741,0.0001316819,0.000055216926,0.000009276892,0.00008648833,0.000043281936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073145074,0.0010484029,0.0014935433,0.0017831686,0.00023824304,0.001172794,0.00076733227,0.0012957526,0.0038614997],"category_scores_gemma":[0.0008012604,0.00031296053,0.00039698998,0.0014822551,0.00046617855,0.0013320689,0.0008423654,0.0020976358,0.0020567137],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012120106,0.00006930385,0.0001221166,0.010483849,0.00006080868,0.00013153064,0.000027926533,0.00033393086,0.002185205,0.002306715,0.058388036,0.9257693],"study_design_scores_gemma":[0.000032119693,0.000086686385,0.00037170577,0.0024242515,0.00011409988,0.000541614,0.00002970167,0.00010781599,0.00037292007,0.0014510013,0.99445516,0.00001300315],"about_ca_topic_score_codex":0.00070987974,"about_ca_topic_score_gemma":0.0017041116,"teacher_disagreement_score":0.0038614997,"about_ca_system_score_codex":0.00056548853,"about_ca_system_score_gemma":0.0013247632,"threshold_uncertainty_score":0.012917936},"labels":[],"label_agreement":null},{"id":"W2148122717","doi":"10.1016/s0305-7372(03)00020-3","title":"Marimastat may not improve survival over placebo following induction therapy for small-cell lung cancer Abstracted from: Shepherd F, Giaccone G, Seymour L et al. Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of Cancer. J Clin Oncol 2002; 20(22): 4434–39.","year":2003,"lang":"en","type":"letter","venue":"Cancer Treatment Reviews","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Lung cancer; Matrix metalloproteinase; Placebo; Oncology; Internal medicine; Randomized controlled trial; Cancer; Surgery; Gastroenterology; Pathology","score_opus":0.0863161860194505,"score_gpt":0.3984681189588007,"score_spread":0.3121519329393502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148122717","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006396377,0.022896435,0.00028055813,0.91730285,0.041043784,0.0001269266,0.00083556696,0.00013089798,0.01098663],"genre_scores_gemma":[0.04412458,0.017183853,0.0005377347,0.8314635,0.0815982,0.00025362975,0.00035296875,0.000064064996,0.02442152],"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99856347,0.0005833905,0.0002342484,0.00015366195,0.000329346,0.00013587622],"domain_scores_gemma":[0.99635434,0.002507494,0.00037105536,0.00007601435,0.00044037073,0.00025064015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002592805,0.00058606867,0.0018609619,0.00039071613,0.00088432536,0.0011681186,0.0008348345,0.013479183,0.006021718],"category_scores_gemma":[0.0117260525,0.00034698474,0.001137286,0.00057299994,0.00075586647,0.00086957536,0.00029231637,0.008897059,0.0056783394],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006624105,0.00016282254,0.0015691267,0.00061053067,0.00015169612,0.0040829275,0.00006729555,0.00012967648,0.0017058345,0.0013484806,0.891654,0.09189348],"study_design_scores_gemma":[0.011867703,0.0023525811,0.011752518,0.0011166717,0.0005908252,0.005018388,0.00018376832,0.0011919442,0.0028839977,0.0064008916,0.95655257,0.000088201945],"about_ca_topic_score_codex":0.0023631204,"about_ca_topic_score_gemma":0.0052180137,"teacher_disagreement_score":0.013479183,"about_ca_system_score_codex":0.0025435053,"about_ca_system_score_gemma":0.0012776497,"threshold_uncertainty_score":0.020144641},"labels":[],"label_agreement":null},{"id":"W2148918407","doi":"10.1016/j.ctrv.2005.09.008","title":"Radical prostatectomy for early prostate cancer improves long term survival","year":2005,"lang":"en","type":"article","venue":"Cancer Treatment Reviews","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Rehabilitation Institute; University Health Network","funders":"","keywords":"Medicine; Watchful waiting; Prostatectomy; Prostate cancer; Prostate; Urology; Cancer; Term (time); Surgery; Oncology; Internal medicine","score_opus":0.046349012118266614,"score_gpt":0.36181457400293515,"score_spread":0.31546556188466857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148918407","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.27763817,0.69742656,0.0005674984,0.0061446265,0.0018013137,0.000062116465,0.00048039109,0.0001525481,0.015726853],"genre_scores_gemma":[0.7927951,0.19309117,0.0011227524,0.0021204897,0.002431035,0.000037563907,0.00055863545,0.00003330645,0.0078099226],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.999749,0.000087475506,0.000020993799,0.000021793987,0.00008666243,0.000034158715],"domain_scores_gemma":[0.999012,0.00035209762,0.0002917549,0.000042026986,0.00012991528,0.00017219054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007017443,0.00021245949,0.00070568634,0.0003687281,0.00018227656,0.00034396522,0.00021378114,0.00026146116,0.0047952333],"category_scores_gemma":[0.0026452986,0.00009110579,0.00057516346,0.00034387535,0.000102029604,0.00030871812,0.00020837704,0.0004879845,0.00039798423],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004068117,0.0008236452,0.03244812,0.00247535,0.0011619003,0.00013875308,0.00014747697,0.00042810588,0.0036554686,0.00043821154,0.02510865,0.9291062],"study_design_scores_gemma":[0.0011769953,0.009344924,0.9039856,0.0008346111,0.0036346493,0.0012850576,0.00015903704,0.00022105558,0.0014519497,0.0006537959,0.07721525,0.000036956928],"about_ca_topic_score_codex":0.0016641563,"about_ca_topic_score_gemma":0.007926894,"teacher_disagreement_score":0.0047952333,"about_ca_system_score_codex":0.0003225964,"about_ca_system_score_gemma":0.0005808901,"threshold_uncertainty_score":0.016041636},"labels":[],"label_agreement":null},{"id":"W2149388503","doi":"10.1016/j.ctrv.2008.02.003","title":"A meta-analysis and systematic review of thalidomide for patients with previously untreated multiple myeloma","year":2008,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; Sudbury Regional Hospital; McMaster University Medical Centre; Princess Margaret Cancer Centre; Queen's University; McMaster University; Cancer Care Ontario; St. Michael's Hospital","funders":"Cancer Care Ontario; Canadian Institutes of Health Research; American Society of Hematology","keywords":"Thalidomide; Medicine; Multiple myeloma; Internal medicine; Meta-analysis; Relative risk; Randomized controlled trial; Transplantation; Surgery; Oncology; Confidence interval","score_opus":0.1545901539710433,"score_gpt":0.39731009047903815,"score_spread":0.24271993650799484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149388503","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0066842693,0.9918543,0.00032995813,0.00018921989,0.0001914436,0.00020719107,0.00029180446,0.000017634819,0.00023424886],"genre_scores_gemma":[0.22841252,0.7668935,0.0020353973,0.0011201141,0.00023153404,0.00050447887,0.00041725358,0.00002100865,0.00036424218],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99329245,0.0035971815,0.0016556055,0.0005694315,0.00066911615,0.00021614603],"domain_scores_gemma":[0.9912464,0.005898755,0.0017946489,0.00027833454,0.0006130608,0.0001687098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008405117,0.0020301996,0.014474825,0.0034333563,0.00051888404,0.0018757284,0.0014794032,0.0014315759,0.002898168],"category_scores_gemma":[0.024726696,0.0013385835,0.022138638,0.0046601016,0.0005494161,0.0011941913,0.001247766,0.0016527985,0.0001909433],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004479612,0.000037889313,0.002923291,0.29969004,0.6732745,0.00016458619,0.00010551502,0.0005013699,0.00030283394,0.00012307154,0.0009814025,0.017415905],"study_design_scores_gemma":[0.0014742842,0.00030529036,0.0027884408,0.013062457,0.98005956,0.000116212905,0.000041720225,0.000095071264,0.000086511136,0.00011210982,0.0018379848,0.000020455245],"about_ca_topic_score_codex":0.012303307,"about_ca_topic_score_gemma":0.0346644,"teacher_disagreement_score":0.014474825,"about_ca_system_score_codex":0.003578071,"about_ca_system_score_gemma":0.0035853942,"threshold_uncertainty_score":0.044451058},"labels":[],"label_agreement":null},{"id":"W2156954151","doi":"10.1016/j.ctrv.2014.02.007","title":"TCTP as therapeutic target in cancers","year":2014,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Malignancy; Cancer research; Extracellular; Cellular stress response; Reversion; Cell biology; Biology; Bioinformatics; Fight-or-flight response; Phenotype; Gene; Pathology; Genetics","score_opus":0.0849936651446577,"score_gpt":0.41368490427667604,"score_spread":0.32869123913201836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156954151","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006368879,0.99920976,0.00005846274,0.00013834416,0.000118234006,0.0000031681366,0.000010343149,0.00000421599,0.00039370707],"genre_scores_gemma":[0.00050701003,0.99882585,0.000096619035,0.00013130317,0.0001232736,0.000003972063,0.000017659415,8.47335e-7,0.0002935362],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.999846,0.000028183447,0.000025997007,0.00002624845,0.000055243065,0.00001836375],"domain_scores_gemma":[0.9997291,0.00013687236,0.00004365539,0.000007743905,0.00006141837,0.000021279935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004825286,0.00073455437,0.0016188765,0.0017866539,0.00030143457,0.0010921536,0.0007353096,0.0010157102,0.0037802677],"category_scores_gemma":[0.0006323068,0.00028012737,0.0005625187,0.0017927693,0.00039482114,0.000981169,0.00060341024,0.0019675228,0.0013580092],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011686154,0.000086665656,0.0001375759,0.020194434,0.00012861573,0.0001500549,0.000044078042,0.00031702584,0.0018733595,0.0022644266,0.025968203,0.9487187],"study_design_scores_gemma":[0.000048293623,0.00016541443,0.00078378915,0.005692763,0.00034443583,0.0010479338,0.00005800217,0.0001521798,0.00067740504,0.0016336332,0.9893734,0.000022701199],"about_ca_topic_score_codex":0.0012507341,"about_ca_topic_score_gemma":0.0031546673,"teacher_disagreement_score":0.0037802677,"about_ca_system_score_codex":0.00055280444,"about_ca_system_score_gemma":0.0010504593,"threshold_uncertainty_score":0.012646258},"labels":[],"label_agreement":null},{"id":"W2157880942","doi":"10.1016/j.ctrv.2007.04.003","title":"Single-agent interleukin-2 in the treatment of metastatic melanoma: A systematic review","year":2007,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":90,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Ottawa Hospital; Princess Margaret Cancer Centre; Cancer Care Ontario; Sunnybrook Health Science Centre","funders":"Cancer Care Ontario","keywords":"Medicine; Randomized controlled trial; Oncology; Melanoma; Internal medicine; Surgery; Complete response; Meta-analysis; Quality of life (healthcare); Chemotherapy; Cancer research","score_opus":0.1395188464822861,"score_gpt":0.38998317011989747,"score_spread":0.2504643236376114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157880942","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018726135,0.9995926,0.000026716456,0.00004860329,0.000042107557,0.000013187192,0.000022056185,0.0000013783183,0.00006608736],"genre_scores_gemma":[0.0024241419,0.9971956,0.00011332359,0.00014009113,0.000038694143,0.000019486943,0.00002299193,5.9881296e-7,0.000044961864],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9994475,0.00016893016,0.00015954742,0.00007302412,0.00012334679,0.000027609458],"domain_scores_gemma":[0.9983637,0.0011109719,0.0003407846,0.000017577566,0.00012433344,0.000042650536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013809648,0.00073007884,0.004316487,0.0019979333,0.00018461725,0.0007667358,0.0009674219,0.00090072764,0.0026584917],"category_scores_gemma":[0.0031443841,0.00033827292,0.0024670628,0.0024150752,0.00030399824,0.0006809861,0.00046182636,0.00067534257,0.0002292823],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001068239,0.0000697638,0.00048813954,0.5893726,0.0071817217,0.00020867785,0.00007141575,0.00038114836,0.0007667844,0.0003214503,0.009699296,0.39037076],"study_design_scores_gemma":[0.0036483798,0.0026008328,0.011876364,0.5766317,0.14455241,0.0025863436,0.00038141842,0.0006018431,0.0014558329,0.0011443932,0.2543924,0.00012808708],"about_ca_topic_score_codex":0.003228236,"about_ca_topic_score_gemma":0.0102058165,"teacher_disagreement_score":0.004316487,"about_ca_system_score_codex":0.00082751276,"about_ca_system_score_gemma":0.0020938055,"threshold_uncertainty_score":0.008893549},"labels":[],"label_agreement":null},{"id":"W2157976923","doi":"10.1016/j.ctrv.2013.03.004","title":"Fulvestrant for advanced breast cancer: A meta-analysis","year":2013,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Fulvestrant; Meta-analysis; Oncology; Breast cancer; Cancer; Internal medicine; Tamoxifen","score_opus":0.1108819317349053,"score_gpt":0.40657892642387516,"score_spread":0.29569699468896987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157976923","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002939021,0.9961188,0.00024396402,0.00012661601,0.000087057015,0.000023250775,0.000242672,0.000012390235,0.00020618652],"genre_scores_gemma":[0.079488665,0.9176115,0.0009557772,0.00074796146,0.00018897833,0.000069036105,0.0004869478,0.000016643713,0.00043451152],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99909365,0.0003649548,0.00018721537,0.00015023565,0.00014893705,0.000054952157],"domain_scores_gemma":[0.9987464,0.0007965817,0.00024813184,0.000059683032,0.00011215463,0.000037088485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025417288,0.001568807,0.0060361135,0.0013115654,0.0001564389,0.00094569195,0.00076516025,0.0006267534,0.0029366296],"category_scores_gemma":[0.0037640028,0.0005009422,0.009965705,0.0025079828,0.00016764938,0.0005846875,0.00059023546,0.0009806467,0.00020799255],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009029601,0.00008968701,0.0070560547,0.19535868,0.61895525,0.00021855833,0.00006665061,0.0018992798,0.0012349782,0.000333262,0.0067617428,0.15899625],"study_design_scores_gemma":[0.0018115144,0.00051470473,0.0106564695,0.008457619,0.9643484,0.00020266695,0.00004658758,0.00035318066,0.00029654114,0.0005731901,0.0126963835,0.00004289807],"about_ca_topic_score_codex":0.0031489565,"about_ca_topic_score_gemma":0.011959312,"teacher_disagreement_score":0.0060361135,"about_ca_system_score_codex":0.00084229634,"about_ca_system_score_gemma":0.0009455375,"threshold_uncertainty_score":0.013442159},"labels":[],"label_agreement":null},{"id":"W2158878352","doi":"10.1016/j.ctrv.2007.10.002","title":"New research findings on zoledronic acid: Survival, pain, and anti-tumour effects","year":2007,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Bone health and treatments","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Notre-Dame","funders":"","keywords":"Zoledronic acid; Medicine; Bisphosphonate; Oncology; Prostate cancer; Internal medicine; Renal cell carcinoma; Incidence (geometry); Bone pain; Kidney cancer; Osteonecrosis of the jaw; Cancer; Osteoporosis","score_opus":0.2530439676291371,"score_gpt":0.5097682949917159,"score_spread":0.25672432736257883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158878352","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005693945,0.9995865,0.000023592836,0.000105600615,0.000069413465,0.0000017524206,0.000008512419,0.0000016571377,0.00014598311],"genre_scores_gemma":[0.00034035518,0.9992374,0.00007371835,0.00014534006,0.00009423066,0.0000023428022,0.000012150503,3.6521394e-7,0.00009409013],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99963856,0.000058348218,0.000074417425,0.00005589406,0.00014684387,0.000025990823],"domain_scores_gemma":[0.99921525,0.00047214996,0.0001356978,0.000013221974,0.00013025462,0.00003339879],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009693557,0.0010385405,0.0032740033,0.0029221477,0.00024518077,0.0013781079,0.00085683906,0.0012248106,0.0040227952],"category_scores_gemma":[0.0014813148,0.00030371262,0.0011127611,0.0047263093,0.00050494034,0.00108626,0.00059525867,0.0015610184,0.0009421186],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002844848,0.00008044781,0.00024673512,0.06281134,0.0005360603,0.00022468615,0.00006436573,0.00031774564,0.0019328928,0.0019679365,0.02591882,0.90561444],"study_design_scores_gemma":[0.0002804238,0.00040211913,0.003966416,0.022168435,0.002945602,0.0021405485,0.00018376773,0.00018033109,0.000784316,0.0029788264,0.96391374,0.00005550281],"about_ca_topic_score_codex":0.0024821113,"about_ca_topic_score_gemma":0.007405064,"teacher_disagreement_score":0.0040227952,"about_ca_system_score_codex":0.0007383371,"about_ca_system_score_gemma":0.0017318858,"threshold_uncertainty_score":0.013457656},"labels":[],"label_agreement":null},{"id":"W2159062994","doi":"10.1016/j.ctrv.2014.11.001","title":"Wellbeing during Active Surveillance for localised prostate cancer: A systematic review of psychological morbidity and quality of life","year":2014,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Newcastle University; Calvary Mater Newcastle","keywords":"Watchful waiting; Medicine; MEDLINE; Observational study; Cochrane Library; Quality of life (healthcare); Adverse effect; Family medicine; Scopus; Meta-analysis; Psychiatry; Prostate cancer; Cancer; Pathology; Nursing; Internal medicine","score_opus":0.14662539733314683,"score_gpt":0.4552984161023068,"score_spread":0.30867301876916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159062994","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017419057,0.99769586,0.00006129724,0.00007936955,0.00005371637,0.000086605694,0.00018874112,0.0000040656682,0.00008833145],"genre_scores_gemma":[0.040216547,0.9583939,0.00053709996,0.00039853517,0.00005630931,0.00016600541,0.00014699792,0.0000053032036,0.000079329],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9957918,0.0015201882,0.0015113349,0.0004259037,0.0005946081,0.00015610016],"domain_scores_gemma":[0.98839253,0.007540045,0.0030350082,0.0001661236,0.00066378067,0.00020246152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005048249,0.0012701693,0.008202813,0.0050327387,0.00044519998,0.002058435,0.0012390675,0.0013895875,0.0029888689],"category_scores_gemma":[0.020861266,0.0010410517,0.010418874,0.0063758655,0.00068733643,0.0015240388,0.001824064,0.0016935033,0.00014303996],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004841321,0.000030295952,0.0030902387,0.89464754,0.059070174,0.00007461975,0.0002888596,0.00015693615,0.00016450234,0.00012438088,0.0011300233,0.04073828],"study_design_scores_gemma":[0.0010207958,0.0005131645,0.025248418,0.5271882,0.4276521,0.0004908465,0.0006207616,0.0001948652,0.00019385347,0.0003175872,0.016448973,0.000110489396],"about_ca_topic_score_codex":0.0134593835,"about_ca_topic_score_gemma":0.055775035,"teacher_disagreement_score":0.0134593835,"about_ca_system_score_codex":0.0025517582,"about_ca_system_score_gemma":0.004907729,"threshold_uncertainty_score":0.026762068},"labels":[],"label_agreement":null},{"id":"W2164958520","doi":"10.1016/j.ctrv.2008.03.082","title":"P61. Identification of serum lactate dehydrogenase (LDH) as a significant prognostic variable for survival: Multivariate analysis in women with metastatic breast cancer (BC)","year":2008,"lang":"en","type":"article","venue":"Cancer Treatment Reviews","topic":"Bone health and treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Medicine; Multivariate analysis; Zoledronic acid; Oncology; Internal medicine; Lactate dehydrogenase; Breast cancer; Metastatic breast cancer; Prognostic variable; Stage (stratigraphy); Multivariate statistics; Overall survival; Cancer; Bone metastasis; Enzyme","score_opus":0.054974949579510775,"score_gpt":0.35844381267195563,"score_spread":0.30346886309244486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164958520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99656737,0.0012028228,0.00036072952,0.00041522802,0.000044877863,0.0000071639674,0.0003985976,0.000013038313,0.000990058],"genre_scores_gemma":[0.9988391,0.00022880947,0.00012662176,0.000034026976,0.000055850476,0.000004553184,0.00026186617,0.0000034255854,0.0004458608],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996778,0.000095510055,0.00003264768,0.000050015136,0.000070763876,0.00007330641],"domain_scores_gemma":[0.99887365,0.00038913946,0.0003414562,0.000059383638,0.00010413419,0.00023210952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059295347,0.00040526228,0.00039142036,0.0005794695,0.0004144046,0.0008065565,0.0003393555,0.00046735856,0.0024600541],"category_scores_gemma":[0.0028277752,0.00016301752,0.00051155355,0.0009042757,0.0003510843,0.0005542038,0.0003648691,0.00068563054,0.00036583495],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010311613,0.000033298067,0.9891076,0.000013590924,0.00006707843,0.00022469606,0.00003456173,0.00012023972,0.0009830508,0.00003948429,0.00030369908,0.008041497],"study_design_scores_gemma":[0.000048651713,0.00055916375,0.99279237,0.00001691168,0.00023028844,0.0017780002,0.00024737275,0.0018145713,0.0010765855,0.00043216365,0.0009945837,0.000009334459],"about_ca_topic_score_codex":0.0014755798,"about_ca_topic_score_gemma":0.0019532356,"teacher_disagreement_score":0.0024600541,"about_ca_system_score_codex":0.00022609718,"about_ca_system_score_gemma":0.0005197201,"threshold_uncertainty_score":0.0082297325},"labels":[],"label_agreement":null},{"id":"W2166580185","doi":"10.1016/j.ctrv.2006.10.005","title":"Rituximab in lymphoma: A systematic review and consensus practice guideline from Cancer Care Ontario","year":2007,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Cancer Care Ontario; Queen's University; Health Sciences Centre; McMaster University","funders":"","keywords":"Rituximab; Medicine; Internal medicine; Lymphoma; Oncology; Follicular lymphoma; Randomized controlled trial; Guideline; Hematology; Chemotherapy; Disease; Pathology","score_opus":0.09197429490376997,"score_gpt":0.43287013386808737,"score_spread":0.3408958389643174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166580185","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012958443,0.9839091,0.0005651712,0.0075271614,0.00087980874,0.001937671,0.0021792622,0.00003862737,0.0016675021],"genre_scores_gemma":[0.018491697,0.9639336,0.007276318,0.0051353085,0.0003391567,0.0025756827,0.0011549161,0.000024215344,0.0010690391],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9769462,0.0060833585,0.010216448,0.0011010849,0.0049774903,0.0006753977],"domain_scores_gemma":[0.9642804,0.011113043,0.0121745,0.00063222245,0.010600272,0.0011995976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.025659792,0.001580714,0.008710611,0.011451915,0.0014765939,0.002703762,0.0032129472,0.0029471854,0.0034426833],"category_scores_gemma":[0.052883647,0.0016663912,0.0068685836,0.0130450055,0.00103557,0.0019366192,0.0027453378,0.002289258,0.00049387914],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083159044,0.00004948773,0.0035400377,0.71684617,0.012932896,0.0003842462,0.0010566288,0.00035799565,0.0007504058,0.0007696002,0.07741698,0.18506388],"study_design_scores_gemma":[0.0025512534,0.0002443993,0.017940555,0.75186414,0.07966426,0.00056740927,0.0005794489,0.00022507776,0.0005429117,0.0006421865,0.14505151,0.00012688329],"about_ca_topic_score_codex":0.15179282,"about_ca_topic_score_gemma":0.4505029,"teacher_disagreement_score":0.8482072,"about_ca_system_score_codex":0.019590933,"about_ca_system_score_gemma":0.063845515,"threshold_uncertainty_score":0.3018186},"labels":[],"label_agreement":null},{"id":"W2205062739","doi":"10.1016/j.ctrv.2015.12.006","title":"Evolution in the eligibility criteria of randomized controlled trials for systemic cancer therapies","year":2015,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Randomized controlled trial; Generalizability theory; Internal medicine; Logistic regression; Cancer","score_opus":0.8089890578173045,"score_gpt":0.6935839612305341,"score_spread":0.11540509658677034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2205062739","genre_codex":"review","genre_gemma":"review","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0029921825,0.8971722,0.07286447,0.016257504,0.0030774113,0.0029244344,0.00063362444,0.0001829737,0.0038951628],"genre_scores_gemma":[0.21303496,0.47325742,0.24797049,0.032534126,0.007907287,0.0209489,0.0017106393,0.0006045101,0.0020315796],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.42553267,0.46504056,0.06749866,0.008187965,0.032145023,0.001595167],"domain_scores_gemma":[0.19772726,0.7588148,0.01854888,0.009262938,0.014727876,0.00091822527],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.4393141,0.0021175898,0.015535093,0.005910262,0.001082327,0.008491403,0.006325693,0.0051450315,0.0035681704],"category_scores_gemma":[0.62659246,0.0017968494,0.011223125,0.0052674618,0.0042886375,0.007477031,0.0048765074,0.007970976,0.0005676232],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005398678,0.00011558927,0.0028226604,0.17814909,0.025038166,0.000105773084,0.0008687717,0.00428694,0.00049432245,0.06886403,0.015803056,0.6980529],"study_design_scores_gemma":[0.015002773,0.0021672968,0.012336205,0.27652207,0.075051494,0.0010112275,0.000666037,0.025906192,0.0024780063,0.38994387,0.1983865,0.0005283288],"about_ca_topic_score_codex":0.002047251,"about_ca_topic_score_gemma":0.0031216624,"teacher_disagreement_score":0.5606859,"about_ca_system_score_codex":0.0068084477,"about_ca_system_score_gemma":0.013091117,"threshold_uncertainty_score":0.69142556},"labels":[],"label_agreement":null},{"id":"W2277945632","doi":"10.1016/j.ctrv.2016.02.004","title":"Clinical predictors of benefit from fulvestrant in advanced breast cancer: A Meta-analysis of randomized controlled trials","year":2016,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Manitoba; University of Toronto; CancerCare Manitoba","funders":"","keywords":"Medicine; Fulvestrant; Randomized controlled trial; Meta-analysis; Oncology; Breast cancer; Internal medicine; Clinical trial; Cancer; Tamoxifen","score_opus":0.09100272314250009,"score_gpt":0.42978530423296596,"score_spread":0.3387825810904659,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2277945632","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0071294582,0.99164903,0.00044499914,0.00013164403,0.000117456024,0.000068495814,0.00027634684,0.000016940747,0.00016572913],"genre_scores_gemma":[0.22899312,0.76560396,0.0022753044,0.0011245795,0.0003998361,0.00027581418,0.0008628096,0.000030074229,0.00043447682],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99701595,0.0014808086,0.00067114044,0.0004468939,0.00026231667,0.00012288874],"domain_scores_gemma":[0.99322104,0.005428186,0.0008410161,0.00019895898,0.00020787446,0.00010287147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005882401,0.0019337446,0.011614554,0.001300688,0.00024961325,0.0017436999,0.0012914189,0.0012502641,0.002917127],"category_scores_gemma":[0.0109126875,0.000784025,0.017142331,0.002286203,0.0004075496,0.0010186596,0.0008012486,0.002073422,0.00020426721],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018412186,0.00007325374,0.0072605107,0.1530275,0.769719,0.00010438607,0.000055524633,0.0011037844,0.00049791165,0.00020282871,0.0012398358,0.048303336],"study_design_scores_gemma":[0.0038890718,0.00051854854,0.006678022,0.005307598,0.9801783,0.00008187289,0.00003873987,0.00029857917,0.0001446729,0.0004569655,0.0023763594,0.00003123315],"about_ca_topic_score_codex":0.0017515093,"about_ca_topic_score_gemma":0.004347434,"teacher_disagreement_score":0.011614554,"about_ca_system_score_codex":0.0008960497,"about_ca_system_score_gemma":0.0010277687,"threshold_uncertainty_score":0.031109452},"labels":[],"label_agreement":null},{"id":"W2300932108","doi":"10.1016/j.ctrv.2016.03.009","title":"The impact of brain metastasis on quality of life, resource utilization and survival in patients with non-small-cell lung cancer","year":2016,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":296,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"F. Hoffmann-La Roche","keywords":"Medicine; Quality of life (healthcare); MEDLINE; Lung cancer; Oncology; Radiation therapy; Internal medicine; Disease; Cancer; Population; Brain metastasis; Systematic review; Intensive care medicine; Metastasis","score_opus":0.11609786579068258,"score_gpt":0.42546623710090925,"score_spread":0.30936837131022665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2300932108","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018692554,0.9995277,0.000012846623,0.000075188706,0.00003233764,0.0000016676299,0.00001847863,7.531392e-7,0.00014416881],"genre_scores_gemma":[0.0022138832,0.9975159,0.00004818434,0.000093937975,0.000050233153,0.000003262992,0.000022045488,3.5052778e-7,0.000052195624],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997483,0.0000560004,0.00005643316,0.000028845017,0.00009053919,0.000019852154],"domain_scores_gemma":[0.9995227,0.00027972268,0.000115736955,0.000004414156,0.00006079768,0.000016682792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055893284,0.00049350713,0.0014087067,0.0012347648,0.00012364169,0.00069789536,0.0004576092,0.0004908066,0.0017858945],"category_scores_gemma":[0.0013424648,0.00017713015,0.0012570507,0.0020367797,0.00022070145,0.000475699,0.0003836197,0.00092032895,0.00020302355],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019257038,0.00006312246,0.002392275,0.0740538,0.0023432807,0.00011870583,0.00006489653,0.00045334737,0.0003626573,0.00089345954,0.014157327,0.90490454],"study_design_scores_gemma":[0.0003632388,0.0009070623,0.056958195,0.12453124,0.018889777,0.0029026654,0.00058450404,0.0008216505,0.0007181203,0.0036262977,0.78953075,0.00016653106],"about_ca_topic_score_codex":0.0044725775,"about_ca_topic_score_gemma":0.011958635,"teacher_disagreement_score":0.0044725775,"about_ca_system_score_codex":0.0005790565,"about_ca_system_score_gemma":0.001211194,"threshold_uncertainty_score":0.008893073},"labels":[],"label_agreement":null},{"id":"W2400707955","doi":"10.1016/j.ctrv.2016.05.003","title":"Diagnosis and management of gastrointestinal neuroendocrine tumors: An evidence-based Canadian consensus","year":2016,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; Foothills Medical Centre; McGill University Health Centre; University of Ottawa; University of Toronto; Western University; University of Calgary; St Joseph's Health Care; Princess Margaret Cancer Centre; CancerCare Manitoba; Health Sciences Centre; University Health Network; Ottawa Hospital; BC Cancer Agency; St. Boniface Hospital; Sunnybrook Health Science Centre; University of British Columbia","funders":"","keywords":"Medicine; Neuroendocrine tumors; Radionuclide therapy; Everolimus; Medical literature; Disease; Intensive care medicine; Internal medicine; Pathology; Medical physics","score_opus":0.18685091968283943,"score_gpt":0.4382014244135304,"score_spread":0.251350504730691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2400707955","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007898457,0.99543434,0.00013666377,0.00315988,0.0004175449,0.000017530489,0.00007032601,0.0000051827037,0.0006795325],"genre_scores_gemma":[0.0009610406,0.9962251,0.00064952916,0.0016282828,0.00022179751,0.000016706002,0.0000946539,0.0000021764802,0.00020062957],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978477,0.00036410254,0.0006104371,0.0002523951,0.00077804213,0.00014731908],"domain_scores_gemma":[0.99402374,0.0022765798,0.00092752243,0.00007618027,0.0024044455,0.0002916264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0059556826,0.0009781147,0.0033714862,0.0051041506,0.00079181296,0.0027842156,0.002633249,0.002524578,0.003580978],"category_scores_gemma":[0.009822766,0.000512504,0.0027515667,0.004233173,0.000961675,0.002637553,0.0015917524,0.0032668065,0.000938129],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002738126,0.000067882305,0.001217649,0.09262973,0.0009133426,0.00027035922,0.00021621189,0.00060542574,0.00075384724,0.0036456836,0.087719336,0.81168675],"study_design_scores_gemma":[0.00016925525,0.00010407781,0.0033883993,0.14736362,0.0032764582,0.0008167355,0.00032079342,0.00020980134,0.00035650242,0.0026856554,0.8412388,0.00006990787],"about_ca_topic_score_codex":0.03164975,"about_ca_topic_score_gemma":0.07511302,"teacher_disagreement_score":0.96835023,"about_ca_system_score_codex":0.0050546527,"about_ca_system_score_gemma":0.020459723,"threshold_uncertainty_score":0.06293106},"labels":[],"label_agreement":null},{"id":"W2461489883","doi":"10.1016/j.ctrv.2016.07.003","title":"The prospect of precision therapy for renal cell carcinoma","year":2016,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Renal cell carcinoma; Oncology; Carcinoma; Intensive care medicine; Internal medicine; Medical physics","score_opus":0.1182675649391262,"score_gpt":0.3909652420386356,"score_spread":0.2726976770995094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2461489883","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000047337413,0.99904627,0.000051821473,0.00020630298,0.0001537506,0.0000024679082,0.000012364327,0.0000030613987,0.0004765421],"genre_scores_gemma":[0.0006445766,0.9983828,0.000114163144,0.00034576637,0.00016512793,0.0000033285608,0.000018235556,0.0000010289907,0.00032498737],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997843,0.000054803295,0.000034018536,0.000029968674,0.00007696347,0.000020000392],"domain_scores_gemma":[0.99957424,0.00023503268,0.00007388878,0.000010605351,0.0000841115,0.000022118002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067518454,0.000655319,0.0016366366,0.0018519997,0.00024190487,0.0011040426,0.0006485021,0.00096391916,0.0050960914],"category_scores_gemma":[0.00089899654,0.00025557526,0.00079470157,0.0016719756,0.00039898348,0.0014369054,0.00066910265,0.0017908871,0.001193427],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010810304,0.0000507427,0.00013516606,0.035838503,0.00021083576,0.000144124,0.000046635403,0.00037480568,0.0012740982,0.0039722645,0.03553453,0.9223101],"study_design_scores_gemma":[0.000048199476,0.00013729758,0.00061022537,0.008566328,0.0004263594,0.00073326175,0.00005156005,0.00013050398,0.00035320455,0.00231427,0.98660684,0.000022071115],"about_ca_topic_score_codex":0.0011424213,"about_ca_topic_score_gemma":0.0034146153,"teacher_disagreement_score":0.0050960914,"about_ca_system_score_codex":0.0005645219,"about_ca_system_score_gemma":0.0010054882,"threshold_uncertainty_score":0.01704806},"labels":[],"label_agreement":null},{"id":"W2496988985","doi":"10.1016/j.ctrv.2016.07.005","title":"How are the kids holding up? A systematic review and meta-analysis on the psychosocial impact of maternal breast cancer on children","year":2016,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Family Support in Illness","field":"Social Sciences","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Psychosocial; Meta-analysis; Breast cancer; Childhood cancer; Cancer; Oncology; Internal medicine; Psychiatry","score_opus":0.1463027417837157,"score_gpt":0.4313877286012478,"score_spread":0.28508498681753214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2496988985","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0030370755,0.99635893,0.00008428042,0.00011936059,0.00008167484,0.00006803342,0.00014127714,0.0000022325794,0.0001070755],"genre_scores_gemma":[0.06858853,0.92979854,0.0005343537,0.0005050183,0.00010759826,0.00018091482,0.00016589712,0.0000038946564,0.000115267445],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9956921,0.0018940945,0.0012991516,0.0004200231,0.0005079254,0.00018678555],"domain_scores_gemma":[0.9902057,0.007566776,0.001375071,0.0001913249,0.00050960376,0.0001515096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006099195,0.0015509163,0.009422514,0.0032630963,0.0005492975,0.0022137654,0.0010663769,0.0017310757,0.0025540907],"category_scores_gemma":[0.02339095,0.0008625572,0.016810179,0.004348914,0.00058900384,0.0013319332,0.0012476738,0.0018534423,0.00014514584],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019649146,0.000069774105,0.00601858,0.653164,0.28742257,0.00018598323,0.00031842972,0.00024350072,0.000253861,0.00021075642,0.0008931316,0.04925456],"study_design_scores_gemma":[0.0007688888,0.00044831654,0.0117872115,0.11901456,0.86128277,0.00025032467,0.00037305366,0.000095658695,0.00016202177,0.00033685414,0.0054271407,0.000053309755],"about_ca_topic_score_codex":0.010703947,"about_ca_topic_score_gemma":0.03250928,"teacher_disagreement_score":0.010703947,"about_ca_system_score_codex":0.001831503,"about_ca_system_score_gemma":0.003944775,"threshold_uncertainty_score":0.032256007},"labels":[],"label_agreement":null},{"id":"W2520692458","doi":"10.1016/j.ctrv.2016.09.001","title":"Post-gemcitabine therapy for patients with advanced pancreatic cancer – A comparative review of randomized trials evaluating oxaliplatin- and/or irinotecan-containing regimens","year":2016,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Irinotecan; Oxaliplatin; Gemcitabine; Internal medicine; Oncology; Pancreatic cancer; Clinical trial; Randomized controlled trial; FOLFIRINOX; Population; Context (archaeology); Progression-free survival; Cancer; Colorectal cancer; Chemotherapy","score_opus":0.30522861975147,"score_gpt":0.5399468667520916,"score_spread":0.2347182470006216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2520692458","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010704754,0.9985127,0.0000437011,0.00006450214,0.000055441924,0.00004452,0.000047473077,0.0000020451855,0.00015916425],"genre_scores_gemma":[0.010899152,0.9881912,0.00032425675,0.00031205543,0.000053519947,0.000046021814,0.00007962009,0.0000021158185,0.00009202392],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9989532,0.0003784927,0.00037644515,0.000110669804,0.00014011818,0.000040981],"domain_scores_gemma":[0.997767,0.0014770732,0.0005604525,0.000033912936,0.00012180741,0.000039744627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024677776,0.0006870846,0.0036504762,0.0014265928,0.00014819358,0.00089984975,0.00094394246,0.00064568274,0.0030960168],"category_scores_gemma":[0.004714962,0.00035267492,0.0040356163,0.0019011209,0.00030345962,0.00075911265,0.00048062674,0.0009593035,0.00016878129],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007244007,0.00015041204,0.00087070616,0.6325984,0.027507488,0.00012078826,0.00012407663,0.00034858886,0.0013031946,0.0005008843,0.0032714647,0.32595998],"study_design_scores_gemma":[0.016220875,0.008131859,0.019211818,0.4008623,0.3695729,0.0015930608,0.00060476543,0.0003848923,0.0017687352,0.0017553824,0.17975695,0.00013651788],"about_ca_topic_score_codex":0.0011638203,"about_ca_topic_score_gemma":0.004484836,"teacher_disagreement_score":0.0036504762,"about_ca_system_score_codex":0.0006851482,"about_ca_system_score_gemma":0.0011308015,"threshold_uncertainty_score":0.013051033},"labels":[],"label_agreement":null},{"id":"W2521763233","doi":"10.1016/j.ctrv.2016.09.013","title":"Bone-targeted therapy use in patients with bone metastases from lung cancer: A systematic review of randomized controlled trials","year":2016,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Bone health and treatments","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Public Health; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Lung cancer; Denosumab; Randomized controlled trial; Meta-analysis; Oncology; Internal medicine; Bone pain; Cancer; Population; Surgery; Osteoporosis","score_opus":0.08462681559930937,"score_gpt":0.40857850373297544,"score_spread":0.32395168813366604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2521763233","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017719385,0.9974687,0.00010661751,0.00007609363,0.000079429694,0.00017333793,0.00019892803,0.000007208974,0.000117639625],"genre_scores_gemma":[0.03604247,0.96201485,0.0007321725,0.0005577601,0.00008372408,0.0002479579,0.00019606166,0.000006367907,0.00011867349],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99592304,0.0013567762,0.0015793053,0.00044976536,0.0005498726,0.00014125183],"domain_scores_gemma":[0.9928128,0.004777575,0.0017844154,0.00011077463,0.000397543,0.00011694956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004516226,0.0015453913,0.010979872,0.0031178868,0.00039169885,0.00176429,0.0016281783,0.001776707,0.0036662298],"category_scores_gemma":[0.016167603,0.0009868921,0.012535195,0.0038486668,0.00075106474,0.0012869248,0.0011071886,0.0017642623,0.0001784994],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002401893,0.000041222167,0.0011994271,0.8916813,0.07467808,0.000070738395,0.000082438324,0.00019166699,0.000283553,0.00010132092,0.0009837388,0.028284704],"study_design_scores_gemma":[0.0059251194,0.0010890497,0.0077951285,0.25897548,0.71314913,0.00037930557,0.00023097567,0.0002069432,0.00032126598,0.0003760962,0.011471645,0.000079865626],"about_ca_topic_score_codex":0.005639475,"about_ca_topic_score_gemma":0.021535655,"teacher_disagreement_score":0.010979872,"about_ca_system_score_codex":0.00197986,"about_ca_system_score_gemma":0.0031080036,"threshold_uncertainty_score":0.023884416},"labels":[],"label_agreement":null},{"id":"W2523098967","doi":"10.1016/j.ctrv.2016.09.011","title":"Mechanism of drug resistance in relation to site of metastasis: Meta-analyses of randomized controlled trials in advanced breast cancer according to anticancer strategy","year":2016,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Medicine; Oncology; Internal medicine; Breast cancer; Randomized controlled trial; Hazard ratio; Metastatic breast cancer; Meta-analysis; Cancer; Palbociclib; Hormone therapy; Metastasis; Sunitinib; Hormonal therapy; Targeted therapy; Confidence interval","score_opus":0.1498119967717804,"score_gpt":0.44889570713484,"score_spread":0.2990837103630596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2523098967","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033555035,0.99583757,0.0003301749,0.000114961076,0.00007596869,0.00003144111,0.00014280296,0.00000818146,0.00010345032],"genre_scores_gemma":[0.13652116,0.85918576,0.0019877634,0.0010577798,0.0003204658,0.00014615017,0.0004707273,0.00002469061,0.00028540846],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9953271,0.002532862,0.0010987084,0.0005755593,0.00032187696,0.00014384715],"domain_scores_gemma":[0.9877295,0.00995405,0.0014925551,0.0003536321,0.00035657498,0.00011373412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00793573,0.0017551517,0.010319359,0.0014304304,0.0002188357,0.0017879581,0.001385065,0.0014764807,0.0027040064],"category_scores_gemma":[0.016689233,0.00080040237,0.01673964,0.0025859124,0.000425549,0.0009980976,0.0008705864,0.0019865553,0.00018926355],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008470257,0.000056006473,0.009241038,0.17321652,0.74812704,0.00011213163,0.00007377697,0.00095411745,0.0004908005,0.00031509064,0.0012808149,0.05766239],"study_design_scores_gemma":[0.0017137197,0.00046593946,0.010052816,0.008623857,0.9732603,0.00012323522,0.00005487473,0.0002973212,0.00020808811,0.00076226314,0.004398964,0.000038747185],"about_ca_topic_score_codex":0.0022373663,"about_ca_topic_score_gemma":0.0055205114,"teacher_disagreement_score":0.010319359,"about_ca_system_score_codex":0.00087012944,"about_ca_system_score_gemma":0.0011152315,"threshold_uncertainty_score":0.041968644},"labels":[],"label_agreement":null},{"id":"W2548925627","doi":"10.1016/j.ctrv.2016.10.007","title":"Approach to evaluation of fever in ambulatory cancer patients receiving chemotherapy: A systematic review","year":2016,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; University of Windsor; Sinai Health System; Princess Margaret Cancer Centre; Health Sciences Centre; University Health Network; Windsor Regional Hospital; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre; Windsor Clinical Research; McMaster University; Cancer Care Ontario; University of Toronto; Grand River Hospital; Ontario Institute for Cancer Research","funders":"National Institutes of Health","keywords":"Medicine; Febrile neutropenia; Ambulatory; Intensive care medicine; Chemotherapy; MEDLINE; Neutropenia; Systematic review; Population; Cancer; Internal medicine","score_opus":0.15135810267013,"score_gpt":0.43302971880095553,"score_spread":0.28167161613082553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548925627","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00088788697,0.99849117,0.00007553296,0.00012083953,0.00006825852,0.00013019796,0.00013312457,0.0000035745707,0.00008944937],"genre_scores_gemma":[0.022991065,0.9750313,0.00091709284,0.00060042326,0.000073128904,0.00020979425,0.00011601241,0.0000034108966,0.000057784608],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99262637,0.0023948953,0.003210031,0.0005878057,0.0009991257,0.00018163772],"domain_scores_gemma":[0.9837865,0.010621636,0.0039439276,0.00019865754,0.0012522866,0.00019706985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0059058405,0.0014163994,0.008088453,0.0069030738,0.00048294824,0.0024339154,0.0014484285,0.0017369088,0.0027308161],"category_scores_gemma":[0.03158594,0.0011688427,0.011354154,0.006648777,0.00073168287,0.0017911086,0.0016468005,0.001818955,0.00016174772],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038223917,0.000035943605,0.0031525728,0.9062036,0.04095296,0.00009504414,0.00024215739,0.00014486643,0.00013966228,0.00015906549,0.0014295069,0.047062375],"study_design_scores_gemma":[0.0008665227,0.00034761164,0.0104806265,0.6892344,0.28421196,0.00047068688,0.00050707755,0.00018665598,0.00016304835,0.00028172656,0.013158056,0.00009163915],"about_ca_topic_score_codex":0.012867787,"about_ca_topic_score_gemma":0.051509526,"teacher_disagreement_score":0.012867787,"about_ca_system_score_codex":0.0030283846,"about_ca_system_score_gemma":0.00722673,"threshold_uncertainty_score":0.03123343},"labels":[],"label_agreement":null},{"id":"W2555449614","doi":"10.1016/j.ctrv.2016.11.009","title":"Statin use and kidney cancer survival outcomes: A systematic review and meta-analysis","year":2016,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; Western University; London Health Sciences Centre; University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Hazard ratio; Internal medicine; Kidney cancer; Publication bias; Statin; Meta-analysis; Oncology; Cancer; Randomized controlled trial; Proportional hazards model; Confidence interval","score_opus":0.1656488248597905,"score_gpt":0.41206211989832026,"score_spread":0.24641329503852977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555449614","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021830746,0.9970893,0.00014325147,0.000093962735,0.00005429767,0.000042579686,0.00029830897,0.0000072634994,0.000087922344],"genre_scores_gemma":[0.053561203,0.9443518,0.00075335737,0.00046781462,0.00012180942,0.00014666059,0.00039644458,0.000008671376,0.0001922214],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9973334,0.0008836013,0.000911482,0.0003711912,0.0003433855,0.00015694264],"domain_scores_gemma":[0.9958604,0.0026929723,0.00087614846,0.00013952541,0.00034732925,0.000083595856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041507035,0.0019957277,0.011210713,0.003422987,0.00044819104,0.0018139629,0.0013876428,0.001515054,0.0031073138],"category_scores_gemma":[0.010865034,0.0010447069,0.01746907,0.006112758,0.00041722012,0.0011068507,0.001317062,0.0013487379,0.00026738006],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002161857,0.000051166415,0.007176881,0.48809752,0.4622455,0.00020314897,0.00011071842,0.0005245292,0.00038550995,0.00017427042,0.0021198215,0.036749158],"study_design_scores_gemma":[0.00046441768,0.00013721852,0.0066660256,0.023459285,0.9647057,0.00016084676,0.00006765475,0.0001150236,0.00011647628,0.0002047217,0.0038687303,0.00003398901],"about_ca_topic_score_codex":0.009417099,"about_ca_topic_score_gemma":0.03211605,"teacher_disagreement_score":0.011210713,"about_ca_system_score_codex":0.0015860308,"about_ca_system_score_gemma":0.0031673354,"threshold_uncertainty_score":0.021951258},"labels":[],"label_agreement":null},{"id":"W2560222145","doi":"10.1016/j.ctrv.2016.11.010","title":"Effects and moderators of exercise on quality of life and physical function in patients with cancer: An individual patient data meta-analysis of 34 RCTs","year":2016,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Cancer survivorship and care","field":"Medicine","cited_by":610,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"KWF Kankerbestrijding","keywords":"Medicine; Meta-analysis; PsycINFO; Quality of life (healthcare); Randomized controlled trial; Physical therapy; Moderation; Psychological intervention; CINAHL; Body mass index; Clinical trial; MEDLINE; Internal medicine","score_opus":0.18206724738803673,"score_gpt":0.40623549348465143,"score_spread":0.2241682460966147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560222145","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012225421,0.98391265,0.0012728664,0.00024297922,0.000274447,0.00053339044,0.00077918515,0.000055879726,0.0007030773],"genre_scores_gemma":[0.39459357,0.5937532,0.005332304,0.001469509,0.00035122375,0.0017545769,0.0015447834,0.00009885891,0.0011019987],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99243915,0.003933465,0.0021799847,0.0006761143,0.0005837445,0.00018762228],"domain_scores_gemma":[0.9848562,0.012431458,0.0014872088,0.00045504502,0.00059944973,0.00017066972],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.012156621,0.0024658216,0.013680589,0.0023823108,0.0006370267,0.0026713032,0.0011026447,0.0019008848,0.0045806947],"category_scores_gemma":[0.029951865,0.0012241884,0.038830377,0.0028560369,0.00069972215,0.0015430613,0.0014047455,0.003134137,0.00043951016],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00824853,0.000054529264,0.0023510228,0.22786497,0.74185413,0.0001239607,0.00009449562,0.00044642427,0.00047261087,0.00014696304,0.00067325437,0.0176692],"study_design_scores_gemma":[0.0014740166,0.00020546022,0.0016815978,0.006116995,0.988825,0.000055279204,0.000023491308,0.000083394225,0.00012310843,0.00013476737,0.0012630211,0.000013813278],"about_ca_topic_score_codex":0.0042288476,"about_ca_topic_score_gemma":0.010901638,"teacher_disagreement_score":0.9863194,"about_ca_system_score_codex":0.0015175786,"about_ca_system_score_gemma":0.0019032476,"threshold_uncertainty_score":0.06429112},"labels":[],"label_agreement":null},{"id":"W2563522215","doi":"10.1016/j.ctrv.2016.12.002","title":"Cardiovascular toxicity of angiogenesis inhibitors in treatment of malignancy: A systematic review and meta-analysis","year":2016,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":254,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; Women's College Hospital; University of Toronto; Institute for Clinical Evaluative Sciences","funders":"","keywords":"Medicine; Number needed to harm; Angiogenesis; Internal medicine; Cardiology; Ischemia; Pharmacology; Relative risk; Number needed to treat; Confidence interval","score_opus":0.12253469518415144,"score_gpt":0.3725759583253476,"score_spread":0.2500412631411962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563522215","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0030489012,0.9962748,0.0001763291,0.00005628104,0.00006473294,0.00006993088,0.00016572123,0.0000070011256,0.00013626332],"genre_scores_gemma":[0.07805613,0.91972584,0.0009343416,0.0005217935,0.00013273764,0.0001594718,0.00023976226,0.000010080111,0.00021977014],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99748296,0.0008852851,0.00084428344,0.0003249017,0.00034816767,0.0001144916],"domain_scores_gemma":[0.9952468,0.0031191849,0.0011077159,0.00012822606,0.00031938957,0.00007864404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038614997,0.0017555768,0.01009596,0.0025324335,0.00035384772,0.0016256201,0.001213741,0.0014165498,0.0030628473],"category_scores_gemma":[0.01044832,0.00096059765,0.019053759,0.0036777488,0.00040500177,0.0011123524,0.0010728555,0.001585177,0.00019674425],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031405666,0.0000643684,0.0035265598,0.51711714,0.43917996,0.00016634261,0.00010345651,0.00064557546,0.0004788406,0.0001423648,0.0010364695,0.034398384],"study_design_scores_gemma":[0.00092911726,0.00036232243,0.0047430326,0.024785193,0.9651158,0.00015694891,0.000062313025,0.00014261634,0.00014503888,0.00017189924,0.0033514795,0.00003424447],"about_ca_topic_score_codex":0.004207435,"about_ca_topic_score_gemma":0.015719939,"teacher_disagreement_score":0.01009596,"about_ca_system_score_codex":0.0011991229,"about_ca_system_score_gemma":0.0015995998,"threshold_uncertainty_score":0.020421803},"labels":[],"label_agreement":null},{"id":"W2564183539","doi":"10.1016/j.ctrv.2016.11.013","title":"Toxicity of concurrent stereotactic radiotherapy and targeted therapy or immunotherapy: A systematic review","year":2016,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":205,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Canada Research Chairs","funders":"","keywords":"Medicine; Radiation therapy; Immunotherapy; Stereotactic radiotherapy; Oncology; Toxicity; Targeted therapy; Medical physics; Radiosurgery; Intensive care medicine; Internal medicine; Cancer","score_opus":0.10906969441442799,"score_gpt":0.41843800132175824,"score_spread":0.30936830690733025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564183539","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010479434,0.9983615,0.00007783971,0.000057581365,0.00005143036,0.000086548425,0.00017552075,0.0000045252655,0.00013704578],"genre_scores_gemma":[0.018226853,0.9806261,0.00037418885,0.0003720448,0.00004602808,0.00012121904,0.0001111572,0.000004441973,0.00011788538],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9970667,0.0009186638,0.0010808124,0.0003143601,0.0005064601,0.00011300743],"domain_scores_gemma":[0.993985,0.0036243154,0.0018172589,0.00008961596,0.00039474704,0.0000890394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032006511,0.0013615179,0.0069246585,0.003290786,0.00029728882,0.0016301412,0.001273642,0.0013466137,0.0036904488],"category_scores_gemma":[0.0123257395,0.0008634293,0.00914583,0.0047919643,0.00056242006,0.001197583,0.0011338012,0.0012472247,0.00020195048],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074979826,0.000023007686,0.0008921904,0.92159605,0.03733084,0.00009880682,0.00009319961,0.00027145314,0.00027617216,0.00014085694,0.0013560774,0.03717158],"study_design_scores_gemma":[0.001530038,0.0007712588,0.008315777,0.41442332,0.5435569,0.00080225075,0.00026901843,0.00022888328,0.00040624174,0.00043286706,0.02917542,0.00008801654],"about_ca_topic_score_codex":0.008599231,"about_ca_topic_score_gemma":0.028424816,"teacher_disagreement_score":0.008599231,"about_ca_system_score_codex":0.00255398,"about_ca_system_score_gemma":0.00424263,"threshold_uncertainty_score":0.018530548},"labels":[],"label_agreement":null},{"id":"W2576814507","doi":"10.1016/j.ctrv.2017.01.003","title":"Biology and patterns of response to EGFR-inhibition in squamous cell cancers of the lung and head & neck","year":2017,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Ottawa; University of Toronto; University Health Network; Ottawa Hospital; Princess Margaret Cancer Centre; McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Epidermal growth factor receptor; Lung cancer; EGFR inhibitors; Head and neck cancer; Biomarker; Oncology; Head and neck squamous-cell carcinoma; Cancer research; Targeted therapy; Cancer; Clinical trial; Squamous carcinoma; Internal medicine; Carcinoma; Biology","score_opus":0.10154198292516915,"score_gpt":0.46727080123517467,"score_spread":0.36572881831000553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2576814507","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00028302518,0.9990074,0.000055075318,0.00012889261,0.00004611437,0.0000042054835,0.000028323158,0.0000032656217,0.00044375722],"genre_scores_gemma":[0.0017533106,0.99757546,0.000104639745,0.00013106415,0.000042184238,0.0000052332693,0.000042054577,7.767234e-7,0.00034529573],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9998516,0.000023175819,0.000024780884,0.000028891443,0.000054075404,0.000017425056],"domain_scores_gemma":[0.99981314,0.00009852514,0.0000377753,0.000004720699,0.00003631263,0.000009465421],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044746342,0.0004709429,0.0012104564,0.0009835768,0.000112089925,0.0007658128,0.0006269218,0.0005264234,0.001944555],"category_scores_gemma":[0.0005834256,0.00020474612,0.0007033069,0.0008599779,0.00021260296,0.00061314687,0.0003140841,0.0011060454,0.00065848214],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017530318,0.000056065055,0.00057503383,0.021071449,0.00030160396,0.00012910388,0.00004340958,0.0004977984,0.0032837372,0.0019244624,0.0116992965,0.96024257],"study_design_scores_gemma":[0.00008706241,0.00049365533,0.0068939887,0.010822231,0.0013723822,0.0024316383,0.00015413098,0.00032333302,0.0038083177,0.002427963,0.9711312,0.00005417311],"about_ca_topic_score_codex":0.0011090281,"about_ca_topic_score_gemma":0.0033737768,"teacher_disagreement_score":0.001944555,"about_ca_system_score_codex":0.0005525795,"about_ca_system_score_gemma":0.0006901182,"threshold_uncertainty_score":0.0065051317},"labels":[],"label_agreement":null},{"id":"W2588571167","doi":"10.1016/j.ctrv.2017.02.003","title":"A systematic review of smell alterations after radiotherapy for head and neck cancer","year":2017,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Olfactory and Sensory Function Studies","field":"Neuroscience","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Olfaction; Olfactory system; Radiation therapy; CINAHL; Head and neck cancer; MEDLINE; Systematic review; Internal medicine; PsycINFO; Oncology; Neuroscience; Psychiatry","score_opus":0.41662792700825413,"score_gpt":0.4571656062967414,"score_spread":0.04053767928848728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588571167","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00046253612,0.9989134,0.00005538135,0.000084080835,0.00007337816,0.00007533709,0.00017693474,0.0000039717365,0.00015498244],"genre_scores_gemma":[0.0054814513,0.9935823,0.0002612802,0.00033040094,0.00004620815,0.00009025133,0.00009748962,0.0000026475338,0.00010795687],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99766576,0.0006041051,0.0010345972,0.00024795014,0.00035837438,0.000089249355],"domain_scores_gemma":[0.9952553,0.0030391773,0.0011503809,0.00007927967,0.0004041825,0.00007163332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030772476,0.0013415484,0.0061788666,0.005968057,0.00037497107,0.001871049,0.0012432898,0.0013569981,0.0038210626],"category_scores_gemma":[0.012148989,0.00068493985,0.005784125,0.006422158,0.0005577865,0.0013518725,0.0013130453,0.0010162024,0.0002761184],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018223833,0.000014470445,0.00036955986,0.93957436,0.009694189,0.00009173959,0.0001246664,0.000086950786,0.00027720665,0.00013123256,0.0017786601,0.04767484],"study_design_scores_gemma":[0.00044166367,0.0004196189,0.005696062,0.7514333,0.17164677,0.00079705496,0.00034161867,0.00007971184,0.00031086436,0.00047343984,0.06828567,0.00007415661],"about_ca_topic_score_codex":0.0076878294,"about_ca_topic_score_gemma":0.02852251,"teacher_disagreement_score":0.0076878294,"about_ca_system_score_codex":0.0017830213,"about_ca_system_score_gemma":0.0055395756,"threshold_uncertainty_score":0.016274273},"labels":[],"label_agreement":null},{"id":"W2590461535","doi":"10.1016/j.ctrv.2017.02.005","title":"Ovarian ablation for premenopausal breast cancer: A review of treatment considerations and the impact of premature menopause","year":2017,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Menopause; Premature Menopause; Breast cancer; Premature ovarian failure; Gynecology; Cancer; Ablation; Oncology; Internal medicine","score_opus":0.05435239297481958,"score_gpt":0.4056446301276318,"score_spread":0.3512922371528122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590461535","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003441436,0.9995596,0.000033651795,0.00011993191,0.00008791552,0.000002053963,0.000009910021,0.0000017616915,0.00015083558],"genre_scores_gemma":[0.00026266882,0.9991736,0.00009942496,0.00019995087,0.000117942334,0.0000031544585,0.000015543737,7.603028e-7,0.00012706086],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99975914,0.000046171786,0.000055166987,0.000040042807,0.00008184172,0.000017538927],"domain_scores_gemma":[0.99929655,0.00046244534,0.00009603835,0.000010371312,0.00010457535,0.00003001525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007753241,0.0005999594,0.0015306765,0.0019947125,0.00021985253,0.00087707746,0.000806256,0.0009131064,0.003306344],"category_scores_gemma":[0.0014593689,0.00027756588,0.00066485937,0.001722846,0.000333736,0.0010657345,0.00059866393,0.0015935685,0.0008003108],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013422145,0.000059183923,0.00021238648,0.03465466,0.0001921814,0.00016540992,0.000043600012,0.000251137,0.00092746434,0.0014579296,0.03032095,0.93158084],"study_design_scores_gemma":[0.0000679864,0.00018032867,0.0012269795,0.01347662,0.00054910744,0.0017898235,0.000079491285,0.00012769205,0.00036995005,0.0014871854,0.98061347,0.000031333137],"about_ca_topic_score_codex":0.0010474798,"about_ca_topic_score_gemma":0.0031064644,"teacher_disagreement_score":0.003306344,"about_ca_system_score_codex":0.00045272108,"about_ca_system_score_gemma":0.0010498741,"threshold_uncertainty_score":0.011060774},"labels":[],"label_agreement":null},{"id":"W2591590744","doi":"10.1016/j.ctrv.2017.02.008","title":"Anti-angiogenic treatment for breast cancer?","year":2017,"lang":"en","type":"letter","venue":"Cancer Treatment Reviews","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia; University of Victoria","funders":"","keywords":"Medicine; Breast cancer; Scopus; Oncology; Cancer; Cancer treatment; Internal medicine; MEDLINE","score_opus":0.06379287675606626,"score_gpt":0.35811604205317804,"score_spread":0.2943231652971118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591590744","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00058975606,0.119042076,0.00029079296,0.8282492,0.041953214,0.00002720461,0.00006587526,0.000054297077,0.009727618],"genre_scores_gemma":[0.011478847,0.13703284,0.0008334319,0.6375569,0.18209973,0.00012682016,0.000088069806,0.0000456928,0.030737713],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99902844,0.00029675613,0.00007991159,0.0000858154,0.0003957841,0.00011328065],"domain_scores_gemma":[0.99813545,0.0010641203,0.00018286804,0.000060475046,0.0002877028,0.00026937912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017595114,0.0005807912,0.0010193358,0.0005832735,0.0009876518,0.0015734207,0.0007155952,0.009001923,0.0077959686],"category_scores_gemma":[0.004960536,0.00030769204,0.00069113827,0.00036550447,0.001491278,0.0023408327,0.0010198622,0.012451378,0.0035374877],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021899241,0.000115989315,0.00020407746,0.0003331163,0.000023471737,0.0006800172,0.000028517072,0.00013755655,0.0008167992,0.009907316,0.89277714,0.09475697],"study_design_scores_gemma":[0.00016868953,0.00010838343,0.00018548152,0.00026309045,0.00001908416,0.0004842381,0.000029551984,0.0001487672,0.00025818395,0.0057960935,0.9925263,0.000012085874],"about_ca_topic_score_codex":0.00075662025,"about_ca_topic_score_gemma":0.0031601829,"teacher_disagreement_score":0.009001923,"about_ca_system_score_codex":0.0016322652,"about_ca_system_score_gemma":0.0013784958,"threshold_uncertainty_score":0.026080072},"labels":[],"label_agreement":null},{"id":"W2604383404","doi":"10.1016/j.ctrv.2017.03.011","title":"Efficacy, safety, tolerability and price of newly approved drugs in solid tumors","year":2017,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Tolerability; Discontinuation; Internal medicine; Hazard ratio; Oncology; Chemotherapy; Immunotherapy; Adverse effect; Cancer; Confidence interval","score_opus":0.14328270882966276,"score_gpt":0.3700561566682588,"score_spread":0.22677344783859604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604383404","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019310131,0.99941957,0.000032638844,0.00011558262,0.000027574162,0.0000021686276,0.000019548756,9.64537e-7,0.0001889713],"genre_scores_gemma":[0.004053205,0.9955439,0.000093299874,0.00010585972,0.0000925033,0.000003872638,0.000023591883,6.572966e-7,0.000083051505],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.999405,0.00019715638,0.00009954895,0.00006136239,0.00020636643,0.000030466525],"domain_scores_gemma":[0.99758005,0.0017730584,0.00044117618,0.000023660637,0.00015013441,0.00003192394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001718393,0.00052374275,0.001662037,0.0015026453,0.000112515394,0.0009113598,0.0005577224,0.00067083276,0.0029349907],"category_scores_gemma":[0.00371881,0.00022974118,0.0014056648,0.0025237566,0.00030637477,0.0007045097,0.000316871,0.001077593,0.00025020822],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039178727,0.00007705462,0.0009567428,0.06842485,0.0019393369,0.00010022271,0.00003352401,0.0015702165,0.0004496916,0.003848293,0.01514054,0.9070678],"study_design_scores_gemma":[0.0005792267,0.0011032061,0.024299886,0.0808616,0.01496895,0.0021841421,0.0002312342,0.0018197452,0.001241143,0.01336712,0.8592209,0.00012274948],"about_ca_topic_score_codex":0.0020386355,"about_ca_topic_score_gemma":0.0052789873,"teacher_disagreement_score":0.0029349907,"about_ca_system_score_codex":0.0008503355,"about_ca_system_score_gemma":0.0011990262,"threshold_uncertainty_score":0.009818554},"labels":[],"label_agreement":null},{"id":"W2734686113","doi":"10.1016/j.ctrv.2017.06.007","title":"Influence of non-measurable disease on progression-free survival in patients with metastatic breast cancer","year":2017,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Breast cancer; Metastatic breast cancer; Hazard ratio; Oncology; Chemotherapy; Disease; Cancer; Clinical trial; Confidence interval; Bone disease; Progression-free survival; Osteoporosis","score_opus":0.10435938010052802,"score_gpt":0.45080077233445087,"score_spread":0.34644139223392284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2734686113","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00045394528,0.9990508,0.000029839413,0.000103418846,0.00004696136,0.0000025512206,0.000024082676,0.0000018981461,0.00028654592],"genre_scores_gemma":[0.0068267267,0.99251986,0.000102271486,0.0002143315,0.00011339428,0.000005966561,0.000049969836,0.0000010106321,0.00016654166],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99980634,0.000054355198,0.000036173027,0.00002766065,0.00005981627,0.000015556458],"domain_scores_gemma":[0.9995421,0.0002923521,0.00009690822,0.0000063195644,0.00004767313,0.000014660716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046340242,0.0003972059,0.0013228429,0.0006547865,0.00008673364,0.0005004119,0.00043188734,0.00036942848,0.0016930599],"category_scores_gemma":[0.0011708781,0.00016176746,0.0008908415,0.0007498033,0.00017694209,0.00036323047,0.0002576286,0.0010066676,0.00022318133],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049689226,0.000089664914,0.002538818,0.027963817,0.0012081878,0.000095720454,0.00004434978,0.00043196406,0.00069383223,0.0007406261,0.00989701,0.9557991],"study_design_scores_gemma":[0.0011972745,0.0027472654,0.09093404,0.05674093,0.0213109,0.0039861277,0.0003266345,0.0014806894,0.0019061284,0.004588458,0.8146007,0.00018082857],"about_ca_topic_score_codex":0.0012113901,"about_ca_topic_score_gemma":0.00401661,"teacher_disagreement_score":0.0016930599,"about_ca_system_score_codex":0.00029688404,"about_ca_system_score_gemma":0.0005821979,"threshold_uncertainty_score":0.0056638718},"labels":[],"label_agreement":null},{"id":"W2746712977","doi":"10.1016/j.ctrv.2017.08.001","title":"Duration of adjuvant trastuzumab in HER2 positive breast cancer: Overall and disease free survival results from meta-analyses of randomized controlled trials","year":2017,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Medicine; Trastuzumab; Hazard ratio; Internal medicine; Breast cancer; Oncology; Meta-analysis; Confidence interval; Randomized controlled trial; Odds ratio; Cancer","score_opus":0.47897338594908834,"score_gpt":0.54750043717925,"score_spread":0.06852705123016167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2746712977","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031453737,0.9960508,0.00026685756,0.00008057368,0.00010397784,0.00005089939,0.00017173991,0.000012281292,0.00011754266],"genre_scores_gemma":[0.11678083,0.87931484,0.0015047656,0.0008768502,0.00026688268,0.00023979558,0.0005918522,0.000033129476,0.0003910934],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99529856,0.0022334144,0.0012282848,0.00059854425,0.00044927312,0.00019187586],"domain_scores_gemma":[0.98887014,0.008931776,0.0013896294,0.0003046387,0.00035206473,0.00015177522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008751426,0.0023865884,0.01455406,0.001911459,0.00029353314,0.0021024253,0.0018021909,0.0017413526,0.0036225803],"category_scores_gemma":[0.018641777,0.0011679049,0.025056668,0.0030455366,0.00052106334,0.0015213217,0.0010926776,0.0026542218,0.0002440822],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011887535,0.00004398453,0.0027342036,0.25904503,0.6920743,0.00008904095,0.000072350784,0.00077955896,0.00041534353,0.00019254263,0.0010931313,0.031572886],"study_design_scores_gemma":[0.0026111202,0.00040318552,0.003873515,0.010024048,0.9796719,0.000076168515,0.000036374946,0.00014614561,0.00012256143,0.00036014753,0.0026492528,0.000025528785],"about_ca_topic_score_codex":0.0036322123,"about_ca_topic_score_gemma":0.008688467,"teacher_disagreement_score":0.01455406,"about_ca_system_score_codex":0.0017523441,"about_ca_system_score_gemma":0.0015868971,"threshold_uncertainty_score":0.04628247},"labels":[],"label_agreement":null},{"id":"W2749459964","doi":"10.1016/j.ctrv.2017.08.008","title":"Efficacy of extended adjuvant therapy with aromatase inhibitors in early breast cancer among common clinicopathologically-defined subgroups: A systematic review and meta-analysis","year":2017,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Aromatase; Meta-analysis; Adjuvant; Oncology; Breast cancer; Internal medicine; Cancer; Gynecology; Adjuvant therapy; Aromatase inhibitor","score_opus":0.11892181173949712,"score_gpt":0.40118202484652005,"score_spread":0.28226021310702293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2749459964","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003626352,0.9955722,0.00019621193,0.0000716079,0.00006588957,0.000053457203,0.000274268,0.0000082931865,0.00013175004],"genre_scores_gemma":[0.14253141,0.8539028,0.0012277801,0.0009646708,0.0001756977,0.00021452148,0.0006182849,0.000020163588,0.00034470315],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9974591,0.0008446313,0.000858452,0.000418057,0.00029501383,0.00012469379],"domain_scores_gemma":[0.9961928,0.0025198013,0.00084003876,0.00014266928,0.00023097936,0.0000737133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004382734,0.0017495779,0.010934445,0.002386065,0.00029494026,0.001804268,0.0013396186,0.0014447683,0.0028534106],"category_scores_gemma":[0.009468873,0.00093907065,0.018893085,0.0038717405,0.00041536623,0.0011424386,0.0011705953,0.001466774,0.00023238263],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029661192,0.00004816484,0.007504135,0.34838185,0.608386,0.00013305653,0.00011498172,0.00060132495,0.00045137882,0.0001555667,0.0010272682,0.03023029],"study_design_scores_gemma":[0.00067132636,0.00020232232,0.0062582227,0.01370862,0.97575617,0.0000976118,0.00005785674,0.0001035669,0.000099457786,0.00018046616,0.0028363357,0.000028039076],"about_ca_topic_score_codex":0.004474931,"about_ca_topic_score_gemma":0.01595442,"teacher_disagreement_score":0.010934445,"about_ca_system_score_codex":0.0011537743,"about_ca_system_score_gemma":0.001681342,"threshold_uncertainty_score":0.023178339},"labels":[],"label_agreement":null},{"id":"W2750695770","doi":"10.1016/j.ctrv.2017.08.011","title":"The Notch-3 receptor: A molecular switch to tumorigenesis?","year":2017,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Developmental Biology and Gene Regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"","keywords":"Notch signaling pathway; Medicine; Receptor; Cancer research; Carcinogenesis; Bioinformatics; Computational biology; Cancer; Internal medicine; Biology","score_opus":0.09881371528737785,"score_gpt":0.4230899546080199,"score_spread":0.32427623932064203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2750695770","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009733704,0.99732435,0.00015208668,0.00083066843,0.00046346543,0.0000022500544,0.000021493248,0.00000925709,0.0010990745],"genre_scores_gemma":[0.00081553345,0.9969116,0.00013635159,0.0006091286,0.00034422943,0.000004131058,0.000029468167,0.0000021530777,0.0011473494],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99987876,0.00001790155,0.000012659463,0.000017530441,0.000056559606,0.000016495218],"domain_scores_gemma":[0.9998541,0.000056710847,0.000020550535,0.0000050440217,0.000041838215,0.000021768565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043958225,0.000566782,0.0008207416,0.00079570606,0.00016531827,0.0009347318,0.00068448926,0.00095893664,0.003978011],"category_scores_gemma":[0.00055353733,0.00016383766,0.00021504432,0.0008414656,0.00043622314,0.0010145009,0.0006045218,0.0019230063,0.00205097],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000108005996,0.000036157402,0.00013756071,0.005298221,0.000050534138,0.00015254895,0.000031659212,0.00027153327,0.0033087395,0.008545836,0.08422164,0.8978375],"study_design_scores_gemma":[0.000014069814,0.000031469463,0.00025849897,0.00090257364,0.00003995382,0.00047282188,0.000032203854,0.000051526873,0.0004635173,0.002072242,0.99565256,0.000008637579],"about_ca_topic_score_codex":0.0007620088,"about_ca_topic_score_gemma":0.0020274778,"teacher_disagreement_score":0.003978011,"about_ca_system_score_codex":0.0006272018,"about_ca_system_score_gemma":0.0008332851,"threshold_uncertainty_score":0.01330781},"labels":[],"label_agreement":null},{"id":"W2757591860","doi":"10.1016/j.ctrv.2017.09.004","title":"Adjuvant therapy in renal cell carcinoma","year":2017,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Renal cell carcinoma; Adjuvant; Immunotherapy; Targeted therapy; Adjuvant therapy; Clinical trial; Disease; Oncology; Kidney cancer; Internal medicine; Cancer","score_opus":0.2687763931843208,"score_gpt":0.4286284167925947,"score_spread":0.15985202360827394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2757591860","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006239923,0.9993332,0.000030758572,0.000105845036,0.000082705985,0.0000044675994,0.000017410179,0.0000024310937,0.00036064273],"genre_scores_gemma":[0.000661039,0.9987602,0.00007648089,0.00021882768,0.00007376843,0.000005184818,0.000023877175,7.0047184e-7,0.00017988794],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99977523,0.000057497673,0.000057044617,0.00003173186,0.000059746453,0.000018787114],"domain_scores_gemma":[0.9995671,0.00023192225,0.00011508939,0.000007602183,0.000059086928,0.000019120345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005879298,0.00067041983,0.0017426097,0.0019055362,0.00019033489,0.0008928453,0.0005924352,0.00070843275,0.0041327984],"category_scores_gemma":[0.0012008597,0.00029061546,0.00080425135,0.001976566,0.00026799514,0.0009077646,0.0005639924,0.001358724,0.0006834685],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014349744,0.00006069578,0.0002349903,0.0863585,0.00039312863,0.000106160725,0.000054244352,0.00041407745,0.0006758159,0.0013255844,0.025686894,0.8845464],"study_design_scores_gemma":[0.00016076188,0.00022786285,0.0017363922,0.052981712,0.0023586347,0.0011057461,0.000081469225,0.00018181387,0.0003674174,0.0012792026,0.93948644,0.000032607226],"about_ca_topic_score_codex":0.0018175789,"about_ca_topic_score_gemma":0.0051425863,"teacher_disagreement_score":0.0041327984,"about_ca_system_score_codex":0.00066713075,"about_ca_system_score_gemma":0.001332107,"threshold_uncertainty_score":0.013825595},"labels":[],"label_agreement":null},{"id":"W2765083464","doi":"10.1016/j.ctrv.2017.09.009","title":"Risk of adverse events with the addition of targeted agents to endocrine therapy in patients with hormone receptor-positive metastatic breast cancer: A systematic review and meta-analysis","year":2017,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Hôpital Charles-Le Moyne; Université de Sherbrooke","funders":"European Society for Medical Oncology","keywords":"Medicine; Internal medicine; Odds ratio; Meta-analysis; Adverse effect; Oncology; Breast cancer; Cochrane Library; Neutropenia; Randomized controlled trial; Metastatic breast cancer; Relative risk; Confidence interval; Cancer; Chemotherapy","score_opus":0.0726883789844289,"score_gpt":0.3747771327808193,"score_spread":0.30208875379639044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765083464","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0054093907,0.99360955,0.00026411933,0.000071211885,0.00009208413,0.00006310425,0.00032105102,0.000009516066,0.00015988009],"genre_scores_gemma":[0.13840356,0.85831773,0.0012259133,0.0007261845,0.00021408341,0.00022404359,0.0005318902,0.000016906595,0.0003396551],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99627614,0.0012758566,0.0012520227,0.0005497128,0.00050286576,0.00014339315],"domain_scores_gemma":[0.99270904,0.005137753,0.001476764,0.0001885669,0.0003978623,0.000089936955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043672207,0.0019662112,0.009981445,0.0023439194,0.00035412697,0.0017354367,0.0012975971,0.001606492,0.0028567323],"category_scores_gemma":[0.013773273,0.0010516664,0.027861854,0.0036120228,0.00042419258,0.0011634589,0.0010771521,0.0021523016,0.00021241879],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040956372,0.000053518677,0.007641037,0.31104425,0.65307605,0.00015876883,0.0000822215,0.000664508,0.00035655327,0.00011690357,0.00085417373,0.021856418],"study_design_scores_gemma":[0.00057694747,0.00023855711,0.0061489353,0.010903709,0.9799717,0.00011969569,0.000044656,0.00013878402,0.00011290466,0.0001386003,0.0015750531,0.000030407708],"about_ca_topic_score_codex":0.005713411,"about_ca_topic_score_gemma":0.015794817,"teacher_disagreement_score":0.009981445,"about_ca_system_score_codex":0.0013352075,"about_ca_system_score_gemma":0.0015305593,"threshold_uncertainty_score":0.023096323},"labels":[],"label_agreement":null},{"id":"W2766249538","doi":"10.1016/j.ctrv.2017.10.008","title":"Epidermal growth factor receptor overexpression and outcomes in early breast cancer: A systematic review and a meta-analysis","year":2017,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Queen's University","funders":"","keywords":"Medicine; Breast cancer; Meta-analysis; Oncology; Internal medicine; Hazard ratio; Epidermal growth factor receptor; Triple-negative breast cancer; Cancer; Confidence interval","score_opus":0.32236565591717875,"score_gpt":0.5041202922561302,"score_spread":0.18175463633895145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766249538","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0047156042,0.99390525,0.00030412708,0.00014409731,0.00012876299,0.00012823578,0.0004933933,0.000018660094,0.00016184372],"genre_scores_gemma":[0.16933765,0.82579976,0.0016165966,0.0013238669,0.00021986906,0.000562391,0.0006400685,0.000029986475,0.00046978323],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9944207,0.0021402845,0.0018548559,0.0007212223,0.0005689041,0.0002940229],"domain_scores_gemma":[0.99124336,0.0058133663,0.0018640918,0.00031649496,0.0005978526,0.00016496041],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0074161408,0.0028111916,0.01566959,0.004153367,0.0005321963,0.0026352797,0.0017874433,0.0021473332,0.004625053],"category_scores_gemma":[0.018507507,0.0018173403,0.030059632,0.006101785,0.00070101506,0.0017703393,0.0019431823,0.002205348,0.0003828105],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015721442,0.000031778014,0.0051610586,0.34803194,0.6348895,0.00015736878,0.000101282465,0.00031529108,0.0002511484,0.00011509921,0.0008648798,0.008508562],"study_design_scores_gemma":[0.00050393055,0.000097048796,0.0028785625,0.013910431,0.98099947,0.000074805066,0.000049099734,0.00006328264,0.00005065437,0.00010810172,0.0012434572,0.000021163016],"about_ca_topic_score_codex":0.00921774,"about_ca_topic_score_gemma":0.029285563,"teacher_disagreement_score":0.01566959,"about_ca_system_score_codex":0.0023188,"about_ca_system_score_gemma":0.0033789128,"threshold_uncertainty_score":0.03922081},"labels":[],"label_agreement":null},{"id":"W2768374708","doi":"10.1016/j.ctrv.2017.10.015","title":"The lymphatics in infiltrating ductal carcinoma (IDC) of the breast","year":2017,"lang":"en","type":"letter","venue":"Cancer Treatment Reviews","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Population and Public Health; University of British Columbia; University of Victoria","funders":"","keywords":"Medicine; Breast cancer; Ductal carcinoma; Lymphatic system; Invasive ductal carcinoma; Cancer; Carcinoma; Confusion; Oncology; Pathology; Hypoxia (environmental); CA15-3; Internal medicine","score_opus":0.028384465867645762,"score_gpt":0.29382892564442187,"score_spread":0.2654444597767761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2768374708","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022847839,0.080774404,0.00028247602,0.8513358,0.057052944,0.000021859147,0.00006734735,0.000036239435,0.008144093],"genre_scores_gemma":[0.033416428,0.13211513,0.00050099246,0.4934769,0.31759015,0.00007776232,0.000102105274,0.000036277623,0.022684174],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9995203,0.00014939379,0.000042413823,0.000038587004,0.00017755204,0.00007180841],"domain_scores_gemma":[0.9982862,0.0010944837,0.00013657189,0.000049619917,0.00023258086,0.00020055211],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009402685,0.0003040539,0.00078079593,0.0003169762,0.0006828061,0.0010986133,0.00047925295,0.005683247,0.0034960816],"category_scores_gemma":[0.0041271816,0.00022111385,0.00032988025,0.00026495103,0.0010873621,0.0012148612,0.00064325175,0.008069705,0.0017568993],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020919467,0.000054566535,0.00076254254,0.0003112972,0.000018126446,0.002279747,0.000058371363,0.00012500079,0.00081956934,0.006388031,0.89927626,0.08969735],"study_design_scores_gemma":[0.00016477011,0.000116880416,0.0010282064,0.00045653517,0.000041871073,0.0036455863,0.00012540826,0.00024038907,0.0004827819,0.006497814,0.9871837,0.000016090295],"about_ca_topic_score_codex":0.0008424857,"about_ca_topic_score_gemma":0.0022158392,"teacher_disagreement_score":0.005683247,"about_ca_system_score_codex":0.0013142575,"about_ca_system_score_gemma":0.0009720891,"threshold_uncertainty_score":0.011695564},"labels":[],"label_agreement":null},{"id":"W2769738013","doi":"10.1016/j.ctrv.2017.11.005","title":"Balancing the benefits and harms of thyroid cancer surveillance in survivors of Childhood, adolescent and young adult cancer: Recommendations from the international Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium","year":2017,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"KWF Kankerbestrijding","keywords":"Medicine; Guideline; Thyroid cancer; Harmonization; Family medicine; Cancer; Multidisciplinary approach; Thyroid nodules; Thyroid; Pathology; Internal medicine","score_opus":0.029434177617291103,"score_gpt":0.3322134058633581,"score_spread":0.302779228246067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2769738013","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013412189,0.9955468,0.0001433259,0.003248231,0.00023275719,0.000044501354,0.0001564001,0.0000060685893,0.00048781882],"genre_scores_gemma":[0.0020654895,0.99388653,0.0008806307,0.0026800483,0.00012579173,0.000065750784,0.00010489076,0.0000036082013,0.00018727264],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99723864,0.0010498018,0.00074317533,0.00015927893,0.0006891762,0.00012003997],"domain_scores_gemma":[0.99431556,0.0037909027,0.00091954536,0.000062325824,0.00080076995,0.00011079047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006637779,0.00092814956,0.0037816276,0.0028399792,0.0004057832,0.002080737,0.002010345,0.0022957525,0.002862334],"category_scores_gemma":[0.013306422,0.00059163925,0.004273927,0.002421886,0.0006046575,0.0017107177,0.0013356813,0.003134015,0.00044134798],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030323974,0.000055584245,0.0010174923,0.18969195,0.0047822827,0.00012434825,0.00026410233,0.0007745429,0.00042808946,0.0053711636,0.046668302,0.75051886],"study_design_scores_gemma":[0.00040743066,0.00016816791,0.0038561795,0.40784588,0.01508479,0.0004052478,0.0004198643,0.00033958966,0.00038758916,0.0067889835,0.5642174,0.000078930345],"about_ca_topic_score_codex":0.014001949,"about_ca_topic_score_gemma":0.047513634,"teacher_disagreement_score":0.014001949,"about_ca_system_score_codex":0.0034313076,"about_ca_system_score_gemma":0.009604648,"threshold_uncertainty_score":0.035104394},"labels":[],"label_agreement":null},{"id":"W2771905132","doi":"10.1016/j.ctrv.2017.12.003","title":"Multi-agent chemotherapy in advanced soft tissue sarcoma (STS) – A systematic review and meta-analysis","year":2017,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Anthracycline; Internal medicine; Hazard ratio; Meta-analysis; Chemotherapy; Oncology; Doxorubicin; Randomized controlled trial; Soft tissue sarcoma; Confidence interval; Surgery; Cancer; Soft tissue; Breast cancer","score_opus":0.266840350468161,"score_gpt":0.4779336853555634,"score_spread":0.2110933348874024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2771905132","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020560399,0.99729294,0.00015571855,0.00007146394,0.00006087834,0.00007676319,0.00016255696,0.0000065653867,0.00011700591],"genre_scores_gemma":[0.064936735,0.93292844,0.00085169874,0.0005606366,0.00010468109,0.00019546504,0.00022401758,0.000009061573,0.00018921701],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9966788,0.0011792491,0.0011921739,0.00038283938,0.00042625342,0.00014062072],"domain_scores_gemma":[0.9943897,0.0035960313,0.0014008243,0.00015728374,0.00035914953,0.000097032775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044625313,0.0017766664,0.010461881,0.0036490022,0.0003853844,0.0019097005,0.00128708,0.0015151132,0.003571218],"category_scores_gemma":[0.013057585,0.001044091,0.018893864,0.00519169,0.00044517659,0.0014495937,0.0012292389,0.0015833881,0.0002557427],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016162661,0.0000528607,0.0032922635,0.59056324,0.37342292,0.00013439212,0.00010971695,0.00053831673,0.00038762167,0.00015422555,0.0009856607,0.02874256],"study_design_scores_gemma":[0.00065613445,0.00026176695,0.00467832,0.041863944,0.9480212,0.00016042659,0.000070560935,0.00012849801,0.00012207555,0.0001840793,0.0038219767,0.000031020933],"about_ca_topic_score_codex":0.006014222,"about_ca_topic_score_gemma":0.022506543,"teacher_disagreement_score":0.010461881,"about_ca_system_score_codex":0.0017114172,"about_ca_system_score_gemma":0.002418904,"threshold_uncertainty_score":0.0236004},"labels":[],"label_agreement":null},{"id":"W2774652621","doi":"10.1016/j.ctrv.2017.12.006","title":"Staging and surgical approaches in gastric cancer: A systematic review","year":2017,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hotel Dieu Hospital; Princess Margaret Cancer Centre; Ottawa Hospital; Grand River Hospital; Humber River Regional Hospital; McMaster University; Juravinski Cancer Centre; Sunnybrook Health Science Centre","funders":"Ontario Ministry of Health and Long-Term Care","keywords":"Medicine; Cancer; MEDLINE; Intensive care medicine; General surgery; Oncology; Internal medicine","score_opus":0.3244429439331436,"score_gpt":0.4413542188612157,"score_spread":0.11691127492807207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2774652621","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004988362,0.9990632,0.000040669776,0.00008396602,0.000054144075,0.000050145194,0.00013195229,0.000002709748,0.0000743261],"genre_scores_gemma":[0.007870873,0.99131835,0.00025357542,0.00030207832,0.00004389661,0.000079143225,0.000080142236,0.0000018273289,0.000050127484],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99706984,0.00080817926,0.0012375328,0.0002921476,0.0004591391,0.00013304503],"domain_scores_gemma":[0.992596,0.0048063686,0.0019153606,0.0000920899,0.00046306086,0.00012723563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035308914,0.0013382343,0.00660496,0.0058517912,0.00037962224,0.0019791762,0.0011929572,0.0013909023,0.0036722857],"category_scores_gemma":[0.015336596,0.0010702586,0.008949941,0.008258567,0.0006658442,0.0016568508,0.0015519187,0.0015236869,0.00021332217],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002448967,0.00002506081,0.0020080325,0.93457574,0.024007352,0.00007301452,0.00014860737,0.00013848535,0.00013940508,0.00015078761,0.0018140154,0.036674585],"study_design_scores_gemma":[0.0006538452,0.00029671963,0.010701239,0.651168,0.31311908,0.00041660533,0.00041106297,0.00012602253,0.00015455246,0.00040648808,0.022474315,0.00007211677],"about_ca_topic_score_codex":0.011574318,"about_ca_topic_score_gemma":0.041487873,"teacher_disagreement_score":0.011574318,"about_ca_system_score_codex":0.0023977365,"about_ca_system_score_gemma":0.006023025,"threshold_uncertainty_score":0.02301389},"labels":[],"label_agreement":null},{"id":"W2792893181","doi":"10.1016/j.ctrv.2018.02.005","title":"Breaking the biomarker code: PD-L1 expression and checkpoint inhibition in advanced NSCLC","year":2018,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Juravinski Cancer Centre; Montreal General Hospital; University of British Columbia; Royal Victoria Regional Health Centre; University of Alberta; Royal Victoria Hospital; University Health Network; University of Toronto; McMaster University; Princess Margaret Cancer Centre; BC Cancer Agency","funders":"Pfizer Canada; Merck Canada; Pfizer; AstraZeneca Canada; Roche Canada","keywords":"Medicine; Biomarker; Cancer research; Oncology; Code (set theory); Internal medicine; Programming language; Genetics","score_opus":0.10290617840553892,"score_gpt":0.40395395192761063,"score_spread":0.3010477735220717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792893181","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007658335,0.99876106,0.000068191985,0.0005550082,0.00023439017,0.0000036490915,0.000013436264,0.0000039592237,0.00028366328],"genre_scores_gemma":[0.0011809277,0.99692935,0.00015947496,0.0008953122,0.0003572613,0.000008944791,0.000033372537,0.0000014160006,0.00043400878],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997013,0.00007079626,0.000054953238,0.000039718594,0.000107438485,0.000025734065],"domain_scores_gemma":[0.9995166,0.00026336464,0.00008160118,0.000011105473,0.00010217313,0.000025126197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010386474,0.0006215054,0.001612804,0.0014061099,0.00019718427,0.0012357945,0.00081218284,0.0013578682,0.0026795198],"category_scores_gemma":[0.0016003653,0.00029095923,0.0007312281,0.0012290693,0.00044995,0.0014084579,0.0007675556,0.00267094,0.001071401],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016509398,0.0000585761,0.00019711864,0.01736104,0.00019327138,0.00009302439,0.00003988373,0.00027963784,0.0010084321,0.0032410354,0.045230623,0.93213207],"study_design_scores_gemma":[0.00011831294,0.00027916688,0.0010875758,0.010249253,0.00048436696,0.00080775726,0.00005542546,0.00025124554,0.00068848336,0.003830438,0.9821125,0.000035619276],"about_ca_topic_score_codex":0.0008844277,"about_ca_topic_score_gemma":0.002235144,"teacher_disagreement_score":0.0026795198,"about_ca_system_score_codex":0.0005866231,"about_ca_system_score_gemma":0.0011670752,"threshold_uncertainty_score":0.008963883},"labels":[],"label_agreement":null},{"id":"W2795044371","doi":"10.1016/j.ctrv.2018.03.006","title":"Outlooks on Epstein-Barr virus associated gastric cancer","year":2018,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":216,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"National Cancer Institute","keywords":"Medicine; Immunotherapy; Cancer; Epstein–Barr virus; Cancer research; Carcinogenesis; Immunology; Biomarker; Immune system; Immune checkpoint; Epstein–Barr virus infection; Virus; Cancer immunotherapy; Internal medicine; Biology; Genetics","score_opus":0.09538164567364876,"score_gpt":0.3900547197652027,"score_spread":0.2946730740915539,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2795044371","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006191681,0.9986891,0.000033387827,0.00025736552,0.00026984615,0.0000023867585,0.000019735277,0.0000033938697,0.0006629203],"genre_scores_gemma":[0.00043313194,0.9985335,0.00008014967,0.00031681222,0.00022841748,0.0000030187966,0.000028093673,7.286457e-7,0.00037614076],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998584,0.000030479328,0.000029189694,0.000021345904,0.000043341886,0.000017211132],"domain_scores_gemma":[0.99963593,0.0001795943,0.000074757314,0.0000067404185,0.000073582654,0.000029509976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045874668,0.0005493538,0.0010010698,0.0019030066,0.00022164873,0.0008638502,0.00043086952,0.0006370519,0.0051775067],"category_scores_gemma":[0.00090240757,0.00020237878,0.0004955527,0.0017752766,0.00025356075,0.001087889,0.00059303886,0.0012343016,0.0010992561],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000115715025,0.00004362508,0.00033043898,0.038149204,0.00015554269,0.0001982289,0.000087788554,0.00030429248,0.00086626224,0.003015281,0.05587231,0.90086144],"study_design_scores_gemma":[0.000024317784,0.000084538275,0.00081835943,0.01257307,0.0003859775,0.00083404145,0.00010478602,0.00006978776,0.0001672111,0.0013743625,0.983548,0.000015409827],"about_ca_topic_score_codex":0.0012253993,"about_ca_topic_score_gemma":0.003559729,"teacher_disagreement_score":0.0051775067,"about_ca_system_score_codex":0.0005531078,"about_ca_system_score_gemma":0.0010364901,"threshold_uncertainty_score":0.017320454},"labels":[],"label_agreement":null},{"id":"W2800540552","doi":"10.1016/j.ctrv.2018.04.005","title":"Molecular analyses in the diagnosis and prediction of prognosis in non-GIST soft tissue sarcomas: A systematic review and meta-analysis","year":2018,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; McMaster University; Juravinski Cancer Centre; Cancer Care Ontario; Mount Sinai Hospital","funders":"","keywords":"Medicine; Liposarcoma; Soft tissue sarcoma; Hazard ratio; Internal medicine; Sarcoma; Confidence interval; Oncology; Meta-analysis; Fluorescence in situ hybridization; GiST; Pathogenesis; Pathology; Synovial sarcoma; Stromal cell; Gene; Genetics","score_opus":0.2435051499371978,"score_gpt":0.4562480861357726,"score_spread":0.21274293619857482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800540552","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018321219,0.99750215,0.0001599954,0.000085474545,0.0000612837,0.000030714076,0.0002374252,0.0000055567302,0.00008529426],"genre_scores_gemma":[0.06620594,0.9311397,0.001014873,0.0006404702,0.00020168777,0.00014568938,0.0004652906,0.000010590222,0.00017568617],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.996375,0.0013178521,0.0011297483,0.00055990316,0.00046263757,0.00015490338],"domain_scores_gemma":[0.990122,0.007566537,0.0014478008,0.0002604025,0.0005025679,0.00010070038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0056663174,0.002139226,0.010287213,0.0038303942,0.00041167496,0.0022271061,0.0014690476,0.0018200661,0.0029561496],"category_scores_gemma":[0.017794743,0.0011802095,0.023110805,0.0055078296,0.00052540627,0.0014558544,0.0012635022,0.001709818,0.0002964694],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017367991,0.000051924533,0.0115375435,0.41966164,0.5247142,0.00017475562,0.00012537315,0.0007179803,0.00041300387,0.00022368303,0.0014352704,0.03920774],"study_design_scores_gemma":[0.00038469853,0.0001721573,0.007908972,0.025428144,0.96189517,0.00014446462,0.00006649902,0.00016592973,0.00011362767,0.0002993682,0.0033839399,0.000037009064],"about_ca_topic_score_codex":0.006098383,"about_ca_topic_score_gemma":0.017684046,"teacher_disagreement_score":0.010287213,"about_ca_system_score_codex":0.0012282629,"about_ca_system_score_gemma":0.0024816757,"threshold_uncertainty_score":0.029966712},"labels":[],"label_agreement":null},{"id":"W2800630992","doi":"10.1016/j.ctrv.2018.04.014","title":"The role of bisphosphonates or denosumab in light of the availability of new therapies for prostate cancer","year":2018,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Bone health and treatments","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Amgen","keywords":"Denosumab; Medicine; Cabazitaxel; Enzalutamide; Abiraterone acetate; Prostate cancer; Radium-223; Zoledronic acid; Oncology; Clinical trial; Docetaxel; Internal medicine; Bisphosphonate; Osteonecrosis of the jaw; Cancer; Osteoporosis; Bone metastasis; Androgen deprivation therapy; Androgen receptor","score_opus":0.08337314094360428,"score_gpt":0.41182926513150525,"score_spread":0.328456124187901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800630992","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000023890163,0.9993455,0.00001901726,0.00023014475,0.00013833947,0.000001525915,0.000008264901,0.0000014646646,0.00023189318],"genre_scores_gemma":[0.00026116878,0.99905795,0.00007018377,0.00027882893,0.00015141144,0.0000018213801,0.000010325003,6.5899053e-7,0.00016765569],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99951684,0.00009464009,0.00009069226,0.00006515364,0.00019446907,0.000038274102],"domain_scores_gemma":[0.99898356,0.000592729,0.00016670974,0.000018712717,0.00018598454,0.000052203573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010627254,0.00072878896,0.001867087,0.0026469019,0.0002982097,0.0015348047,0.00092998333,0.0015071959,0.0054633277],"category_scores_gemma":[0.0019327465,0.00029680313,0.0010362777,0.0025099518,0.00059807935,0.0015572795,0.00076146406,0.0025798318,0.0012897735],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013220927,0.000054911827,0.00016461228,0.04656119,0.00031081526,0.00013681449,0.00005795764,0.00023167762,0.00082163647,0.003984524,0.036271997,0.91127163],"study_design_scores_gemma":[0.000040032366,0.00009163545,0.00076664565,0.013826369,0.0004552592,0.0006568508,0.00008282853,0.000069907845,0.00016048722,0.0017369695,0.9820948,0.000018352921],"about_ca_topic_score_codex":0.0025173714,"about_ca_topic_score_gemma":0.006376793,"teacher_disagreement_score":0.0054633277,"about_ca_system_score_codex":0.00067853637,"about_ca_system_score_gemma":0.0019837248,"threshold_uncertainty_score":0.018276691},"labels":[],"label_agreement":null},{"id":"W2803396907","doi":"10.1016/j.ctrv.2018.05.007","title":"Tumor necrosis and clinical outcomes following neoadjuvant therapy in soft tissue sarcoma: A systematic review and meta-analysis","year":2018,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Hazard ratio; Internal medicine; Radiation therapy; Meta-analysis; Odds ratio; Soft tissue sarcoma; Necrosis; Neoadjuvant therapy; Oncology; Chemotherapy; Surgery; Confidence interval; Soft tissue; Cancer","score_opus":0.2316832925001087,"score_gpt":0.4804624741231427,"score_spread":0.248779181623034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803396907","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004745929,0.9945041,0.00015703712,0.000086180975,0.0000675443,0.00006232331,0.00025191717,0.000006651155,0.00011829921],"genre_scores_gemma":[0.16700885,0.82992256,0.0009886469,0.00086747983,0.00017683831,0.00028960715,0.00044600686,0.000015527135,0.0002845621],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99609476,0.0013717099,0.0014139973,0.0004999749,0.00043763046,0.0001818732],"domain_scores_gemma":[0.99194056,0.0054093865,0.0018960297,0.0002214603,0.00040601077,0.00012660737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004742138,0.0016763422,0.009253056,0.0029214406,0.0003957353,0.0020152042,0.0011887657,0.0015033559,0.003177757],"category_scores_gemma":[0.015149221,0.0011397857,0.020188894,0.0044579413,0.00058074313,0.0014240112,0.0013414614,0.0017272416,0.00023994913],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019686432,0.000046269408,0.010129017,0.45316035,0.5133019,0.00014622162,0.0001557651,0.0003885286,0.00034990392,0.00011749977,0.0008637493,0.019372135],"study_design_scores_gemma":[0.00052626105,0.00020582437,0.00837436,0.024547668,0.96356523,0.00014183913,0.0000930548,0.000092530376,0.00009384163,0.00014974513,0.0021763644,0.000033330416],"about_ca_topic_score_codex":0.0056814444,"about_ca_topic_score_gemma":0.020709738,"teacher_disagreement_score":0.009253056,"about_ca_system_score_codex":0.0016273359,"about_ca_system_score_gemma":0.0023978609,"threshold_uncertainty_score":0.025079072},"labels":[],"label_agreement":null},{"id":"W2805329954","doi":"10.1016/j.ctrv.2018.05.017","title":"Chemotherapy and cognition: International cognition and cancer task force recommendations for harmonising preclinical research","year":2018,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trent University; Baycrest Hospital; University of Toronto","funders":"Canadian Institutes of Health Research; National Institutes of Health; Institut National Du Cancer; Institut de France; Ligue Contre le Cancer; Indonesia Climate Change Trust Fund","keywords":"Medicine; Cognition; Neurochemical; Disease; Task force; Affect (linguistics); Clinical trial; Cancer; Mechanism (biology); Psychiatry; Pathology; Psychology; Internal medicine","score_opus":0.4277431736626132,"score_gpt":0.5675078931782638,"score_spread":0.13976471951565056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2805329954","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00061364565,0.9656604,0.0027018567,0.018865153,0.0032551724,0.004439822,0.0023209057,0.00018097619,0.0019621227],"genre_scores_gemma":[0.007871423,0.9235756,0.032453477,0.019226216,0.0014781462,0.010697552,0.0034889677,0.000121978585,0.0010866795],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.94716096,0.021740263,0.018198265,0.0021643552,0.009390786,0.0013454637],"domain_scores_gemma":[0.8911184,0.055238184,0.019990515,0.003876854,0.026747664,0.0030284645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.12632142,0.0038389515,0.018583223,0.010873402,0.0021812692,0.0090687135,0.0066910316,0.0063086436,0.006960723],"category_scores_gemma":[0.13535358,0.002771406,0.017246423,0.009905034,0.0026055127,0.006114473,0.009452612,0.009097873,0.0020377939],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002502528,0.00038961254,0.0022619348,0.36165476,0.015972396,0.00012129603,0.0005648088,0.0006808462,0.00082577864,0.004299364,0.10145407,0.5092726],"study_design_scores_gemma":[0.0037096867,0.00055202655,0.00918483,0.6380478,0.053320292,0.00018373888,0.0005590972,0.00046222887,0.00062066223,0.0052382965,0.28791165,0.00020960798],"about_ca_topic_score_codex":0.026352802,"about_ca_topic_score_gemma":0.054701127,"teacher_disagreement_score":0.12632142,"about_ca_system_score_codex":0.01095162,"about_ca_system_score_gemma":0.05700432,"threshold_uncertainty_score":0.66805947},"labels":[],"label_agreement":null},{"id":"W2810728079","doi":"10.1016/j.ctrv.2018.07.001","title":"Tobacco smoking and survival after a prostate cancer diagnosis: A systematic review and meta-analysis","year":2018,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Health and Medical Research Council; Medical Research Council","keywords":"Medicine; Prostate cancer; Meta-analysis; Hazard ratio; Oncology; Internal medicine; Cancer; Population; Systematic review; MEDLINE; Confidence interval; Environmental health","score_opus":0.14158501726053063,"score_gpt":0.4087204551280374,"score_spread":0.26713543786750676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810728079","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028105653,0.9961874,0.00017406834,0.000100819234,0.000097645716,0.00008015038,0.00041441232,0.000011824979,0.00012309625],"genre_scores_gemma":[0.10562315,0.8910423,0.001028142,0.00094366877,0.00018157801,0.0002775195,0.0005152089,0.00002116253,0.00036729508],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9961211,0.0013753392,0.001289506,0.0005288315,0.00045660028,0.00022867112],"domain_scores_gemma":[0.9920974,0.0052158833,0.0017432475,0.00026143863,0.00052878883,0.00015329925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00567,0.0025241156,0.011750651,0.00475372,0.0005394465,0.0024415744,0.001750741,0.0021670032,0.0048375567],"category_scores_gemma":[0.017130934,0.0017653416,0.028853325,0.0061276634,0.0006031242,0.0016161635,0.0017607479,0.0022042277,0.00037306832],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011709263,0.000035765504,0.00533941,0.41810653,0.56039244,0.00016085096,0.00011677796,0.0003684114,0.00023396034,0.00011260724,0.0010527162,0.012909596],"study_design_scores_gemma":[0.00036144012,0.00010686861,0.003965404,0.022005705,0.9711245,0.00010918248,0.000054356813,0.000073135954,0.000055764955,0.000103168524,0.0020165474,0.000023957895],"about_ca_topic_score_codex":0.013366469,"about_ca_topic_score_gemma":0.04537766,"teacher_disagreement_score":0.013366469,"about_ca_system_score_codex":0.0023238477,"about_ca_system_score_gemma":0.0039755274,"threshold_uncertainty_score":0.029986143},"labels":[],"label_agreement":null},{"id":"W2810974217","doi":"10.1016/j.ctrv.2018.06.015","title":"Optimal sequence of adjuvant endocrine and radiation therapy in early-stage breast cancer – A systematic review","year":2018,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Tamoxifen; Breast cancer; Oncology; Internal medicine; Radiation therapy; Randomized controlled trial; Aromatase inhibitor; Adjuvant therapy; Cancer; Clinical trial","score_opus":0.056386258084545435,"score_gpt":0.37534734821830956,"score_spread":0.3189610901337641,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810974217","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00041904429,0.9991617,0.000056775658,0.00007726954,0.000049357095,0.000032500575,0.00008452839,0.0000022184304,0.00011665506],"genre_scores_gemma":[0.0073934244,0.9915671,0.00035284823,0.0004021073,0.000055157383,0.00005562653,0.00009524735,0.000002108044,0.00007630077],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9987863,0.00040090788,0.00043886405,0.00015727953,0.00016746791,0.000049190323],"domain_scores_gemma":[0.9969983,0.0022134194,0.00056306896,0.00003954319,0.00014063668,0.00004498518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024608043,0.0008459718,0.0046658996,0.0018589956,0.00019890623,0.0011228218,0.0011007127,0.0010107842,0.004157223],"category_scores_gemma":[0.008401322,0.0005079057,0.0049818982,0.0023367195,0.00031847224,0.00093376345,0.0005434277,0.0010702983,0.00024640546],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012238873,0.00006807598,0.0010373425,0.806915,0.02074081,0.000069610636,0.00008214537,0.00044790484,0.0003608858,0.0003957967,0.0034653116,0.16519332],"study_design_scores_gemma":[0.0025016149,0.0011366628,0.008990967,0.6156353,0.29397067,0.0005720715,0.00025261135,0.0002943511,0.0004316983,0.0012840395,0.07484399,0.00008602979],"about_ca_topic_score_codex":0.0048179054,"about_ca_topic_score_gemma":0.017238133,"teacher_disagreement_score":0.0048179054,"about_ca_system_score_codex":0.0012302153,"about_ca_system_score_gemma":0.0028504883,"threshold_uncertainty_score":0.013907254},"labels":[],"label_agreement":null},{"id":"W2883475115","doi":"10.1016/j.ctrv.2018.07.011","title":"Risk factors for loco-regional recurrence after radical cystectomy of muscle-invasive bladder cancer: A systematic-review and framework for adjuvant radiotherapy","year":2018,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"National Cancer Institute","keywords":"Medicine; Cystectomy; Bladder cancer; Lymph node; Dissection (medical); Radiation therapy; Systematic review; Oncology; Perioperative; Pathological; Cancer; Internal medicine; MEDLINE; Surgery","score_opus":0.07949940888877625,"score_gpt":0.4023044407904984,"score_spread":0.3228050319017221,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883475115","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00061443285,0.99883085,0.00007557796,0.00010428248,0.0000561281,0.0000653539,0.00016054178,0.0000034223508,0.00008937848],"genre_scores_gemma":[0.016270313,0.982321,0.00050169666,0.00044549673,0.00005841645,0.00014421305,0.00016621979,0.0000039786464,0.00008861894],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9962741,0.0010915232,0.0014707905,0.00044009552,0.00054863957,0.00017477515],"domain_scores_gemma":[0.9907356,0.006551047,0.0018798694,0.00014440171,0.00057144125,0.00011767058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050069527,0.0014708927,0.0083330665,0.005999949,0.0004251895,0.0022337895,0.0015443234,0.0016854567,0.0031592774],"category_scores_gemma":[0.020695662,0.0009677505,0.014369363,0.0061905286,0.0006803507,0.0016477149,0.0014796484,0.0017129359,0.0002055669],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000273565,0.000026872558,0.002584772,0.9016152,0.054681588,0.00007594546,0.00020286629,0.00019826519,0.00017939752,0.00033309797,0.0016160243,0.038212337],"study_design_scores_gemma":[0.00043140235,0.00022262479,0.010183467,0.5118345,0.45911536,0.00031352838,0.00035982954,0.00015268521,0.00015484048,0.0006127921,0.016546872,0.000072259485],"about_ca_topic_score_codex":0.015636947,"about_ca_topic_score_gemma":0.0465634,"teacher_disagreement_score":0.015636947,"about_ca_system_score_codex":0.0027138859,"about_ca_system_score_gemma":0.006416224,"threshold_uncertainty_score":0.031091869},"labels":[],"label_agreement":null},{"id":"W2884829265","doi":"10.1016/j.ctrv.2018.07.012","title":"Systematic review and meta-analysis of distance-based physical activity interventions for cancer survivors (2013–2018): We still haven’t found what we’re looking for","year":2018,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Cancer survivorship and care","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Athabasca University","funders":"Canada Research Chairs","keywords":"Medicine; Psychological intervention; Meta-analysis; Haven; Cancer; Systematic review; MEDLINE; Gerontology; Safe haven; Oncology; Internal medicine; Psychiatry","score_opus":0.2767488603845295,"score_gpt":0.4641507615719709,"score_spread":0.18740190118744138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884829265","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013087998,0.9974009,0.00019726399,0.00021299176,0.00018659754,0.00021357514,0.0003232105,0.000016558599,0.00014010126],"genre_scores_gemma":[0.03910271,0.9565112,0.0014612563,0.0013723109,0.00016204754,0.0006695142,0.00043914386,0.000020668964,0.00026115327],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9891543,0.003655892,0.0043569603,0.0009211857,0.0015052465,0.0004064522],"domain_scores_gemma":[0.98446494,0.010428817,0.002972068,0.00048980955,0.0013702362,0.0002740595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011923889,0.0028132482,0.019450719,0.005474662,0.00083300687,0.0035678265,0.0021013923,0.002537004,0.0038069328],"category_scores_gemma":[0.046624474,0.0015802628,0.029271526,0.006794902,0.00096808793,0.0025319203,0.0026056687,0.0029355409,0.00036399896],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009891908,0.000023531216,0.001115903,0.73661876,0.24240403,0.00007553531,0.0001290676,0.00013388602,0.00019574568,0.00013096229,0.0010286208,0.017154645],"study_design_scores_gemma":[0.00075435627,0.00019110978,0.002670569,0.12003005,0.87064284,0.0000933196,0.000100654484,0.000044248143,0.00012836684,0.00020043303,0.005113636,0.000030465031],"about_ca_topic_score_codex":0.018061524,"about_ca_topic_score_gemma":0.05203999,"teacher_disagreement_score":0.019450719,"about_ca_system_score_codex":0.004143187,"about_ca_system_score_gemma":0.008812204,"threshold_uncertainty_score":0.06306034},"labels":[],"label_agreement":null},{"id":"W2888428143","doi":"10.1016/j.ctrv.2018.08.009","title":"Evolution in sites of recurrence over time in breast cancer patients treated with adjuvant endocrine therapy","year":2018,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Adjuvant therapy; Adjuvant; Internal medicine; Cancer; Oncology; Endocrine system; Randomized controlled trial; Surgery; Hormonal therapy; Disease; Hormone","score_opus":0.03017103205909811,"score_gpt":0.33316974438187646,"score_spread":0.30299871232277836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888428143","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00038424885,0.9990426,0.00004265931,0.00016253433,0.000057682886,0.0000017078848,0.00003504033,0.0000016480457,0.00027181843],"genre_scores_gemma":[0.0029018165,0.99642146,0.00014859722,0.00017360138,0.00009720803,0.0000035158855,0.000052337233,0.0000010436629,0.00020038741],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998103,0.000042048378,0.0000361411,0.000039073522,0.0000562721,0.000016222926],"domain_scores_gemma":[0.9993685,0.00035887185,0.00014966483,0.00001089683,0.000092797236,0.000019274932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005620838,0.00032030407,0.000817736,0.0013106226,0.00010205296,0.0006788591,0.00042239472,0.00048209136,0.0015721178],"category_scores_gemma":[0.0017252924,0.00014621572,0.0005636294,0.0015314748,0.00023556665,0.00042614265,0.00028490368,0.0006593255,0.00028123765],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018674537,0.000029987279,0.00428911,0.017570172,0.0003999696,0.00011942326,0.00006732425,0.00026559923,0.00048627044,0.0010387221,0.012448559,0.96309805],"study_design_scores_gemma":[0.000099440425,0.00044143153,0.04930641,0.03222443,0.0038339307,0.0054351306,0.0004877214,0.00030253566,0.0010095213,0.0024796166,0.9042938,0.00008608026],"about_ca_topic_score_codex":0.0021205007,"about_ca_topic_score_gemma":0.004859511,"teacher_disagreement_score":0.0021205007,"about_ca_system_score_codex":0.00039941483,"about_ca_system_score_gemma":0.00076694915,"threshold_uncertainty_score":0.005259335},"labels":[],"label_agreement":null},{"id":"W2896552420","doi":"10.1016/j.ctrv.2018.10.010","title":"Absolute benefit from adjuvant chemotherapy in contemporary clinical trials: A systemic review and meta-analysis","year":2018,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Breast cancer; Oncology; Meta-analysis; Chemotherapy; Clinical trial; Adjuvant; Estrogen receptor; Disease; Randomized controlled trial; Adjuvant chemotherapy; Proportional hazards model; Cancer","score_opus":0.49227477311335927,"score_gpt":0.5228902450112396,"score_spread":0.03061547189788033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896552420","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008658279,0.9983803,0.00023363701,0.000111879075,0.00007106165,0.000036550842,0.00016720821,0.000006503907,0.00012704465],"genre_scores_gemma":[0.06648925,0.92936105,0.0014543432,0.0014529014,0.0003245651,0.00019308312,0.00043857656,0.000027499587,0.00025870613],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9942918,0.0025238423,0.0017232812,0.0007040649,0.0006004678,0.00015656432],"domain_scores_gemma":[0.98603475,0.010941781,0.0019585781,0.00041238632,0.000521719,0.00013087974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011537245,0.001873324,0.013415432,0.0029380736,0.00026319842,0.0025850171,0.0015986231,0.0015538506,0.0049339687],"category_scores_gemma":[0.024102928,0.0010449417,0.015447945,0.0045307884,0.0006348711,0.0017336236,0.0013224139,0.0021004365,0.0003633522],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003751971,0.000032219592,0.0031818766,0.43341878,0.49839336,0.00010088831,0.000106010324,0.0007090152,0.00040384792,0.00049308455,0.00221459,0.05719438],"study_design_scores_gemma":[0.0011427171,0.00021504165,0.0036371432,0.028477117,0.9579153,0.000120344084,0.00005506591,0.0001588719,0.00013170266,0.00082392275,0.007291174,0.000031650656],"about_ca_topic_score_codex":0.0018537969,"about_ca_topic_score_gemma":0.006562645,"teacher_disagreement_score":0.013415432,"about_ca_system_score_codex":0.0014680485,"about_ca_system_score_gemma":0.0016798212,"threshold_uncertainty_score":0.061015487},"labels":[],"label_agreement":null},{"id":"W2914108875","doi":"10.1016/j.ctrv.2019.02.001","title":"Network meta-analysis of therapies for previously untreated advanced BRAF-mutated melanoma","year":2019,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; McMaster University; Impact","funders":"","keywords":"Medicine; Dabrafenib; Vemurafenib; Trametinib; Dacarbazine; Oncology; Internal medicine; Ipilimumab; Melanoma; Hazard ratio; Nivolumab; Randomized controlled trial; Population; Progression-free survival; Metastatic melanoma; Cancer; Immunotherapy; Chemotherapy; Cancer research; Overall survival; Confidence interval","score_opus":0.20660714001164493,"score_gpt":0.3974582458880378,"score_spread":0.19085110587639287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914108875","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0029441123,0.9940461,0.0008071962,0.00054305507,0.00023871975,0.000023218709,0.0009081113,0.000024763684,0.00046471934],"genre_scores_gemma":[0.121936016,0.870844,0.0021843119,0.0013220147,0.00076737197,0.00013851034,0.002160602,0.00004421702,0.0006029361],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99820757,0.001131258,0.00018753517,0.0002444292,0.00016696576,0.00006222084],"domain_scores_gemma":[0.99591917,0.0032889391,0.00041636222,0.00013351571,0.0001752977,0.00006672683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003248981,0.0012633764,0.004352498,0.0009895354,0.000115235714,0.00080062205,0.0008657574,0.00059361366,0.0033273406],"category_scores_gemma":[0.007516473,0.0003414374,0.009451126,0.0017220785,0.0001373714,0.00048204223,0.00058675,0.0011906628,0.00024395518],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007042921,0.00007515756,0.0107260225,0.11938472,0.4963322,0.00013629369,0.000056850455,0.006398163,0.0008507258,0.0012758514,0.019350505,0.33837053],"study_design_scores_gemma":[0.0022578721,0.00085691595,0.040084213,0.019533824,0.87580335,0.00036566283,0.00006700597,0.003906976,0.00061426975,0.0067474535,0.049660698,0.0001018124],"about_ca_topic_score_codex":0.0037125119,"about_ca_topic_score_gemma":0.010800838,"teacher_disagreement_score":0.004352498,"about_ca_system_score_codex":0.00085889647,"about_ca_system_score_gemma":0.0009906669,"threshold_uncertainty_score":0.01718241},"labels":[],"label_agreement":null},{"id":"W2922823095","doi":"10.1016/j.ctrv.2019.03.002","title":"Emerging therapeutic targets for patients with advanced prostate cancer","year":2019,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Pfizer","keywords":"Medicine; Prostate cancer; Cancer; Clinical trial; Oncology; Cancer research; EZH2; Disease; Prostate; Internal medicine; Epigenetics","score_opus":0.09584489418431515,"score_gpt":0.4380468469586624,"score_spread":0.3422019527743473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922823095","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000044748056,0.99884963,0.000049568727,0.0002961393,0.00016487336,0.0000052737237,0.000021473546,0.0000060035245,0.00056239584],"genre_scores_gemma":[0.00046662998,0.9984315,0.0001066494,0.00044843132,0.00012953281,0.000007612543,0.000025699073,0.000001286987,0.00038272268],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997117,0.00007216312,0.000054527503,0.000042683285,0.000087412525,0.000031509557],"domain_scores_gemma":[0.9994574,0.00029461196,0.000118081865,0.000011173419,0.00008430564,0.000034386303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008781939,0.0010798532,0.0022300093,0.002366081,0.00023951667,0.001224932,0.0007643765,0.0010969532,0.0073001687],"category_scores_gemma":[0.0013365167,0.00038047077,0.00092000497,0.0019449253,0.00035086065,0.0012457062,0.0007991144,0.002377117,0.0016449303],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012723237,0.000058310754,0.00013725988,0.03367487,0.00020967811,0.000074973585,0.000038813007,0.00030602075,0.00065456866,0.0018089894,0.036467534,0.92644167],"study_design_scores_gemma":[0.00014653784,0.0003052553,0.0010950769,0.022397669,0.0010877743,0.0006731474,0.0000772472,0.00017651966,0.00032872838,0.001923985,0.97175646,0.000031619995],"about_ca_topic_score_codex":0.0014593718,"about_ca_topic_score_gemma":0.005661307,"teacher_disagreement_score":0.0073001687,"about_ca_system_score_codex":0.0007548263,"about_ca_system_score_gemma":0.0015501421,"threshold_uncertainty_score":0.024421513},"labels":[],"label_agreement":null},{"id":"W2944914845","doi":"10.1016/j.ctrv.2019.05.002","title":"PD-L1 expression and clinical outcomes in patients with advanced urothelial carcinoma treated with checkpoint inhibitors: A meta-analysis","year":2019,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Queen's University","funders":"","keywords":"Medicine; Metastatic Urothelial Carcinoma; Internal medicine; Oncology; Bladder cancer; Context (archaeology); Immunotherapy; Meta-analysis; Odds ratio; PD-L1; Pembrolizumab; Carcinoma; Urothelial carcinoma; Cancer","score_opus":0.1338417283217021,"score_gpt":0.406187911463415,"score_spread":0.2723461831417129,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944914845","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010739231,0.98777336,0.00028850243,0.0001404715,0.00016095892,0.000040431412,0.0005917044,0.000017487087,0.00024789432],"genre_scores_gemma":[0.2891235,0.7061327,0.0009804853,0.0011556682,0.00035849054,0.00018688136,0.0013178473,0.0000350058,0.0007093693],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99813545,0.000705421,0.00046880654,0.0003623786,0.00020471228,0.00012322857],"domain_scores_gemma":[0.99758327,0.0015123517,0.0005143575,0.00011417969,0.00019566069,0.0000801917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030140122,0.0017037367,0.008353222,0.0015920465,0.0002985186,0.0016834299,0.0012234073,0.0012617079,0.0030248482],"category_scores_gemma":[0.0057539693,0.0010497051,0.023248335,0.0033327925,0.0003235333,0.00090212555,0.0010484108,0.0020052504,0.00032227577],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065073534,0.00005000541,0.015204933,0.1169335,0.83382154,0.00010429539,0.00006305579,0.00070475804,0.00042146645,0.00012783083,0.0017461503,0.024315067],"study_design_scores_gemma":[0.0008870812,0.0002218562,0.0115799485,0.004451738,0.9799998,0.00006771086,0.000038336,0.00017643879,0.00008661193,0.00016287432,0.0023003267,0.000027245442],"about_ca_topic_score_codex":0.0059295907,"about_ca_topic_score_gemma":0.013941,"teacher_disagreement_score":0.008353222,"about_ca_system_score_codex":0.0010401807,"about_ca_system_score_gemma":0.0011673049,"threshold_uncertainty_score":0.015939832},"labels":[],"label_agreement":null},{"id":"W2947340802","doi":"10.1016/j.ctrv.2019.05.006","title":"Prognostic value of receptor tyrosine kinase-like orphan receptor (ROR) family in cancer: A meta-analysis","year":2019,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Instituto de Salud Carlos III","keywords":"Medicine; Orphan receptor; ROR1; Oncology; Internal medicine; Hazard ratio; Meta-analysis; Subgroup analysis; Confidence interval; Cancer; Lung cancer; Receptor; Gene; Biology; Genetics","score_opus":0.15298336154643505,"score_gpt":0.3828456729642744,"score_spread":0.22986231141783936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947340802","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011820429,0.9849458,0.0008845033,0.00038629884,0.0002619747,0.000026503307,0.0012313956,0.000028816572,0.00041426017],"genre_scores_gemma":[0.33473778,0.6568299,0.0019537085,0.0014373233,0.0007913104,0.0001357312,0.0030373805,0.00006413451,0.001012756],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9982066,0.0007779279,0.0002928181,0.00041072498,0.00021524052,0.0000965666],"domain_scores_gemma":[0.99774665,0.0015255049,0.00032369775,0.0001516876,0.00016874804,0.00008354709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035668367,0.0012694835,0.005485569,0.0013092103,0.00016391843,0.0013270027,0.0010007818,0.00081688253,0.0028348742],"category_scores_gemma":[0.004128275,0.00047716065,0.013633354,0.002475404,0.00022654905,0.0006568854,0.0007282103,0.0011845862,0.00028697334],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068756044,0.00005825977,0.051116083,0.06187427,0.759858,0.00023785006,0.00006776555,0.0024678975,0.0011800766,0.00041289124,0.0071269544,0.108724445],"study_design_scores_gemma":[0.0009962703,0.00047472768,0.04685847,0.004107705,0.9340299,0.00026423132,0.000077820965,0.0010221961,0.00032901965,0.000976566,0.010791772,0.00007128474],"about_ca_topic_score_codex":0.0028677012,"about_ca_topic_score_gemma":0.0077097267,"teacher_disagreement_score":0.005485569,"about_ca_system_score_codex":0.00067231245,"about_ca_system_score_gemma":0.0008098435,"threshold_uncertainty_score":0.01886344},"labels":[],"label_agreement":null},{"id":"W2952944061","doi":"10.1016/j.ctrv.2019.05.001","title":"Androgen receptor plasticity and its implications for prostate cancer therapy","year":2019,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; University of British Columbia","funders":"","keywords":"Enzalutamide; Prostate cancer; Androgen receptor; Medicine; Mechanism (biology); Cancer; Androgen deprivation therapy; Cancer research; Receptor; Drug resistance; Bioinformatics; Oncology; Internal medicine; Genetics; Biology","score_opus":0.2532166580661024,"score_gpt":0.4788837669870904,"score_spread":0.225667108920988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952944061","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000018248538,0.9991059,0.0000241484,0.00023745364,0.00018928295,0.0000019187923,0.000012528838,0.0000030019412,0.0004074647],"genre_scores_gemma":[0.00023614666,0.99886924,0.000054450906,0.00029091333,0.00019831966,0.0000037643067,0.000013314964,7.6437306e-7,0.00033294744],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996675,0.00007926041,0.000050140796,0.000051909064,0.00011604497,0.000035117304],"domain_scores_gemma":[0.99926263,0.00045341882,0.000105231586,0.00001741285,0.00011292199,0.000048412643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011689417,0.0010887779,0.0020001659,0.0024278585,0.00030935067,0.0016564778,0.0009401884,0.0014483111,0.008137731],"category_scores_gemma":[0.0017527888,0.00044550223,0.00073854334,0.0028688142,0.00065547734,0.0015231872,0.00093732314,0.0026200025,0.0025204348],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001525274,0.0000586878,0.00013246607,0.032976974,0.00020344039,0.00010463808,0.00004980802,0.00044183113,0.0006035724,0.0049191844,0.07233364,0.88802326],"study_design_scores_gemma":[0.00005471046,0.00010672378,0.0005402732,0.008639113,0.00032811097,0.00040359262,0.000050374583,0.00008374776,0.00012605825,0.0024686693,0.98717785,0.000020789506],"about_ca_topic_score_codex":0.0023864417,"about_ca_topic_score_gemma":0.007000052,"teacher_disagreement_score":0.008137731,"about_ca_system_score_codex":0.0011347715,"about_ca_system_score_gemma":0.0021391546,"threshold_uncertainty_score":0.027223408},"labels":[],"label_agreement":null},{"id":"W3004630265","doi":"10.1016/j.ctrv.2020.101979","title":"Toxicity management with combination chemotherapy and programmed death 1/programmed death ligand 1 inhibitor therapy in advanced lung cancer","year":2020,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Merck Sharp and Dohme","keywords":"Medicine; Nivolumab; Pembrolizumab; Atezolizumab; Lung cancer; Chemotherapy; Oncology; Internal medicine; Immunotherapy; Cancer","score_opus":0.05420534162604314,"score_gpt":0.37431323484624324,"score_spread":0.3201078932202001,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3004630265","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023935677,0.99903214,0.000115756186,0.00010083742,0.000068522146,0.000008033095,0.000015572145,0.0000054803104,0.00041436552],"genre_scores_gemma":[0.002662715,0.99603844,0.00032526333,0.0003251197,0.00012709743,0.000020138157,0.00005622375,0.0000021369913,0.00044276493],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99983835,0.000046298162,0.000027457163,0.000024133653,0.000048566028,0.000015228847],"domain_scores_gemma":[0.9998124,0.00010162749,0.000044700257,0.0000040409955,0.000027722244,0.000009414055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005605109,0.0005672849,0.0017589101,0.0008257684,0.00011837198,0.00060364575,0.0006613992,0.00054562313,0.0022193042],"category_scores_gemma":[0.00061200693,0.00019568905,0.0008406354,0.00084566075,0.00016267714,0.0005418998,0.00039374782,0.0012565486,0.0005368413],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021959556,0.00007265365,0.00014735259,0.018088903,0.00028819632,0.0000676221,0.00001796929,0.000513838,0.0009414051,0.0007205204,0.011531652,0.9673903],"study_design_scores_gemma":[0.0008945543,0.0016491954,0.004662978,0.02049048,0.0029942964,0.0025306926,0.00007181625,0.0011173427,0.0015772115,0.0026730944,0.96127176,0.00006650093],"about_ca_topic_score_codex":0.00062326534,"about_ca_topic_score_gemma":0.0019463976,"teacher_disagreement_score":0.0022193042,"about_ca_system_score_codex":0.00039887207,"about_ca_system_score_gemma":0.0005867439,"threshold_uncertainty_score":0.0074242353},"labels":[],"label_agreement":null},{"id":"W3006060452","doi":"10.1016/j.ctrv.2020.101987","title":"An evidence-based guideline on the application of molecular testing in the diagnosis, prediction of prognosis, and selection of therapy in non-GIST soft tissue sarcomas","year":2020,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Population Health Research Institute; Cancer Care Ontario; McMaster University; Juravinski Cancer Centre; Mount Sinai Hospital","funders":"Ontario Ministry of Health and Long-Term Care","keywords":"Medicine; Liposarcoma; Guideline; GiST; Sarcoma; Leiomyosarcoma; Soft tissue sarcoma; MEDLINE; Internal medicine; Fluorescence in situ hybridization; Sunitinib; Cochrane Library; Oncology; Cancer; Pathology; Meta-analysis; Stromal cell","score_opus":0.1782895704646649,"score_gpt":0.438689119759938,"score_spread":0.2603995492952731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006060452","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001648491,0.99009854,0.0009376866,0.0037367775,0.0013429786,0.00027713284,0.0009320963,0.00005835205,0.0024515444],"genre_scores_gemma":[0.0012391449,0.98704785,0.003920575,0.0043377737,0.00039103345,0.00028801573,0.0013730067,0.000011573232,0.0013908881],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9975528,0.0007280152,0.00082114484,0.00016859849,0.00062531757,0.00010422814],"domain_scores_gemma":[0.9956201,0.0023307009,0.00079459354,0.00006718121,0.001049732,0.00013767282],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040767905,0.0014774771,0.004333125,0.004802967,0.0003987156,0.0016757493,0.0035374155,0.003524773,0.0046983566],"category_scores_gemma":[0.0077759223,0.00060562015,0.00478655,0.0035279468,0.00045146424,0.0013546435,0.0010918857,0.0029828772,0.00237981],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036312258,0.00010878707,0.00034842253,0.16146284,0.0015316169,0.00030046757,0.00010219248,0.0006975931,0.0010318176,0.003031722,0.18134847,0.649673],"study_design_scores_gemma":[0.00053118943,0.00018326909,0.0024654276,0.24105813,0.005877708,0.00075048726,0.00007926003,0.00034794203,0.0003753179,0.003414108,0.74484843,0.00006876565],"about_ca_topic_score_codex":0.008685111,"about_ca_topic_score_gemma":0.018453956,"teacher_disagreement_score":0.008685111,"about_ca_system_score_codex":0.0019686203,"about_ca_system_score_gemma":0.0067982078,"threshold_uncertainty_score":0.02156043},"labels":[],"label_agreement":null},{"id":"W3030007841","doi":"10.1016/j.ctrv.2020.102032","title":"Systemic adjuvant therapy for adult patients at high risk for recurrent melanoma: A systematic review","year":2020,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Ottawa; Health Sciences Centre; Credit Valley Hospital; Sunnybrook Health Science Centre; Juravinski Cancer Centre; Queen's University; McMaster University; Grand River Hospital; Ottawa Hospital; Kingston General Hospital","funders":"Ministry of Health, Ontario","keywords":"Medicine; Melanoma; Adjuvant; Adjuvant therapy; Guideline; Oncology; Systemic therapy; Internal medicine; Targeted therapy; Sentinel lymph node; Dermatology; Cancer; Surgery; Breast cancer; Pathology; Cancer research","score_opus":0.05222711110885997,"score_gpt":0.34799767661670644,"score_spread":0.2957705655078465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3030007841","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00086966663,0.9985624,0.000046834888,0.00009387568,0.000069005175,0.00006639956,0.00015082657,0.000004283871,0.00013662869],"genre_scores_gemma":[0.015219499,0.9836331,0.0002558901,0.0005335685,0.00005278894,0.000093789924,0.000101645695,0.000002517867,0.0001072207],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99867177,0.00042886657,0.00047541945,0.00015636033,0.00019630091,0.00007130836],"domain_scores_gemma":[0.99668187,0.0019369349,0.0010325045,0.000040918403,0.00022352443,0.00008433564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019072545,0.0009060101,0.0048559722,0.0028078638,0.00025047676,0.0012044992,0.0008372519,0.0012587773,0.0048121335],"category_scores_gemma":[0.008082494,0.00066829775,0.005886373,0.0032963397,0.00035555993,0.0010519841,0.00087684096,0.0012115159,0.0002376065],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007170848,0.000043285065,0.0016436885,0.8999464,0.02689853,0.000105502346,0.00012722032,0.00018308286,0.00028174339,0.00012871799,0.0033244279,0.06660024],"study_design_scores_gemma":[0.0022151312,0.000763884,0.012673937,0.6267464,0.32629704,0.00058103446,0.0002981723,0.00019276059,0.0002402974,0.0002873993,0.029635025,0.00006886889],"about_ca_topic_score_codex":0.0074753608,"about_ca_topic_score_gemma":0.030148925,"teacher_disagreement_score":0.0074753608,"about_ca_system_score_codex":0.0015064806,"about_ca_system_score_gemma":0.0031226922,"threshold_uncertainty_score":0.016098142},"labels":[],"label_agreement":null},{"id":"W3043154728","doi":"10.1016/j.ctrv.2020.102084","title":"Impact of high tumor mutational burden in solid tumors and challenges for biomarker application","year":2020,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Immunotherapy; Biomarker; Oncology; Cancer; Melanoma; Lung cancer; Clinical trial; Targeted therapy; Circulating tumor cell; Internal medicine; Computational biology; Cancer research; Metastasis","score_opus":0.12482030120339196,"score_gpt":0.42675127690850645,"score_spread":0.3019309757051145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043154728","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010163154,0.998066,0.00016456719,0.0008785425,0.00023901563,0.0000030397266,0.000026127362,0.000007819991,0.00051314104],"genre_scores_gemma":[0.0012633731,0.9966689,0.00031528834,0.00090024044,0.00037888726,0.000008163455,0.000045383917,0.000002440005,0.00041731808],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995499,0.00011510596,0.00005920487,0.00008047478,0.0001577555,0.000037457172],"domain_scores_gemma":[0.9982834,0.0011019176,0.00019055611,0.000029842464,0.00033183888,0.000062591964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001706819,0.00059911713,0.0017031571,0.0013437523,0.00016864584,0.0013837967,0.00061796646,0.0011689111,0.0032446415],"category_scores_gemma":[0.0028748934,0.00024158749,0.00064826454,0.0013047545,0.00045969375,0.0012970422,0.0006898025,0.0018231727,0.0010648541],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000092314665,0.000023921972,0.00038294544,0.012175721,0.00011459681,0.0000810239,0.000030983025,0.00041038427,0.0009252554,0.0038616525,0.029791046,0.9521101],"study_design_scores_gemma":[0.000036838985,0.00017104398,0.0015556528,0.008908822,0.0003676861,0.00082635623,0.000078829275,0.00029956526,0.000565308,0.0048010224,0.9823637,0.000025120182],"about_ca_topic_score_codex":0.0013798159,"about_ca_topic_score_gemma":0.0032195784,"teacher_disagreement_score":0.0032446415,"about_ca_system_score_codex":0.0007884323,"about_ca_system_score_gemma":0.0019050038,"threshold_uncertainty_score":0.010854423},"labels":[],"label_agreement":null},{"id":"W3049702673","doi":"10.1016/j.ctrv.2020.102086","title":"Comparison of treatment-related adverse events of different Cyclin-dependent kinase 4/6 inhibitors in metastatic breast cancer: A network meta-analysis","year":2020,"lang":"en","type":"article","venue":"Cancer Treatment Reviews","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Palbociclib; Medicine; Fulvestrant; Tolerability; Metastatic breast cancer; Internal medicine; Oncology; Adverse effect; Neutropenia; Discontinuation; Breast cancer; Hazard ratio; Pharmacology; Cancer; Chemotherapy; Estrogen receptor; Confidence interval","score_opus":0.13815874616013846,"score_gpt":0.40500467243691196,"score_spread":0.2668459262767735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3049702673","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18996572,0.7904147,0.0093927365,0.0008109549,0.0013297616,0.00038461015,0.005474308,0.00031057026,0.0019166343],"genre_scores_gemma":[0.94505346,0.04714263,0.0031764824,0.00095633965,0.00041741034,0.00038548114,0.0017137978,0.0001621243,0.0009922542],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98376507,0.010471334,0.0016678076,0.0026717805,0.00088355463,0.0005405629],"domain_scores_gemma":[0.98156744,0.013929918,0.002050906,0.0014810903,0.0006506839,0.00031991012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014260656,0.0031673142,0.01116152,0.0018825963,0.0005086173,0.0026042291,0.0020805835,0.0023723894,0.0038470384],"category_scores_gemma":[0.024041213,0.0018128606,0.046934765,0.00286633,0.000692187,0.001764128,0.0020086172,0.0036931266,0.0003515886],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012788254,0.000020487894,0.0111343665,0.007782141,0.9641112,0.000050918778,0.000025583506,0.0010605231,0.00021232675,0.0000845343,0.00034610188,0.002383597],"study_design_scores_gemma":[0.002449383,0.0003574497,0.010621629,0.00049039867,0.9841059,0.000049266397,0.000025165598,0.0008318983,0.000108458094,0.00030004815,0.0006347387,0.000025761547],"about_ca_topic_score_codex":0.0069006123,"about_ca_topic_score_gemma":0.009053685,"teacher_disagreement_score":0.014260656,"about_ca_system_score_codex":0.0013606449,"about_ca_system_score_gemma":0.0008511348,"threshold_uncertainty_score":0.07541841},"labels":[],"label_agreement":null},{"id":"W3093476204","doi":"10.1016/j.ctrv.2020.102113","title":"National comprehensive cancer network recommendations for drugs without US food and drug administration approval in metastatic breast cancer: A cross-sectional study","year":2020,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Food and drug administration; Metastatic breast cancer; Cancer; Breast cancer; Drug; Cancer drugs; Oncology; Drug approval; Drug administration; Internal medicine; Intensive care medicine; Pharmacology","score_opus":0.2736387104802975,"score_gpt":0.5247481558783833,"score_spread":0.25110944539808583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093476204","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00071746664,0.9904525,0.000368444,0.002809653,0.00046260323,0.00026104302,0.0026297553,0.000026794456,0.0022716664],"genre_scores_gemma":[0.0048663034,0.98778594,0.0019152972,0.0028147248,0.0001338021,0.0002830746,0.0014168166,0.00001437097,0.0007695877],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9963068,0.0011295864,0.0009953479,0.00030237297,0.0011444417,0.00012137619],"domain_scores_gemma":[0.99077564,0.0046684747,0.0022336082,0.00018276337,0.0018939114,0.00024564247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009292885,0.000709261,0.0030351575,0.0033381952,0.00033221036,0.0015020267,0.0019327613,0.0014496462,0.00582151],"category_scores_gemma":[0.015385077,0.0005881831,0.0039220224,0.00396448,0.00033590078,0.0015115818,0.000663494,0.0017672763,0.0009984605],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090788834,0.0001681436,0.0049060397,0.1993446,0.006826169,0.00008399417,0.00013625191,0.0005097982,0.00052202115,0.0023766146,0.1508569,0.6333615],"study_design_scores_gemma":[0.0011448611,0.0004167242,0.03291266,0.2819427,0.02519646,0.00038497138,0.00027045494,0.00033614424,0.00053107354,0.0013779625,0.6553824,0.00010355546],"about_ca_topic_score_codex":0.014760422,"about_ca_topic_score_gemma":0.05258242,"teacher_disagreement_score":0.014760422,"about_ca_system_score_codex":0.002746495,"about_ca_system_score_gemma":0.007002084,"threshold_uncertainty_score":0.049146056},"labels":[],"label_agreement":null},{"id":"W3093855610","doi":"10.1016/j.ctrv.2020.102115","title":"Sarcomas: Immune biomarker expression and checkpoint inhibitor trials","year":2020,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"Terry Fox Research Institute; Canadian Cancer Society","keywords":"Medicine; Biomarker; Immune checkpoint; Cancer research; Immune system; Immunotherapy; Oncology; Immunology; Genetics","score_opus":0.23283391994023742,"score_gpt":0.44218175392257025,"score_spread":0.20934783398233284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093855610","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000079095465,0.9994097,0.00002756416,0.00016266214,0.00008272858,0.000009480477,0.00003633494,0.0000032157966,0.00018918437],"genre_scores_gemma":[0.0012153239,0.9977259,0.00010594039,0.0005998521,0.00011685806,0.000022472552,0.000051799256,0.0000016534032,0.00016027062],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99929535,0.00022232432,0.0001815408,0.00009001314,0.00015484885,0.000055867516],"domain_scores_gemma":[0.99745244,0.0016669569,0.0005678292,0.000037171998,0.0001984433,0.000077226934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002496653,0.0011276288,0.0046898527,0.0022475605,0.00017399168,0.0016495875,0.0011024972,0.0015147337,0.006641855],"category_scores_gemma":[0.0047457675,0.0004662457,0.0027907502,0.0027523716,0.00045093565,0.0011061613,0.00079120987,0.0024275654,0.0008298608],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018606773,0.00010184493,0.00030050214,0.1842161,0.0026345893,0.000083179315,0.000041943422,0.0005301981,0.0007214243,0.0012162727,0.025597222,0.782696],"study_design_scores_gemma":[0.0042672455,0.002560893,0.0054063993,0.23468095,0.030073512,0.0011790196,0.00015176689,0.00052602845,0.0008349409,0.0031951505,0.71701926,0.000104798724],"about_ca_topic_score_codex":0.0017409746,"about_ca_topic_score_gemma":0.0067668115,"teacher_disagreement_score":0.006641855,"about_ca_system_score_codex":0.0012481844,"about_ca_system_score_gemma":0.0020995622,"threshold_uncertainty_score":0.02221924},"labels":[],"label_agreement":null},{"id":"W3106231563","doi":"10.1016/j.ctrv.2020.102125","title":"Bugs as drugs: The role of microbiome in cancer focusing on immunotherapeutics","year":2020,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Princess Margaret Cancer Foundation","keywords":"Medicine; Microbiome; Cancer; Oncology; Computational biology; Bioinformatics; Internal medicine","score_opus":0.052150591589164796,"score_gpt":0.3979215327201149,"score_spread":0.3457709411309501,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3106231563","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003850382,0.99874747,0.000073355266,0.00035755226,0.0003981295,0.0000016614059,0.00001021296,0.000004829587,0.0003682628],"genre_scores_gemma":[0.0003513664,0.9983169,0.00010845734,0.00030139426,0.00037470987,0.000003198378,0.000014329529,0.0000016065608,0.0005281032],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997291,0.0000683537,0.000023899222,0.00003919881,0.000109245884,0.0000300984],"domain_scores_gemma":[0.9994411,0.0003329043,0.000054277338,0.000012911363,0.00010013957,0.00005853955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071013585,0.0008895454,0.0015382437,0.0015956439,0.0002465286,0.001449823,0.0007087289,0.0014562038,0.0049187606],"category_scores_gemma":[0.0012917185,0.00019907454,0.0005039645,0.0016554451,0.0005710078,0.0015663652,0.0010031984,0.002456066,0.001696072],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000118391225,0.00005960276,0.00012380285,0.013114079,0.00009489787,0.00010100448,0.000044978766,0.00026853505,0.001536974,0.005937929,0.07035181,0.90824807],"study_design_scores_gemma":[0.000022160157,0.00008245111,0.0004155218,0.0038874212,0.00009530588,0.00035002842,0.000051936586,0.000101893864,0.0002210531,0.002964982,0.9917932,0.000014149981],"about_ca_topic_score_codex":0.0010115076,"about_ca_topic_score_gemma":0.002709576,"teacher_disagreement_score":0.0049187606,"about_ca_system_score_codex":0.0006110697,"about_ca_system_score_gemma":0.0009815585,"threshold_uncertainty_score":0.016454875},"labels":[],"label_agreement":null},{"id":"W3107738233","doi":"10.1016/j.ctrv.2020.102134","title":"Association between immune-related side effects and efficacy and benefit of immune checkpoint inhibitors – A systematic review and meta-analysis","year":2020,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":375,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Western University","funders":"","keywords":"Medicine; Meta-analysis; Immune system; Oncology; Bioinformatics; Immunology; Internal medicine","score_opus":0.05682420004956792,"score_gpt":0.3523567482553131,"score_spread":0.2955325482057452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3107738233","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004727499,0.9940154,0.00034815332,0.000114623625,0.0001247206,0.0000944427,0.00038754308,0.000014753202,0.00017287197],"genre_scores_gemma":[0.1542427,0.84120893,0.0014907882,0.0011350294,0.0003125929,0.00036875144,0.00073038664,0.000028185672,0.00048264558],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99643147,0.0014428176,0.0010825514,0.00048903585,0.00039543005,0.00015859396],"domain_scores_gemma":[0.991892,0.0060198065,0.0013491219,0.00025618466,0.00037575062,0.00010714234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006123393,0.0019608429,0.012198735,0.002292001,0.00034842186,0.002035275,0.0014281995,0.0016988259,0.004273535],"category_scores_gemma":[0.014249506,0.001110534,0.028622221,0.0033788742,0.0005155956,0.0011621519,0.0011829626,0.0021860215,0.0003303848],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003775,0.00003805466,0.003647992,0.27144396,0.70411813,0.00010068092,0.000051353923,0.0004886765,0.00031037943,0.0001260134,0.00075333036,0.015146293],"study_design_scores_gemma":[0.0007612878,0.0001572886,0.0033789098,0.008906984,0.9851258,0.000057724905,0.000021311194,0.000103810926,0.0000720185,0.00013808344,0.0012597083,0.000017025282],"about_ca_topic_score_codex":0.0053476016,"about_ca_topic_score_gemma":0.013980654,"teacher_disagreement_score":0.012198735,"about_ca_system_score_codex":0.0014054023,"about_ca_system_score_gemma":0.0017946518,"threshold_uncertainty_score":0.03238398},"labels":[],"label_agreement":null},{"id":"W3129770065","doi":"10.1016/j.ctrv.2021.102167","title":"Fragility index of trials supporting approval of anti-cancer drugs in common solid tumours","year":2021,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Clinical endpoint; Randomized controlled trial; Statistical significance; Informed consent; Internal medicine; Clinical trial; Sample size determination; Prostate cancer; Surgery; Cancer; Alternative medicine; Pathology","score_opus":0.7670505635966346,"score_gpt":0.678180220305882,"score_spread":0.08887034329075261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129770065","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016331058,0.99205095,0.0019410162,0.00054887624,0.00021494488,0.00040430378,0.0009537294,0.00005658694,0.0021965008],"genre_scores_gemma":[0.14392382,0.84022564,0.0090066735,0.0020099536,0.0009757338,0.0013695718,0.0016240586,0.00006299879,0.0008015236],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9778089,0.011539931,0.0049255495,0.0011802725,0.0042563747,0.00028898637],"domain_scores_gemma":[0.81568766,0.15068543,0.02651114,0.0020045235,0.004297937,0.00081334595],"candidate_categories":["metaresearch","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.035635103,0.0015789751,0.007051131,0.008642506,0.00032778704,0.002285282,0.0013998249,0.0014726599,0.007258475],"category_scores_gemma":[0.12604798,0.0007375375,0.008638667,0.006808734,0.0012030442,0.0021438948,0.0015891508,0.0022906633,0.00047593392],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009775809,0.000053219053,0.0051713088,0.47797433,0.07465947,0.0001335594,0.00019071295,0.0028308493,0.00081756077,0.005199576,0.007871082,0.41532257],"study_design_scores_gemma":[0.006231702,0.002978642,0.043969344,0.26524773,0.5034766,0.0013225379,0.00028758406,0.0043040984,0.0016616596,0.02431848,0.14597052,0.00023112018],"about_ca_topic_score_codex":0.0013795912,"about_ca_topic_score_gemma":0.0032043958,"teacher_disagreement_score":0.9929489,"about_ca_system_score_codex":0.0025654386,"about_ca_system_score_gemma":0.003084777,"threshold_uncertainty_score":0.18845868},"labels":[],"label_agreement":null},{"id":"W3137251658","doi":"10.1016/j.ctrv.2021.102187","title":"Avelumab first-line maintenance in locally advanced or metastatic urothelial carcinoma: Applying clinical trial findings to clinical practice","year":2021,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Pfizer Foundation; Merck KGaA; EMD Serono; Pfizer","keywords":"Avelumab; Medicine; Metastatic Urothelial Carcinoma; Carboplatin; Chemotherapy; Oncology; Internal medicine; Maintenance therapy; Cisplatin; Clinical trial; Bladder cancer; Javelin; Cancer; Immunotherapy; Nivolumab; Urothelial carcinoma","score_opus":0.3066253015532885,"score_gpt":0.5286651053873425,"score_spread":0.22203980383405397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3137251658","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00028358403,0.99901354,0.000051066374,0.00017150168,0.000104147584,0.000013826496,0.000039159324,0.0000049691007,0.0003181362],"genre_scores_gemma":[0.002909877,0.9961655,0.00018067025,0.00039569606,0.00008007757,0.000020819238,0.00005266742,0.000002247845,0.00019253133],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995975,0.00015299738,0.00008005363,0.000062495004,0.00008178449,0.000025199193],"domain_scores_gemma":[0.99866605,0.00093485165,0.00022702721,0.000022310636,0.00010724599,0.000042462285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019140773,0.0005860991,0.002842734,0.0010638924,0.00012480393,0.001211502,0.0009836012,0.000875597,0.004842024],"category_scores_gemma":[0.0026883932,0.00023048847,0.0019494458,0.0012870756,0.00030158262,0.00079663994,0.00036856753,0.001716506,0.0006159225],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012959295,0.00010151754,0.00028295597,0.09862004,0.0020031699,0.000074624404,0.00004874415,0.0004101697,0.0009305442,0.0012243525,0.017228924,0.87777907],"study_design_scores_gemma":[0.006661545,0.0043550516,0.008360535,0.13177586,0.022210797,0.001316219,0.00021912165,0.0008196194,0.0014737025,0.0033719055,0.8193041,0.00013146453],"about_ca_topic_score_codex":0.0012555969,"about_ca_topic_score_gemma":0.0036126254,"teacher_disagreement_score":0.004842024,"about_ca_system_score_codex":0.0006362534,"about_ca_system_score_gemma":0.0012512435,"threshold_uncertainty_score":0.016198158},"labels":[],"label_agreement":null},{"id":"W3138024387","doi":"10.1016/j.ctrv.2021.102188","title":"The COVID-19 pandemic: An opportunity to rethink and harmonise the frequency of follow-up visits for patients with early stage breast cancer","year":2021,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Thunder Bay Regional Health Sciences Centre; University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Randomized controlled trial; Cochrane Library; MEDLINE; Quality of life (healthcare); Cohort; Breast cancer; Cohort study; Pandemic; Internal medicine; Stage (stratigraphy); Adverse effect; Physical therapy; Coronavirus disease 2019 (COVID-19); Cancer; Disease; Nursing","score_opus":0.32922199234492694,"score_gpt":0.49569022118323264,"score_spread":0.1664682288383057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3138024387","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006020873,0.96338296,0.0010001153,0.023753362,0.0023787296,0.0010743792,0.00082830875,0.00004731043,0.0015140348],"genre_scores_gemma":[0.12205982,0.7867107,0.03333152,0.045234907,0.003917799,0.006210124,0.0019563446,0.000083975225,0.0004948341],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.91004485,0.06344017,0.015193016,0.0023589528,0.007878296,0.0010847028],"domain_scores_gemma":[0.71134996,0.21770687,0.042553496,0.00655339,0.018163994,0.003672294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.13360931,0.0008072393,0.0054542725,0.006915192,0.0007616379,0.005651984,0.003637001,0.0055602985,0.003275309],"category_scores_gemma":[0.2899834,0.00077493745,0.007622674,0.0068310266,0.0015746932,0.007242974,0.0043884655,0.0047557866,0.00046730487],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037628682,0.0002615479,0.0093743205,0.5074145,0.010167244,0.00012268596,0.0016544018,0.00078624627,0.00035851513,0.005060575,0.025123293,0.43591383],"study_design_scores_gemma":[0.0048746765,0.0018914281,0.023457766,0.8204062,0.015242818,0.00035874997,0.0019239925,0.0006308784,0.00028981685,0.0041999537,0.126493,0.0002306644],"about_ca_topic_score_codex":0.010778028,"about_ca_topic_score_gemma":0.021378368,"teacher_disagreement_score":0.13360931,"about_ca_system_score_codex":0.007326589,"about_ca_system_score_gemma":0.020896163,"threshold_uncertainty_score":0.706602},"labels":[],"label_agreement":null},{"id":"W3138763072","doi":"10.1016/j.ctrv.2021.102190","title":"Treatment of venous thromboembolism in cancer patients: The dark side of the moon","year":2021,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Intensive care medicine; Cancer; Thrombosis; Venous thromboembolism; Disease; Population; Venous thrombosis; Internal medicine","score_opus":0.08660830747067964,"score_gpt":0.39007039099869933,"score_spread":0.3034620835280197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3138763072","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000023483939,0.99944633,0.000014914934,0.00023439045,0.00012254243,0.0000014586009,0.000006641838,0.0000019152003,0.00014839972],"genre_scores_gemma":[0.00023078154,0.99921715,0.000047873553,0.00026191957,0.0001316325,0.0000019794438,0.000008819687,5.868421e-7,0.000099132],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99950707,0.0001353157,0.000079756515,0.00006173153,0.00018475772,0.00003139694],"domain_scores_gemma":[0.9988533,0.00069365004,0.00019086595,0.00001685571,0.00018622064,0.000059051097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008914826,0.00068891427,0.0022025073,0.0017368683,0.0002668216,0.0013544888,0.00089030474,0.0013169918,0.0042684693],"category_scores_gemma":[0.001962009,0.00027750395,0.00094306597,0.0021162883,0.00041123983,0.0012453859,0.0005481868,0.0021680375,0.00096802117],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010650295,0.00005099863,0.00018483671,0.045346353,0.00027796775,0.00006851518,0.000052025323,0.00021861325,0.00038325982,0.0015440591,0.05085849,0.90090823],"study_design_scores_gemma":[0.000118660064,0.00021564774,0.0020759031,0.06594003,0.0010868546,0.0009602917,0.0001258413,0.00018549108,0.00014495077,0.0020610061,0.9270466,0.00003872503],"about_ca_topic_score_codex":0.0027037929,"about_ca_topic_score_gemma":0.007619656,"teacher_disagreement_score":0.0042684693,"about_ca_system_score_codex":0.0007648384,"about_ca_system_score_gemma":0.001546351,"threshold_uncertainty_score":0.014279425},"labels":[],"label_agreement":null},{"id":"W3174377969","doi":"10.1016/j.ctrv.2021.102254","title":"De-escalating adjuvant therapies in older patients with lower risk estrogen receptor-positive breast cancer treated with breast-conserving surgery: A systematic review and meta-analysis","year":2021,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Meta-analysis; Breast cancer; Oncology; Adjuvant; Estrogen receptor; Breast-conserving surgery; Internal medicine; Gynecology; Cancer; Surgery; Mastectomy","score_opus":0.027057366162339922,"score_gpt":0.30202799814013903,"score_spread":0.2749706319777991,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3174377969","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0036643757,0.99558026,0.0001942702,0.00007684125,0.00008769881,0.00006773344,0.00018111271,0.00000847979,0.00013916873],"genre_scores_gemma":[0.11197883,0.8848641,0.0011794901,0.000906158,0.000159255,0.00020227594,0.00037572178,0.000015245898,0.00031891195],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9978643,0.0008947018,0.00063313305,0.0002879968,0.00022487472,0.00009507394],"domain_scores_gemma":[0.9972313,0.0018319406,0.00063126563,0.000091284965,0.00015971005,0.00005458948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003976445,0.0016259329,0.010522785,0.001825201,0.000250109,0.0016098315,0.001163141,0.0012907506,0.003313287],"category_scores_gemma":[0.008528523,0.00083182537,0.017158156,0.0027247756,0.0003424165,0.0010118879,0.0008777656,0.0016564865,0.0002291621],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052910456,0.00008601186,0.00394997,0.43349847,0.5049915,0.00010082481,0.00010956731,0.0007684591,0.0004960433,0.00017466862,0.0010831034,0.04945039],"study_design_scores_gemma":[0.0021577922,0.00043073564,0.005632992,0.02563884,0.9620597,0.000093689545,0.00006890614,0.000197129,0.00013930563,0.00025606985,0.0032910514,0.000033939807],"about_ca_topic_score_codex":0.0044540656,"about_ca_topic_score_gemma":0.016246362,"teacher_disagreement_score":0.010522785,"about_ca_system_score_codex":0.001131965,"about_ca_system_score_gemma":0.0012565169,"threshold_uncertainty_score":0.02102971},"labels":[],"label_agreement":null},{"id":"W3196883315","doi":"10.1016/j.ctrv.2021.102283","title":"Platinum-based chemotherapy in early-stage triple negative breast cancer: A meta-analysis","year":2021,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Triple-negative breast cancer; Oncology; Taxane; Hazard ratio; Breast cancer; Anthracycline; Meta-analysis; Neutropenia; Confidence interval; Chemotherapy; Stage (stratigraphy); Cancer; Surgery","score_opus":0.11330154597979047,"score_gpt":0.395675935329519,"score_spread":0.2823743893497285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3196883315","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0030704136,0.9960303,0.00024106607,0.00011501798,0.000097058364,0.000022809869,0.0002472662,0.000010619974,0.00016551788],"genre_scores_gemma":[0.09502813,0.9020347,0.00087021705,0.00073883386,0.00022752161,0.00008090413,0.0005842305,0.000020731466,0.0004147232],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.998359,0.0007400394,0.00036200203,0.00026081287,0.00019541437,0.00008259181],"domain_scores_gemma":[0.9974245,0.0017879849,0.00042076752,0.00012046331,0.00018469903,0.00006166668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034208584,0.0016096022,0.0076490655,0.0013436615,0.00019454026,0.001345494,0.0010333271,0.0009917605,0.0032469109],"category_scores_gemma":[0.006065261,0.0007101132,0.014497317,0.002826911,0.0002333064,0.00074898737,0.0007222043,0.0015054137,0.00027874013],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063978834,0.000060471688,0.008216479,0.17113903,0.7486311,0.00014245347,0.000059652033,0.0010173456,0.00062081835,0.00022710832,0.0029213296,0.060566377],"study_design_scores_gemma":[0.00094190496,0.00027377155,0.008851037,0.008156474,0.9764662,0.00009881912,0.000035324803,0.00019696019,0.00014325455,0.00029203563,0.0045164875,0.000027745167],"about_ca_topic_score_codex":0.004527445,"about_ca_topic_score_gemma":0.012974863,"teacher_disagreement_score":0.0076490655,"about_ca_system_score_codex":0.000881374,"about_ca_system_score_gemma":0.0010098481,"threshold_uncertainty_score":0.01809144},"labels":[],"label_agreement":null},{"id":"W3200484435","doi":"10.1016/j.ctrv.2021.102294","title":"The role of the tumor primary chemosensitivity relative to the success of the medical-surgical management in patients with advanced ovarian carcinomas","year":2021,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Institute for Health and Care Research","keywords":"Debulking; Medicine; Tumor Debulking; Oncology; Bevacizumab; Chemotherapy; Ovarian cancer; Internal medicine; Primary tumor; Clinical trial; Surgery; Cancer; Metastasis","score_opus":0.019109934841371513,"score_gpt":0.3121977706038538,"score_spread":0.29308783576248226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200484435","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09938207,0.8950162,0.0011245598,0.0014563444,0.00016740982,0.000017597946,0.0004109718,0.000017867029,0.0024070165],"genre_scores_gemma":[0.60260797,0.39381725,0.0011823574,0.0006973461,0.0006301046,0.000029556002,0.00046005053,0.000010936607,0.00056439237],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99934536,0.0002531597,0.00012467986,0.00008421255,0.00015937767,0.00003316134],"domain_scores_gemma":[0.9978114,0.0014003807,0.00050084037,0.00004149025,0.00018994759,0.000055887005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001152049,0.00019119598,0.0007746012,0.00061396585,0.00009481177,0.0006703757,0.00016491221,0.00023669594,0.0006815523],"category_scores_gemma":[0.004281681,0.00007964871,0.0005163695,0.000971392,0.00024648325,0.000461285,0.00026329982,0.0004411175,0.00008945078],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001244093,0.00006447966,0.15116094,0.01316364,0.0023341342,0.0011406693,0.0005753519,0.0015794853,0.004675948,0.0014495733,0.00351464,0.819097],"study_design_scores_gemma":[0.00009222972,0.0012701286,0.8764282,0.005032929,0.0049111987,0.010128314,0.00088415697,0.0010785221,0.0042151115,0.0047021597,0.09116088,0.00009620365],"about_ca_topic_score_codex":0.0004217968,"about_ca_topic_score_gemma":0.0008795141,"teacher_disagreement_score":0.001152049,"about_ca_system_score_codex":0.00027839912,"about_ca_system_score_gemma":0.00043816713,"threshold_uncertainty_score":0.006092727},"labels":[],"label_agreement":null},{"id":"W3200782887","doi":"10.1016/j.ctrv.2021.102293","title":"The impact of radiological assessment schedules on progression-free survival in metastatic breast cancer: A systemic review and meta-analysis","year":2021,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Confidence interval; Hazard ratio; Metastatic breast cancer; Internal medicine; Breast cancer; Oncology; Meta-analysis; Population; Randomized controlled trial; Subgroup analysis; Cancer","score_opus":0.12793987392326162,"score_gpt":0.46872736857275327,"score_spread":0.34078749464949165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200782887","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007430703,0.9987393,0.00011671856,0.00007168554,0.00006263393,0.000016240667,0.00015901768,0.0000050347194,0.000086408196],"genre_scores_gemma":[0.029135395,0.9689019,0.000594555,0.00062370836,0.0001606631,0.000060950715,0.00033428174,0.000015910593,0.00017259285],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.997498,0.0009941894,0.00068552245,0.000412265,0.0003207017,0.00008933099],"domain_scores_gemma":[0.99244165,0.00594551,0.0009790022,0.00021121363,0.000346599,0.00007593581],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006185918,0.0017328819,0.0100995265,0.0020745923,0.00020245195,0.0019364284,0.0013492255,0.0013180426,0.0038616736],"category_scores_gemma":[0.013081258,0.0008261698,0.017767355,0.0036634947,0.00041440065,0.0010335722,0.0009385527,0.0018021795,0.00035141013],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047060843,0.00006306036,0.0046852254,0.40667242,0.45165104,0.00009413124,0.00008839035,0.0012870983,0.0005639002,0.00034197926,0.003131947,0.12671463],"study_design_scores_gemma":[0.0009912474,0.00051012106,0.008755143,0.034173172,0.9428722,0.00014368926,0.000064246065,0.00025016558,0.00021899905,0.00058763835,0.0113772005,0.000056191817],"about_ca_topic_score_codex":0.0041201552,"about_ca_topic_score_gemma":0.010389907,"teacher_disagreement_score":0.0100995265,"about_ca_system_score_codex":0.0012635022,"about_ca_system_score_gemma":0.001486345,"threshold_uncertainty_score":0.032714665},"labels":[],"label_agreement":null},{"id":"W3203279168","doi":"10.1016/j.ctrv.2021.102299","title":"Prognostic factors for relapse in resected gastroenteropancreatic neuroendocrine neoplasms: A systematic review and meta-analysis","year":2021,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Perineural invasion; Internal medicine; Lymph node; Oncology; Subgroup analysis; Disease; Cohort; Meta-analysis; Gastroenterology; Surgery; Cancer","score_opus":0.1709972473452934,"score_gpt":0.4411561825446852,"score_spread":0.2701589351993918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3203279168","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0038904313,0.9951691,0.00018029704,0.00010085295,0.00007901467,0.00005418607,0.00040209762,0.000010104448,0.00011392695],"genre_scores_gemma":[0.12411244,0.872569,0.0009906868,0.0008350957,0.00018915317,0.00023278178,0.0007436532,0.00002006669,0.00030714847],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9976178,0.00076861493,0.0007877168,0.00041666147,0.00027302743,0.00013614635],"domain_scores_gemma":[0.9950518,0.0033435225,0.0010478321,0.00015880329,0.0003030405,0.00009488602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040389923,0.0017950388,0.010195779,0.0031333235,0.00035753634,0.0019745305,0.0013464456,0.0015425737,0.003955648],"category_scores_gemma":[0.009761911,0.0010884658,0.021838343,0.0051633473,0.000490634,0.001440663,0.0013153163,0.0016646778,0.0003351331],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019190984,0.000043714957,0.012376367,0.4126264,0.54307014,0.00016387913,0.00014453278,0.0005418907,0.00038452898,0.00012458352,0.0016533062,0.026951527],"study_design_scores_gemma":[0.0005348435,0.00015299678,0.009663421,0.02203303,0.9643528,0.00012505955,0.00009600718,0.00014140877,0.00007788041,0.00017633602,0.002609614,0.000036662015],"about_ca_topic_score_codex":0.005439167,"about_ca_topic_score_gemma":0.019273648,"teacher_disagreement_score":0.010195779,"about_ca_system_score_codex":0.0012360765,"about_ca_system_score_gemma":0.002057584,"threshold_uncertainty_score":0.021360457},"labels":[],"label_agreement":null},{"id":"W3210523511","doi":"10.1016/j.ctrv.2021.102310","title":"Genomic sequencing to inform therapy in advanced pancreatic cancer: A systematic review and meta-analysis of prospective studies","year":2021,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; McGill University Health Centre; University Health Network; Dalhousie University; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pancreatic cancer; Meta-analysis; Internal medicine; Oncology; Hazard ratio; Targeted therapy; Cancer; Confidence interval; Bioinformatics; Biology","score_opus":0.3355794220963075,"score_gpt":0.520829721966734,"score_spread":0.18525029987042657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3210523511","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002151789,0.9968707,0.00032135152,0.0001251847,0.000074933145,0.00005721227,0.0002866138,0.000006967289,0.00010530095],"genre_scores_gemma":[0.08106308,0.9153696,0.0016875122,0.00084852224,0.00016775187,0.00017567074,0.00051547046,0.000018037279,0.00015443905],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9942768,0.0027463883,0.0014660149,0.0007643785,0.00056660146,0.00017976487],"domain_scores_gemma":[0.98776823,0.009716551,0.0015425453,0.00033797312,0.00050437433,0.0001303512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008801639,0.0019862016,0.011183071,0.0035599305,0.00038632646,0.0024434438,0.0015172925,0.0018011463,0.0031703673],"category_scores_gemma":[0.022559877,0.0010889833,0.020798031,0.005810342,0.000581981,0.0015313952,0.001475688,0.0019413937,0.00027120864],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019846957,0.000038093054,0.0075692455,0.37583685,0.5714325,0.0001288632,0.00014071097,0.00068795145,0.00039717995,0.00025188888,0.0011289523,0.040403012],"study_design_scores_gemma":[0.00058523973,0.00019563817,0.0061424733,0.032787066,0.9561462,0.00010757253,0.00007769758,0.00014448419,0.00012562466,0.00041828188,0.00323643,0.00003324417],"about_ca_topic_score_codex":0.004853367,"about_ca_topic_score_gemma":0.014249762,"teacher_disagreement_score":0.011183071,"about_ca_system_score_codex":0.001242347,"about_ca_system_score_gemma":0.0028685085,"threshold_uncertainty_score":0.04654807},"labels":[],"label_agreement":null},{"id":"W4245954238","doi":"10.1016/s0305-7372(04)00144-6","title":"Gefitinib does not improve survival when combined with paclitaxel and carboplatin chemotherapy in people with advanced non-small-cell lung cancer☆, ☆, ☆☆Abstracted from: Herbst RS, Giaccone G, Schiller JH et al. Gefitinib in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: a phase III trial – INTACT 2. J Clin Oncol 2004;22:785–94.","year":2004,"lang":"en","type":"article","venue":"Cancer Treatment Reviews","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario","funders":"","keywords":"Gefitinib; Medicine; Carboplatin; Paclitaxel; Lung cancer; Oncology; Chemotherapy; Epidermal growth factor receptor; Internal medicine; Tyrosine-kinase inhibitor; Tyrosine kinase; Cancer research; Cancer; Cisplatin; Receptor","score_opus":0.013877398128715145,"score_gpt":0.32741736364032537,"score_spread":0.31353996551161023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245954238","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89072156,0.08763315,0.00017316341,0.0068580895,0.0015480337,0.00015509335,0.0016401407,0.0001440221,0.011126806],"genre_scores_gemma":[0.9848305,0.011319161,0.00014940559,0.0011327844,0.000568951,0.000054480624,0.0005512598,0.000010688248,0.0013827079],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99953425,0.00017183131,0.000040444567,0.0000641805,0.00008187522,0.0001075379],"domain_scores_gemma":[0.99943167,0.00019053438,0.00015662846,0.000029510247,0.000043941887,0.00014756755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086068944,0.0003131241,0.001937317,0.00028238923,0.00030909065,0.0005344875,0.00027703104,0.00086094777,0.0049261837],"category_scores_gemma":[0.0020166978,0.00015516677,0.0018367505,0.00034243005,0.00028520016,0.0005734876,0.00021222627,0.0008854264,0.00048250167],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.32329306,0.0026097514,0.0623669,0.0028325624,0.008112031,0.0008976233,0.00017178163,0.0010188306,0.010458431,0.00026578468,0.033041257,0.554932],"study_design_scores_gemma":[0.12945029,0.14334545,0.64720374,0.0010574936,0.01864968,0.0034000678,0.00027525506,0.001577444,0.0052450947,0.0008342415,0.04884807,0.00011316867],"about_ca_topic_score_codex":0.0013878915,"about_ca_topic_score_gemma":0.0064575216,"teacher_disagreement_score":0.0049261837,"about_ca_system_score_codex":0.0005607131,"about_ca_system_score_gemma":0.000478409,"threshold_uncertainty_score":0.016479671},"labels":[],"label_agreement":null},{"id":"W4292253343","doi":"10.1016/j.ctrv.2022.102455","title":"Retrospective observational studies in ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society (CTOS) community of experts on the minimum requirements for the evaluation of activity of systemic treatments","year":2022,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Princess Margaret Cancer Centre; University of Toronto; SickKids Foundation; Mount Sinai Hospital","funders":"Connective Tissue Oncology Society","keywords":"Medicine; Observational study; Context (archaeology); Medical physics; Family medicine; Intensive care medicine; Pathology","score_opus":0.668078266631063,"score_gpt":0.5380330149164358,"score_spread":0.1300452517146271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292253343","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005107376,0.99732107,0.00040618592,0.00074651226,0.00040301518,0.00013212959,0.00025120942,0.0000050042645,0.00022420062],"genre_scores_gemma":[0.0075736283,0.9874315,0.0016273176,0.00205925,0.00040777426,0.00031699942,0.0004562541,0.0000091543825,0.00011810434],"study_design_codex":"systematic_review","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9797207,0.0059069213,0.009580682,0.0015151988,0.002966027,0.0003104526],"domain_scores_gemma":[0.8998776,0.08239763,0.009833917,0.0018241106,0.0056293453,0.0004374051],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.03662255,0.0010378249,0.007565797,0.0036875287,0.00042353375,0.0029427204,0.0025763346,0.0028218948,0.0018210193],"category_scores_gemma":[0.07736796,0.00084710674,0.007485539,0.0042024814,0.0007703295,0.0021493623,0.0016511667,0.0025669034,0.00047163293],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018134158,0.000077942466,0.006625556,0.612359,0.038448103,0.00027473978,0.00036207715,0.0003138118,0.000932085,0.0016458892,0.016695024,0.3204524],"study_design_scores_gemma":[0.0014856685,0.0003890856,0.026582822,0.6238433,0.14566258,0.0012902911,0.0004271234,0.00023927026,0.0010489352,0.0021393974,0.19673574,0.00015573022],"about_ca_topic_score_codex":0.0027740614,"about_ca_topic_score_gemma":0.0076326,"teacher_disagreement_score":0.9633775,"about_ca_system_score_codex":0.0018047334,"about_ca_system_score_gemma":0.006588389,"threshold_uncertainty_score":0.19368088},"labels":[],"label_agreement":null},{"id":"W4293428565","doi":"10.1016/j.ctrv.2022.102453","title":"Cabozantinib after prior checkpoint inhibitor therapy in patients with solid tumors: A systematic literature review","year":2022,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; CancerCare Manitoba","funders":"Ipsen","keywords":"Cabozantinib; Medicine; Renal cell carcinoma; Tolerability; Oncology; Observational study; Clinical trial; Cochrane Library; Internal medicine; Systematic review; Kidney cancer; MEDLINE; Adverse effect; Meta-analysis","score_opus":0.04775146533847868,"score_gpt":0.33780633725682585,"score_spread":0.29005487191834717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293428565","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011234777,0.9969151,0.00018197109,0.00037730142,0.00012871642,0.0005462719,0.00050042605,0.000009272152,0.00021738313],"genre_scores_gemma":[0.02027823,0.97436565,0.0013133553,0.0010260672,0.00018491581,0.0021536069,0.0004974548,0.000008816902,0.00017183086],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9863651,0.005133855,0.0048896805,0.0010971187,0.002133532,0.00038061006],"domain_scores_gemma":[0.95114803,0.03277401,0.0114127565,0.00075448316,0.0034558163,0.00045506321],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015368126,0.0017075553,0.009253869,0.01225889,0.0007895556,0.003092856,0.0019764022,0.0024574543,0.00595474],"category_scores_gemma":[0.054338828,0.0012186709,0.0072801537,0.012228447,0.0011280092,0.0030082532,0.0015204925,0.0012595677,0.00048437138],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012536625,0.00000800581,0.00047644303,0.98136085,0.0043231975,0.0000590386,0.00009008924,0.00005018441,0.000084154395,0.00011316125,0.0007638924,0.012545655],"study_design_scores_gemma":[0.00025916466,0.00017922765,0.0028222199,0.9447175,0.04086588,0.00026817643,0.00016292023,0.00005931113,0.000112904505,0.00023521649,0.0102914125,0.00002600263],"about_ca_topic_score_codex":0.0065352055,"about_ca_topic_score_gemma":0.018056776,"teacher_disagreement_score":0.015368126,"about_ca_system_score_codex":0.0050246674,"about_ca_system_score_gemma":0.016979992,"threshold_uncertainty_score":0.081275344},"labels":[],"label_agreement":null},{"id":"W4318205427","doi":"10.1016/j.ctrv.2023.102519","title":"A systematic review of eHealth technologies for breast cancer supportive care","year":2023,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Cancer survivorship and care","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"eHealth; Medicine; CINAHL; Psychological intervention; Breast cancer; Context (archaeology); Randomized controlled trial; MEDLINE; Patient satisfaction; Telemedicine; Family medicine; Cancer; Health care; Internal medicine; Nursing","score_opus":0.10151399184867065,"score_gpt":0.44242813454720326,"score_spread":0.3409141426985326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318205427","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007422837,0.9979176,0.00013572517,0.00014021798,0.00011027772,0.00031425865,0.0003689322,0.00001000881,0.00026067693],"genre_scores_gemma":[0.009455034,0.9885817,0.000694767,0.000543257,0.000050860355,0.0003459007,0.00014446849,0.000005956618,0.00017812448],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9952897,0.0016888678,0.0016790858,0.00037583796,0.00079780724,0.0001687715],"domain_scores_gemma":[0.989007,0.007599945,0.0022546342,0.00015071726,0.0008254258,0.00016238909],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0058030905,0.0014833827,0.008231246,0.0064288666,0.0005854476,0.0025056503,0.0015348404,0.0016787403,0.006500533],"category_scores_gemma":[0.023470426,0.00088661845,0.008160921,0.008352014,0.00072830264,0.002039244,0.0016489798,0.0016993111,0.00037383768],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029322153,0.00001582298,0.00029458347,0.95252603,0.014285634,0.00005168126,0.00011443748,0.000072320465,0.00012703512,0.00014533069,0.0012452113,0.030828752],"study_design_scores_gemma":[0.0008288343,0.00034561218,0.0035181374,0.7888455,0.18428415,0.00023473123,0.00021046631,0.00008717103,0.00016008317,0.00029813245,0.021140782,0.000046408597],"about_ca_topic_score_codex":0.011950109,"about_ca_topic_score_gemma":0.040303018,"teacher_disagreement_score":0.011950109,"about_ca_system_score_codex":0.0030000857,"about_ca_system_score_gemma":0.007759174,"threshold_uncertainty_score":0.030690074},"labels":[],"label_agreement":null},{"id":"W4320717817","doi":"10.1016/j.ctrv.2023.102525","title":"nmCRPC, a look in the continuous care of prostate cancer patients: state of art and future perspectives","year":2023,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Cilag","keywords":"Medicine; Prostate cancer; Incidence (geometry); Clinical trial; Metastasis; Oncology; Adverse effect; Internal medicine; Cancer","score_opus":0.05666846989924946,"score_gpt":0.40249026250732234,"score_spread":0.3458217926080729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4320717817","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000034593075,0.99863464,0.000035164052,0.00073612673,0.00020497508,0.0000019834151,0.000007779817,0.000003874309,0.00034081534],"genre_scores_gemma":[0.0003025592,0.99875605,0.00009846472,0.00048446003,0.00018612012,0.000003651726,0.000013056958,0.0000011020345,0.0001545383],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99964225,0.00011024066,0.000049491486,0.000050766277,0.000109861045,0.00003739082],"domain_scores_gemma":[0.998887,0.00062392163,0.00012467298,0.000021537644,0.00026489847,0.00007789286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001227166,0.00066428457,0.0013644001,0.0019359556,0.00031468118,0.0013938699,0.00093948015,0.0014308732,0.004379487],"category_scores_gemma":[0.0016133884,0.00022681315,0.0007638307,0.0023357214,0.0005390314,0.00197075,0.0007337784,0.0023098763,0.0014438151],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009479045,0.000061583516,0.000169469,0.031417895,0.00009892962,0.00011667613,0.000083901876,0.0002583261,0.00043212573,0.004532854,0.049504735,0.9132287],"study_design_scores_gemma":[0.00002825117,0.0001112959,0.00079681724,0.01879582,0.00017828813,0.00079918135,0.00014322398,0.0001123387,0.000088442546,0.0021801323,0.97674483,0.000021443713],"about_ca_topic_score_codex":0.0019724746,"about_ca_topic_score_gemma":0.00397501,"teacher_disagreement_score":0.004379487,"about_ca_system_score_codex":0.0008611045,"about_ca_system_score_gemma":0.0023650087,"threshold_uncertainty_score":0.014650822},"labels":[],"label_agreement":null},{"id":"W4322774020","doi":"10.1016/j.ctrv.2023.102526","title":"Clinical consensus statement: Establishing the roles of locoregional and systemic therapies for the treatment of intermediate-stage hepatocellular carcinoma in Canada","year":2023,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; University of New Brunswick; Université de Montréal; University of Toronto; Western University; McGill University; Hôpital du Sacré-Cœur de Montréal; Juravinski Cancer Centre; Vancouver General Hospital; Princess Margaret Cancer Centre; University of Calgary; BC Cancer Agency; Dalhousie University","funders":"","keywords":"Medicine; Systemic therapy; Context (archaeology); Stage (stratigraphy); Hepatocellular carcinoma; Radiation therapy; Intensive care medicine; Internal medicine; Oncology; Surgery; Cancer","score_opus":0.2824124292356557,"score_gpt":0.3892550520759621,"score_spread":0.10684262284030643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322774020","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00040830314,0.84690624,0.0008130062,0.11914301,0.021619005,0.00053721847,0.003615722,0.000059040856,0.006898407],"genre_scores_gemma":[0.0029856423,0.94237304,0.0039454717,0.037370075,0.004256614,0.00039713993,0.0024370856,0.000036193447,0.006198803],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99478036,0.0010473789,0.0011824482,0.00040721602,0.0020549234,0.0005277003],"domain_scores_gemma":[0.97046477,0.005153843,0.003152594,0.00034567274,0.018099885,0.0027831497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016505234,0.0010745422,0.003825748,0.0044241333,0.0016766407,0.003555645,0.004395647,0.005754193,0.005202876],"category_scores_gemma":[0.021329038,0.0006030854,0.0036767987,0.0069928407,0.0016012989,0.0018585746,0.0022078604,0.0062551983,0.00207965],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031383487,0.000056264056,0.00081699045,0.032356218,0.00041106844,0.00012765518,0.00014671109,0.0003883009,0.0005028462,0.0036646414,0.68781793,0.2733976],"study_design_scores_gemma":[0.00023958138,0.000065409455,0.0032237694,0.058948684,0.0011939944,0.0001541183,0.0001743527,0.00013225945,0.0002737959,0.0014337364,0.93409777,0.000062533],"about_ca_topic_score_codex":0.24169917,"about_ca_topic_score_gemma":0.3417826,"teacher_disagreement_score":0.75830084,"about_ca_system_score_codex":0.018955765,"about_ca_system_score_gemma":0.12843448,"threshold_uncertainty_score":0.48058462},"labels":[],"label_agreement":null},{"id":"W4377969156","doi":"10.1016/j.ctrv.2023.102583","title":"Clinical trial designs for evaluating and exploiting cancer evolution","year":2023,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Imperial Experimental Cancer Medicine Centre; National Institute for Health and Care Research; Cancer Research UK","keywords":"Medicine; Clinical trial; Somatic evolution in cancer; Clinical study design; Intensive care medicine; Cancer; Bioinformatics; Internal medicine; Biology","score_opus":0.5524420529314084,"score_gpt":0.5605969373199633,"score_spread":0.00815488438855494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377969156","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00038967613,0.9859222,0.0052443235,0.0037834574,0.0012619614,0.00033192575,0.00024648887,0.00005461415,0.0027653228],"genre_scores_gemma":[0.010670801,0.9572893,0.016225904,0.009041805,0.002588519,0.0016020886,0.0005902771,0.000037255533,0.0019540873],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956677,0.0029346,0.0002862783,0.00035279524,0.0006223159,0.00013632335],"domain_scores_gemma":[0.9748355,0.022072036,0.0011590458,0.00047710573,0.0010310565,0.00042521514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019326983,0.0013788805,0.0038902836,0.0016459274,0.00024155316,0.0025463244,0.0020067128,0.0029182602,0.008135275],"category_scores_gemma":[0.02429604,0.0004557916,0.0015677252,0.0015714825,0.0011736333,0.0015852298,0.0011652891,0.0044790385,0.0013989327],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012080825,0.00024551165,0.00045449426,0.017015526,0.00080863736,0.000118217344,0.000043700722,0.0017638194,0.0012410404,0.019639844,0.031357095,0.92610407],"study_design_scores_gemma":[0.0060690255,0.003884719,0.003097973,0.033340488,0.0041210167,0.0010083548,0.00014317055,0.0023801564,0.0021958419,0.07692874,0.866694,0.00013647026],"about_ca_topic_score_codex":0.0009931717,"about_ca_topic_score_gemma":0.0019576503,"teacher_disagreement_score":0.019326983,"about_ca_system_score_codex":0.001782506,"about_ca_system_score_gemma":0.0033979975,"threshold_uncertainty_score":0.10221207},"labels":[],"label_agreement":null},{"id":"W4378530156","doi":"10.1016/j.ctrv.2023.102584","title":"The evolution of immune checkpoint inhibitor combinations in advanced hepatocellular carcinoma – A systematic review","year":2023,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of British Columbia; BC Cancer Agency; Princess Margaret Cancer Centre; Juravinski Cancer Centre; Dalhousie University; University of Toronto; McMaster University","funders":"","keywords":"Sorafenib; Medicine; Bevacizumab; Oncology; Durvalumab; Atezolizumab; Internal medicine; Hepatocellular carcinoma; Clinical trial; Regimen; Immunotherapy; Cancer; Nivolumab; Chemotherapy","score_opus":0.1175993671776607,"score_gpt":0.34778021340634835,"score_spread":0.23018084622868765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378530156","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002811334,0.9993863,0.000035029865,0.000062849824,0.00004888698,0.00002239992,0.000077605095,0.0000022864613,0.00008350773],"genre_scores_gemma":[0.004132489,0.9952716,0.00014715892,0.00025981446,0.000044587043,0.000031551644,0.00005839321,0.0000018691082,0.00005241457],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99831885,0.0004645569,0.0006521951,0.00020194863,0.0002921266,0.00007027982],"domain_scores_gemma":[0.99462587,0.0034937796,0.001363631,0.00007061027,0.00035910122,0.00008692438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027853174,0.00092922297,0.00679854,0.004119999,0.00028482842,0.0018610272,0.0011597505,0.0013254283,0.0040468974],"category_scores_gemma":[0.009113568,0.0006490815,0.006756955,0.0059340135,0.00042676931,0.0014008557,0.00092767616,0.0013263659,0.00032367863],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006560252,0.000031590545,0.00090324273,0.8706831,0.027058003,0.00009471665,0.00008986906,0.00025719978,0.00031726816,0.00025261266,0.0032528823,0.09640356],"study_design_scores_gemma":[0.0011344891,0.0005810282,0.00871425,0.60987973,0.32571974,0.0005816352,0.0002353633,0.00023707416,0.0002753767,0.00063910295,0.051917158,0.00008501397],"about_ca_topic_score_codex":0.0050946097,"about_ca_topic_score_gemma":0.018570647,"teacher_disagreement_score":0.00679854,"about_ca_system_score_codex":0.0014359615,"about_ca_system_score_gemma":0.0031860422,"threshold_uncertainty_score":0.014730275},"labels":[],"label_agreement":null},{"id":"W4386800011","doi":"10.1016/j.ctrv.2023.102626","title":"Managing postoperative biochemical relapse in prostate cancer, from the perspective of the Francophone group of Urological radiotherapy (GFRU)","year":2023,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kelowna General Hospital; Hôpital Charles-Le Moyne","funders":"","keywords":"Medicine; Prostate cancer; Radiation therapy; Androgen deprivation therapy; Radiological weapon; Disease; Positron emission tomography; Clinical trial; Management of prostate cancer; Prostate; Biochemical recurrence; Cancer; Oncology; Radiology; Internal medicine; Prostatectomy","score_opus":0.08208481369047983,"score_gpt":0.4076436679264487,"score_spread":0.32555885423596886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386800011","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000047846825,0.99959594,0.000013712137,0.00013742948,0.00006397406,0.0000018013204,0.0000062049053,0.000001197502,0.00013195597],"genre_scores_gemma":[0.00043164234,0.9991528,0.00006184127,0.00016273964,0.000059340102,0.0000022663064,0.000012762031,4.015929e-7,0.000116214294],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997811,0.00004911719,0.000037810994,0.000030583502,0.00007822541,0.000023261156],"domain_scores_gemma":[0.9996594,0.00015993806,0.00007794759,0.000004939871,0.00007156053,0.000026266636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007262193,0.0006052975,0.0012192015,0.0016117026,0.00023968138,0.0009478276,0.000777122,0.00088724005,0.0022068792],"category_scores_gemma":[0.0010762675,0.00017008782,0.00072510453,0.001477803,0.0002593728,0.0007021232,0.00048705348,0.0012004108,0.00045807572],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012333205,0.000047430716,0.00023886685,0.037782226,0.00025553996,0.00010147088,0.000052810545,0.0002451946,0.00043382958,0.00087004347,0.02222696,0.93762225],"study_design_scores_gemma":[0.00015761527,0.00030351916,0.0048072375,0.049118463,0.0011851013,0.0019341876,0.00021932292,0.00016105722,0.0002770815,0.0011101308,0.9406839,0.00004233125],"about_ca_topic_score_codex":0.005041363,"about_ca_topic_score_gemma":0.01411877,"teacher_disagreement_score":0.005041363,"about_ca_system_score_codex":0.0006433566,"about_ca_system_score_gemma":0.0017409307,"threshold_uncertainty_score":0.010024011},"labels":[],"label_agreement":null},{"id":"W4388049965","doi":"10.1016/j.ctrv.2023.102649","title":"Molecular profiling in cholangiocarcinoma: A practical guide to next-generation sequencing","year":2023,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Agence Nationale de la Recherche; Sociedad Española de Oncología Médica; European Commission; Incyte","keywords":"Medicine; DNA sequencing; Computational biology; Targeted therapy; Bioinformatics; Liquid biopsy; Molecular diagnostics; Profiling (computer programming); Disease; Gene; Internal medicine; Cancer; Genetics; Biology","score_opus":0.40081382377839403,"score_gpt":0.4724980599402206,"score_spread":0.07168423616182656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388049965","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001271332,0.67794526,0.19595805,0.07794004,0.012536545,0.0006786635,0.002405369,0.0052166856,0.026048144],"genre_scores_gemma":[0.005807934,0.59633803,0.32440746,0.03694107,0.009345737,0.0016882389,0.003110069,0.0010474,0.021314165],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970336,0.0010706007,0.00045283622,0.00031407908,0.0010184415,0.00011044555],"domain_scores_gemma":[0.99392337,0.003229504,0.00036732308,0.00033448404,0.0017731808,0.00037217137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048174416,0.0017992732,0.0018432522,0.004762146,0.000604444,0.002450642,0.002514387,0.004576496,0.0077137877],"category_scores_gemma":[0.0106662735,0.0014743522,0.0012994318,0.0024039163,0.0014798575,0.002902287,0.0016548746,0.008564058,0.011259256],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011450113,0.00011564817,0.0010370457,0.0029065644,0.00013061172,0.0013756165,0.00033349756,0.0012705215,0.00856266,0.007933554,0.4653315,0.5108882],"study_design_scores_gemma":[0.000029922197,0.000086339,0.0010479657,0.0015134735,0.000059332688,0.0048055104,0.000096957905,0.0011498175,0.0016094333,0.0107543105,0.97877026,0.00007662866],"about_ca_topic_score_codex":0.0024500543,"about_ca_topic_score_gemma":0.0054177656,"teacher_disagreement_score":0.0077137877,"about_ca_system_score_codex":0.0010644464,"about_ca_system_score_gemma":0.0021420044,"threshold_uncertainty_score":0.025805235},"labels":[],"label_agreement":null},{"id":"W4388341977","doi":"10.1016/j.ctrv.2023.102652","title":"Vascular endothelial growth factor-targeted therapy in patients with renal cell carcinoma pretreated with immune checkpoint inhibitors: A systematic literature review","year":2023,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Ipsen; Ipsen Fund","keywords":"Medicine; Cabozantinib; Tolerability; Pazopanib; Renal cell carcinoma; Oncology; Internal medicine; Vascular endothelial growth factor; Adverse effect; Systematic review; Regimen; Cochrane Library; Sunitinib; MEDLINE; Randomized controlled trial; VEGF receptors","score_opus":0.03545536927305138,"score_gpt":0.285767195707976,"score_spread":0.2503118264349246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388341977","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016368979,0.9965932,0.00015869323,0.00027487386,0.00009217849,0.00042914387,0.0005720417,0.000008205114,0.00023479837],"genre_scores_gemma":[0.02177965,0.9747838,0.000931338,0.0007026063,0.00010784079,0.0011773625,0.00039388743,0.000005680266,0.00011790158],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99219185,0.002684233,0.0031710009,0.00067677366,0.0010464547,0.00022966524],"domain_scores_gemma":[0.9732718,0.017211441,0.006546131,0.0003782691,0.002318483,0.00027393608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009150035,0.0013500404,0.008171307,0.01148207,0.0006099043,0.0022811736,0.0017949645,0.0017886118,0.004145905],"category_scores_gemma":[0.038151667,0.0009771348,0.007007205,0.011173304,0.0008355902,0.002264751,0.0012705886,0.0008793515,0.00028299753],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000122171,0.0000101916075,0.0007810701,0.9755839,0.0058321194,0.00006147586,0.000097870456,0.000063407046,0.00010537073,0.000105342995,0.0007229248,0.016514128],"study_design_scores_gemma":[0.0002772084,0.00022261006,0.004292794,0.9234613,0.06069087,0.00033791258,0.0001947275,0.0000798613,0.00013476473,0.00022642122,0.010051291,0.000030391533],"about_ca_topic_score_codex":0.007042616,"about_ca_topic_score_gemma":0.0193996,"teacher_disagreement_score":0.01148207,"about_ca_system_score_codex":0.0037282577,"about_ca_system_score_gemma":0.013024174,"threshold_uncertainty_score":0.048390567},"labels":[],"label_agreement":null},{"id":"W4388461381","doi":"10.1016/j.ctrv.2023.102653","title":"Pharmacotherapy for leptomeningeal disease in breast cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Treatment Reviews","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"Seagen","keywords":"Medicine; Breast cancer; Trastuzumab; Clinical trial; Oncology; Metastatic breast cancer; Systemic therapy; Cancer; Internal medicine; Disease","score_opus":0.0922318840725777,"score_gpt":0.43915167979962827,"score_spread":0.34691979572705056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388461381","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016282044,0.9723799,0.00079871475,0.00255149,0.00021053216,0.000103520535,0.00021658593,0.00004044805,0.0074167424],"genre_scores_gemma":[0.1872756,0.8033195,0.0025091309,0.0033847145,0.0005035741,0.00027202108,0.00054102205,0.00001454846,0.0021797398],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997472,0.00012463582,0.000036095556,0.000025170708,0.00004538092,0.000021511218],"domain_scores_gemma":[0.9997842,0.00010747988,0.000061189116,0.00000949355,0.000025607882,0.000012126535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043539598,0.00015645081,0.00055028894,0.00062039273,0.00013663941,0.0003961265,0.00023064544,0.00028348956,0.0017502992],"category_scores_gemma":[0.00087465177,0.000067354435,0.0005027913,0.0005399447,0.00014086899,0.00022553501,0.00022649614,0.0005271625,0.00036672884],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012072201,0.00023056827,0.002249582,0.015139514,0.0007583142,0.00050330063,0.00007433177,0.0005492809,0.005489099,0.0016075206,0.016654842,0.9555365],"study_design_scores_gemma":[0.003054357,0.0044851424,0.051674824,0.01674313,0.0035632257,0.008388692,0.00024399403,0.0015988371,0.0099576805,0.009681073,0.8905305,0.0000785915],"about_ca_topic_score_codex":0.000512689,"about_ca_topic_score_gemma":0.0020820978,"teacher_disagreement_score":0.0017502992,"about_ca_system_score_codex":0.00044571655,"about_ca_system_score_gemma":0.0004980583,"threshold_uncertainty_score":0.005855322},"labels":[],"label_agreement":null},{"id":"W4389001294","doi":"10.1016/j.ctrv.2023.102663","title":"A systematic review of the role of chemotherapy in retroperitoneal sarcoma by the Australia and New Zealand sarcoma association clinical practice guidelines working party","year":2023,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Australia and New Zealand Sarcoma Association","keywords":"Medicine; Sarcoma; Chemotherapy; Clinical Practice; Oncology; General surgery; Internal medicine; Family medicine; Pathology","score_opus":0.22139979854696398,"score_gpt":0.4828110196235043,"score_spread":0.26141122107654036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389001294","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001750908,0.9872727,0.00070593564,0.002329552,0.00048630766,0.0042600944,0.002170428,0.000027198792,0.0009968608],"genre_scores_gemma":[0.023853978,0.9548563,0.0051295515,0.0029204248,0.0001835359,0.011285741,0.0012362078,0.000028826582,0.00050541473],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9577463,0.014669322,0.018175188,0.0021481065,0.0065610586,0.00070004916],"domain_scores_gemma":[0.92156816,0.041735567,0.023264263,0.001564943,0.010821271,0.0010458061],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03338887,0.0018699719,0.010870576,0.015588513,0.0013128489,0.0037560076,0.0038314112,0.0032046456,0.0054263924],"category_scores_gemma":[0.115850285,0.0015687518,0.009486721,0.014823534,0.001769843,0.0041149524,0.003217519,0.0019397221,0.0005931734],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015410033,0.000008708973,0.0008264353,0.96096706,0.005224086,0.000076386015,0.00029916977,0.000093598144,0.00015152484,0.00025533157,0.003868485,0.028075079],"study_design_scores_gemma":[0.0002997255,0.00009146239,0.0033056862,0.9559554,0.024135115,0.00015826739,0.00019586831,0.00006352252,0.000106174855,0.00032724623,0.015332525,0.000029031296],"about_ca_topic_score_codex":0.017974002,"about_ca_topic_score_gemma":0.049783453,"teacher_disagreement_score":0.03338887,"about_ca_system_score_codex":0.01000798,"about_ca_system_score_gemma":0.03657601,"threshold_uncertainty_score":0.1765793},"labels":[],"label_agreement":null},{"id":"W4389248415","doi":"10.1016/j.ctrv.2023.102666","title":"Reporting of post-protocol therapies in metastatic breast cancer registration clinical trials: A systematic review","year":2023,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Protocol (science); Clinical trial; Breast cancer; Population; Metastatic breast cancer; Research design; Clinical study design; Internal medicine; Oncology; Cancer; Alternative medicine; Pathology","score_opus":0.5415218340859154,"score_gpt":0.6121691677018806,"score_spread":0.0706473336159652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389248415","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013251385,0.9953518,0.00053392,0.00038618897,0.00027785657,0.0010817858,0.00063377974,0.00002416371,0.00038545343],"genre_scores_gemma":[0.05202631,0.9390272,0.0029524898,0.002389302,0.00024424077,0.0024144894,0.0005784874,0.000036643858,0.00033081265],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.93118167,0.035951503,0.022752877,0.003114579,0.0061036353,0.00089569425],"domain_scores_gemma":[0.8737235,0.0838861,0.033818774,0.0027008003,0.0050244527,0.00084626244],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.044900652,0.001968863,0.013100067,0.0062336004,0.0005460253,0.0046597677,0.0027661484,0.0029803596,0.0066980585],"category_scores_gemma":[0.1613124,0.002027474,0.014583024,0.006528187,0.002027171,0.0041586603,0.002970582,0.0034945651,0.00045911397],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009697758,0.000018013485,0.0007553075,0.9273164,0.044696093,0.000037372538,0.0001555678,0.00010730581,0.00012885872,0.00022256788,0.0015232153,0.024069602],"study_design_scores_gemma":[0.0037465182,0.0004175115,0.004364406,0.6369683,0.33703846,0.00020550114,0.00024964084,0.00018697341,0.00024204269,0.00068613916,0.015823849,0.00007068079],"about_ca_topic_score_codex":0.0052979635,"about_ca_topic_score_gemma":0.019129144,"teacher_disagreement_score":0.95509934,"about_ca_system_score_codex":0.005394355,"about_ca_system_score_gemma":0.012322252,"threshold_uncertainty_score":0.2374602},"labels":[],"label_agreement":null},{"id":"W4396847506","doi":"10.1016/j.ctrv.2024.102753","title":"Oncological outcomes of local excision versus radical surgery for early rectal cancer in the context of staging and surveillance: A systematic review and meta-analysis","year":2024,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Department of Health and Social Care; National Institute for Health and Care Research","keywords":"Medicine; Meta-analysis; Context (archaeology); Relative risk; Colorectal cancer; MEDLINE; Surgery; Internal medicine; Cancer; Confidence interval","score_opus":0.2657512587046783,"score_gpt":0.4697405175223402,"score_spread":0.2039892588176619,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396847506","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00540595,0.99333835,0.00037283642,0.00013933367,0.00012233914,0.00024088158,0.00022395683,0.000014558168,0.00014179158],"genre_scores_gemma":[0.21275495,0.7810622,0.002558876,0.00088011177,0.00032646337,0.0015252966,0.0005385218,0.000031512285,0.00032203406],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9873914,0.006864758,0.0032247202,0.0010966673,0.0010791441,0.0003433142],"domain_scores_gemma":[0.977523,0.016622525,0.0036471598,0.0005492013,0.0013650501,0.000293099],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017186323,0.0030417182,0.021686338,0.0064351596,0.00062789384,0.003664678,0.0021766247,0.002778111,0.0023998169],"category_scores_gemma":[0.037447322,0.0016088285,0.04604253,0.0061642956,0.0009048532,0.0018269062,0.0015983697,0.0020272955,0.00022235276],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002217789,0.00003072728,0.0022343777,0.3064033,0.6808947,0.00010546163,0.00008320652,0.0005895434,0.00017020636,0.00010455184,0.0002845584,0.0068816226],"study_design_scores_gemma":[0.00048210507,0.00023044768,0.0019314316,0.016162433,0.9800111,0.00006673031,0.000037859827,0.00015714299,0.00008840329,0.00011876467,0.0006948046,0.000018844314],"about_ca_topic_score_codex":0.006859141,"about_ca_topic_score_gemma":0.014112407,"teacher_disagreement_score":0.021686338,"about_ca_system_score_codex":0.0032855303,"about_ca_system_score_gemma":0.0033306296,"threshold_uncertainty_score":0.09089106},"labels":[],"label_agreement":null},{"id":"W4404367648","doi":"10.1016/j.ctrv.2024.102853","title":"Expert recommendations on treatment sequencing and challenging clinical scenarios in human epidermal growth factor receptor 2-positive (HER2-positive) metastatic breast cancer","year":2024,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Foundation; Spinal Cord Injury BC; BC Cancer Agency","funders":"Seagen; Pfizer","keywords":"Medicine; Human Epidermal Growth Factor Receptor 2; Metastatic breast cancer; Breast cancer; Oncology; Cancer; Internal medicine; Epidermal growth factor receptor; Lapatinib; Cancer research; Trastuzumab","score_opus":0.3394679420235394,"score_gpt":0.5386860887968553,"score_spread":0.1992181467733159,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404367648","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025380247,0.08506217,0.034606203,0.8138598,0.02355869,0.0015456631,0.0008481093,0.00070342224,0.037277956],"genre_scores_gemma":[0.0558421,0.16187839,0.22493038,0.501186,0.023056487,0.0051640044,0.0038935477,0.0006142126,0.023434995],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9620283,0.022467291,0.0074254107,0.0011525181,0.0050741755,0.0018523136],"domain_scores_gemma":[0.90919274,0.041382592,0.006516665,0.001844361,0.033930037,0.0071335514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.040988106,0.0014091537,0.0019093641,0.0026848733,0.0025405504,0.0037399943,0.0058254553,0.018267276,0.007065966],"category_scores_gemma":[0.09948337,0.00082159176,0.004160758,0.0017993049,0.0025109572,0.0056614815,0.004468174,0.016010882,0.0052782563],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000114478076,0.00013714959,0.0010834056,0.004771849,0.00012209719,0.0013699912,0.0016786843,0.0019957535,0.0008435608,0.010128664,0.7423956,0.23535882],"study_design_scores_gemma":[0.00012838707,0.00008779719,0.00096815533,0.015556832,0.0001846462,0.001299445,0.0017380132,0.0008127238,0.0004432466,0.016681936,0.96197116,0.00012754451],"about_ca_topic_score_codex":0.0055735838,"about_ca_topic_score_gemma":0.01237237,"teacher_disagreement_score":0.040988106,"about_ca_system_score_codex":0.0046041366,"about_ca_system_score_gemma":0.016727895,"threshold_uncertainty_score":0.21676838},"labels":[],"label_agreement":null},{"id":"W4404452346","doi":"10.1016/j.ctrv.2024.102860","title":"Expert consensus on the prevention of brain metastases in patients with HER2-positive breast cancer","year":2024,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"Seagen","keywords":"Medicine; Breast cancer; Oncology; Internal medicine; Cancer","score_opus":0.07654962218260253,"score_gpt":0.39905532278408096,"score_spread":0.32250570060147843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404452346","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0023741235,0.893013,0.0075631794,0.06499822,0.016949112,0.001958149,0.0008953216,0.000079500016,0.012169385],"genre_scores_gemma":[0.034982596,0.9085869,0.02198908,0.022011578,0.0035712367,0.0026221506,0.001520571,0.0000571373,0.004658812],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.945796,0.029043699,0.012845085,0.0016810757,0.009539,0.0010951171],"domain_scores_gemma":[0.92990345,0.038356677,0.0075929794,0.0012846115,0.02112246,0.0017397576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.060309872,0.0012500219,0.0030952177,0.0054622814,0.00092863175,0.002640731,0.003407012,0.0052263197,0.003964036],"category_scores_gemma":[0.09050851,0.0007046695,0.003860636,0.0039313347,0.0013770249,0.0027602252,0.0034458535,0.0037752828,0.0014336858],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035729277,0.00007647668,0.00058003026,0.25052956,0.0010555383,0.00047737206,0.0028882625,0.0008784965,0.0017599672,0.0070675295,0.14615221,0.5881773],"study_design_scores_gemma":[0.0002396184,0.00022693636,0.0021131714,0.3595305,0.002541076,0.00096404593,0.0013841003,0.00041801887,0.0011130252,0.008267927,0.62308675,0.00011489009],"about_ca_topic_score_codex":0.0027291195,"about_ca_topic_score_gemma":0.0036425812,"teacher_disagreement_score":0.060309872,"about_ca_system_score_codex":0.003093207,"about_ca_system_score_gemma":0.020653443,"threshold_uncertainty_score":0.31895292},"labels":[],"label_agreement":null},{"id":"W4406788450","doi":"10.1016/j.ctrv.2025.102889","title":"Diagnosis and management of bispecific T cell–engaging antibody toxicity: A primer for emergency physicians","year":2025,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Micropharma (Canada)","funders":"University of Texas MD Anderson Cancer Center","keywords":"Medicine; Primer (cosmetics); Bispecific antibody; Toxicity; Antibody; Medical emergency; Family medicine; Immunology; Internal medicine; Monoclonal antibody","score_opus":0.14107790887362762,"score_gpt":0.469043019803262,"score_spread":0.32796511092963443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406788450","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00002747843,0.9973641,0.00013529343,0.0016873628,0.0004818744,0.0000037742489,0.0000077428895,0.0000051489615,0.00028729683],"genre_scores_gemma":[0.00043423506,0.9954744,0.0004095047,0.0019136696,0.0014380713,0.000010949167,0.000020627815,0.0000015812477,0.00029696705],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994293,0.00017761817,0.000104236045,0.000071901646,0.0001693555,0.00004757456],"domain_scores_gemma":[0.9984175,0.00087295583,0.00019877081,0.000025082583,0.00039639053,0.0000893351],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017177965,0.00094124733,0.0020331822,0.0021218592,0.00038867941,0.0018676159,0.0011594368,0.0026071118,0.0028231188],"category_scores_gemma":[0.002684466,0.00038670137,0.001024755,0.0011569494,0.0006814383,0.0028476382,0.00081230275,0.0052333153,0.0012958939],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013648065,0.00011075923,0.00032459985,0.015116718,0.00011382275,0.0003847474,0.000073660914,0.00043784993,0.00075506786,0.0045179664,0.12049185,0.8575365],"study_design_scores_gemma":[0.00007248899,0.00021472719,0.0008872444,0.021373197,0.00019759253,0.002165549,0.00013614348,0.0002980072,0.00020817948,0.0038589828,0.9705467,0.000041099564],"about_ca_topic_score_codex":0.0017575703,"about_ca_topic_score_gemma":0.0040496136,"teacher_disagreement_score":0.0028231188,"about_ca_system_score_codex":0.0012593246,"about_ca_system_score_gemma":0.002099698,"threshold_uncertainty_score":0.009444237},"labels":[],"label_agreement":null},{"id":"W4408014611","doi":"10.1016/j.ctrv.2025.102909","title":"First versus second-generation molecular profiling tests: How both can guide decision-making in early-stage hormone-receptor positive breast cancers?","year":2025,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval; Centre hospitalier universitaire de Québec","funders":"Fonds de Recherche du Québec - Santé; Génome Québec","keywords":"Medicine; Oncology; Hormone receptor; Profiling (computer programming); Stage (stratigraphy); Internal medicine; Breast cancer; Gynecology; Cancer research; Cancer","score_opus":0.033526328969651076,"score_gpt":0.35042296870750844,"score_spread":0.31689663973785737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408014611","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005933858,0.9979436,0.00017047394,0.0011024462,0.0002724849,0.0000031588247,0.00003235053,0.0000057606712,0.00041040577],"genre_scores_gemma":[0.000997966,0.9965648,0.0005056158,0.0010603379,0.00043676476,0.000007828681,0.000051068793,0.0000028293612,0.00037283602],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999456,0.00019661909,0.00005319568,0.000090033194,0.00015803926,0.000046261088],"domain_scores_gemma":[0.99789953,0.0014340584,0.00016293373,0.000039939066,0.00037922594,0.00008427488],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021961797,0.0008211358,0.0025199603,0.0013419719,0.00019501869,0.0018275314,0.0013611673,0.0016523745,0.004675727],"category_scores_gemma":[0.0038335687,0.0002651729,0.0011165512,0.0014475425,0.00059543713,0.0016558289,0.0005574113,0.0030826766,0.0019080298],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020734742,0.00005212343,0.000404208,0.007962691,0.0002497979,0.000088126006,0.000027309045,0.00027886216,0.0004969506,0.0037176393,0.039081227,0.94743365],"study_design_scores_gemma":[0.00015772576,0.00028295658,0.0022794784,0.0142807765,0.00086727215,0.0011691812,0.0001204304,0.00031004316,0.0004848913,0.007835166,0.9721459,0.00006617532],"about_ca_topic_score_codex":0.0025659793,"about_ca_topic_score_gemma":0.005601478,"teacher_disagreement_score":0.004675727,"about_ca_system_score_codex":0.00086625834,"about_ca_system_score_gemma":0.0017033484,"threshold_uncertainty_score":0.015641809},"labels":[],"label_agreement":null},{"id":"W4409613307","doi":"10.1016/j.ctrv.2025.102944","title":"Adjuvant CDK4/6 inhibitors in breast cancer: Interpreting trial design, evidence, and uncertainty","year":2025,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Adjuvant; Oncology; Breast cancer; Palbociclib; Internal medicine; Clinical trial; Cancer; Metastatic breast cancer","score_opus":0.11247059329814481,"score_gpt":0.43692024393763434,"score_spread":0.32444965063948955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409613307","genre_codex":"review","genre_gemma":"review","domain_codex":"methods","domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019628027,0.6289265,0.07515775,0.23531659,0.022546466,0.006415615,0.0015762548,0.00044756764,0.009985246],"genre_scores_gemma":[0.4755988,0.09267977,0.15826839,0.22096236,0.033866603,0.01530921,0.0011021632,0.00069503475,0.0015176518],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.1941484,0.69693553,0.067273796,0.010969996,0.02900633,0.0016660668],"domain_scores_gemma":[0.0713558,0.8494213,0.0361923,0.02107887,0.019741235,0.0022104348],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.7135278,0.0025030156,0.009996431,0.007182347,0.002089318,0.014562611,0.0075499024,0.009739889,0.0025216856],"category_scores_gemma":[0.82476217,0.0018892922,0.0076869093,0.005406251,0.010099255,0.010841297,0.0055340254,0.009335763,0.00069603196],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020055668,0.000489821,0.03243443,0.09410317,0.069867775,0.0010049392,0.006696404,0.010955583,0.0011920014,0.08145455,0.079534285,0.60221136],"study_design_scores_gemma":[0.011954091,0.00496369,0.018070187,0.16049834,0.06127434,0.0012503213,0.00244584,0.027961228,0.0023617134,0.524242,0.18413745,0.0008407868],"about_ca_topic_score_codex":0.0036498203,"about_ca_topic_score_gemma":0.004623611,"teacher_disagreement_score":0.7135278,"about_ca_system_score_codex":0.009498428,"about_ca_system_score_gemma":0.014150783,"threshold_uncertainty_score":0.3532713},"labels":[],"label_agreement":null},{"id":"W4413364870","doi":"10.1016/j.ctrv.2025.103015","title":"Advances in the management of locally advanced rectal cancer: A shift toward a patient-centred approach to balance outcomes and quality of life","year":2025,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"MSD Italia; Genentech; Foundation Medicine; Sierra Oncology; Daiichi Sankyo Europe; Servier; European Society for Medical Oncology; FibroGen; Astellas Pharma; Fundación Científica Asociación Española Contra el Cáncer; Sirtex Medical; Natera; Seagen; Sociedad Española de Oncología Médica; BeiGene; INCLIVA Instituto de Investigación Sanitaria; GlaxoSmithKline; G1 Therapeutics; Takeda Pharmaceuticals U.S.A.; Instituto de Salud Carlos III; Amgen; Pfizer; Les Laboratories Pierre Fabre; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Quality of life (healthcare); Colorectal cancer; Balance (ability); Cancer; Intensive care medicine; Gerontology; Oncology; Internal medicine; Physical therapy; Nursing","score_opus":0.1135901835730734,"score_gpt":0.41248256483886775,"score_spread":0.2988923812657943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413364870","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024193414,0.9723093,0.0022829205,0.018935144,0.0006943566,0.000015684253,0.00004574935,0.000043063657,0.0032544867],"genre_scores_gemma":[0.027606003,0.95723015,0.005362563,0.005933846,0.002367709,0.000038561342,0.000107882806,0.000023719373,0.0013295381],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991327,0.00039696248,0.00008560275,0.00008247046,0.00023746476,0.00006473026],"domain_scores_gemma":[0.9986986,0.000655127,0.00020418203,0.000038309056,0.00024190143,0.000161796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017103693,0.00040939494,0.0008507809,0.00070917484,0.00038141152,0.0013713947,0.00057923066,0.0010135846,0.0019677605],"category_scores_gemma":[0.002602559,0.00010997668,0.0005689369,0.0007814163,0.00094914343,0.0014286729,0.0010651235,0.0026281918,0.0007170731],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020132317,0.00007419839,0.0015832356,0.0116643775,0.0001251615,0.00058919954,0.00042617472,0.001449878,0.0034235336,0.010917503,0.025654007,0.9438916],"study_design_scores_gemma":[0.00005775634,0.00081924745,0.008896893,0.009819524,0.00022899876,0.005198108,0.00092864153,0.0010201,0.0015006859,0.014239544,0.95720166,0.00008879589],"about_ca_topic_score_codex":0.0012119458,"about_ca_topic_score_gemma":0.002836035,"teacher_disagreement_score":0.0019677605,"about_ca_system_score_codex":0.0010444925,"about_ca_system_score_gemma":0.002083047,"threshold_uncertainty_score":0.009045422},"labels":[],"label_agreement":null},{"id":"W4413758373","doi":"10.1016/j.ctrv.2025.103017","title":"Radioimmunotherapy for lung and head and neck cancers: A comparative review of clinical trial results and sequencing strategies","year":2025,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Radioimmunotherapy; Head and neck; Oncology; Clinical trial; Lung cancer; Internal medicine; Medical physics; Surgery; Immunology","score_opus":0.33177876822560887,"score_gpt":0.5618173600734572,"score_spread":0.2300385918478483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413758373","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012581187,0.9995505,0.0000479354,0.00007929665,0.000044470235,0.000013841278,0.000024526638,0.000002255939,0.00011140894],"genre_scores_gemma":[0.0015348062,0.9978052,0.00021905293,0.0002745355,0.00004510633,0.000021868798,0.000031591804,0.0000019411846,0.000065902714],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99887496,0.00039983806,0.0003022206,0.00014407987,0.0002263042,0.000052478616],"domain_scores_gemma":[0.9958568,0.0031617382,0.00058297446,0.00005899974,0.00027237582,0.00006705852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004590958,0.0008550386,0.0043453663,0.0023560019,0.00015826136,0.0014973739,0.0013902328,0.0010679247,0.0034231318],"category_scores_gemma":[0.0061072567,0.00040029443,0.0032507018,0.0027896303,0.00045369944,0.0010432464,0.00063995825,0.0013867174,0.00040284355],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013782566,0.0000816537,0.00032095448,0.26189137,0.005125132,0.00007881016,0.000074791504,0.00054960756,0.0010363581,0.0014628149,0.008352962,0.7196473],"study_design_scores_gemma":[0.0037847445,0.0036229433,0.0077919494,0.31986162,0.07181071,0.001432356,0.00029749624,0.0006394311,0.0017106996,0.0038725873,0.58502054,0.00015489462],"about_ca_topic_score_codex":0.0015314259,"about_ca_topic_score_gemma":0.004455635,"teacher_disagreement_score":0.004590958,"about_ca_system_score_codex":0.0011531787,"about_ca_system_score_gemma":0.0021812452,"threshold_uncertainty_score":0.024279594},"labels":[],"label_agreement":null},{"id":"W4414521801","doi":"10.1016/j.ctrv.2025.103024","title":"Impact of brain metastases on systemic renal cell carcinoma treatment outcomes: A systematic literature review","year":2025,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"Ipsen Biopharmaceuticals","keywords":"Systemic therapy; Renal cell carcinoma; Systematic review; Kidney cancer; MEDLINE; Carcinoma; Chemotherapy","score_opus":0.06955937531142792,"score_gpt":0.417139175122783,"score_spread":0.34757979981135506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414521801","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003055774,0.99451387,0.00014123166,0.00030023922,0.000059911075,0.00029234285,0.0012789607,0.000010143342,0.00034754933],"genre_scores_gemma":[0.040783327,0.9559811,0.00062735996,0.00059417984,0.00009983181,0.00091476453,0.00086516084,0.000008490787,0.00012575879],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.992572,0.0023374374,0.0031674001,0.0006513758,0.0010500123,0.0002217666],"domain_scores_gemma":[0.9586478,0.029293604,0.008335402,0.0004681926,0.0028848941,0.00037009825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007403911,0.0012481695,0.008261368,0.012436832,0.0005128075,0.0021861629,0.0015946263,0.0013389889,0.004897686],"category_scores_gemma":[0.03294363,0.000814584,0.006770726,0.01553022,0.00087953045,0.0017211763,0.001363328,0.0008408233,0.00033053412],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019664415,0.000009917055,0.0015498074,0.9713699,0.010021594,0.00008435801,0.00012797244,0.00006934186,0.00009123207,0.00010401021,0.0009403348,0.015434849],"study_design_scores_gemma":[0.00039710372,0.0002337297,0.010557734,0.8585556,0.1185616,0.00045972326,0.00031484602,0.000105284045,0.00015756892,0.0002753867,0.0103398925,0.000041465508],"about_ca_topic_score_codex":0.0071944967,"about_ca_topic_score_gemma":0.019047197,"teacher_disagreement_score":0.012436832,"about_ca_system_score_codex":0.0032649608,"about_ca_system_score_gemma":0.010039077,"threshold_uncertainty_score":0.03915608},"labels":[],"label_agreement":null},{"id":"W7117422237","doi":"10.1016/j.ctrv.2025.103073","title":"Targeted therapies in optic pathway gliomas","year":2025,"lang":"en","type":"article","venue":"Cancer Treatment Reviews","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Ministero della Salute","keywords":"Targeted therapy; Disease; Disease control; Radiation therapy; Glioma; MEDLINE","score_opus":0.04199492782811227,"score_gpt":0.33495590207131193,"score_spread":0.29296097424319967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117422237","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00040870943,0.99848807,0.0001315683,0.00020488657,0.00008222687,0.000058698013,0.00015172709,0.000005554166,0.0004685821],"genre_scores_gemma":[0.008001913,0.9903951,0.00058982015,0.00045741905,0.0001160799,0.00012501213,0.00018532964,0.000003552336,0.00012580157],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969279,0.00097251,0.0011117774,0.0002765847,0.0006201502,0.0000911224],"domain_scores_gemma":[0.99187475,0.005653798,0.0016136197,0.00012600851,0.00065045897,0.00008139881],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033319867,0.00083646807,0.0030838589,0.007129802,0.0003778014,0.0021214394,0.0010734465,0.0012489794,0.004018711],"category_scores_gemma":[0.012055153,0.00036080444,0.0030550996,0.0044379686,0.0005244221,0.0014584563,0.00084860536,0.00087576563,0.00050102477],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033451582,0.00002995489,0.0006901982,0.7057803,0.0043841703,0.00017107309,0.00012510033,0.00033576772,0.0008401253,0.0012093318,0.003780934,0.2823184],"study_design_scores_gemma":[0.0003191479,0.00045010564,0.003344933,0.8225598,0.025967008,0.0014759768,0.0003205055,0.00021424207,0.00095168984,0.002111078,0.14223832,0.0000471226],"about_ca_topic_score_codex":0.0023776498,"about_ca_topic_score_gemma":0.0052573173,"teacher_disagreement_score":0.007129802,"about_ca_system_score_codex":0.0016047789,"about_ca_system_score_gemma":0.005420562,"threshold_uncertainty_score":0.017621458},"labels":[],"label_agreement":null}]}